id	sid	tid	token	lemma	pos
dpc-2415	1	1	dermatology	dermatology	NOUN
dpc-2415	1	2	:	:	PUNCT
dpc-2415	1	3	practical	practical	ADJ
dpc-2415	1	4	and	and	CCONJ
dpc-2415	1	5	conceptual	conceptual	ADJ
dpc-2415	1	6	review	review	NOUN
dpc-2415	1	7	|	|	ADV
dpc-2415	1	8	dermatol	dermatol	ADJ
dpc-2415	1	9	pract	pract	NOUN
dpc-2415	1	10	concept	concept	NOUN
dpc-2415	1	11	.	.	PUNCT
dpc-2415	2	1	2023;13(1):e2023016	2023;13(1):e2023016	NUM
dpc-2415	2	2	1	1	NUM
dpc-2415	2	3	management	management	NOUN
dpc-2415	2	4	of	of	ADP
dpc-2415	2	5	infections	infection	NOUN
dpc-2415	2	6	in	in	ADP
dpc-2415	2	7	psoriatic	psoriatic	ADJ
dpc-2415	2	8	patients	patient	NOUN
dpc-2415	2	9	treated	treat	VERB
dpc-2415	2	10	with	with	ADP
dpc-2415	2	11	systemic	systemic	ADJ
dpc-2415	2	12	therapies	therapy	NOUN
dpc-2415	2	13	:	:	PUNCT
dpc-2415	2	14	a	a	DET
dpc-2415	2	15	lesson	lesson	NOUN
dpc-2415	2	16	from	from	ADP
dpc-2415	2	17	the	the	DET
dpc-2415	2	18	immunopathogenesis	immunopathogenesis	NOUN
dpc-2415	2	19	of	of	ADP
dpc-2415	2	20	psoriasis	psoriasis	NOUN
dpc-2415	2	21	anna	anna	PROPN
dpc-2415	2	22	balato1	balato1	PROPN
dpc-2415	2	23	,	,	PUNCT
dpc-2415	2	24	emanuele	emanuele	PROPN
dpc-2415	2	25	scala2,3	scala2,3	PROPN
dpc-2415	2	26	,	,	PUNCT
dpc-2415	2	27	kilian	kilian	PROPN
dpc-2415	2	28	eyerich2,3,4	eyerich2,3,4	PROPN
dpc-2415	2	29	,	,	PUNCT
dpc-2415	2	30	nicolò	nicolò	VERB
dpc-2415	2	31	costantino	costantino	PROPN
dpc-2415	2	32	brembilla5	brembilla5	PROPN
dpc-2415	2	33	,	,	PUNCT
dpc-2415	2	34	andrea	andrea	PROPN
dpc-2415	2	35	 	 	SPACE
dpc-2415	2	36	chiricozzi6	chiricozzi6	PROPN
dpc-2415	2	37	,	,	PUNCT
dpc-2415	2	38	robert	robert	PROPN
dpc-2415	2	39	sabat7,8	sabat7,8	PROPN
dpc-2415	2	40	,	,	PUNCT
dpc-2415	2	41	kamran	kamran	PROPN
dpc-2415	2	42	ghoreschi9	ghoreschi9	PROPN
dpc-2415	2	43	1	1	NUM
dpc-2415	2	44	dermatology	dermatology	NOUN
dpc-2415	2	45	unit	unit	NOUN
dpc-2415	2	46	,	,	PUNCT
dpc-2415	2	47	university	university	PROPN
dpc-2415	2	48	of	of	ADP
dpc-2415	2	49	campania	campania	PROPN
dpc-2415	2	50	,	,	PUNCT
dpc-2415	2	51	naples	naples	PROPN
dpc-2415	2	52	,	,	PUNCT
dpc-2415	2	53	italy	italy	PROPN
dpc-2415	2	54	2	2	NUM
dpc-2415	2	55	division	division	NOUN
dpc-2415	2	56	of	of	ADP
dpc-2415	2	57	dermatology	dermatology	NOUN
dpc-2415	2	58	and	and	CCONJ
dpc-2415	2	59	venereology	venereology	NOUN
dpc-2415	2	60	,	,	PUNCT
dpc-2415	2	61	department	department	NOUN
dpc-2415	2	62	of	of	ADP
dpc-2415	2	63	medicine	medicine	PROPN
dpc-2415	2	64	solna	solna	PROPN
dpc-2415	2	65	,	,	PUNCT
dpc-2415	2	66	and	and	CCONJ
dpc-2415	2	67	center	center	NOUN
dpc-2415	2	68	for	for	ADP
dpc-2415	2	69	molecular	molecular	ADJ
dpc-2415	2	70	medicine	medicine	NOUN
dpc-2415	2	71	,	,	PUNCT
dpc-2415	2	72	karolinska	karolinska	PROPN
dpc-2415	2	73	institutet	institutet	PROPN
dpc-2415	2	74	,	,	PUNCT
dpc-2415	2	75	stockholm	stockholm	PROPN
dpc-2415	2	76	,	,	PUNCT
dpc-2415	2	77	sweden	sweden	PROPN
dpc-2415	2	78	3	3	NUM
dpc-2415	2	79	department	department	NOUN
dpc-2415	2	80	of	of	ADP
dpc-2415	2	81	dermatology	dermatology	NOUN
dpc-2415	2	82	and	and	CCONJ
dpc-2415	2	83	venereology	venereology	NOUN
dpc-2415	2	84	,	,	PUNCT
dpc-2415	2	85	medical	medical	ADJ
dpc-2415	2	86	center	center	NOUN
dpc-2415	2	87	–	–	PUNCT
dpc-2415	2	88	university	university	NOUN
dpc-2415	2	89	of	of	ADP
dpc-2415	2	90	freiburg	freiburg	PROPN
dpc-2415	2	91	,	,	PUNCT
dpc-2415	2	92	faculty	faculty	NOUN
dpc-2415	2	93	of	of	ADP
dpc-2415	2	94	medicine	medicine	NOUN
dpc-2415	2	95	,	,	PUNCT
dpc-2415	2	96	university	university	NOUN
dpc-2415	2	97	of	of	ADP
dpc-2415	2	98	freiburg	freiburg	PROPN
dpc-2415	2	99	,	,	PUNCT
dpc-2415	2	100	freiburg	freiburg	PROPN
dpc-2415	2	101	,	,	PUNCT
dpc-2415	2	102	germany	germany	PROPN
dpc-2415	2	103	4	4	NUM
dpc-2415	2	104	department	department	NOUN
dpc-2415	2	105	of	of	ADP
dpc-2415	2	106	dermatology	dermatology	NOUN
dpc-2415	2	107	and	and	CCONJ
dpc-2415	2	108	venereology	venereology	NOUN
dpc-2415	2	109	,	,	PUNCT
dpc-2415	2	110	unit	unit	NOUN
dpc-2415	2	111	of	of	ADP
dpc-2415	2	112	dermatology	dermatology	NOUN
dpc-2415	2	113	,	,	PUNCT
dpc-2415	2	114	karolinska	karolinska	PROPN
dpc-2415	2	115	university	university	PROPN
dpc-2415	2	116	hospital	hospital	NOUN
dpc-2415	2	117	,	,	PUNCT
dpc-2415	2	118	stockholm	stockholm	PROPN
dpc-2415	2	119	,	,	PUNCT
dpc-2415	2	120	sweden	sweden	PROPN
dpc-2415	2	121	5	5	NUM
dpc-2415	2	122	department	department	NOUN
dpc-2415	2	123	of	of	ADP
dpc-2415	2	124	pathology	pathology	NOUN
dpc-2415	2	125	and	and	CCONJ
dpc-2415	2	126	immunology	immunology	NOUN
dpc-2415	2	127	,	,	PUNCT
dpc-2415	2	128	university	university	NOUN
dpc-2415	2	129	of	of	ADP
dpc-2415	2	130	geneva	geneva	PROPN
dpc-2415	2	131	,	,	PUNCT
dpc-2415	2	132	geneva	geneva	PROPN
dpc-2415	2	133	,	,	PUNCT
dpc-2415	2	134	switzerland	switzerland	PROPN
dpc-2415	2	135	6	6	NUM
dpc-2415	2	136	institute	institute	PROPN
dpc-2415	2	137	of	of	ADP
dpc-2415	2	138	dermatology	dermatology	NOUN
dpc-2415	2	139	,	,	PUNCT
dpc-2415	2	140	catholic	catholic	PROPN
dpc-2415	2	141	university	university	PROPN
dpc-2415	2	142	,	,	PUNCT
dpc-2415	2	143	rome	rome	PROPN
dpc-2415	2	144	,	,	PUNCT
dpc-2415	2	145	italy	italy	PROPN
dpc-2415	2	146	7	7	NUM
dpc-2415	2	147	interdisciplinary	interdisciplinary	NOUN
dpc-2415	2	148	group	group	NOUN
dpc-2415	2	149	of	of	ADP
dpc-2415	2	150	molecular	molecular	ADJ
dpc-2415	2	151	immunopathology	immunopathology	NOUN
dpc-2415	2	152	,	,	PUNCT
dpc-2415	2	153	dermatology	dermatology	NOUN
dpc-2415	2	154	/	/	SYM
dpc-2415	2	155	medical	medical	ADJ
dpc-2415	2	156	immunology	immunology	NOUN
dpc-2415	2	157	,	,	PUNCT
dpc-2415	2	158	charité	charité	PROPN
dpc-2415	2	159	–	–	PUNCT
dpc-2415	2	160	universitätsmedizin	universitätsmedizin	NOUN
dpc-2415	2	161	,	,	PUNCT
dpc-2415	2	162	berlin	berlin	PROPN
dpc-2415	2	163	,	,	PUNCT
dpc-2415	2	164	germany	germany	PROPN
dpc-2415	2	165	8	8	NUM
dpc-2415	2	166	psoriasis	psoriasis	NOUN
dpc-2415	2	167	research	research	NOUN
dpc-2415	2	168	and	and	CCONJ
dpc-2415	2	169	treatment	treatment	NOUN
dpc-2415	2	170	center	center	NOUN
dpc-2415	2	171	,	,	PUNCT
dpc-2415	2	172	department	department	NOUN
dpc-2415	2	173	of	of	ADP
dpc-2415	2	174	dermatology	dermatology	NOUN
dpc-2415	2	175	and	and	CCONJ
dpc-2415	2	176	allergy	allergy	NOUN
dpc-2415	2	177	and	and	CCONJ
dpc-2415	2	178	institute	institute	PROPN
dpc-2415	2	179	of	of	ADP
dpc-2415	2	180	medical	medical	ADJ
dpc-2415	2	181	immunology	immunology	NOUN
dpc-2415	2	182	,	,	PUNCT
dpc-2415	2	183	charité	charité	PROPN
dpc-2415	2	184	–	–	PUNCT
dpc-2415	2	185	universitätsmedizin	universitätsmedizin	NOUN
dpc-2415	2	186	,	,	PUNCT
dpc-2415	2	187	berlin	berlin	PROPN
dpc-2415	2	188	,	,	PUNCT
dpc-2415	2	189	germany	germany	PROPN
dpc-2415	2	190	9	9	NUM
dpc-2415	2	191	department	department	NOUN
dpc-2415	2	192	of	of	ADP
dpc-2415	2	193	dermatology	dermatology	NOUN
dpc-2415	2	194	,	,	PUNCT
dpc-2415	2	195	venereology	venereology	NOUN
dpc-2415	2	196	and	and	CCONJ
dpc-2415	2	197	allergology	allergology	NOUN
dpc-2415	2	198	,	,	PUNCT
dpc-2415	2	199	charité	charité	PROPN
dpc-2415	2	200	–	–	PUNCT
dpc-2415	2	201	universitätsmedizin	universitätsmedizin	NOUN
dpc-2415	2	202	,	,	PUNCT
dpc-2415	2	203	berlin	berlin	PROPN
dpc-2415	2	204	,	,	PUNCT
dpc-2415	2	205	germany	germany	PROPN
dpc-2415	2	206	key	key	ADJ
dpc-2415	2	207	words	word	NOUN
dpc-2415	2	208	:	:	PUNCT
dpc-2415	2	209	psoriasis	psoriasis	NOUN
dpc-2415	2	210	,	,	PUNCT
dpc-2415	2	211	infection	infection	NOUN
dpc-2415	2	212	,	,	PUNCT
dpc-2415	2	213	prevention	prevention	NOUN
dpc-2415	2	214	,	,	PUNCT
dpc-2415	2	215	management	management	NOUN
dpc-2415	2	216	,	,	PUNCT
dpc-2415	2	217	covid-19	covid-19	PROPN
dpc-2415	2	218	citation	citation	NOUN
dpc-2415	2	219	:	:	PUNCT
dpc-2415	2	220	balato	balato	NOUN
dpc-2415	2	221	a	a	PRON
dpc-2415	2	222	,	,	PUNCT
dpc-2415	2	223	scala	scala	PROPN
dpc-2415	2	224	e	e	NOUN
dpc-2415	2	225	,	,	PUNCT
dpc-2415	2	226	eyerich	eyerich	PROPN
dpc-2415	2	227	k	k	NOUN
dpc-2415	2	228	,	,	PUNCT
dpc-2415	2	229	et	et	PROPN
dpc-2415	2	230	al	al	PROPN
dpc-2415	2	231	.	.	PUNCT
dpc-2415	2	232	management	management	NOUN
dpc-2415	2	233	of	of	ADP
dpc-2415	2	234	infections	infection	NOUN
dpc-2415	2	235	in	in	ADP
dpc-2415	2	236	psoriatic	psoriatic	ADJ
dpc-2415	2	237	patients	patient	NOUN
dpc-2415	2	238	treated	treat	VERB
dpc-2415	2	239	with	with	ADP
dpc-2415	2	240	systemic	systemic	ADJ
dpc-2415	2	241	therapies	therapy	NOUN
dpc-2415	2	242	:	:	PUNCT
dpc-2415	2	243	a	a	DET
dpc-2415	2	244	lesson	lesson	NOUN
dpc-2415	2	245	from	from	ADP
dpc-2415	2	246	the	the	DET
dpc-2415	2	247	immunopathogenesis	immunopathogenesis	NOUN
dpc-2415	2	248	of	of	ADP
dpc-2415	2	249	psoriasis	psoriasis	NOUN
dpc-2415	2	250	.	.	PUNCT
dpc-2415	3	1	dermatol	dermatol	NOUN
dpc-2415	3	2	pract	pract	PROPN
dpc-2415	3	3	concept	concept	NOUN
dpc-2415	3	4	.	.	PUNCT
dpc-2415	4	1	2023;13(1):e2023016	2023;13(1):e2023016	NUM
dpc-2415	4	2	.	.	PUNCT
dpc-2415	4	3	doi	doi	PROPN
dpc-2415	4	4	:	:	PUNCT
dpc-2415	4	5	https://doi	https://doi	PROPN
dpc-2415	4	6	.org/10.5826	.org/10.5826	PROPN
dpc-2415	4	7	/	/	SYM
dpc-2415	4	8	dpc.1301a16	dpc.1301a16	NOUN
dpc-2415	4	9	accepted	accept	VERB
dpc-2415	4	10	:	:	PUNCT
dpc-2415	4	11	may	may	AUX
dpc-2415	4	12	30	30	NUM
dpc-2415	4	13	,	,	PUNCT
dpc-2415	4	14	2022	2022	NUM
dpc-2415	4	15	;	;	PUNCT
dpc-2415	4	16	published	publish	VERB
dpc-2415	4	17	:	:	PUNCT
dpc-2415	5	1	january	january	NOUN
dpc-2415	5	2	2023	2023	NUM
dpc-2415	5	3	copyright	copyright	NOUN
dpc-2415	5	4	:	:	PUNCT
dpc-2415	5	5	©	©	PROPN
dpc-2415	5	6	2023	2023	NUM
dpc-2415	5	7	balato	balato	NOUN
dpc-2415	5	8	et	et	PROPN
dpc-2415	5	9	al	al	PROPN
dpc-2415	5	10	.	.	PUNCT
dpc-2415	6	1	this	this	PRON
dpc-2415	6	2	is	be	AUX
dpc-2415	6	3	an	an	DET
dpc-2415	6	4	open	open	ADJ
dpc-2415	6	5	-	-	PUNCT
dpc-2415	6	6	access	access	NOUN
dpc-2415	6	7	article	article	NOUN
dpc-2415	6	8	distributed	distribute	VERB
dpc-2415	6	9	under	under	ADP
dpc-2415	6	10	the	the	DET
dpc-2415	6	11	terms	term	NOUN
dpc-2415	6	12	of	of	ADP
dpc-2415	6	13	the	the	DET
dpc-2415	6	14	creative	creative	ADJ
dpc-2415	6	15	commons	common	NOUN
dpc-2415	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2415	6	17	license	license	NOUN
dpc-2415	6	18	(	(	PUNCT
dpc-2415	6	19	by	by	ADP
dpc-2415	6	20	-	-	PUNCT
dpc-2415	6	21	nc-4.0	nc-4.0	NOUN
dpc-2415	6	22	)	)	PUNCT
dpc-2415	6	23	,	,	PUNCT
dpc-2415	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2415	6	25	,	,	PUNCT
dpc-2415	6	26	which	which	PRON
dpc-2415	6	27	permits	permit	VERB
dpc-2415	6	28	unrestricted	unrestricted	ADJ
dpc-2415	6	29	noncommercial	noncommercial	ADJ
dpc-2415	6	30	use	use	NOUN
dpc-2415	6	31	,	,	PUNCT
dpc-2415	6	32	distribution	distribution	NOUN
dpc-2415	6	33	,	,	PUNCT
dpc-2415	6	34	and	and	CCONJ
dpc-2415	6	35	reproduction	reproduction	NOUN
dpc-2415	6	36	in	in	ADP
dpc-2415	6	37	any	any	DET
dpc-2415	6	38	medium	medium	NOUN
dpc-2415	6	39	,	,	PUNCT
dpc-2415	6	40	provided	provide	VERB
dpc-2415	6	41	the	the	DET
dpc-2415	6	42	original	original	ADJ
dpc-2415	6	43	authors	author	NOUN
dpc-2415	6	44	and	and	CCONJ
dpc-2415	6	45	source	source	NOUN
dpc-2415	6	46	are	be	AUX
dpc-2415	6	47	credited	credit	VERB
dpc-2415	6	48	.	.	PUNCT
dpc-2415	7	1	funding	funding	NOUN
dpc-2415	7	2	:	:	PUNCT
dpc-2415	7	3	none	none	NOUN
dpc-2415	7	4	.	.	PUNCT
dpc-2415	8	1	competing	compete	VERB
dpc-2415	8	2	interests	interest	NOUN
dpc-2415	8	3	:	:	PUNCT
dpc-2415	8	4	none	none	NOUN
dpc-2415	8	5	.	.	PUNCT
dpc-2415	9	1	authorship	authorship	NOUN
dpc-2415	9	2	:	:	PUNCT
dpc-2415	9	3	all	all	DET
dpc-2415	9	4	authors	author	NOUN
dpc-2415	9	5	have	have	AUX
dpc-2415	9	6	contributed	contribute	VERB
dpc-2415	9	7	significantly	significantly	ADV
dpc-2415	9	8	to	to	ADP
dpc-2415	9	9	this	this	DET
dpc-2415	9	10	publication	publication	NOUN
dpc-2415	9	11	.	.	PUNCT
dpc-2415	10	1	corresponding	correspond	VERB
dpc-2415	10	2	author	author	NOUN
dpc-2415	10	3	:	:	PUNCT
dpc-2415	10	4	emanuele	emanuele	PROPN
dpc-2415	10	5	scala	scala	PROPN
dpc-2415	10	6	,	,	PUNCT
dpc-2415	10	7	phd	phd	NOUN
dpc-2415	10	8	,	,	PUNCT
dpc-2415	10	9	division	division	NOUN
dpc-2415	10	10	of	of	ADP
dpc-2415	10	11	dermatology	dermatology	NOUN
dpc-2415	10	12	and	and	CCONJ
dpc-2415	10	13	venereology	venereology	NOUN
dpc-2415	10	14	,	,	PUNCT
dpc-2415	10	15	department	department	NOUN
dpc-2415	10	16	of	of	ADP
dpc-2415	10	17	medicine	medicine	PROPN
dpc-2415	10	18	solna	solna	PROPN
dpc-2415	10	19	,	,	PUNCT
dpc-2415	10	20	and	and	CCONJ
dpc-2415	10	21	center	center	NOUN
dpc-2415	10	22	for	for	ADP
dpc-2415	10	23	molecular	molecular	ADJ
dpc-2415	10	24	medicine	medicine	NOUN
dpc-2415	10	25	,	,	PUNCT
dpc-2415	10	26	karolinska	karolinska	PROPN
dpc-2415	10	27	institutet	institutet	NOUN
dpc-2415	10	28	,	,	PUNCT
dpc-2415	10	29	17176	17176	NUM
dpc-2415	10	30	stockholm	stockholm	PROPN
dpc-2415	10	31	,	,	PUNCT
dpc-2415	10	32	sweden	sweden	PROPN
dpc-2415	10	33	.	.	PUNCT
dpc-2415	10	34	email	email	NOUN
dpc-2415	10	35	:	:	PUNCT
dpc-2415	10	36	emanuele.scala@ki.se	emanuele.scala@ki.se	ADJ
dpc-2415	10	37	modern	modern	ADJ
dpc-2415	10	38	treatments	treatment	NOUN
dpc-2415	10	39	continue	continue	VERB
dpc-2415	10	40	to	to	PART
dpc-2415	10	41	be	be	AUX
dpc-2415	10	42	developed	develop	VERB
dpc-2415	10	43	based	base	VERB
dpc-2415	10	44	on	on	ADP
dpc-2415	10	45	identifying	identify	VERB
dpc-2415	10	46	targets	target	NOUN
dpc-2415	10	47	within	within	ADP
dpc-2415	10	48	the	the	DET
dpc-2415	10	49	innate	innate	ADJ
dpc-2415	10	50	and	and	CCONJ
dpc-2415	10	51	adaptive	adaptive	ADJ
dpc-2415	10	52	immune	immune	ADJ
dpc-2415	10	53	pathways	pathway	NOUN
dpc-2415	10	54	associated	associate	VERB
dpc-2415	10	55	with	with	ADP
dpc-2415	10	56	psoriasis	psoriasis	NOUN
dpc-2415	10	57	.	.	PUNCT
dpc-2415	11	1	whilst	whilst	SCONJ
dpc-2415	11	2	there	there	PRON
dpc-2415	11	3	is	be	VERB
dpc-2415	11	4	a	a	DET
dpc-2415	11	5	sound	sound	ADJ
dpc-2415	11	6	biologic	biologic	NOUN
dpc-2415	11	7	rationale	rationale	NOUN
dpc-2415	11	8	for	for	ADP
dpc-2415	11	9	increased	increase	VERB
dpc-2415	11	10	risk	risk	NOUN
dpc-2415	11	11	of	of	ADP
dpc-2415	11	12	infection	infection	NOUN
dpc-2415	11	13	following	follow	VERB
dpc-2415	11	14	treatment	treatment	NOUN
dpc-2415	11	15	with	with	ADP
dpc-2415	11	16	immunomodulators	immunomodulator	NOUN
dpc-2415	11	17	,	,	PUNCT
dpc-2415	11	18	the	the	DET
dpc-2415	11	19	clinical	clinical	ADJ
dpc-2415	11	20	evidence	evidence	NOUN
dpc-2415	11	21	is	be	AUX
dpc-2415	11	22	confounded	confound	VERB
dpc-2415	11	23	by	by	ADP
dpc-2415	11	24	these	these	DET
dpc-2415	11	25	agents	agent	NOUN
dpc-2415	11	26	being	be	AUX
dpc-2415	11	27	used	use	VERB
dpc-2415	11	28	in	in	ADP
dpc-2415	11	29	patients	patient	NOUN
dpc-2415	11	30	affected	affect	VERB
dpc-2415	11	31	with	with	ADP
dpc-2415	11	32	several	several	ADJ
dpc-2415	11	33	comorbidities	comorbiditie	NOUN
dpc-2415	11	34	.	.	PUNCT
dpc-2415	12	1	in	in	ADP
dpc-2415	12	2	an	an	DET
dpc-2415	12	3	era	era	NOUN
dpc-2415	12	4	characterized	characterize	VERB
dpc-2415	12	5	by	by	ADP
dpc-2415	12	6	an	an	DET
dpc-2415	12	7	ever	ever	ADV
dpc-2415	12	8	greater	great	ADJ
dpc-2415	12	9	and	and	CCONJ
dpc-2415	12	10	growing	grow	VERB
dpc-2415	12	11	risk	risk	NOUN
dpc-2415	12	12	of	of	ADP
dpc-2415	12	13	infections	infection	NOUN
dpc-2415	12	14	,	,	PUNCT
dpc-2415	12	15	it	it	PRON
dpc-2415	12	16	is	be	AUX
dpc-2415	12	17	necessary	necessary	ADJ
dpc-2415	12	18	to	to	PART
dpc-2415	12	19	always	always	ADV
dpc-2415	12	20	be	be	AUX
dpc-2415	12	21	updated	update	VERB
dpc-2415	12	22	on	on	ADP
dpc-2415	12	23	this	this	DET
dpc-2415	12	24	risk	risk	NOUN
dpc-2415	12	25	.	.	PUNCT
dpc-2415	13	1	in	in	ADP
dpc-2415	13	2	this	this	DET
dpc-2415	13	3	mini	mini	NOUN
dpc-2415	13	4	-	-	NOUN
dpc-2415	13	5	review	review	NOUN
dpc-2415	13	6	,	,	PUNCT
dpc-2415	13	7	we	we	PRON
dpc-2415	13	8	will	will	AUX
dpc-2415	13	9	discuss	discuss	VERB
dpc-2415	13	10	recent	recent	ADJ
dpc-2415	13	11	updates	update	NOUN
dpc-2415	13	12	in	in	ADP
dpc-2415	13	13	psoriasis	psoriasis	NOUN
dpc-2415	13	14	immunopathogenesis	immunopathogenesis	NOUN
dpc-2415	13	15	as	as	ADP
dpc-2415	13	16	a	a	DET
dpc-2415	13	17	rationale	rationale	NOUN
dpc-2415	13	18	for	for	ADP
dpc-2415	13	19	systemic	systemic	ADJ
dpc-2415	13	20	therapy	therapy	NOUN
dpc-2415	13	21	,	,	PUNCT
dpc-2415	13	22	outline	outline	VERB
dpc-2415	13	23	the	the	DET
dpc-2415	13	24	risk	risk	NOUN
dpc-2415	13	25	of	of	ADP
dpc-2415	13	26	infections	infection	NOUN
dpc-2415	13	27	linked	link	VERB
dpc-2415	13	28	to	to	ADP
dpc-2415	13	29	the	the	DET
dpc-2415	13	30	disease	disease	NOUN
dpc-2415	13	31	itself	itself	PRON
dpc-2415	13	32	and	and	CCONJ
dpc-2415	13	33	systemic	systemic	ADJ
dpc-2415	13	34	therapy	therapy	NOUN
dpc-2415	13	35	as	as	ADV
dpc-2415	13	36	well	well	ADV
dpc-2415	13	37	,	,	PUNCT
dpc-2415	13	38	and	and	CCONJ
dpc-2415	13	39	provide	provide	VERB
dpc-2415	13	40	an	an	DET
dpc-2415	13	41	overview	overview	NOUN
dpc-2415	13	42	of	of	ADP
dpc-2415	13	43	the	the	DET
dpc-2415	13	44	prevention	prevention	NOUN
dpc-2415	13	45	and	and	CCONJ
dpc-2415	13	46	management	management	NOUN
dpc-2415	13	47	of	of	ADP
dpc-2415	13	48	infections	infection	NOUN
dpc-2415	13	49	.	.	PUNCT
dpc-2415	14	1	abstract	abstract	ADJ
dpc-2415	14	2	2	2	NUM
dpc-2415	14	3	review	review	NOUN
dpc-2415	14	4	|	|	ADV
dpc-2415	14	5	dermatol	dermatol	ADJ
dpc-2415	14	6	pract	pract	NOUN
dpc-2415	14	7	concept	concept	NOUN
dpc-2415	14	8	.	.	PUNCT
dpc-2415	15	1	2023;13(1):e2023016	2023;13(1):e2023016	NUM
dpc-2415	15	2	introduction	introduction	NOUN
dpc-2415	15	3	in	in	ADP
dpc-2415	15	4	the	the	DET
dpc-2415	15	5	last	last	ADJ
dpc-2415	15	6	decade	decade	NOUN
dpc-2415	15	7	,	,	PUNCT
dpc-2415	15	8	our	our	PRON
dpc-2415	15	9	understanding	understanding	NOUN
dpc-2415	15	10	of	of	ADP
dpc-2415	15	11	psoriasis	psoriasis	NOUN
dpc-2415	15	12	pathogenesis	pathogenesis	NOUN
dpc-2415	15	13	made	make	VERB
dpc-2415	15	14	significant	significant	ADJ
dpc-2415	15	15	steps	step	NOUN
dpc-2415	15	16	forwards	forward	NOUN
dpc-2415	15	17	leading	lead	VERB
dpc-2415	15	18	to	to	ADP
dpc-2415	15	19	the	the	DET
dpc-2415	15	20	development	development	NOUN
dpc-2415	15	21	of	of	ADP
dpc-2415	15	22	multiple	multiple	ADJ
dpc-2415	15	23	game	game	NOUN
dpc-2415	15	24	-	-	PUNCT
dpc-2415	15	25	changer	changer	NOUN
dpc-2415	15	26	therapies	therapy	NOUN
dpc-2415	15	27	[	[	X
dpc-2415	15	28	1	1	NUM
dpc-2415	15	29	]	]	PUNCT
dpc-2415	15	30	.	.	PUNCT
dpc-2415	16	1	although	although	SCONJ
dpc-2415	16	2	we	we	PRON
dpc-2415	16	3	can	can	AUX
dpc-2415	16	4	confidently	confidently	ADV
dpc-2415	16	5	say	say	VERB
dpc-2415	16	6	that	that	SCONJ
dpc-2415	16	7	the	the	DET
dpc-2415	16	8	horizon	horizon	NOUN
dpc-2415	16	9	is	be	AUX
dpc-2415	16	10	now	now	ADV
dpc-2415	16	11	a	a	DET
dpc-2415	16	12	little	little	ADV
dpc-2415	16	13	brighter	bright	ADJ
dpc-2415	16	14	,	,	PUNCT
dpc-2415	16	15	we	we	PRON
dpc-2415	16	16	can	can	AUX
dpc-2415	16	17	not	not	PART
dpc-2415	16	18	argue	argue	VERB
dpc-2415	16	19	that	that	SCONJ
dpc-2415	16	20	“	"	PUNCT
dpc-2415	16	21	the	the	DET
dpc-2415	16	22	whole	whole	ADJ
dpc-2415	16	23	job	job	NOUN
dpc-2415	16	24	”	"	PUNCT
dpc-2415	16	25	has	have	AUX
dpc-2415	16	26	been	be	AUX
dpc-2415	16	27	done	do	VERB
dpc-2415	16	28	.	.	PUNCT
dpc-2415	17	1	the	the	DET
dpc-2415	17	2	advent	advent	NOUN
dpc-2415	17	3	of	of	ADP
dpc-2415	17	4	therapies	therapy	NOUN
dpc-2415	17	5	targeting	target	VERB
dpc-2415	17	6	specific	specific	ADJ
dpc-2415	17	7	components	component	NOUN
dpc-2415	17	8	of	of	ADP
dpc-2415	17	9	the	the	DET
dpc-2415	17	10	immune	immune	ADJ
dpc-2415	17	11	response	response	NOUN
dpc-2415	17	12	has	have	AUX
dpc-2415	17	13	highlighted	highlight	VERB
dpc-2415	17	14	the	the	DET
dpc-2415	17	15	possible	possible	ADJ
dpc-2415	17	16	association	association	NOUN
dpc-2415	17	17	of	of	ADP
dpc-2415	17	18	infections	infection	NOUN
dpc-2415	17	19	with	with	ADP
dpc-2415	17	20	psoriasis	psoriasis	NOUN
dpc-2415	17	21	.	.	PUNCT
dpc-2415	18	1	whilst	whilst	SCONJ
dpc-2415	18	2	there	there	PRON
dpc-2415	18	3	is	be	VERB
dpc-2415	18	4	a	a	DET
dpc-2415	18	5	sound	sound	ADJ
dpc-2415	18	6	biologic	biologic	NOUN
dpc-2415	18	7	rationale	rationale	NOUN
dpc-2415	18	8	for	for	ADP
dpc-2415	18	9	increased	increase	VERB
dpc-2415	18	10	risk	risk	NOUN
dpc-2415	18	11	of	of	ADP
dpc-2415	18	12	infection	infection	NOUN
dpc-2415	18	13	following	follow	VERB
dpc-2415	18	14	treatment	treatment	NOUN
dpc-2415	18	15	with	with	ADP
dpc-2415	18	16	immunomodulators	immunomodulator	NOUN
dpc-2415	18	17	,	,	PUNCT
dpc-2415	18	18	the	the	DET
dpc-2415	18	19	clinical	clinical	ADJ
dpc-2415	18	20	evidence	evidence	NOUN
dpc-2415	18	21	is	be	AUX
dpc-2415	18	22	confounded	confound	VERB
dpc-2415	18	23	by	by	ADP
dpc-2415	18	24	these	these	DET
dpc-2415	18	25	agents	agent	NOUN
dpc-2415	18	26	being	be	AUX
dpc-2415	18	27	used	use	VERB
dpc-2415	18	28	in	in	ADP
dpc-2415	18	29	moderate	moderate	ADJ
dpc-2415	18	30	-	-	PUNCT
dpc-2415	18	31	to	to	ADP
dpc-2415	18	32	-	-	PUNCT
dpc-2415	18	33	severe	severe	ADJ
dpc-2415	18	34	psoriasis	psoriasis	NOUN
dpc-2415	18	35	in	in	ADP
dpc-2415	18	36	association	association	NOUN
dpc-2415	18	37	with	with	ADP
dpc-2415	18	38	several	several	ADJ
dpc-2415	18	39	comorbidities	comorbiditie	NOUN
dpc-2415	18	40	.	.	PUNCT
dpc-2415	19	1	in	in	ADP
dpc-2415	19	2	this	this	DET
dpc-2415	19	3	article	article	NOUN
dpc-2415	19	4	,	,	PUNCT
dpc-2415	19	5	we	we	PRON
dpc-2415	19	6	summarize	summarize	VERB
dpc-2415	19	7	the	the	DET
dpc-2415	19	8	available	available	ADJ
dpc-2415	19	9	information	information	NOUN
dpc-2415	19	10	on	on	ADP
dpc-2415	19	11	the	the	DET
dpc-2415	19	12	risk	risk	NOUN
dpc-2415	19	13	of	of	ADP
dpc-2415	19	14	infections	infection	NOUN
dpc-2415	19	15	,	,	PUNCT
dpc-2415	19	16	including	include	VERB
dpc-2415	19	17	the	the	DET
dpc-2415	19	18	respiratory	respiratory	ADJ
dpc-2415	19	19	ones	one	NOUN
dpc-2415	19	20	,	,	PUNCT
dpc-2415	19	21	linked	link	VERB
dpc-2415	19	22	to	to	ADP
dpc-2415	19	23	psoriasis	psoriasis	NOUN
dpc-2415	19	24	and	and	CCONJ
dpc-2415	19	25	immunomodulators	immunomodulator	NOUN
dpc-2415	19	26	as	as	ADV
dpc-2415	19	27	well	well	ADV
dpc-2415	19	28	.	.	PUNCT
dpc-2415	20	1	lastly	lastly	ADV
dpc-2415	20	2	,	,	PUNCT
dpc-2415	20	3	we	we	PRON
dpc-2415	20	4	provide	provide	VERB
dpc-2415	20	5	an	an	DET
dpc-2415	20	6	overview	overview	NOUN
dpc-2415	20	7	of	of	ADP
dpc-2415	20	8	the	the	DET
dpc-2415	20	9	prevention	prevention	NOUN
dpc-2415	20	10	and	and	CCONJ
dpc-2415	20	11	management	management	NOUN
dpc-2415	20	12	of	of	ADP
dpc-2415	20	13	infections	infection	NOUN
dpc-2415	20	14	in	in	ADP
dpc-2415	20	15	psoriatic	psoriatic	ADJ
dpc-2415	20	16	patients	patient	NOUN
dpc-2415	20	17	on	on	ADP
dpc-2415	20	18	immunomodulatory	immunomodulatory	ADJ
dpc-2415	20	19	therapies	therapy	NOUN
dpc-2415	20	20	.	.	PUNCT
dpc-2415	21	1	immunopathogenesis	immunopathogenesis	NOUN
dpc-2415	21	2	of	of	ADP
dpc-2415	21	3	psoriasis	psoriasis	NOUN
dpc-2415	21	4	:	:	PUNCT
dpc-2415	21	5	an	an	DET
dpc-2415	21	6	update	update	NOUN
dpc-2415	21	7	psoriasis	psoriasis	NOUN
dpc-2415	21	8	has	have	AUX
dpc-2415	21	9	been	be	AUX
dpc-2415	21	10	primarily	primarily	ADV
dpc-2415	21	11	defined	define	VERB
dpc-2415	21	12	as	as	ADP
dpc-2415	21	13	an	an	DET
dpc-2415	21	14	autoimmune	autoimmune	ADJ
dpc-2415	21	15	,	,	PUNCT
dpc-2415	21	16	t	t	NOUN
dpc-2415	21	17	-	-	PUNCT
dpc-2415	21	18	cell	cell	NOUN
dpc-2415	21	19	-	-	PUNCT
dpc-2415	21	20	mediated	mediate	VERB
dpc-2415	21	21	disease	disease	NOUN
dpc-2415	21	22	with	with	ADP
dpc-2415	21	23	dysregulated	dysregulate	VERB
dpc-2415	21	24	inflammatory	inflammatory	ADJ
dpc-2415	21	25	response	response	NOUN
dpc-2415	21	26	that	that	PRON
dpc-2415	21	27	is	be	AUX
dpc-2415	21	28	composed	compose	VERB
dpc-2415	21	29	of	of	ADP
dpc-2415	21	30	both	both	CCONJ
dpc-2415	21	31	innate	innate	ADJ
dpc-2415	21	32	and	and	CCONJ
dpc-2415	21	33	adaptive	adaptive	ADJ
dpc-2415	21	34	immunity	immunity	NOUN
dpc-2415	21	35	[	[	X
dpc-2415	21	36	1	1	NUM
dpc-2415	21	37	-	-	SYM
dpc-2415	21	38	4	4	NUM
dpc-2415	21	39	]	]	PUNCT
dpc-2415	21	40	.	.	PUNCT
dpc-2415	22	1	other	other	ADJ
dpc-2415	22	2	factors	factor	NOUN
dpc-2415	22	3	such	such	ADJ
dpc-2415	22	4	as	as	ADP
dpc-2415	22	5	environmental	environmental	ADJ
dpc-2415	22	6	ones	one	NOUN
dpc-2415	22	7	and	and	CCONJ
dpc-2415	22	8	genetic	genetic	ADJ
dpc-2415	22	9	susceptibility	susceptibility	NOUN
dpc-2415	22	10	are	be	AUX
dpc-2415	22	11	also	also	ADV
dpc-2415	22	12	involved	involve	VERB
dpc-2415	22	13	[	[	PUNCT
dpc-2415	22	14	4,5	4,5	NUM
dpc-2415	22	15	]	]	PUNCT
dpc-2415	22	16	.	.	PUNCT
dpc-2415	23	1	several	several	ADJ
dpc-2415	23	2	gene	gene	NOUN
dpc-2415	23	3	loci	locus	NOUN
dpc-2415	23	4	are	be	AUX
dpc-2415	23	5	associated	associate	VERB
dpc-2415	23	6	with	with	ADP
dpc-2415	23	7	psoriasis	psoriasis	NOUN
dpc-2415	23	8	,	,	PUNCT
dpc-2415	23	9	such	such	ADJ
dpc-2415	23	10	as	as	ADP
dpc-2415	23	11	hla	hla	NOUN
dpc-2415	23	12	-	-	PUNCT
dpc-2415	23	13	cw6	cw6	PROPN
dpc-2415	23	14	and	and	CCONJ
dpc-2415	23	15	psors1	psors1	NOUN
dpc-2415	23	16	-	-	SYM
dpc-2415	23	17	9	9	NUM
dpc-2415	23	18	,	,	PUNCT
dpc-2415	23	19	providing	provide	VERB
dpc-2415	23	20	initial	initial	ADJ
dpc-2415	23	21	evidence	evidence	NOUN
dpc-2415	23	22	of	of	ADP
dpc-2415	23	23	a	a	DET
dpc-2415	23	24	possibly	possibly	ADV
dpc-2415	23	25	(	(	PUNCT
dpc-2415	23	26	auto	auto	NOUN
dpc-2415	23	27	)	)	PUNCT
dpc-2415	23	28	immune	immune	ADJ
dpc-2415	23	29	component	component	NOUN
dpc-2415	24	1	[	[	X
dpc-2415	24	2	6,7	6,7	NUM
dpc-2415	24	3	]	]	PUNCT
dpc-2415	24	4	.	.	PUNCT
dpc-2415	25	1	however	however	ADV
dpc-2415	25	2	,	,	PUNCT
dpc-2415	25	3	~	~	PUNCT
dpc-2415	25	4	60	60	NUM
dpc-2415	25	5	loci	locus	NOUN
dpc-2415	25	6	identified	identify	VERB
dpc-2415	25	7	contain	contain	NOUN
dpc-2415	25	8	genes	gene	NOUN
dpc-2415	25	9	involved	involve	VERB
dpc-2415	25	10	in	in	ADP
dpc-2415	25	11	the	the	DET
dpc-2415	25	12	immune	immune	ADJ
dpc-2415	25	13	system	system	NOUN
dpc-2415	25	14	at	at	ADP
dpc-2415	25	15	large	large	ADJ
dpc-2415	25	16	and	and	CCONJ
dpc-2415	25	17	the	the	DET
dpc-2415	25	18	interleukin	interleukin	NOUN
dpc-2415	25	19	(	(	PUNCT
dpc-2415	25	20	il)-23	il)-23	PROPN
dpc-2415	25	21	/	/	SYM
dpc-2415	25	22	t	t	PROPN
dpc-2415	25	23	helper	helper	NOUN
dpc-2415	25	24	(	(	PUNCT
dpc-2415	25	25	th)17	th)17	NOUN
dpc-2415	25	26	pathway	pathway	NOUN
dpc-2415	25	27	in	in	ADP
dpc-2415	25	28	particular	particular	ADJ
dpc-2415	25	29	[	[	X
dpc-2415	25	30	8,9	8,9	NUM
dpc-2415	25	31	]	]	PUNCT
dpc-2415	25	32	.	.	PUNCT
dpc-2415	26	1	il-17a	il-17a	PROPN
dpc-2415	26	2	is	be	AUX
dpc-2415	26	3	the	the	DET
dpc-2415	26	4	most	most	ADV
dpc-2415	26	5	studied	studied	ADJ
dpc-2415	26	6	cytokine	cytokine	NOUN
dpc-2415	26	7	of	of	ADP
dpc-2415	26	8	the	the	DET
dpc-2415	26	9	psoriatic	psoriatic	ADJ
dpc-2415	26	10	il-23	il-23	NOUN
dpc-2415	26	11	/	/	SYM
dpc-2415	26	12	th17	th17	NOUN
dpc-2415	26	13	cell	cell	NOUN
dpc-2415	26	14	pathogenic	pathogenic	ADJ
dpc-2415	26	15	axis	axis	NOUN
dpc-2415	26	16	and	and	CCONJ
dpc-2415	26	17	is	be	AUX
dpc-2415	26	18	claimed	claim	VERB
dpc-2415	26	19	to	to	PART
dpc-2415	26	20	be	be	AUX
dpc-2415	26	21	directly	directly	ADV
dpc-2415	26	22	responsible	responsible	ADJ
dpc-2415	26	23	for	for	ADP
dpc-2415	26	24	the	the	DET
dpc-2415	26	25	development	development	NOUN
dpc-2415	26	26	of	of	ADP
dpc-2415	26	27	the	the	DET
dpc-2415	26	28	psoriatic	psoriatic	ADJ
dpc-2415	26	29	lesion	lesion	NOUN
dpc-2415	26	30	[	[	X
dpc-2415	26	31	10,11	10,11	NOUN
dpc-2415	26	32	]	]	PUNCT
dpc-2415	26	33	.	.	PUNCT
dpc-2415	27	1	it	it	PRON
dpc-2415	27	2	does	do	AUX
dpc-2415	27	3	not	not	PART
dpc-2415	27	4	act	act	VERB
dpc-2415	27	5	as	as	ADP
dpc-2415	27	6	a	a	DET
dpc-2415	27	7	single	single	ADJ
dpc-2415	27	8	cytokine	cytokine	NOUN
dpc-2415	27	9	but	but	CCONJ
dpc-2415	27	10	exerts	exert	VERB
dpc-2415	27	11	its	its	PRON
dpc-2415	27	12	function	function	NOUN
dpc-2415	27	13	in	in	ADP
dpc-2415	27	14	a	a	DET
dpc-2415	27	15	complex	complex	ADJ
dpc-2415	27	16	cytokine	cytokine	NOUN
dpc-2415	27	17	network	network	NOUN
dpc-2415	27	18	which	which	PRON
dpc-2415	27	19	includes	include	VERB
dpc-2415	27	20	il-19	il-19	PRON
dpc-2415	27	21	,	,	PUNCT
dpc-2415	27	22	il-22	il-22	NOUN
dpc-2415	27	23	,	,	PUNCT
dpc-2415	27	24	il-23	il-23	NOUN
dpc-2415	27	25	,	,	PUNCT
dpc-2415	27	26	tumor	tumor	NOUN
dpc-2415	27	27	necrosis	necrosis	NOUN
dpc-2415	27	28	factor	factor	NOUN
dpc-2415	27	29	(	(	PUNCT
dpc-2415	27	30	tnf)-α	tnf)-α	NOUN
dpc-2415	27	31	and	and	CCONJ
dpc-2415	27	32	several	several	ADJ
dpc-2415	27	33	il-1	il-1	ADP
dpc-2415	27	34	family	family	NOUN
dpc-2415	27	35	members	member	NOUN
dpc-2415	27	36	[	[	PUNCT
dpc-2415	27	37	12	12	NUM
dpc-2415	27	38	-	-	SYM
dpc-2415	27	39	15	15	NUM
dpc-2415	27	40	]	]	PUNCT
dpc-2415	27	41	.	.	PUNCT
dpc-2415	28	1	il-17a	il-17a	PROPN
dpc-2415	28	2	is	be	AUX
dpc-2415	28	3	not	not	PART
dpc-2415	28	4	exclusively	exclusively	ADV
dpc-2415	28	5	produced	produce	VERB
dpc-2415	28	6	by	by	ADP
dpc-2415	28	7	th17	th17	NOUN
dpc-2415	28	8	cells	cell	NOUN
dpc-2415	28	9	in	in	ADP
dpc-2415	28	10	the	the	DET
dpc-2415	28	11	lesion	lesion	NOUN
dpc-2415	28	12	,	,	PUNCT
dpc-2415	28	13	but	but	CCONJ
dpc-2415	28	14	possibly	possibly	ADV
dpc-2415	28	15	also	also	ADV
dpc-2415	28	16	by	by	ADP
dpc-2415	28	17	several	several	ADJ
dpc-2415	28	18	other	other	ADJ
dpc-2415	28	19	cells	cell	NOUN
dpc-2415	28	20	:	:	PUNCT
dpc-2415	28	21	such	such	ADJ
dpc-2415	28	22	as	as	ADP
dpc-2415	28	23	γδ	γδ	ADP
dpc-2415	28	24	t	t	NOUN
dpc-2415	28	25	cells	cell	NOUN
dpc-2415	28	26	,	,	PUNCT
dpc-2415	28	27	type	type	NOUN
dpc-2415	28	28	3	3	NUM
dpc-2415	28	29	innate	innate	ADJ
dpc-2415	28	30	lymphoid	lymphoid	ADJ
dpc-2415	28	31	cells	cell	NOUN
dpc-2415	28	32	(	(	PUNCT
dpc-2415	28	33	ilc3s	ilc3s	NOUN
dpc-2415	28	34	)	)	PUNCT
dpc-2415	28	35	and	and	CCONJ
dpc-2415	28	36	invariant	invariant	ADJ
dpc-2415	28	37	natural	natural	ADJ
dpc-2415	28	38	killer	killer	NOUN
dpc-2415	28	39	(	(	PUNCT
dpc-2415	28	40	ink)t	ink)t	PROPN
dpc-2415	28	41	cells	cell	NOUN
dpc-2415	28	42	,	,	PUNCT
dpc-2415	28	43	and	and	CCONJ
dpc-2415	28	44	other	other	ADJ
dpc-2415	28	45	thymus	thymus	ADJ
dpc-2415	28	46	-	-	PUNCT
dpc-2415	28	47	independent	independent	ADJ
dpc-2415	28	48	cells	cell	NOUN
dpc-2415	28	49	,	,	PUNCT
dpc-2415	28	50	including	include	VERB
dpc-2415	28	51	mast	mast	NOUN
dpc-2415	28	52	cells	cell	NOUN
dpc-2415	28	53	and	and	CCONJ
dpc-2415	28	54	neutrophils	neutrophil	NOUN
dpc-2415	28	55	[	[	X
dpc-2415	28	56	16	16	NUM
dpc-2415	28	57	-	-	SYM
dpc-2415	28	58	19	19	NUM
dpc-2415	28	59	]	]	PUNCT
dpc-2415	28	60	.	.	PUNCT
dpc-2415	29	1	besides	besides	SCONJ
dpc-2415	29	2	il-17a	il-17a	PROPN
dpc-2415	29	3	,	,	PUNCT
dpc-2415	29	4	the	the	DET
dpc-2415	29	5	immune	immune	NOUN
dpc-2415	29	6	-	-	PUNCT
dpc-2415	29	7	derived	derive	VERB
dpc-2415	29	8	il17f	il17f	ADP
dpc-2415	29	9	,	,	PUNCT
dpc-2415	29	10	the	the	DET
dpc-2415	29	11	epithelial	epithelial	NOUN
dpc-2415	29	12	-	-	PUNCT
dpc-2415	29	13	derived	derive	VERB
dpc-2415	29	14	il-17c	il-17c	NOUN
dpc-2415	29	15	and	and	CCONJ
dpc-2415	29	16	il-17e	il-17e	NOUN
dpc-2415	29	17	,	,	PUNCT
dpc-2415	29	18	have	have	AUX
dpc-2415	29	19	all	all	PRON
dpc-2415	29	20	been	be	AUX
dpc-2415	29	21	shown	show	VERB
dpc-2415	29	22	to	to	PART
dpc-2415	29	23	independently	independently	ADV
dpc-2415	29	24	participate	participate	VERB
dpc-2415	29	25	in	in	ADP
dpc-2415	29	26	psoriasiform	psoriasiform	NOUN
dpc-2415	29	27	inflammation	inflammation	NOUN
dpc-2415	29	28	in	in	ADP
dpc-2415	29	29	murine	murine	ADJ
dpc-2415	29	30	models	model	NOUN
dpc-2415	29	31	[	[	X
dpc-2415	29	32	20	20	NUM
dpc-2415	29	33	-	-	SYM
dpc-2415	29	34	22	22	NUM
dpc-2415	29	35	]	]	PUNCT
dpc-2415	29	36	.	.	PUNCT
dpc-2415	30	1	interestingly	interestingly	ADV
dpc-2415	30	2	,	,	PUNCT
dpc-2415	30	3	the	the	DET
dpc-2415	30	4	inhibition	inhibition	NOUN
dpc-2415	30	5	of	of	ADP
dpc-2415	30	6	the	the	DET
dpc-2415	30	7	il-17a	il-17a	PROPN
dpc-2415	30	8	/	/	SYM
dpc-2415	30	9	il-23	il-23	NOUN
dpc-2415	30	10	axis	axis	NOUN
dpc-2415	30	11	might	might	AUX
dpc-2415	30	12	potentially	potentially	ADV
dpc-2415	30	13	lead	lead	VERB
dpc-2415	30	14	to	to	ADP
dpc-2415	30	15	the	the	DET
dpc-2415	30	16	enhancement	enhancement	NOUN
dpc-2415	30	17	of	of	ADP
dpc-2415	30	18	other	other	ADJ
dpc-2415	30	19	il-17	il-17	NUM
dpc-2415	30	20	cytokine	cytokine	ADJ
dpc-2415	30	21	members	member	NOUN
dpc-2415	30	22	,	,	PUNCT
dpc-2415	30	23	particularly	particularly	ADV
dpc-2415	30	24	the	the	DET
dpc-2415	30	25	epithelial	epithelial	ADJ
dpc-2415	30	26	-	-	PUNCT
dpc-2415	30	27	derived	derive	VERB
dpc-2415	30	28	cytokines	cytokine	NOUN
dpc-2415	30	29	.	.	PUNCT
dpc-2415	31	1	a	a	DET
dpc-2415	31	2	better	well	ADJ
dpc-2415	31	3	assessment	assessment	NOUN
dpc-2415	31	4	of	of	ADP
dpc-2415	31	5	the	the	DET
dpc-2415	31	6	different	different	ADJ
dpc-2415	31	7	sources	source	NOUN
dpc-2415	31	8	and	and	CCONJ
dpc-2415	31	9	the	the	DET
dpc-2415	31	10	possible	possible	ADJ
dpc-2415	31	11	il-17	il-17	NUM
dpc-2415	31	12	substitute	substitute	ADJ
dpc-2415	31	13	cytokines	cytokine	NOUN
dpc-2415	31	14	is	be	AUX
dpc-2415	31	15	critical	critical	ADJ
dpc-2415	31	16	to	to	PART
dpc-2415	31	17	better	well	ADV
dpc-2415	31	18	understand	understand	VERB
dpc-2415	31	19	the	the	DET
dpc-2415	31	20	mechanism	mechanism	NOUN
dpc-2415	31	21	of	of	ADP
dpc-2415	31	22	action	action	NOUN
dpc-2415	31	23	of	of	ADP
dpc-2415	31	24	the	the	DET
dpc-2415	31	25	current	current	ADJ
dpc-2415	31	26	il-23	il-23	NOUN
dpc-2415	31	27	/	/	SYM
dpc-2415	31	28	il-17	il-17	ADV
dpc-2415	31	29	-	-	PUNCT
dpc-2415	31	30	targeted	target	VERB
dpc-2415	31	31	therapies	therapy	NOUN
dpc-2415	31	32	,	,	PUNCT
dpc-2415	31	33	possibly	possibly	ADV
dpc-2415	31	34	helping	help	VERB
dpc-2415	31	35	to	to	PART
dpc-2415	31	36	explain	explain	VERB
dpc-2415	31	37	unwanted	unwanted	ADJ
dpc-2415	31	38	effects	effect	NOUN
dpc-2415	31	39	or	or	CCONJ
dpc-2415	31	40	secondary	secondary	ADJ
dpc-2415	31	41	loss	loss	NOUN
dpc-2415	31	42	of	of	ADP
dpc-2415	31	43	efficacy	efficacy	NOUN
dpc-2415	31	44	.	.	PUNCT
dpc-2415	32	1	psoriasis	psoriasis	NOUN
dpc-2415	32	2	and	and	CCONJ
dpc-2415	32	3	skin	skin	NOUN
dpc-2415	32	4	infection	infection	NOUN
dpc-2415	32	5	psoriatic	psoriatic	ADJ
dpc-2415	32	6	lesions	lesion	NOUN
dpc-2415	32	7	show	show	VERB
dpc-2415	32	8	a	a	DET
dpc-2415	32	9	disturbed	disturbed	ADJ
dpc-2415	32	10	skin	skin	NOUN
dpc-2415	32	11	barrier	barrier	NOUN
dpc-2415	32	12	function	function	NOUN
dpc-2415	32	13	,	,	PUNCT
dpc-2415	32	14	similar	similar	ADJ
dpc-2415	32	15	to	to	ADP
dpc-2415	32	16	the	the	DET
dpc-2415	32	17	affected	affected	ADJ
dpc-2415	32	18	skin	skin	NOUN
dpc-2415	32	19	of	of	ADP
dpc-2415	32	20	patients	patient	NOUN
dpc-2415	32	21	with	with	ADP
dpc-2415	32	22	atopic	atopic	NOUN
dpc-2415	32	23	dermatitis	dermatitis	NOUN
dpc-2415	32	24	(	(	PUNCT
dpc-2415	32	25	ad	ad	NOUN
dpc-2415	32	26	)	)	PUNCT
dpc-2415	33	1	[	[	X
dpc-2415	33	2	23	23	NUM
dpc-2415	33	3	-	-	SYM
dpc-2415	33	4	24	24	NUM
dpc-2415	33	5	]	]	PUNCT
dpc-2415	33	6	.	.	PUNCT
dpc-2415	34	1	this	this	PRON
dpc-2415	34	2	altered	alter	VERB
dpc-2415	34	3	epidermal	epidermal	ADJ
dpc-2415	34	4	barrier	barrier	NOUN
dpc-2415	34	5	facilitates	facilitate	VERB
dpc-2415	34	6	the	the	DET
dpc-2415	34	7	penetration	penetration	NOUN
dpc-2415	34	8	of	of	ADP
dpc-2415	34	9	bacteria	bacteria	NOUN
dpc-2415	34	10	and	and	CCONJ
dpc-2415	34	11	viruses	virus	NOUN
dpc-2415	34	12	into	into	ADP
dpc-2415	34	13	the	the	DET
dpc-2415	34	14	skin	skin	NOUN
dpc-2415	34	15	and	and	CCONJ
dpc-2415	34	16	should	should	AUX
dpc-2415	34	17	lead	lead	VERB
dpc-2415	34	18	to	to	ADP
dpc-2415	34	19	an	an	DET
dpc-2415	34	20	increased	increase	VERB
dpc-2415	34	21	incidence	incidence	NOUN
dpc-2415	34	22	of	of	ADP
dpc-2415	34	23	cutaneous	cutaneous	ADJ
dpc-2415	34	24	infections	infection	NOUN
dpc-2415	34	25	.	.	PUNCT
dpc-2415	35	1	however	however	ADV
dpc-2415	35	2	,	,	PUNCT
dpc-2415	35	3	the	the	DET
dpc-2415	35	4	frequency	frequency	NOUN
dpc-2415	35	5	of	of	ADP
dpc-2415	35	6	skin	skin	NOUN
dpc-2415	35	7	infections	infection	NOUN
dpc-2415	35	8	is	be	AUX
dpc-2415	35	9	impressively	impressively	ADV
dpc-2415	35	10	underrepresented	underrepresented	ADJ
dpc-2415	35	11	in	in	ADP
dpc-2415	35	12	patients	patient	NOUN
dpc-2415	35	13	with	with	ADP
dpc-2415	35	14	psoriasis	psoriasis	NOUN
dpc-2415	35	15	[	[	X
dpc-2415	35	16	25	25	NUM
dpc-2415	35	17	,	,	PUNCT
dpc-2415	35	18	26	26	NUM
dpc-2415	35	19	]	]	PUNCT
dpc-2415	35	20	.	.	PUNCT
dpc-2415	36	1	the	the	DET
dpc-2415	36	2	main	main	ADJ
dpc-2415	36	3	reason	reason	NOUN
dpc-2415	36	4	for	for	ADP
dpc-2415	36	5	this	this	DET
dpc-2415	36	6	clinical	clinical	ADJ
dpc-2415	36	7	observation	observation	NOUN
dpc-2415	36	8	is	be	AUX
dpc-2415	36	9	the	the	DET
dpc-2415	36	10	specific	specific	ADJ
dpc-2415	36	11	increase	increase	NOUN
dpc-2415	36	12	in	in	ADP
dpc-2415	36	13	the	the	DET
dpc-2415	36	14	levels	level	NOUN
dpc-2415	36	15	of	of	ADP
dpc-2415	36	16	antimicrobial	antimicrobial	ADJ
dpc-2415	36	17	peptides	peptide	NOUN
dpc-2415	36	18	(	(	PUNCT
dpc-2415	36	19	amps	amp	NOUN
dpc-2415	36	20	)	)	PUNCT
dpc-2415	36	21	and	and	CCONJ
dpc-2415	36	22	antiviral	antiviral	ADJ
dpc-2415	36	23	peptides	peptide	NOUN
dpc-2415	36	24	(	(	PUNCT
dpc-2415	36	25	avps	avps	NOUN
dpc-2415	36	26	)	)	PUNCT
dpc-2415	36	27	within	within	ADP
dpc-2415	36	28	the	the	DET
dpc-2415	36	29	epidermis	epidermis	NOUN
dpc-2415	36	30	of	of	ADP
dpc-2415	36	31	psoriatic	psoriatic	ADJ
dpc-2415	36	32	lesions	lesion	NOUN
dpc-2415	36	33	[	[	X
dpc-2415	36	34	14	14	NUM
dpc-2415	36	35	,	,	PUNCT
dpc-2415	36	36	27	27	NUM
dpc-2415	36	37	-	-	SYM
dpc-2415	36	38	29	29	NUM
dpc-2415	36	39	]	]	PUNCT
dpc-2415	36	40	.	.	PUNCT
dpc-2415	37	1	correspondingly	correspondingly	ADV
dpc-2415	37	2	,	,	PUNCT
dpc-2415	37	3	the	the	DET
dpc-2415	37	4	enhancement	enhancement	NOUN
dpc-2415	37	5	of	of	ADP
dpc-2415	37	6	amps	amp	NOUN
dpc-2415	37	7	and	and	CCONJ
dpc-2415	37	8	avps	avps	NOUN
dpc-2415	37	9	in	in	ADP
dpc-2415	37	10	the	the	DET
dpc-2415	37	11	affected	affected	ADJ
dpc-2415	37	12	skin	skin	NOUN
dpc-2415	37	13	of	of	ADP
dpc-2415	37	14	ad	ad	NOUN
dpc-2415	37	15	patients	patient	NOUN
dpc-2415	37	16	is	be	AUX
dpc-2415	37	17	only	only	ADV
dpc-2415	37	18	minimal	minimal	ADJ
dpc-2415	37	19	and	and	CCONJ
dpc-2415	37	20	these	these	DET
dpc-2415	37	21	patients	patient	NOUN
dpc-2415	37	22	often	often	ADV
dpc-2415	37	23	suffer	suffer	VERB
dpc-2415	37	24	from	from	ADP
dpc-2415	37	25	bacterial	bacterial	ADJ
dpc-2415	37	26	and	and	CCONJ
dpc-2415	37	27	viral	viral	ADJ
dpc-2415	37	28	skin	skin	NOUN
dpc-2415	37	29	infections	infection	NOUN
dpc-2415	37	30	.	.	PUNCT
dpc-2415	38	1	the	the	DET
dpc-2415	38	2	mostly	mostly	ADV
dpc-2415	38	3	up	up	ADV
dpc-2415	38	4	-	-	PUNCT
dpc-2415	38	5	regulated	regulate	VERB
dpc-2415	38	6	amps	amp	NOUN
dpc-2415	38	7	in	in	ADP
dpc-2415	38	8	psoriatic	psoriatic	ADJ
dpc-2415	38	9	skin	skin	NOUN
dpc-2415	38	10	are	be	AUX
dpc-2415	38	11	human	human	ADJ
dpc-2415	38	12	β	β	NOUN
dpc-2415	38	13	-	-	NOUN
dpc-2415	38	14	defensin	defensin	ADJ
dpc-2415	38	15	(	(	PUNCT
dpc-2415	38	16	hbd)-2	hbd)-2	NOUN
dpc-2415	38	17	,	,	PUNCT
dpc-2415	38	18	s100a7	s100a7	VERB
dpc-2415	38	19	(	(	PUNCT
dpc-2415	38	20	psoriasin	psoriasin	PROPN
dpc-2415	38	21	)	)	PUNCT
dpc-2415	38	22	and	and	CCONJ
dpc-2415	38	23	to	to	ADP
dpc-2415	38	24	a	a	DET
dpc-2415	38	25	lesser	less	ADJ
dpc-2415	38	26	extent	extent	NOUN
dpc-2415	38	27	hbd-3	hbd-3	NOUN
dpc-2415	38	28	,	,	PUNCT
dpc-2415	38	29	s100a8	s100a8	PROPN
dpc-2415	38	30	(	(	PUNCT
dpc-2415	38	31	calgranulin	calgranulin	PROPN
dpc-2415	38	32	a	a	PRON
dpc-2415	38	33	)	)	PUNCT
dpc-2415	38	34	,	,	PUNCT
dpc-2415	38	35	s100a9	s100a9	PROPN
dpc-2415	38	36	(	(	PUNCT
dpc-2415	38	37	calgranulin	calgranulin	PROPN
dpc-2415	38	38	b	b	PROPN
dpc-2415	38	39	)	)	PUNCT
dpc-2415	38	40	,	,	PUNCT
dpc-2415	38	41	and	and	CCONJ
dpc-2415	38	42	lipocalin	lipocalin	X
dpc-2415	38	43	(	(	PUNCT
dpc-2415	38	44	lcn)-2	lcn)-2	PROPN
dpc-2415	38	45	[	[	X
dpc-2415	38	46	27	27	NUM
dpc-2415	38	47	,	,	PUNCT
dpc-2415	38	48	30	30	NUM
dpc-2415	38	49	-	-	SYM
dpc-2415	38	50	32	32	NUM
dpc-2415	38	51	]	]	PUNCT
dpc-2415	38	52	.	.	PUNCT
dpc-2415	39	1	the	the	DET
dpc-2415	39	2	spectrum	spectrum	NOUN
dpc-2415	39	3	of	of	ADP
dpc-2415	39	4	affected	affect	VERB
dpc-2415	39	5	microbes	microbe	NOUN
dpc-2415	39	6	differs	differ	VERB
dpc-2415	39	7	among	among	ADP
dpc-2415	39	8	the	the	DET
dpc-2415	39	9	diverse	diverse	ADJ
dpc-2415	39	10	amps	amp	NOUN
dpc-2415	39	11	.	.	PUNCT
dpc-2415	40	1	for	for	ADP
dpc-2415	40	2	example	example	NOUN
dpc-2415	40	3	,	,	PUNCT
dpc-2415	40	4	s100a7	s100a7	VERB
dpc-2415	40	5	is	be	AUX
dpc-2415	40	6	primarily	primarily	ADV
dpc-2415	40	7	an	an	DET
dpc-2415	40	8	e.	e.	PROPN
dpc-2415	40	9	coli	coli	NOUN
dpc-2415	40	10	-	-	PUNCT
dpc-2415	40	11	killing	kill	VERB
dpc-2415	40	12	antimicrobial	antimicrobial	ADJ
dpc-2415	40	13	peptide	peptide	NOUN
dpc-2415	40	14	,	,	PUNCT
dpc-2415	40	15	whereas	whereas	SCONJ
dpc-2415	40	16	hbd-3	hbd-3	PUNCT
dpc-2415	40	17	exhibits	exhibit	VERB
dpc-2415	40	18	a	a	DET
dpc-2415	40	19	broad	broad	ADJ
dpc-2415	40	20	spectrum	spectrum	NOUN
dpc-2415	40	21	of	of	ADP
dpc-2415	40	22	antimicrobial	antimicrobial	ADJ
dpc-2415	40	23	activity	activity	NOUN
dpc-2415	40	24	against	against	ADP
dpc-2415	40	25	various	various	ADJ
dpc-2415	40	26	gram‐negative	gram‐negative	ADJ
dpc-2415	40	27	and	and	CCONJ
dpc-2415	40	28	gram‐positive	gram‐positive	ADJ
dpc-2415	40	29	bacteria	bacteria	NOUN
dpc-2415	40	30	as	as	ADV
dpc-2415	40	31	well	well	ADV
dpc-2415	40	32	as	as	ADP
dpc-2415	40	33	fungi	fungus	NOUN
dpc-2415	40	34	[	[	X
dpc-2415	40	35	33	33	NUM
dpc-2415	40	36	]	]	PUNCT
dpc-2415	40	37	.	.	PUNCT
dpc-2415	41	1	amps	amp	NOUN
dpc-2415	41	2	inhibit	inhibit	VERB
dpc-2415	41	3	propagation	propagation	NOUN
dpc-2415	41	4	and	and	CCONJ
dpc-2415	41	5	kill	kill	VERB
dpc-2415	41	6	microbes	microbe	NOUN
dpc-2415	41	7	through	through	ADP
dpc-2415	41	8	various	various	ADJ
dpc-2415	41	9	mechanisms	mechanism	NOUN
dpc-2415	41	10	such	such	ADJ
dpc-2415	41	11	as	as	ADP
dpc-2415	41	12	destabilization	destabilization	NOUN
dpc-2415	41	13	of	of	ADP
dpc-2415	41	14	their	their	PRON
dpc-2415	41	15	membrane	membrane	NOUN
dpc-2415	41	16	or	or	CCONJ
dpc-2415	41	17	sequestrating	sequestrating	NOUN
dpc-2415	41	18	metal	metal	NOUN
dpc-2415	41	19	ions	ion	NOUN
dpc-2415	41	20	[	[	X
dpc-2415	41	21	33	33	NUM
dpc-2415	41	22	,	,	PUNCT
dpc-2415	41	23	34	34	NUM
dpc-2415	41	24	]	]	PUNCT
dpc-2415	41	25	.	.	PUNCT
dpc-2415	42	1	most	most	ADJ
dpc-2415	42	2	of	of	ADP
dpc-2415	42	3	the	the	DET
dpc-2415	42	4	amps	amp	NOUN
dpc-2415	42	5	are	be	AUX
dpc-2415	42	6	constitutively	constitutively	ADV
dpc-2415	42	7	expressed	express	VERB
dpc-2415	42	8	at	at	ADP
dpc-2415	42	9	low	low	ADJ
dpc-2415	42	10	levels	level	NOUN
dpc-2415	42	11	in	in	ADP
dpc-2415	42	12	keratinocytes	keratinocyte	NOUN
dpc-2415	42	13	and	and	CCONJ
dpc-2415	42	14	might	might	AUX
dpc-2415	42	15	be	be	AUX
dpc-2415	42	16	strongly	strongly	ADV
dpc-2415	42	17	up	up	ADV
dpc-2415	42	18	-	-	PUNCT
dpc-2415	42	19	regulated	regulate	VERB
dpc-2415	42	20	by	by	ADP
dpc-2415	42	21	cytokines	cytokine	NOUN
dpc-2415	42	22	under	under	ADP
dpc-2415	42	23	inflammatory	inflammatory	ADJ
dpc-2415	42	24	conditions	condition	NOUN
dpc-2415	42	25	.	.	PUNCT
dpc-2415	43	1	the	the	DET
dpc-2415	43	2	powerful	powerful	ADJ
dpc-2415	43	3	inducers	inducer	NOUN
dpc-2415	43	4	of	of	ADP
dpc-2415	43	5	amps	amp	NOUN
dpc-2415	43	6	in	in	ADP
dpc-2415	43	7	epithelial	epithelial	ADJ
dpc-2415	43	8	cells	cell	NOUN
dpc-2415	43	9	are	be	AUX
dpc-2415	43	10	il-17	il-17	ADP
dpc-2415	43	11	and	and	CCONJ
dpc-2415	43	12	il-22	il-22	NUM
dpc-2415	43	13	[	[	X
dpc-2415	43	14	31	31	NUM
dpc-2415	43	15	,	,	PUNCT
dpc-2415	43	16	35	35	NUM
dpc-2415	43	17	]	]	PUNCT
dpc-2415	43	18	.	.	PUNCT
dpc-2415	44	1	however	however	ADV
dpc-2415	44	2	,	,	PUNCT
dpc-2415	44	3	the	the	DET
dpc-2415	44	4	synergistic	synergistic	ADJ
dpc-2415	44	5	action	action	NOUN
dpc-2415	44	6	of	of	ADP
dpc-2415	44	7	both	both	DET
dpc-2415	44	8	cytokines	cytokine	NOUN
dpc-2415	44	9	is	be	AUX
dpc-2415	44	10	essential	essential	ADJ
dpc-2415	44	11	for	for	ADP
dpc-2415	44	12	the	the	DET
dpc-2415	44	13	strong	strong	ADJ
dpc-2415	44	14	induction	induction	NOUN
dpc-2415	44	15	of	of	ADP
dpc-2415	44	16	amps	amp	NOUN
dpc-2415	44	17	in	in	ADP
dpc-2415	44	18	keratinocytes	keratinocyte	NOUN
dpc-2415	44	19	[	[	X
dpc-2415	44	20	36	36	NUM
dpc-2415	44	21	,	,	PUNCT
dpc-2415	44	22	37	37	NUM
dpc-2415	44	23	]	]	PUNCT
dpc-2415	44	24	.	.	PUNCT
dpc-2415	45	1	in	in	ADP
dpc-2415	45	2	psoriatic	psoriatic	ADJ
dpc-2415	45	3	lesions	lesion	NOUN
dpc-2415	45	4	,	,	PUNCT
dpc-2415	45	5	this	this	DET
dpc-2415	45	6	effect	effect	NOUN
dpc-2415	45	7	might	might	AUX
dpc-2415	45	8	be	be	AUX
dpc-2415	45	9	amplified	amplify	VERB
dpc-2415	45	10	by	by	ADP
dpc-2415	45	11	tnf	tnf	PROPN
dpc-2415	45	12	-	-	PUNCT
dpc-2415	45	13	α	α	PROPN
dpc-2415	45	14	,	,	PUNCT
dpc-2415	45	15	interferon	interferon	NOUN
dpc-2415	45	16	(	(	PUNCT
dpc-2415	45	17	ifn)-γ	ifn)-γ	NOUN
dpc-2415	45	18	,	,	PUNCT
dpc-2415	45	19	il-19	il-19	PRON
dpc-2415	45	20	,	,	PUNCT
dpc-2415	45	21	and	and	CCONJ
dpc-2415	45	22	il-36s	il-36s	VERB
dpc-2415	45	23	[	[	X
dpc-2415	45	24	15	15	NUM
dpc-2415	45	25	,	,	PUNCT
dpc-2415	45	26	37	37	NUM
dpc-2415	45	27	-	-	SYM
dpc-2415	45	28	39	39	NUM
dpc-2415	45	29	]	]	PUNCT
dpc-2415	45	30	.	.	PUNCT
dpc-2415	46	1	interestingly	interestingly	ADV
dpc-2415	46	2	,	,	PUNCT
dpc-2415	46	3	the	the	DET
dpc-2415	46	4	joint	joint	ADJ
dpc-2415	46	5	action	action	NOUN
dpc-2415	46	6	of	of	ADP
dpc-2415	46	7	il-22	il-22	NOUN
dpc-2415	46	8	and	and	CCONJ
dpc-2415	46	9	tnf	tnf	PROPN
dpc-2415	46	10	-	-	PUNCT
dpc-2415	46	11	α	α	PROPN
dpc-2415	46	12	seems	seem	VERB
dpc-2415	46	13	to	to	PART
dpc-2415	46	14	be	be	AUX
dpc-2415	46	15	relevant	relevant	ADJ
dpc-2415	46	16	for	for	ADP
dpc-2415	46	17	the	the	DET
dpc-2415	46	18	maintenance	maintenance	NOUN
dpc-2415	46	19	of	of	ADP
dpc-2415	46	20	epidermal	epidermal	ADJ
dpc-2415	46	21	integrity	integrity	NOUN
dpc-2415	46	22	during	during	ADP
dpc-2415	46	23	infection	infection	NOUN
dpc-2415	46	24	with	with	ADP
dpc-2415	46	25	candida	candida	PROPN
dpc-2415	46	26	albicans	albican	NOUN
dpc-2415	46	27	[	[	PUNCT
dpc-2415	46	28	38	38	NUM
dpc-2415	46	29	]	]	PUNCT
dpc-2415	46	30	.	.	PUNCT
dpc-2415	47	1	the	the	DET
dpc-2415	47	2	up	up	ADV
dpc-2415	47	3	-	-	PUNCT
dpc-2415	47	4	regulated	regulate	VERB
dpc-2415	47	5	avps	avps	NOUN
dpc-2415	47	6	in	in	ADP
dpc-2415	47	7	psoriatic	psoriatic	ADJ
dpc-2415	47	8	lesions	lesion	NOUN
dpc-2415	47	9	comprise	comprise	VERB
dpc-2415	47	10	oas2	oas2	NOUN
dpc-2415	47	11	,	,	PUNCT
dpc-2415	47	12	bst2	bst2	PROPN
dpc-2415	47	13	(	(	PUNCT
dpc-2415	47	14	tetherin	tetherin	NOUN
dpc-2415	47	15	)	)	PUNCT
dpc-2415	47	16	,	,	PUNCT
dpc-2415	47	17	mx1	mx1	PROPN
dpc-2415	47	18	,	,	PUNCT
dpc-2415	47	19	and	and	CCONJ
dpc-2415	47	20	isg15	isg15	VERB
dpc-2415	47	21	[	[	PUNCT
dpc-2415	47	22	29	29	NUM
dpc-2415	47	23	]	]	PUNCT
dpc-2415	47	24	.	.	PUNCT
dpc-2415	48	1	the	the	DET
dpc-2415	48	2	main	main	ADJ
dpc-2415	48	3	driver	driver	NOUN
dpc-2415	48	4	for	for	ADP
dpc-2415	48	5	this	this	DET
dpc-2415	48	6	increase	increase	NOUN
dpc-2415	48	7	is	be	AUX
dpc-2415	48	8	il-29	il-29	NUM
dpc-2415	48	9	,	,	PUNCT
dpc-2415	48	10	a	a	DET
dpc-2415	48	11	member	member	NOUN
dpc-2415	48	12	of	of	ADP
dpc-2415	48	13	the	the	DET
dpc-2415	48	14	il-10	il-10	PRON
dpc-2415	48	15	-	-	PUNCT
dpc-2415	48	16	ifn	ifn	NOUN
dpc-2415	48	17	family	family	NOUN
dpc-2415	48	18	of	of	ADP
dpc-2415	48	19	cytokines	cytokine	NOUN
dpc-2415	48	20	[	[	X
dpc-2415	48	21	40	40	NUM
dpc-2415	48	22	]	]	PUNCT
dpc-2415	48	23	.	.	PUNCT
dpc-2415	49	1	in	in	ADP
dpc-2415	49	2	psoriatic	psoriatic	ADJ
dpc-2415	49	3	lesions	lesion	NOUN
dpc-2415	49	4	,	,	PUNCT
dpc-2415	49	5	il-29	il-29	NUM
dpc-2415	49	6	is	be	AUX
dpc-2415	49	7	produced	produce	VERB
dpc-2415	49	8	by	by	ADP
dpc-2415	49	9	th17	th17	NOUN
dpc-2415	49	10	cells	cell	NOUN
dpc-2415	49	11	[	[	X
dpc-2415	49	12	29	29	NUM
dpc-2415	49	13	]	]	PUNCT
dpc-2415	49	14	.	.	PUNCT
dpc-2415	50	1	it	it	PRON
dpc-2415	50	2	directly	directly	ADV
dpc-2415	50	3	acts	act	VERB
dpc-2415	50	4	on	on	ADP
dpc-2415	50	5	keratinocytes	keratinocyte	NOUN
dpc-2415	50	6	via	via	ADP
dpc-2415	50	7	the	the	DET
dpc-2415	50	8	transmembrane	transmembrane	ADJ
dpc-2415	50	9	receptor	receptor	NOUN
dpc-2415	50	10	complex	complex	NOUN
dpc-2415	50	11	composed	compose	VERB
dpc-2415	50	12	of	of	ADP
dpc-2415	50	13	il-28r1	il-28r1	PROPN
dpc-2415	50	14	and	and	CCONJ
dpc-2415	50	15	il-10r2	il-10r2	PROPN
dpc-2415	50	16	and	and	CCONJ
dpc-2415	50	17	activates	activate	VERB
dpc-2415	50	18	intracellular	intracellular	ADJ
dpc-2415	50	19	jak	jak	PROPN
dpc-2415	50	20	-	-	PUNCT
dpc-2415	50	21	stat	stat	NOUN
dpc-2415	50	22	signaling	signaling	NOUN
dpc-2415	50	23	.	.	PUNCT
dpc-2415	51	1	interestingly	interestingly	ADV
dpc-2415	51	2	,	,	PUNCT
dpc-2415	51	3	il-10r2	il-10r2	PROPN
dpc-2415	51	4	is	be	AUX
dpc-2415	51	5	also	also	ADV
dpc-2415	51	6	a	a	DET
dpc-2415	51	7	part	part	NOUN
dpc-2415	51	8	of	of	ADP
dpc-2415	51	9	the	the	DET
dpc-2415	51	10	il-22	il-22	ADJ
dpc-2415	51	11	receptor	receptor	NOUN
dpc-2415	51	12	complex	complex	NOUN
dpc-2415	52	1	[	[	X
dpc-2415	52	2	41	41	NUM
dpc-2415	52	3	]	]	PUNCT
dpc-2415	52	4	.	.	PUNCT
dpc-2415	53	1	the	the	DET
dpc-2415	53	2	avp	avp	VERB
dpc-2415	53	3	-	-	PUNCT
dpc-2415	53	4	inducing	inducing	ADJ
dpc-2415	53	5	effect	effect	NOUN
dpc-2415	53	6	of	of	ADP
dpc-2415	53	7	il-29	il-29	PRON
dpc-2415	53	8	can	can	AUX
dpc-2415	53	9	be	be	AUX
dpc-2415	53	10	only	only	ADV
dpc-2415	53	11	minimally	minimally	ADV
dpc-2415	53	12	amplified	amplify	VERB
dpc-2415	53	13	by	by	ADP
dpc-2415	53	14	ifn	ifn	PROPN
dpc-2415	53	15	-	-	PUNCT
dpc-2415	53	16	γ	γ	NOUN
dpc-2415	53	17	in	in	ADP
dpc-2415	53	18	keratinocytes	keratinocyte	NOUN
dpc-2415	53	19	[	[	X
dpc-2415	53	20	40	40	NUM
dpc-2415	53	21	]	]	PUNCT
dpc-2415	53	22	.	.	PUNCT
dpc-2415	54	1	an	an	DET
dpc-2415	54	2	overview	overview	NOUN
dpc-2415	54	3	of	of	ADP
dpc-2415	54	4	the	the	DET
dpc-2415	54	5	main	main	ADJ
dpc-2415	54	6	psoriasis	psoriasis	NOUN
dpc-2415	54	7	signature	signature	NOUN
dpc-2415	54	8	cytokines	cytokine	NOUN
dpc-2415	54	9	and	and	CCONJ
dpc-2415	54	10	their	their	PRON
dpc-2415	54	11	effects	effect	NOUN
dpc-2415	54	12	on	on	ADP
dpc-2415	54	13	infections	infection	NOUN
dpc-2415	54	14	is	be	AUX
dpc-2415	54	15	shown	show	VERB
dpc-2415	54	16	in	in	ADP
dpc-2415	54	17	table	table	NOUN
dpc-2415	54	18	1	1	NUM
dpc-2415	54	19	.	.	X
dpc-2415	54	20	review	review	VERB
dpc-2415	54	21	|	|	ADV
dpc-2415	54	22	dermatol	dermatol	ADJ
dpc-2415	54	23	pract	pract	NOUN
dpc-2415	54	24	concept	concept	NOUN
dpc-2415	54	25	.	.	PUNCT
dpc-2415	55	1	2023;13(1):e2023016	2023;13(1):e2023016	NUM
dpc-2415	55	2	3	3	NUM
dpc-2415	55	3	psoriasis	psoriasis	NOUN
dpc-2415	55	4	and	and	CCONJ
dpc-2415	55	5	respiratory	respiratory	ADJ
dpc-2415	55	6	infections	infection	NOUN
dpc-2415	55	7	lower	low	ADJ
dpc-2415	55	8	respiratory	respiratory	ADJ
dpc-2415	55	9	tract	tract	NOUN
dpc-2415	55	10	infections	infection	NOUN
dpc-2415	55	11	including	include	VERB
dpc-2415	55	12	pneumonia	pneumonia	NOUN
dpc-2415	55	13	are	be	AUX
dpc-2415	55	14	the	the	DET
dpc-2415	55	15	most	most	ADV
dpc-2415	55	16	frequent	frequent	ADJ
dpc-2415	55	17	types	type	NOUN
dpc-2415	55	18	of	of	ADP
dpc-2415	55	19	serious	serious	ADJ
dpc-2415	55	20	infections	infection	NOUN
dpc-2415	55	21	among	among	ADP
dpc-2415	55	22	psoriasis	psoriasis	NOUN
dpc-2415	55	23	patients	patient	NOUN
dpc-2415	55	24	as	as	SCONJ
dpc-2415	55	25	documented	document	VERB
dpc-2415	55	26	by	by	ADP
dpc-2415	55	27	numerous	numerous	ADJ
dpc-2415	55	28	registries	registry	NOUN
dpc-2415	55	29	[	[	X
dpc-2415	55	30	42	42	NUM
dpc-2415	55	31	,	,	PUNCT
dpc-2415	55	32	43	43	NUM
dpc-2415	55	33	]	]	PUNCT
dpc-2415	55	34	.	.	PUNCT
dpc-2415	56	1	the	the	DET
dpc-2415	56	2	incidence	incidence	NOUN
dpc-2415	56	3	of	of	ADP
dpc-2415	56	4	pneumonia	pneumonia	NOUN
dpc-2415	56	5	seems	seem	VERB
dpc-2415	56	6	to	to	PART
dpc-2415	56	7	be	be	AUX
dpc-2415	56	8	even	even	ADV
dpc-2415	56	9	increased	increase	VERB
dpc-2415	56	10	among	among	ADP
dpc-2415	56	11	psoriasis	psoriasis	NOUN
dpc-2415	56	12	patients	patient	NOUN
dpc-2415	56	13	compared	compare	VERB
dpc-2415	56	14	to	to	ADP
dpc-2415	56	15	those	those	PRON
dpc-2415	56	16	without	without	ADP
dpc-2415	56	17	psoriasis	psoriasis	NOUN
dpc-2415	56	18	[	[	X
dpc-2415	56	19	44,45	44,45	NOUN
dpc-2415	56	20	]	]	X
dpc-2415	56	21	.	.	PUNCT
dpc-2415	57	1	however	however	ADV
dpc-2415	57	2	,	,	PUNCT
dpc-2415	57	3	it	it	PRON
dpc-2415	57	4	is	be	AUX
dpc-2415	57	5	not	not	PART
dpc-2415	57	6	definitely	definitely	ADV
dpc-2415	57	7	clear	clear	ADJ
dpc-2415	57	8	to	to	ADP
dpc-2415	57	9	what	what	DET
dpc-2415	57	10	extent	extent	NOUN
dpc-2415	57	11	this	this	DET
dpc-2415	57	12	increase	increase	NOUN
dpc-2415	57	13	is	be	AUX
dpc-2415	57	14	related	relate	VERB
dpc-2415	57	15	,	,	PUNCT
dpc-2415	57	16	either	either	CCONJ
dpc-2415	57	17	to	to	PART
dpc-2415	57	18	psoriasis	psoriasis	VERB
dpc-2415	57	19	itself	itself	PRON
dpc-2415	57	20	,	,	PUNCT
dpc-2415	57	21	its	its	PRON
dpc-2415	57	22	concomitant	concomitant	ADJ
dpc-2415	57	23	disorders	disorder	NOUN
dpc-2415	57	24	,	,	PUNCT
dpc-2415	57	25	or	or	CCONJ
dpc-2415	57	26	its	its	PRON
dpc-2415	57	27	treatment	treatment	NOUN
dpc-2415	57	28	[	[	X
dpc-2415	57	29	44	44	NUM
dpc-2415	57	30	]	]	PUNCT
dpc-2415	57	31	.	.	PUNCT
dpc-2415	58	1	in	in	ADP
dpc-2415	58	2	fact	fact	NOUN
dpc-2415	58	3	,	,	PUNCT
dpc-2415	58	4	psoriasis	psoriasis	NOUN
dpc-2415	58	5	patients	patient	NOUN
dpc-2415	58	6	frequently	frequently	ADV
dpc-2415	58	7	suffer	suffer	VERB
dpc-2415	58	8	from	from	ADP
dpc-2415	58	9	diabetes	diabetes	NOUN
dpc-2415	58	10	mellitus	mellitus	NOUN
dpc-2415	58	11	,	,	PUNCT
dpc-2415	58	12	hyperlipidemia	hyperlipidemia	NOUN
dpc-2415	58	13	,	,	PUNCT
dpc-2415	58	14	and	and	CCONJ
dpc-2415	58	15	hypertension	hypertension	NOUN
dpc-2415	58	16	,	,	PUNCT
dpc-2415	58	17	are	be	AUX
dpc-2415	58	18	smokers	smoker	NOUN
dpc-2415	58	19	,	,	PUNCT
dpc-2415	58	20	and	and	CCONJ
dpc-2415	58	21	have	have	VERB
dpc-2415	58	22	elevated	elevated	ADJ
dpc-2415	58	23	body	body	NOUN
dpc-2415	58	24	mass	mass	NOUN
dpc-2415	58	25	index	index	NOUN
dpc-2415	58	26	(	(	PUNCT
dpc-2415	58	27	bmi	bmi	PROPN
dpc-2415	58	28	)	)	PUNCT
dpc-2415	58	29	,	,	PUNCT
dpc-2415	58	30	which	which	PRON
dpc-2415	58	31	can	can	AUX
dpc-2415	58	32	make	make	VERB
dpc-2415	58	33	them	they	PRON
dpc-2415	58	34	vulnerable	vulnerable	ADJ
dpc-2415	58	35	to	to	ADP
dpc-2415	58	36	infectious	infectious	ADJ
dpc-2415	58	37	diseases	disease	NOUN
dpc-2415	58	38	[	[	X
dpc-2415	58	39	25,46	25,46	X
dpc-2415	58	40	]	]	X
dpc-2415	58	41	.	.	PUNCT
dpc-2415	59	1	systemic	systemic	ADJ
dpc-2415	59	2	therapies	therapy	NOUN
dpc-2415	59	3	and	and	CCONJ
dpc-2415	59	4	infection	infection	NOUN
dpc-2415	59	5	risk	risk	NOUN
dpc-2415	59	6	,	,	PUNCT
dpc-2415	59	7	including	include	VERB
dpc-2415	59	8	sars	sar	NOUN
dpc-2415	59	9	-	-	PUNCT
dpc-2415	59	10	cov-2	cov-2	NOUN
dpc-2415	59	11	the	the	DET
dpc-2415	59	12	conventional	conventional	ADJ
dpc-2415	59	13	systemic	systemic	ADJ
dpc-2415	59	14	therapies	therapy	NOUN
dpc-2415	59	15	for	for	ADP
dpc-2415	59	16	plaque	plaque	NOUN
dpc-2415	59	17	psoriasis	psoriasis	NOUN
dpc-2415	59	18	include	include	VERB
dpc-2415	59	19	cyclosporine	cyclosporine	NOUN
dpc-2415	59	20	,	,	PUNCT
dpc-2415	59	21	methotrexate	methotrexate	ADJ
dpc-2415	59	22	,	,	PUNCT
dpc-2415	59	23	and	and	CCONJ
dpc-2415	59	24	oral	oral	ADJ
dpc-2415	59	25	retinoids	retinoid	NOUN
dpc-2415	59	26	[	[	X
dpc-2415	59	27	47	47	NUM
dpc-2415	59	28	]	]	PUNCT
dpc-2415	59	29	.	.	PUNCT
dpc-2415	60	1	cyclosporine	cyclosporine	PROPN
dpc-2415	60	2	is	be	AUX
dpc-2415	60	3	a	a	DET
dpc-2415	60	4	calcineurin	calcineurin	ADJ
dpc-2415	60	5	inhibitor	inhibitor	NOUN
dpc-2415	60	6	broadly	broadly	ADV
dpc-2415	60	7	suppressing	suppress	VERB
dpc-2415	60	8	t	t	NOUN
dpc-2415	60	9	cells	cell	NOUN
dpc-2415	60	10	;	;	PUNCT
dpc-2415	60	11	methotrexate	methotrexate	NOUN
dpc-2415	60	12	,	,	PUNCT
dpc-2415	60	13	and	and	CCONJ
dpc-2415	60	14	retinoids	retinoid	NOUN
dpc-2415	60	15	have	have	VERB
dpc-2415	60	16	multiple	multiple	ADJ
dpc-2415	60	17	effects	effect	NOUN
dpc-2415	60	18	on	on	ADP
dpc-2415	60	19	several	several	ADJ
dpc-2415	60	20	immune	immune	ADJ
dpc-2415	60	21	cells	cell	NOUN
dpc-2415	60	22	.	.	PUNCT
dpc-2415	61	1	more	more	ADV
dpc-2415	61	2	recently	recently	ADV
dpc-2415	61	3	,	,	PUNCT
dpc-2415	61	4	2	2	NUM
dpc-2415	61	5	small	small	ADJ
dpc-2415	61	6	-	-	PUNCT
dpc-2415	61	7	molecule	molecule	NOUN
dpc-2415	61	8	drugs	drug	NOUN
dpc-2415	61	9	table	table	NOUN
dpc-2415	61	10	1	1	NUM
dpc-2415	61	11	.	.	X
dpc-2415	62	1	psoriasis	psoriasis	NOUN
dpc-2415	62	2	signature	signature	NOUN
dpc-2415	62	3	cytokines	cytokine	NOUN
dpc-2415	62	4	and	and	CCONJ
dpc-2415	62	5	their	their	PRON
dpc-2415	62	6	effects	effect	NOUN
dpc-2415	62	7	on	on	ADP
dpc-2415	62	8	infections	infection	NOUN
dpc-2415	62	9	.	.	PUNCT
dpc-2415	63	1	cytokines	cytokine	VERB
dpc-2415	63	2	cellular	cellular	ADJ
dpc-2415	63	3	sources	source	NOUN
dpc-2415	63	4	findings	finding	VERB
dpc-2415	63	5	il-12	il-12	PRON
dpc-2415	63	6	dcs	dcs	PROPN
dpc-2415	63	7	,	,	PUNCT
dpc-2415	63	8	monocytes	monocyte	NOUN
dpc-2415	63	9	,	,	PUNCT
dpc-2415	63	10	macrophages	macrophage	NOUN
dpc-2415	63	11	,	,	PUNCT
dpc-2415	63	12	neutrophils	neutrophil	NOUN
dpc-2415	63	13	,	,	PUNCT
dpc-2415	63	14	b	b	NOUN
dpc-2415	63	15	cells	cell	NOUN
dpc-2415	63	16	and	and	CCONJ
dpc-2415	63	17	kcs	kcs	NOUN
dpc-2415	63	18	enhances	enhance	NOUN
dpc-2415	63	19	hbd-2	hbd-2	ADP
dpc-2415	63	20	production	production	NOUN
dpc-2415	63	21	in	in	ADP
dpc-2415	63	22	kcs	kcs	PROPN
dpc-2415	63	23	,	,	PUNCT
dpc-2415	63	24	and	and	CCONJ
dpc-2415	63	25	the	the	DET
dpc-2415	63	26	antimicrobial	antimicrobial	ADJ
dpc-2415	63	27	activity	activity	NOUN
dpc-2415	63	28	of	of	ADP
dpc-2415	63	29	macrophages	macrophage	NOUN
dpc-2415	63	30	il-17a	il-17a	PROPN
dpc-2415	63	31	th17	th17	PROPN
dpc-2415	63	32	cells	cell	NOUN
dpc-2415	63	33	,	,	PUNCT
dpc-2415	63	34	ilc3s	ilc3s	NOUN
dpc-2415	63	35	,	,	PUNCT
dpc-2415	63	36	mast	mast	NOUN
dpc-2415	63	37	cells	cell	NOUN
dpc-2415	63	38	,	,	PUNCT
dpc-2415	63	39	neutrophils	neutrophil	NOUN
dpc-2415	63	40	,	,	PUNCT
dpc-2415	63	41	cd8	cd8	PROPN
dpc-2415	63	42	+	+	PROPN
dpc-2415	63	43	t	t	NOUN
dpc-2415	63	44	cells	cell	NOUN
dpc-2415	63	45	,	,	PUNCT
dpc-2415	63	46	γδ	γδ	ADP
dpc-2415	63	47	t	t	NOUN
dpc-2415	63	48	cells	cell	NOUN
dpc-2415	63	49	,	,	PUNCT
dpc-2415	63	50	nk	nk	PROPN
dpc-2415	63	51	cells	cell	NOUN
dpc-2415	63	52	,	,	PUNCT
dpc-2415	63	53	inkt	inkt	NOUN
dpc-2415	63	54	cells	cell	NOUN
dpc-2415	63	55	,	,	PUNCT
dpc-2415	63	56	and	and	CCONJ
dpc-2415	63	57	lti	lti	PROPN
dpc-2415	63	58	cells	cell	NOUN
dpc-2415	63	59	induces	induce	VERB
dpc-2415	63	60	the	the	DET
dpc-2415	63	61	production	production	NOUN
dpc-2415	63	62	of	of	ADP
dpc-2415	63	63	amps	amp	NOUN
dpc-2415	63	64	(	(	PUNCT
dpc-2415	63	65	hbd-2	hbd-2	NOUN
dpc-2415	63	66	,	,	PUNCT
dpc-2415	63	67	ll-37	ll-37	NOUN
dpc-2415	63	68	,	,	PUNCT
dpc-2415	63	69	lcn-2	lcn-2	X
dpc-2415	63	70	,	,	PUNCT
dpc-2415	63	71	and	and	CCONJ
dpc-2415	63	72	s100a7	s100a7	VERB
dpc-2415	63	73	-	-	PUNCT
dpc-2415	63	74	9	9	NUM
dpc-2415	63	75	)	)	PUNCT
dpc-2415	63	76	in	in	ADP
dpc-2415	63	77	kcs	kcs	PROPN
dpc-2415	63	78	,	,	PUNCT
dpc-2415	63	79	neutrophil	neutrophil	ADJ
dpc-2415	63	80	recruitment	recruitment	NOUN
dpc-2415	63	81	,	,	PUNCT
dpc-2415	63	82	and	and	CCONJ
dpc-2415	63	83	immunity	immunity	NOUN
dpc-2415	63	84	to	to	ADP
dpc-2415	63	85	extracellular	extracellular	ADJ
dpc-2415	63	86	pathogens	pathogen	NOUN
dpc-2415	63	87	il-17c	il-17c	VERB
dpc-2415	63	88	prostate	prostate	NOUN
dpc-2415	63	89	and	and	CCONJ
dpc-2415	63	90	fetal	fetal	ADJ
dpc-2415	63	91	kidney	kidney	NOUN
dpc-2415	63	92	cells	cell	NOUN
dpc-2415	63	93	,	,	PUNCT
dpc-2415	63	94	kcs	kcs	NOUN
dpc-2415	63	95	,	,	PUNCT
dpc-2415	63	96	colonic	colonic	ADJ
dpc-2415	63	97	epithelial	epithelial	ADJ
dpc-2415	63	98	cells	cell	NOUN
dpc-2415	63	99	,	,	PUNCT
dpc-2415	63	100	and	and	CCONJ
dpc-2415	63	101	lung	lung	NOUN
dpc-2415	63	102	epithelial	epithelial	ADJ
dpc-2415	63	103	cells	cell	NOUN
dpc-2415	63	104	enhances	enhance	VERB
dpc-2415	63	105	epithelial	epithelial	ADJ
dpc-2415	63	106	host	host	NOUN
dpc-2415	63	107	defense	defense	NOUN
dpc-2415	63	108	(	(	PUNCT
dpc-2415	63	109	hbd-2/-3	hbd-2/-3	PROPN
dpc-2415	63	110	,	,	PUNCT
dpc-2415	63	111	and	and	CCONJ
dpc-2415	63	112	s100a7	s100a7	VERB
dpc-2415	63	113	-	-	PUNCT
dpc-2415	63	114	9	9	NUM
dpc-2415	63	115	)	)	PUNCT
dpc-2415	63	116	in	in	ADP
dpc-2415	63	117	an	an	DET
dpc-2415	63	118	autocrine	autocrine	NOUN
dpc-2415	63	119	/	/	SYM
dpc-2415	63	120	paracrine	paracrine	NOUN
dpc-2415	63	121	manner	manner	NOUN
dpc-2415	63	122	il-17e	il-17e	NOUN
dpc-2415	63	123	intraepithelial	intraepithelial	ADJ
dpc-2415	63	124	lymphocytes	lymphocyte	NOUN
dpc-2415	63	125	,	,	PUNCT
dpc-2415	63	126	lung	lung	NOUN
dpc-2415	63	127	epithelial	epithelial	ADJ
dpc-2415	63	128	cells	cell	NOUN
dpc-2415	63	129	,	,	PUNCT
dpc-2415	63	130	alveolar	alveolar	ADJ
dpc-2415	63	131	macrophages	macrophage	NOUN
dpc-2415	63	132	,	,	PUNCT
dpc-2415	63	133	eosinophils	eosinophil	NOUN
dpc-2415	63	134	,	,	PUNCT
dpc-2415	63	135	basophils	basophils	PROPN
dpc-2415	63	136	,	,	PUNCT
dpc-2415	63	137	nkt	nkt	NOUN
dpc-2415	63	138	cells	cell	NOUN
dpc-2415	63	139	,	,	PUNCT
dpc-2415	63	140	th2	th2	PROPN
dpc-2415	63	141	cells	cell	NOUN
dpc-2415	63	142	,	,	PUNCT
dpc-2415	63	143	mast	mast	NOUN
dpc-2415	63	144	cells	cell	NOUN
dpc-2415	63	145	,	,	PUNCT
dpc-2415	63	146	and	and	CCONJ
dpc-2415	63	147	cells	cell	NOUN
dpc-2415	63	148	of	of	ADP
dpc-2415	63	149	the	the	DET
dpc-2415	63	150	gastrointestinal	gastrointestinal	ADJ
dpc-2415	63	151	tract	tract	NOUN
dpc-2415	63	152	and	and	CCONJ
dpc-2415	63	153	uterus	uterus	NOUN
dpc-2415	63	154	promotes	promote	VERB
dpc-2415	63	155	innate	innate	ADJ
dpc-2415	63	156	cell	cell	NOUN
dpc-2415	63	157	recruitment	recruitment	NOUN
dpc-2415	63	158	and	and	CCONJ
dpc-2415	63	159	activation	activation	NOUN
dpc-2415	63	160	.	.	PUNCT
dpc-2415	64	1	provides	provide	VERB
dpc-2415	64	2	immunity	immunity	NOUN
dpc-2415	64	3	to	to	ADP
dpc-2415	64	4	extracellular	extracellular	ADJ
dpc-2415	64	5	pathogens	pathogen	NOUN
dpc-2415	64	6	il-17f	il-17f	ADP
dpc-2415	64	7	th17	th17	NOUN
dpc-2415	64	8	cells	cell	NOUN
dpc-2415	64	9	,	,	PUNCT
dpc-2415	64	10	mast	mast	NOUN
dpc-2415	64	11	cells	cell	NOUN
dpc-2415	64	12	,	,	PUNCT
dpc-2415	64	13	neutrophils	neutrophil	NOUN
dpc-2415	64	14	,	,	PUNCT
dpc-2415	64	15	cd8	cd8	PROPN
dpc-2415	64	16	+	+	PROPN
dpc-2415	64	17	t	t	NOUN
dpc-2415	64	18	cells	cell	NOUN
dpc-2415	64	19	,	,	PUNCT
dpc-2415	64	20	γδ	γδ	ADP
dpc-2415	64	21	t	t	NOUN
dpc-2415	64	22	cells	cell	NOUN
dpc-2415	64	23	,	,	PUNCT
dpc-2415	64	24	nk	nk	PROPN
dpc-2415	64	25	cells	cell	NOUN
dpc-2415	64	26	,	,	PUNCT
dpc-2415	64	27	nkt	nkt	NOUN
dpc-2415	64	28	cells	cell	NOUN
dpc-2415	64	29	,	,	PUNCT
dpc-2415	64	30	and	and	CCONJ
dpc-2415	64	31	lti	lti	PROPN
dpc-2415	64	32	cells	cell	NOUN
dpc-2415	64	33	synergistically	synergistically	ADV
dpc-2415	64	34	cooperates	cooperate	VERB
dpc-2415	64	35	with	with	ADP
dpc-2415	64	36	il-17a	il-17a	PROPN
dpc-2415	64	37	and	and	CCONJ
dpc-2415	64	38	il-22	il-22	NOUN
dpc-2415	64	39	for	for	ADP
dpc-2415	64	40	the	the	DET
dpc-2415	64	41	induction	induction	NOUN
dpc-2415	64	42	of	of	ADP
dpc-2415	64	43	amps	amp	NOUN
dpc-2415	64	44	in	in	ADP
dpc-2415	64	45	kcs	kcs	PROPN
dpc-2415	64	46	.	.	PUNCT
dpc-2415	64	47	provides	provide	VERB
dpc-2415	64	48	immunity	immunity	NOUN
dpc-2415	64	49	to	to	ADP
dpc-2415	64	50	extracellular	extracellular	ADJ
dpc-2415	64	51	pathogens	pathogen	NOUN
dpc-2415	64	52	and	and	CCONJ
dpc-2415	64	53	is	be	AUX
dpc-2415	64	54	involved	involve	VERB
dpc-2415	64	55	in	in	ADP
dpc-2415	64	56	neutrophil	neutrophil	ADJ
dpc-2415	64	57	recruitment	recruitment	NOUN
dpc-2415	64	58	il-19	il-19	ADP
dpc-2415	64	59	monocytes	monocyte	NOUN
dpc-2415	64	60	,	,	PUNCT
dpc-2415	64	61	dcs	dcs	PROPN
dpc-2415	64	62	and	and	CCONJ
dpc-2415	64	63	kcs	kcs	PROPN
dpc-2415	64	64	increases	increase	VERB
dpc-2415	64	65	the	the	DET
dpc-2415	64	66	production	production	NOUN
dpc-2415	64	67	of	of	ADP
dpc-2415	64	68	amps	amp	NOUN
dpc-2415	64	69	(	(	PUNCT
dpc-2415	64	70	s100a7	s100a7	VERB
dpc-2415	64	71	-	-	PUNCT
dpc-2415	64	72	9	9	NUM
dpc-2415	64	73	)	)	PUNCT
dpc-2415	64	74	in	in	ADP
dpc-2415	64	75	kcs	kcs	PROPN
dpc-2415	64	76	and	and	CCONJ
dpc-2415	64	77	amplifies	amplify	VERB
dpc-2415	64	78	il-17a	il-17a	PROPN
dpc-2415	64	79	activity	activity	NOUN
dpc-2415	64	80	.	.	PUNCT
dpc-2415	65	1	il-21	il-21	PRON
dpc-2415	65	2	th17	th17	PROPN
dpc-2415	65	3	cells	cell	NOUN
dpc-2415	65	4	,	,	PUNCT
dpc-2415	65	5	th1	th1	PROPN
dpc-2415	65	6	*	*	NOUN
dpc-2415	65	7	cells	cell	NOUN
dpc-2415	65	8	,	,	PUNCT
dpc-2415	65	9	th2	th2	PROPN
dpc-2415	65	10	cells	cell	NOUN
dpc-2415	65	11	,	,	PUNCT
dpc-2415	65	12	cd8	cd8	PROPN
dpc-2415	65	13	+	+	PROPN
dpc-2415	65	14	t	t	NOUN
dpc-2415	65	15	cells	cell	NOUN
dpc-2415	65	16	,	,	PUNCT
dpc-2415	65	17	and	and	CCONJ
dpc-2415	65	18	nkt	nkt	NOUN
dpc-2415	65	19	cells	cell	NOUN
dpc-2415	65	20	enhances	enhance	VERB
dpc-2415	65	21	the	the	DET
dpc-2415	65	22	antimicrobial	antimicrobial	ADJ
dpc-2415	65	23	activity	activity	NOUN
dpc-2415	65	24	of	of	ADP
dpc-2415	65	25	macrophages	macrophage	NOUN
dpc-2415	65	26	,	,	PUNCT
dpc-2415	65	27	and	and	CCONJ
dpc-2415	65	28	maintains	maintain	VERB
dpc-2415	65	29	the	the	DET
dpc-2415	65	30	cd8	cd8	PROPN
dpc-2415	65	31	+	+	PROPN
dpc-2415	65	32	t	t	PROPN
dpc-2415	65	33	cell	cell	NOUN
dpc-2415	65	34	effector	effector	NOUN
dpc-2415	65	35	activity	activity	NOUN
dpc-2415	65	36	during	during	ADP
dpc-2415	65	37	the	the	DET
dpc-2415	65	38	infection	infection	NOUN
dpc-2415	65	39	il-22	il-22	PRON
dpc-2415	65	40	th22	th22	PROPN
dpc-2415	65	41	cells	cell	NOUN
dpc-2415	65	42	,	,	PUNCT
dpc-2415	65	43	th17	th17	PROPN
dpc-2415	65	44	cells	cell	NOUN
dpc-2415	65	45	,	,	PUNCT
dpc-2415	65	46	th1	th1	NOUN
dpc-2415	65	47	cells	cell	NOUN
dpc-2415	65	48	,	,	PUNCT
dpc-2415	65	49	cd8	cd8	PROPN
dpc-2415	65	50	+	+	PROPN
dpc-2415	65	51	t	t	NOUN
dpc-2415	65	52	cells	cell	NOUN
dpc-2415	65	53	,	,	PUNCT
dpc-2415	65	54	γδ	γδ	ADP
dpc-2415	65	55	t	t	NOUN
dpc-2415	65	56	cells	cell	NOUN
dpc-2415	65	57	,	,	PUNCT
dpc-2415	65	58	ilc3s	ilc3s	PROPN
dpc-2415	65	59	,	,	PUNCT
dpc-2415	65	60	nkt	nkt	NOUN
dpc-2415	65	61	cells	cell	NOUN
dpc-2415	65	62	,	,	PUNCT
dpc-2415	65	63	lti	lti	PROPN
dpc-2415	65	64	cells	cell	NOUN
dpc-2415	65	65	,	,	PUNCT
dpc-2415	65	66	alveolar	alveolar	ADJ
dpc-2415	65	67	macrophages	macrophage	NOUN
dpc-2415	65	68	*	*	PUNCT
dpc-2415	65	69	,	,	PUNCT
dpc-2415	65	70	and	and	CCONJ
dpc-2415	65	71	neutrophils	neutrophil	NOUN
dpc-2415	65	72	*	*	NOUN
dpc-2415	65	73	increases	increase	VERB
dpc-2415	65	74	the	the	DET
dpc-2415	65	75	expression	expression	NOUN
dpc-2415	65	76	of	of	ADP
dpc-2415	65	77	hbd-2/-3	hbd-2/-3	PROPN
dpc-2415	65	78	,	,	PUNCT
dpc-2415	65	79	and	and	CCONJ
dpc-2415	65	80	s100a7	s100a7	VERB
dpc-2415	65	81	-	-	PUNCT
dpc-2415	65	82	9	9	NUM
dpc-2415	65	83	in	in	ADP
dpc-2415	65	84	kcs	kcs	NOUN
dpc-2415	65	85	,	,	PUNCT
dpc-2415	65	86	and	and	CCONJ
dpc-2415	65	87	reinforces	reinforce	VERB
dpc-2415	65	88	tnf	tnf	PROPN
dpc-2415	65	89	-	-	PUNCT
dpc-2415	65	90	α	α	NOUN
dpc-2415	65	91	activity	activity	NOUN
dpc-2415	65	92	il-23	il-23	X
dpc-2415	65	93	dcs	dcs	PROPN
dpc-2415	65	94	,	,	PUNCT
dpc-2415	65	95	macrophages	macrophage	NOUN
dpc-2415	65	96	,	,	PUNCT
dpc-2415	65	97	and	and	CCONJ
dpc-2415	65	98	psoriatic	psoriatic	ADJ
dpc-2415	65	99	kcs	kcs	NOUN
dpc-2415	65	100	induces	induce	VERB
dpc-2415	65	101	hbd-2	hbd-2	NOUN
dpc-2415	65	102	expression	expression	NOUN
dpc-2415	65	103	in	in	ADP
dpc-2415	65	104	kcs	kcs	NOUN
dpc-2415	65	105	,	,	PUNCT
dpc-2415	65	106	and	and	CCONJ
dpc-2415	65	107	optimizes	optimize	VERB
dpc-2415	65	108	the	the	DET
dpc-2415	65	109	antimicrobial	antimicrobial	ADJ
dpc-2415	65	110	activity	activity	NOUN
dpc-2415	65	111	of	of	ADP
dpc-2415	65	112	macrophages	macrophage	NOUN
dpc-2415	65	113	il-26	il-26	PART
dpc-2415	65	114	th17	th17	NOUN
dpc-2415	65	115	cells	cell	NOUN
dpc-2415	65	116	,	,	PUNCT
dpc-2415	65	117	th1	th1	NOUN
dpc-2415	65	118	cells	cell	NOUN
dpc-2415	65	119	,	,	PUNCT
dpc-2415	65	120	epithelial	epithelial	ADJ
dpc-2415	65	121	cells	cell	NOUN
dpc-2415	65	122	,	,	PUNCT
dpc-2415	65	123	nk	nk	PROPN
dpc-2415	65	124	cells	cell	NOUN
dpc-2415	65	125	,	,	PUNCT
dpc-2415	65	126	alveolar	alveolar	ADJ
dpc-2415	65	127	macrophages	macrophage	NOUN
dpc-2415	65	128	,	,	PUNCT
dpc-2415	65	129	and	and	CCONJ
dpc-2415	65	130	macrophage	macrophage	ADJ
dpc-2415	65	131	-	-	PUNCT
dpc-2415	65	132	like	like	ADJ
dpc-2415	65	133	synoviocytes	synoviocyte	NOUN
dpc-2415	65	134	exerts	exert	VERB
dpc-2415	65	135	antiviral	antiviral	ADJ
dpc-2415	65	136	and	and	CCONJ
dpc-2415	65	137	antimicrobial	antimicrobial	ADJ
dpc-2415	65	138	actions	action	NOUN
dpc-2415	65	139	,	,	PUNCT
dpc-2415	65	140	as	as	ADV
dpc-2415	65	141	well	well	ADV
dpc-2415	65	142	as	as	ADP
dpc-2415	65	143	regulates	regulate	VERB
dpc-2415	65	144	the	the	DET
dpc-2415	65	145	expression	expression	NOUN
dpc-2415	65	146	of	of	ADP
dpc-2415	65	147	hbd-2/-3	hbd-2/-3	PROPN
dpc-2415	65	148	il-29	il-29	NUM
dpc-2415	65	149	(	(	PUNCT
dpc-2415	65	150	alternative	alternative	ADJ
dpc-2415	65	151	name	name	NOUN
dpc-2415	65	152	infλ	infλ	NOUN
dpc-2415	65	153	)	)	PUNCT
dpc-2415	66	1	th17	th17	NOUN
dpc-2415	66	2	cells	cell	NOUN
dpc-2415	66	3	,	,	PUNCT
dpc-2415	66	4	dcs	dcs	PROPN
dpc-2415	66	5	,	,	PUNCT
dpc-2415	66	6	macrophages	macrophage	NOUN
dpc-2415	66	7	,	,	PUNCT
dpc-2415	66	8	mast	mast	NOUN
dpc-2415	66	9	cells	cell	NOUN
dpc-2415	66	10	,	,	PUNCT
dpc-2415	66	11	and	and	CCONJ
dpc-2415	66	12	alveolar	alveolar	ADJ
dpc-2415	66	13	cells	cell	NOUN
dpc-2415	66	14	induces	induce	VERB
dpc-2415	66	15	the	the	DET
dpc-2415	66	16	production	production	NOUN
dpc-2415	66	17	of	of	ADP
dpc-2415	66	18	antiviral	antiviral	ADJ
dpc-2415	66	19	proteins	protein	NOUN
dpc-2415	66	20	(	(	PUNCT
dpc-2415	66	21	mx1	mx1	PROPN
dpc-2415	66	22	,	,	PUNCT
dpc-2415	66	23	bst2	bst2	PROPN
dpc-2415	66	24	,	,	PUNCT
dpc-2415	66	25	isg15	isg15	PROPN
dpc-2415	66	26	,	,	PUNCT
dpc-2415	66	27	and	and	CCONJ
dpc-2415	66	28	oas2	oas2	PROPN
dpc-2415	66	29	)	)	PUNCT
dpc-2415	66	30	in	in	ADP
dpc-2415	66	31	kcs	kcs	PROPN
dpc-2415	66	32	il-36s	il-36s	PROPN
dpc-2415	66	33	kcs	kcs	PROPN
dpc-2415	66	34	,	,	PUNCT
dpc-2415	66	35	macrophages	macrophage	NOUN
dpc-2415	66	36	,	,	PUNCT
dpc-2415	66	37	monocytes	monocyte	NOUN
dpc-2415	66	38	,	,	PUNCT
dpc-2415	66	39	dcs	dcs	PROPN
dpc-2415	66	40	,	,	PUNCT
dpc-2415	66	41	and	and	CCONJ
dpc-2415	66	42	lymphocytes	lymphocyte	NOUN
dpc-2415	66	43	promote	promote	VERB
dpc-2415	66	44	viral	viral	ADJ
dpc-2415	66	45	resistance	resistance	NOUN
dpc-2415	66	46	,	,	PUNCT
dpc-2415	66	47	and	and	CCONJ
dpc-2415	66	48	the	the	DET
dpc-2415	66	49	production	production	NOUN
dpc-2415	66	50	of	of	ADP
dpc-2415	66	51	amps	amp	NOUN
dpc-2415	66	52	in	in	ADP
dpc-2415	66	53	kcs	kcs	PROPN
dpc-2415	66	54	tnf	tnf	PROPN
dpc-2415	66	55	-	-	PUNCT
dpc-2415	66	56	α	α	PROPN
dpc-2415	66	57	macrophages	macrophage	NOUN
dpc-2415	66	58	,	,	PUNCT
dpc-2415	66	59	monocytes	monocyte	NOUN
dpc-2415	66	60	,	,	PUNCT
dpc-2415	66	61	dcs	dcs	PROPN
dpc-2415	66	62	,	,	PUNCT
dpc-2415	66	63	nk	nk	PROPN
dpc-2415	66	64	cells	cell	NOUN
dpc-2415	66	65	,	,	PUNCT
dpc-2415	66	66	t	t	NOUN
dpc-2415	66	67	cells	cell	NOUN
dpc-2415	66	68	,	,	PUNCT
dpc-2415	66	69	b	b	NOUN
dpc-2415	66	70	cells	cell	NOUN
dpc-2415	66	71	,	,	PUNCT
dpc-2415	66	72	and	and	CCONJ
dpc-2415	66	73	kcs	kcs	PROPN
dpc-2415	66	74	induces	induce	VERB
dpc-2415	66	75	the	the	DET
dpc-2415	66	76	production	production	NOUN
dpc-2415	66	77	of	of	ADP
dpc-2415	66	78	s100a7	s100a7	ADJ
dpc-2415	66	79	and	and	CCONJ
dpc-2415	66	80	hbd-2/-3	hbd-2/-3	PROPN
dpc-2415	66	81	,	,	PUNCT
dpc-2415	66	82	as	as	ADV
dpc-2415	66	83	well	well	ADV
dpc-2415	66	84	as	as	ADP
dpc-2415	66	85	antimicrobial	antimicrobial	ADJ
dpc-2415	66	86	chemokines	chemokine	NOUN
dpc-2415	66	87	cxcl-9/-10/11	cxcl-9/-10/11	X
dpc-2415	66	88	in	in	ADP
dpc-2415	66	89	kcs	kcs	PROPN
dpc-2415	66	90	*	*	PUNCT
dpc-2415	66	91	controversial	controversial	ADJ
dpc-2415	66	92	among	among	ADP
dpc-2415	66	93	researchers	researcher	NOUN
dpc-2415	66	94	.	.	PUNCT
dpc-2415	67	1	amps	amp	NOUN
dpc-2415	67	2	antimicrobial	antimicrobial	ADJ
dpc-2415	67	3	peptides	peptide	NOUN
dpc-2415	67	4	,	,	PUNCT
dpc-2415	67	5	dcs	dcs	PROPN
dpc-2415	67	6	dendritic	dendritic	ADJ
dpc-2415	67	7	cells	cell	NOUN
dpc-2415	67	8	,	,	PUNCT
dpc-2415	67	9	ilc3s	ilc3s	NOUN
dpc-2415	67	10	type	type	NOUN
dpc-2415	67	11	3	3	NUM
dpc-2415	67	12	innate	innate	ADJ
dpc-2415	67	13	lymphoid	lymphoid	ADJ
dpc-2415	67	14	cells	cell	NOUN
dpc-2415	67	15	,	,	PUNCT
dpc-2415	67	16	kcs	kcs	PROPN
dpc-2415	67	17	keratinocytes	keratinocytes	PROPN
dpc-2415	67	18	,	,	PUNCT
dpc-2415	67	19	lti	lti	PROPN
dpc-2415	67	20	lymphoid	lymphoid	ADJ
dpc-2415	67	21	tissue	tissue	NOUN
dpc-2415	67	22	inducer	inducer	NOUN
dpc-2415	67	23	,	,	PUNCT
dpc-2415	67	24	inkt	inkt	NOUN
dpc-2415	67	25	invariant	invariant	ADJ
dpc-2415	67	26	natural	natural	ADJ
dpc-2415	67	27	killer	killer	NOUN
dpc-2415	67	28	t	t	PROPN
dpc-2415	67	29	cells	cell	NOUN
dpc-2415	67	30	,	,	PUNCT
dpc-2415	67	31	th	th	X
dpc-2415	67	32	t	t	PROPN
dpc-2415	67	33	helper	helper	NOUN
dpc-2415	67	34	.	.	PUNCT
dpc-2415	68	1	data	datum	NOUN
dpc-2415	68	2	from	from	ADP
dpc-2415	68	3	multiple	multiple	ADJ
dpc-2415	68	4	sources	source	NOUN
dpc-2415	68	5	[	[	X
dpc-2415	68	6	12	12	NUM
dpc-2415	68	7	-	-	SYM
dpc-2415	68	8	15	15	NUM
dpc-2415	68	9	,	,	PUNCT
dpc-2415	68	10	20	20	NUM
dpc-2415	68	11	-	-	SYM
dpc-2415	68	12	22	22	NUM
dpc-2415	68	13	,	,	PUNCT
dpc-2415	68	14	29	29	NUM
dpc-2415	68	15	,	,	PUNCT
dpc-2415	68	16	31	31	NUM
dpc-2415	68	17	,	,	PUNCT
dpc-2415	68	18	35	35	NUM
dpc-2415	68	19	-	-	SYM
dpc-2415	68	20	41	41	NUM
dpc-2415	68	21	,	,	PUNCT
dpc-2415	68	22	81	81	NUM
dpc-2415	68	23	-	-	SYM
dpc-2415	68	24	98	98	NUM
dpc-2415	68	25	]	]	SYM
dpc-2415	68	26	4	4	NUM
dpc-2415	68	27	review	review	NOUN
dpc-2415	68	28	|	|	ADV
dpc-2415	68	29	dermatol	dermatol	ADJ
dpc-2415	68	30	pract	pract	NOUN
dpc-2415	68	31	concept	concept	NOUN
dpc-2415	68	32	.	.	PUNCT
dpc-2415	69	1	2023;13(1):e2023016	2023;13(1):e2023016	NUM
dpc-2415	69	2	such	such	ADJ
dpc-2415	69	3	as	as	ADP
dpc-2415	69	4	il-1β	il-1β	PROPN
dpc-2415	69	5	and	and	CCONJ
dpc-2415	69	6	il-6	il-6	NOUN
dpc-2415	69	7	,	,	PUNCT
dpc-2415	69	8	which	which	PRON
dpc-2415	69	9	may	may	AUX
dpc-2415	69	10	play	play	VERB
dpc-2415	69	11	a	a	DET
dpc-2415	69	12	pathogenic	pathogenic	ADJ
dpc-2415	69	13	role	role	NOUN
dpc-2415	69	14	in	in	ADP
dpc-2415	69	15	the	the	DET
dpc-2415	69	16	severe	severe	ADJ
dpc-2415	69	17	/	/	SYM
dpc-2415	69	18	fatal	fatal	ADJ
dpc-2415	69	19	course	course	NOUN
dpc-2415	69	20	of	of	ADP
dpc-2415	69	21	covid-19	covid-19	PROPN
dpc-2415	69	22	infection	infection	NOUN
dpc-2415	69	23	are	be	AUX
dpc-2415	69	24	only	only	ADV
dpc-2415	69	25	moderately	moderately	ADV
dpc-2415	69	26	expressed	express	VERB
dpc-2415	69	27	in	in	ADP
dpc-2415	69	28	psoriatic	psoriatic	ADJ
dpc-2415	69	29	lesions	lesion	NOUN
dpc-2415	69	30	and	and	CCONJ
dpc-2415	69	31	do	do	AUX
dpc-2415	69	32	not	not	PART
dpc-2415	69	33	play	play	VERB
dpc-2415	69	34	an	an	DET
dpc-2415	69	35	important	important	ADJ
dpc-2415	69	36	role	role	NOUN
dpc-2415	69	37	in	in	ADP
dpc-2415	69	38	psoriasis	psoriasis	NOUN
dpc-2415	69	39	pathogenesis	pathogenesis	NOUN
dpc-2415	69	40	compared	compare	VERB
dpc-2415	69	41	to	to	ADP
dpc-2415	69	42	other	other	ADJ
dpc-2415	69	43	inflammatory	inflammatory	ADJ
dpc-2415	69	44	skin	skin	NOUN
dpc-2415	69	45	diseases	disease	NOUN
dpc-2415	69	46	[	[	X
dpc-2415	69	47	57,58	57,58	NUM
dpc-2415	69	48	]	]	PUNCT
dpc-2415	69	49	.	.	PUNCT
dpc-2415	70	1	importantly	importantly	ADV
dpc-2415	70	2	,	,	PUNCT
dpc-2415	70	3	the	the	DET
dpc-2415	70	4	incidence	incidence	NOUN
dpc-2415	70	5	of	of	ADP
dpc-2415	70	6	covid-19	covid-19	PROPN
dpc-2415	70	7	infection	infection	NOUN
dpc-2415	70	8	,	,	PUNCT
dpc-2415	70	9	covid-19	covid-19	PROPN
dpc-2415	70	10	-	-	PUNCT
dpc-2415	70	11	related	relate	VERB
dpc-2415	70	12	hospitalization	hospitalization	NOUN
dpc-2415	70	13	,	,	PUNCT
dpc-2415	70	14	and	and	CCONJ
dpc-2415	70	15	covid-19	covid-19	PROPN
dpc-2415	70	16	-	-	PUNCT
dpc-2415	70	17	related	relate	VERB
dpc-2415	70	18	death	death	NOUN
dpc-2415	70	19	do	do	AUX
dpc-2415	70	20	not	not	PART
dpc-2415	70	21	seem	seem	VERB
dpc-2415	70	22	to	to	PART
dpc-2415	70	23	be	be	AUX
dpc-2415	70	24	elevated	elevate	VERB
dpc-2415	70	25	among	among	ADP
dpc-2415	70	26	psoriasis	psoriasis	NOUN
dpc-2415	70	27	patients	patient	NOUN
dpc-2415	70	28	treated	treat	VERB
dpc-2415	70	29	with	with	ADP
dpc-2415	70	30	biologics	biologic	NOUN
dpc-2415	70	31	[	[	X
dpc-2415	70	32	60,61	60,61	NOUN
dpc-2415	70	33	]	]	PUNCT
dpc-2415	70	34	.	.	PUNCT
dpc-2415	71	1	the	the	DET
dpc-2415	71	2	disease	disease	NOUN
dpc-2415	71	3	course	course	NOUN
dpc-2415	71	4	in	in	ADP
dpc-2415	71	5	most	most	ADJ
dpc-2415	71	6	patients	patient	NOUN
dpc-2415	71	7	with	with	ADP
dpc-2415	71	8	biological	biological	ADJ
dpc-2415	71	9	treatment	treatment	NOUN
dpc-2415	71	10	was	be	AUX
dpc-2415	71	11	even	even	ADV
dpc-2415	71	12	milder	mild	ADJ
dpc-2415	71	13	,	,	PUNCT
dpc-2415	71	14	indicating	indicate	VERB
dpc-2415	71	15	that	that	SCONJ
dpc-2415	71	16	the	the	DET
dpc-2415	71	17	anti	anti	ADJ
dpc-2415	71	18	-	-	ADJ
dpc-2415	71	19	cytokine	cytokine	ADJ
dpc-2415	71	20	therapy	therapy	NOUN
dpc-2415	71	21	may	may	AUX
dpc-2415	71	22	be	be	AUX
dpc-2415	71	23	beneficial	beneficial	ADJ
dpc-2415	71	24	in	in	ADP
dpc-2415	71	25	preventing	prevent	VERB
dpc-2415	71	26	a	a	DET
dpc-2415	71	27	severe	severe	ADJ
dpc-2415	71	28	cytokine	cytokine	NOUN
dpc-2415	71	29	storm	storm	NOUN
dpc-2415	71	30	[	[	X
dpc-2415	71	31	59,62	59,62	NOUN
dpc-2415	71	32	]	]	PUNCT
dpc-2415	71	33	.	.	PUNCT
dpc-2415	72	1	a	a	DET
dpc-2415	72	2	schematization	schematization	NOUN
dpc-2415	72	3	of	of	ADP
dpc-2415	72	4	the	the	DET
dpc-2415	72	5	risks	risk	NOUN
dpc-2415	72	6	and	and	CCONJ
dpc-2415	72	7	benefits	benefit	NOUN
dpc-2415	72	8	of	of	ADP
dpc-2415	72	9	cytokine	cytokine	NOUN
dpc-2415	72	10	-	-	PUNCT
dpc-2415	72	11	blocking	block	VERB
dpc-2415	72	12	therapies	therapy	NOUN
dpc-2415	72	13	in	in	ADP
dpc-2415	72	14	psoriasis	psoriasis	NOUN
dpc-2415	72	15	is	be	AUX
dpc-2415	72	16	displayed	display	VERB
dpc-2415	72	17	in	in	ADP
dpc-2415	72	18	figure	figure	NOUN
dpc-2415	72	19	1	1	NUM
dpc-2415	72	20	.	.	PUNCT
dpc-2415	72	21	prevention	prevention	NOUN
dpc-2415	72	22	and	and	CCONJ
dpc-2415	72	23	management	management	NOUN
dpc-2415	72	24	of	of	ADP
dpc-2415	72	25	infections	infection	NOUN
dpc-2415	72	26	in	in	ADP
dpc-2415	72	27	psoriatic	psoriatic	ADJ
dpc-2415	72	28	patients	patient	NOUN
dpc-2415	72	29	treated	treat	VERB
dpc-2415	72	30	with	with	ADP
dpc-2415	72	31	systemic	systemic	ADJ
dpc-2415	72	32	therapies	therapy	NOUN
dpc-2415	72	33	as	as	SCONJ
dpc-2415	72	34	any	any	DET
dpc-2415	72	35	patient	patient	NOUN
dpc-2415	72	36	with	with	ADP
dpc-2415	72	37	moderate	moderate	ADJ
dpc-2415	72	38	to	to	ADP
dpc-2415	72	39	severe	severe	ADJ
dpc-2415	72	40	psoriasis	psoriasis	NOUN
dpc-2415	72	41	may	may	AUX
dpc-2415	72	42	progress	progress	VERB
dpc-2415	72	43	to	to	ADP
dpc-2415	72	44	immunomodulatory	immunomodulatory	ADJ
dpc-2415	72	45	therapies	therapy	NOUN
dpc-2415	72	46	,	,	PUNCT
dpc-2415	72	47	it	it	PRON
dpc-2415	72	48	is	be	AUX
dpc-2415	72	49	important	important	ADJ
dpc-2415	72	50	that	that	SCONJ
dpc-2415	72	51	their	their	PRON
dpc-2415	72	52	immunizations	immunization	NOUN
dpc-2415	72	53	are	be	AUX
dpc-2415	72	54	up	up	ADP
dpc-2415	72	55	to	to	ADP
dpc-2415	72	56	date	date	NOUN
dpc-2415	72	57	.	.	PUNCT
dpc-2415	73	1	two	two	NUM
dpc-2415	73	2	general	general	ADJ
dpc-2415	73	3	strategies	strategy	NOUN
dpc-2415	73	4	have	have	AUX
dpc-2415	73	5	been	be	AUX
dpc-2415	73	6	suggested	suggest	VERB
dpc-2415	73	7	:	:	PUNCT
dpc-2415	73	8	screening	screen	VERB
dpc-2415	73	9	for	for	ADP
dpc-2415	73	10	infection	infection	NOUN
dpc-2415	73	11	prior	prior	ADV
dpc-2415	73	12	to	to	ADP
dpc-2415	73	13	therapy	therapy	NOUN
dpc-2415	73	14	initiation	initiation	NOUN
dpc-2415	73	15	as	as	ADV
dpc-2415	73	16	well	well	ADV
dpc-2415	73	17	as	as	ADP
dpc-2415	73	18	providing	provide	VERB
dpc-2415	73	19	protection	protection	NOUN
dpc-2415	73	20	through	through	ADP
dpc-2415	73	21	vaccination	vaccination	NOUN
dpc-2415	73	22	.	.	PUNCT
dpc-2415	74	1	as	as	ADP
dpc-2415	74	2	for	for	ADP
dpc-2415	74	3	the	the	DET
dpc-2415	74	4	first	first	ADJ
dpc-2415	74	5	strategy	strategy	NOUN
dpc-2415	74	6	,	,	PUNCT
dpc-2415	74	7	guidelines	guideline	NOUN
dpc-2415	74	8	suggest	suggest	VERB
dpc-2415	74	9	tuberculosis	tuberculosis	PRON
dpc-2415	74	10	screening	screen	VERB
dpc-2415	74	11	before	before	ADP
dpc-2415	74	12	starting	start	VERB
dpc-2415	74	13	all	all	DET
dpc-2415	74	14	biological	biological	ADJ
dpc-2415	74	15	therapies	therapy	NOUN
dpc-2415	74	16	[	[	X
dpc-2415	74	17	63,64	63,64	NUM
dpc-2415	74	18	]	]	X
dpc-2415	74	19	.	.	PUNCT
dpc-2415	75	1	however	however	ADV
dpc-2415	75	2	,	,	PUNCT
dpc-2415	75	3	data	datum	NOUN
dpc-2415	75	4	from	from	ADP
dpc-2415	75	5	clinical	clinical	ADJ
dpc-2415	75	6	trials	trial	NOUN
dpc-2415	75	7	and	and	CCONJ
dpc-2415	75	8	post	post	ADJ
dpc-2415	75	9	-	-	ADJ
dpc-2415	75	10	marketing	marketing	ADJ
dpc-2415	75	11	surveillance	surveillance	NOUN
dpc-2415	75	12	with	with	ADP
dpc-2415	75	13	il-23	il-23	NOUN
dpc-2415	75	14	and	and	CCONJ
dpc-2415	75	15	il-17	il-17	NUM
dpc-2415	75	16	inhibitors	inhibitor	NOUN
dpc-2415	75	17	suggest	suggest	VERB
dpc-2415	75	18	that	that	SCONJ
dpc-2415	75	19	they	they	PRON
dpc-2415	75	20	are	be	AUX
dpc-2415	75	21	not	not	PART
dpc-2415	75	22	crucial	crucial	ADJ
dpc-2415	75	23	to	to	ADP
dpc-2415	75	24	tuberculosis	tuberculosis	NOUN
dpc-2415	75	25	reactivation	reactivation	NOUN
dpc-2415	75	26	[	[	X
dpc-2415	75	27	65	65	NUM
dpc-2415	75	28	]	]	PUNCT
dpc-2415	75	29	.	.	PUNCT
dpc-2415	76	1	furthermore	furthermore	ADV
dpc-2415	76	2	,	,	PUNCT
dpc-2415	76	3	screening	screen	VERB
dpc-2415	76	4	for	for	ADP
dpc-2415	76	5	candida	candida	PROPN
dpc-2415	76	6	infections	infection	NOUN
dpc-2415	76	7	,	,	PUNCT
dpc-2415	76	8	hepatitis	hepatitis	NOUN
dpc-2415	76	9	,	,	PUNCT
dpc-2415	76	10	human	human	ADJ
dpc-2415	76	11	immunodeficiency	immunodeficiency	NOUN
dpc-2415	76	12	virus	virus	NOUN
dpc-2415	76	13	(	(	PUNCT
dpc-2415	76	14	hiv	hiv	PROPN
dpc-2415	76	15	)	)	PUNCT
dpc-2415	76	16	,	,	PUNCT
dpc-2415	76	17	and	and	CCONJ
dpc-2415	76	18	other	other	ADJ
dpc-2415	76	19	chronic	chronic	ADJ
dpc-2415	76	20	infections	infection	NOUN
dpc-2415	76	21	is	be	AUX
dpc-2415	76	22	generally	generally	ADV
dpc-2415	76	23	recommended	recommend	VERB
dpc-2415	76	24	.	.	PUNCT
dpc-2415	77	1	as	as	ADP
dpc-2415	77	2	for	for	ADP
dpc-2415	77	3	the	the	DET
dpc-2415	77	4	latter	latter	ADJ
dpc-2415	77	5	,	,	PUNCT
dpc-2415	77	6	vaccination	vaccination	NOUN
dpc-2415	77	7	is	be	AUX
dpc-2415	77	8	a	a	DET
dpc-2415	77	9	proven	prove	VERB
dpc-2415	77	10	strategy	strategy	NOUN
dpc-2415	77	11	to	to	PART
dpc-2415	77	12	reduce	reduce	VERB
dpc-2415	77	13	infections	infection	NOUN
dpc-2415	77	14	.	.	PUNCT
dpc-2415	78	1	in	in	ADP
dpc-2415	78	2	view	view	NOUN
dpc-2415	78	3	of	of	ADP
dpc-2415	78	4	this	this	PRON
dpc-2415	78	5	,	,	PUNCT
dpc-2415	78	6	dermatologists	dermatologist	NOUN
dpc-2415	78	7	can	can	AUX
dpc-2415	78	8	play	play	VERB
dpc-2415	78	9	an	an	DET
dpc-2415	78	10	important	important	ADJ
dpc-2415	78	11	role	role	NOUN
dpc-2415	78	12	in	in	ADP
dpc-2415	78	13	educating	educate	VERB
dpc-2415	78	14	patients	patient	NOUN
dpc-2415	78	15	about	about	ADP
dpc-2415	78	16	immunizations	immunization	NOUN
dpc-2415	78	17	.	.	PUNCT
dpc-2415	79	1	to	to	PART
dpc-2415	79	2	prevent	prevent	VERB
dpc-2415	79	3	severe	severe	ADJ
dpc-2415	79	4	infections	infection	NOUN
dpc-2415	79	5	,	,	PUNCT
dpc-2415	79	6	it	it	PRON
dpc-2415	79	7	is	be	AUX
dpc-2415	79	8	suggested	suggest	VERB
dpc-2415	79	9	that	that	SCONJ
dpc-2415	79	10	psoriatic	psoriatic	ADJ
dpc-2415	79	11	patients	patient	NOUN
dpc-2415	79	12	receive	receive	VERB
dpc-2415	79	13	their	their	PRON
dpc-2415	79	14	complete	complete	ADJ
dpc-2415	79	15	recommended	recommend	VERB
dpc-2415	79	16	vaccinations	vaccination	NOUN
dpc-2415	79	17	(	(	PUNCT
dpc-2415	79	18	especially	especially	ADV
dpc-2415	79	19	live	live	ADJ
dpc-2415	79	20	vaccines	vaccine	NOUN
dpc-2415	79	21	)	)	PUNCT
dpc-2415	79	22	before	before	ADP
dpc-2415	79	23	initiating	initiate	VERB
dpc-2415	79	24	biological	biological	ADJ
dpc-2415	79	25	therapy	therapy	NOUN
dpc-2415	79	26	[	[	X
dpc-2415	79	27	66	66	NUM
dpc-2415	79	28	]	]	PUNCT
dpc-2415	79	29	.	.	PUNCT
dpc-2415	80	1	in	in	ADP
dpc-2415	80	2	short	short	ADJ
dpc-2415	80	3	,	,	PUNCT
dpc-2415	80	4	the	the	DET
dpc-2415	80	5	medical	medical	ADJ
dpc-2415	80	6	board	board	NOUN
dpc-2415	80	7	of	of	ADP
dpc-2415	80	8	the	the	DET
dpc-2415	80	9	national	national	ADJ
dpc-2415	80	10	psoriasis	psoriasis	NOUN
dpc-2415	80	11	foundation	foundation	NOUN
dpc-2415	80	12	recommends	recommend	VERB
dpc-2415	80	13	that	that	SCONJ
dpc-2415	80	14	all	all	DET
dpc-2415	80	15	patients	patient	NOUN
dpc-2415	80	16	with	with	ADP
dpc-2415	80	17	moderate	moderate	ADJ
dpc-2415	80	18	-	-	PUNCT
dpc-2415	80	19	to	to	ADP
dpc-2415	80	20	-	-	PUNCT
dpc-2415	80	21	severe	severe	ADJ
dpc-2415	80	22	psoriasis	psoriasis	NOUN
dpc-2415	80	23	have	have	VERB
dpc-2415	80	24	an	an	DET
dpc-2415	80	25	assessment	assessment	NOUN
dpc-2415	80	26	of	of	ADP
dpc-2415	80	27	their	their	PRON
dpc-2415	80	28	immunization	immunization	NOUN
dpc-2415	80	29	status	status	NOUN
dpc-2415	80	30	,	,	PUNCT
dpc-2415	80	31	including	include	VERB
dpc-2415	80	32	immunization	immunization	NOUN
dpc-2415	80	33	or	or	CCONJ
dpc-2415	80	34	disease	disease	NOUN
dpc-2415	80	35	history	history	NOUN
dpc-2415	80	36	for	for	ADP
dpc-2415	80	37	varicella	varicella	NOUN
dpc-2415	80	38	zoster	zoster	NOUN
dpc-2415	80	39	,	,	PUNCT
dpc-2415	80	40	haemophilus	haemophilus	X
dpc-2415	80	41	influenzae	influenzae	X
dpc-2415	80	42	,	,	PUNCT
dpc-2415	80	43	tetanus	tetanus	NOUN
dpc-2415	80	44	,	,	PUNCT
dpc-2415	80	45	pertussis	pertussis	NOUN
dpc-2415	80	46	,	,	PUNCT
dpc-2415	80	47	hepatitis	hepatitis	NOUN
dpc-2415	80	48	a	a	NOUN
dpc-2415	80	49	and	and	CCONJ
dpc-2415	80	50	b	b	NOUN
dpc-2415	80	51	,	,	PUNCT
dpc-2415	80	52	human	human	ADJ
dpc-2415	80	53	papillomavirus	papillomavirus	NOUN
dpc-2415	80	54	(	(	PUNCT
dpc-2415	80	55	hpv	hpv	NOUN
dpc-2415	80	56	)	)	PUNCT
dpc-2415	80	57	,	,	PUNCT
dpc-2415	80	58	influenza	influenza	NOUN
dpc-2415	80	59	,	,	PUNCT
dpc-2415	80	60	neisseria	neisseria	PROPN
dpc-2415	80	61	meningitides	meningitide	NOUN
dpc-2415	80	62	,	,	PUNCT
dpc-2415	80	63	and	and	CCONJ
dpc-2415	80	64	streptococcus	streptococcus	VERB
dpc-2415	80	65	pneumoniae	pneumoniae	ADV
dpc-2415	80	66	during	during	ADP
dpc-2415	80	67	initial	initial	ADJ
dpc-2415	80	68	workup	workup	NOUN
dpc-2415	81	1	[	[	X
dpc-2415	81	2	67	67	NUM
dpc-2415	81	3	]	]	PUNCT
dpc-2415	81	4	.	.	PUNCT
dpc-2415	82	1	notably	notably	ADV
dpc-2415	82	2	,	,	PUNCT
dpc-2415	82	3	vaccines	vaccine	NOUN
dpc-2415	82	4	such	such	ADJ
dpc-2415	82	5	as	as	ADP
dpc-2415	82	6	mycobacterium	mycobacterium	PROPN
dpc-2415	82	7	vaccae	vaccae	NOUN
dpc-2415	82	8	,	,	PUNCT
dpc-2415	82	9	live	live	VERB
dpc-2415	82	10	attenuated	attenuated	ADJ
dpc-2415	82	11	varicella	varicella	NOUN
dpc-2415	82	12	zoster	zoster	NOUN
dpc-2415	82	13	virus	virus	NOUN
dpc-2415	82	14	and	and	CCONJ
dpc-2415	82	15	leishmania	leishmania	NOUN
dpc-2415	82	16	amastigotes	amastigote	NOUN
dpc-2415	82	17	have	have	AUX
dpc-2415	82	18	been	be	AUX
dpc-2415	82	19	reported	report	VERB
dpc-2415	82	20	to	to	PART
dpc-2415	82	21	be	be	AUX
dpc-2415	82	22	effective	effective	ADJ
dpc-2415	82	23	during	during	ADP
dpc-2415	82	24	psoriasis	psoriasis	NOUN
dpc-2415	82	25	treatment	treatment	NOUN
dpc-2415	82	26	[	[	X
dpc-2415	82	27	68	68	NUM
dpc-2415	82	28	-	-	SYM
dpc-2415	82	29	70	70	NUM
dpc-2415	82	30	]	]	PUNCT
dpc-2415	82	31	even	even	ADV
dpc-2415	82	32	though	though	SCONJ
dpc-2415	82	33	these	these	DET
dpc-2415	82	34	data	datum	NOUN
dpc-2415	82	35	need	need	VERB
dpc-2415	82	36	to	to	PART
dpc-2415	82	37	be	be	AUX
dpc-2415	82	38	confirmed	confirm	VERB
dpc-2415	82	39	in	in	ADP
dpc-2415	82	40	larger	large	ADJ
dpc-2415	82	41	and	and	CCONJ
dpc-2415	82	42	controlled	control	VERB
dpc-2415	82	43	clinical	clinical	ADJ
dpc-2415	82	44	trials	trial	NOUN
dpc-2415	82	45	.	.	PUNCT
dpc-2415	83	1	lastly	lastly	ADV
dpc-2415	83	2	,	,	PUNCT
dpc-2415	83	3	vaccination	vaccination	NOUN
dpc-2415	83	4	against	against	ADP
dpc-2415	83	5	sars	sar	NOUN
dpc-2415	83	6	-	-	PUNCT
dpc-2415	83	7	cov-2	cov-2	NUM
dpc-2415	83	8	is	be	AUX
dpc-2415	83	9	recommended	recommend	VERB
dpc-2415	83	10	in	in	ADP
dpc-2415	83	11	patients	patient	NOUN
dpc-2415	83	12	with	with	ADP
dpc-2415	83	13	psoriasis	psoriasis	NOUN
dpc-2415	83	14	,	,	PUNCT
dpc-2415	83	15	even	even	ADV
dpc-2415	83	16	in	in	ADP
dpc-2415	83	17	those	those	PRON
dpc-2415	83	18	under	under	ADP
dpc-2415	83	19	biological	biological	ADJ
dpc-2415	83	20	therapy	therapy	NOUN
dpc-2415	83	21	[	[	X
dpc-2415	83	22	71	71	NUM
dpc-2415	83	23	]	]	PUNCT
dpc-2415	83	24	.	.	PUNCT
dpc-2415	84	1	hence	hence	ADV
dpc-2415	84	2	,	,	PUNCT
dpc-2415	84	3	it	it	PRON
dpc-2415	84	4	is	be	AUX
dpc-2415	84	5	clear	clear	ADJ
dpc-2415	84	6	now	now	ADV
dpc-2415	84	7	that	that	SCONJ
dpc-2415	84	8	immune	immune	ADJ
dpc-2415	84	9	pathways	pathway	NOUN
dpc-2415	84	10	involved	involve	VERB
dpc-2415	84	11	in	in	ADP
dpc-2415	84	12	psoriasis	psoriasis	NOUN
dpc-2415	84	13	pathogenesis	pathogenesi	NOUN
dpc-2415	84	14	contribute	contribute	VERB
dpc-2415	84	15	to	to	ADP
dpc-2415	84	16	host	host	NOUN
dpc-2415	84	17	defense	defense	NOUN
dpc-2415	84	18	against	against	ADP
dpc-2415	84	19	certain	certain	ADJ
dpc-2415	84	20	pathogens	pathogen	NOUN
dpc-2415	84	21	,	,	PUNCT
dpc-2415	84	22	thus	thus	ADV
dpc-2415	84	23	a	a	DET
dpc-2415	84	24	possible	possible	ADJ
dpc-2415	84	25	consequence	consequence	NOUN
dpc-2415	84	26	is	be	AUX
dpc-2415	84	27	represented	represent	VERB
dpc-2415	84	28	have	have	AUX
dpc-2415	84	29	been	be	AUX
dpc-2415	84	30	approved	approve	VERB
dpc-2415	84	31	for	for	ADP
dpc-2415	84	32	the	the	DET
dpc-2415	84	33	treatment	treatment	NOUN
dpc-2415	84	34	of	of	ADP
dpc-2415	84	35	plaque	plaque	NOUN
dpc-2415	84	36	psoriasis	psoriasis	NOUN
dpc-2415	84	37	:	:	PUNCT
dpc-2415	85	1	apremilast	apremilast	ADJ
dpc-2415	85	2	,	,	PUNCT
dpc-2415	85	3	an	an	DET
dpc-2415	85	4	oral	oral	ADJ
dpc-2415	85	5	phosphodiesterase	phosphodiesterase	NOUN
dpc-2415	85	6	(	(	PUNCT
dpc-2415	85	7	pde)-4	pde)-4	NOUN
dpc-2415	85	8	inhibitor	inhibitor	NOUN
dpc-2415	85	9	,	,	PUNCT
dpc-2415	85	10	and	and	CCONJ
dpc-2415	85	11	dimethyl	dimethyl	NOUN
dpc-2415	85	12	fumarate	fumarate	NOUN
dpc-2415	86	1	[	[	X
dpc-2415	86	2	48,49	48,49	X
dpc-2415	86	3	]	]	PUNCT
dpc-2415	86	4	.	.	PUNCT
dpc-2415	87	1	both	both	DET
dpc-2415	87	2	molecules	molecule	NOUN
dpc-2415	87	3	impact	impact	VERB
dpc-2415	87	4	the	the	DET
dpc-2415	87	5	nf	nf	ADJ
dpc-2415	87	6	-	-	PUNCT
dpc-2415	87	7	kb	kb	NOUN
dpc-2415	87	8	complex	complex	NOUN
dpc-2415	87	9	and	and	CCONJ
dpc-2415	87	10	have	have	VERB
dpc-2415	87	11	broad	broad	ADJ
dpc-2415	87	12	functions	function	NOUN
dpc-2415	87	13	on	on	ADP
dpc-2415	87	14	the	the	DET
dpc-2415	87	15	immune	immune	ADJ
dpc-2415	87	16	system	system	NOUN
dpc-2415	87	17	.	.	PUNCT
dpc-2415	88	1	modern	modern	ADJ
dpc-2415	88	2	biological	biological	ADJ
dpc-2415	88	3	therapies	therapy	NOUN
dpc-2415	88	4	,	,	PUNCT
dpc-2415	88	5	such	such	ADJ
dpc-2415	88	6	as	as	ADP
dpc-2415	88	7	anti	anti	ADJ
dpc-2415	88	8	-	-	ADJ
dpc-2415	88	9	tnf	tnf	ADJ
dpc-2415	88	10	-	-	PUNCT
dpc-2415	88	11	α	α	PROPN
dpc-2415	88	12	,	,	PUNCT
dpc-2415	88	13	anti	anti	ADJ
dpc-2415	88	14	-	-	ADJ
dpc-2415	88	15	il-12/23	il-12/23	ADJ
dpc-2415	88	16	,	,	PUNCT
dpc-2415	88	17	anti	anti	ADJ
dpc-2415	88	18	-	-	ADJ
dpc-2415	88	19	il-17	il-17	NUM
dpc-2415	88	20	,	,	PUNCT
dpc-2415	88	21	and	and	CCONJ
dpc-2415	88	22	anti	anti	ADJ
dpc-2415	88	23	-	-	ADJ
dpc-2415	88	24	il-23	il-23	NOUN
dpc-2415	88	25	antibodies	antibody	NOUN
dpc-2415	88	26	,	,	PUNCT
dpc-2415	88	27	are	be	AUX
dpc-2415	88	28	designed	design	VERB
dpc-2415	88	29	to	to	PART
dpc-2415	88	30	block	block	VERB
dpc-2415	88	31	specific	specific	ADJ
dpc-2415	88	32	molecular	molecular	ADJ
dpc-2415	88	33	steps	step	NOUN
dpc-2415	88	34	important	important	ADJ
dpc-2415	88	35	in	in	ADP
dpc-2415	88	36	the	the	DET
dpc-2415	88	37	pathogenesis	pathogenesis	NOUN
dpc-2415	88	38	of	of	ADP
dpc-2415	88	39	psoriasis	psoriasis	NOUN
dpc-2415	88	40	.	.	PUNCT
dpc-2415	89	1	namely	namely	ADV
dpc-2415	89	2	,	,	PUNCT
dpc-2415	89	3	anti	anti	ADJ
dpc-2415	89	4	-	-	ADJ
dpc-2415	89	5	tnf	tnf	ADJ
dpc-2415	89	6	-	-	PUNCT
dpc-2415	89	7	α	α	NOUN
dpc-2415	89	8	agents	agent	NOUN
dpc-2415	89	9	neutralize	neutralize	VERB
dpc-2415	89	10	tnf	tnf	PROPN
dpc-2415	89	11	-	-	PUNCT
dpc-2415	89	12	α	α	PROPN
dpc-2415	89	13	which	which	PRON
dpc-2415	89	14	has	have	VERB
dpc-2415	89	15	a	a	DET
dpc-2415	89	16	dual	dual	ADJ
dpc-2415	89	17	role	role	NOUN
dpc-2415	89	18	as	as	ADP
dpc-2415	89	19	an	an	DET
dpc-2415	89	20	upstream	upstream	ADJ
dpc-2415	89	21	mediator	mediator	NOUN
dpc-2415	89	22	of	of	ADP
dpc-2415	89	23	t	t	PROPN
dpc-2415	89	24	cell	cell	NOUN
dpc-2415	89	25	differentiation	differentiation	NOUN
dpc-2415	89	26	into	into	ADP
dpc-2415	89	27	th1	th1	PROPN
dpc-2415	89	28	,	,	PUNCT
dpc-2415	89	29	th17	th17	PROPN
dpc-2415	89	30	and	and	CCONJ
dpc-2415	89	31	th22	th22	PROPN
dpc-2415	89	32	cells	cell	NOUN
dpc-2415	89	33	,	,	PUNCT
dpc-2415	89	34	as	as	ADV
dpc-2415	89	35	well	well	ADV
dpc-2415	89	36	as	as	ADP
dpc-2415	89	37	a	a	DET
dpc-2415	89	38	pro	pro	ADJ
dpc-2415	89	39	-	-	ADJ
dpc-2415	89	40	inflammatory	inflammatory	ADJ
dpc-2415	89	41	mediator	mediator	NOUN
dpc-2415	89	42	synergistic	synergistic	ADJ
dpc-2415	89	43	with	with	ADP
dpc-2415	89	44	il-17a	il-17a	PROPN
dpc-2415	89	45	,	,	PUNCT
dpc-2415	89	46	il-17f	il-17f	NOUN
dpc-2415	89	47	,	,	PUNCT
dpc-2415	89	48	and	and	CCONJ
dpc-2415	89	49	il-22	il-22	NOUN
dpc-2415	90	1	[	[	X
dpc-2415	90	2	50	50	NUM
dpc-2415	90	3	]	]	PUNCT
dpc-2415	90	4	.	.	PUNCT
dpc-2415	91	1	the	the	DET
dpc-2415	91	2	anti	anti	ADJ
dpc-2415	91	3	-	-	ADJ
dpc-2415	91	4	il-12/23	il-12/23	ADJ
dpc-2415	91	5	agent	agent	NOUN
dpc-2415	91	6	targets	target	VERB
dpc-2415	91	7	the	the	DET
dpc-2415	91	8	p40	p40	NOUN
dpc-2415	91	9	subunit	subunit	NOUN
dpc-2415	91	10	shared	share	VERB
dpc-2415	91	11	by	by	ADP
dpc-2415	91	12	il-12	il-12	NOUN
dpc-2415	91	13	and	and	CCONJ
dpc-2415	91	14	il-23	il-23	NOUN
dpc-2415	91	15	preventing	prevent	VERB
dpc-2415	91	16	their	their	PRON
dpc-2415	91	17	interaction	interaction	NOUN
dpc-2415	91	18	with	with	ADP
dpc-2415	91	19	the	the	DET
dpc-2415	91	20	receptor	receptor	NOUN
dpc-2415	91	21	and	and	CCONJ
dpc-2415	91	22	thereby	thereby	ADV
dpc-2415	91	23	blocking	block	VERB
dpc-2415	91	24	th1/	th1/	PROPN
dpc-2415	91	25	th17	th17	PROPN
dpc-2415	91	26	immunity	immunity	NOUN
dpc-2415	91	27	[	[	X
dpc-2415	91	28	1,50	1,50	X
dpc-2415	91	29	]	]	X
dpc-2415	91	30	.	.	PUNCT
dpc-2415	92	1	this	this	PRON
dpc-2415	92	2	was	be	AUX
dpc-2415	92	3	further	far	ADV
dpc-2415	92	4	developed	develop	VERB
dpc-2415	92	5	into	into	ADP
dpc-2415	92	6	biologics	biologic	NOUN
dpc-2415	92	7	neutralizing	neutralize	VERB
dpc-2415	92	8	only	only	ADV
dpc-2415	92	9	il-23	il-23	NOUN
dpc-2415	92	10	via	via	ADP
dpc-2415	92	11	the	the	DET
dpc-2415	92	12	p19	p19	NOUN
dpc-2415	92	13	subunit	subunit	NOUN
dpc-2415	92	14	,	,	PUNCT
dpc-2415	92	15	thereby	thereby	ADV
dpc-2415	92	16	only	only	ADV
dpc-2415	92	17	blocking	block	VERB
dpc-2415	92	18	th17	th17	PROPN
dpc-2415	92	19	immunity	immunity	NOUN
dpc-2415	92	20	[	[	X
dpc-2415	92	21	1	1	NUM
dpc-2415	92	22	]	]	PUNCT
dpc-2415	92	23	.	.	PUNCT
dpc-2415	93	1	finally	finally	ADV
dpc-2415	93	2	,	,	PUNCT
dpc-2415	93	3	direct	direct	ADJ
dpc-2415	93	4	interaction	interaction	NOUN
dpc-2415	93	5	with	with	ADP
dpc-2415	93	6	il-17a	il-17a	PROPN
dpc-2415	93	7	and/or	and/or	CCONJ
dpc-2415	93	8	other	other	ADJ
dpc-2415	93	9	members	member	NOUN
dpc-2415	93	10	of	of	ADP
dpc-2415	93	11	the	the	PRON
dpc-2415	93	12	il-17	il-17	NUM
dpc-2415	93	13	family	family	NOUN
dpc-2415	93	14	is	be	AUX
dpc-2415	93	15	a	a	DET
dpc-2415	93	16	successful	successful	ADJ
dpc-2415	93	17	strategy	strategy	NOUN
dpc-2415	93	18	realized	realize	VERB
dpc-2415	93	19	through	through	ADP
dpc-2415	93	20	il-17a	il-17a	PROPN
dpc-2415	93	21	,	,	PUNCT
dpc-2415	93	22	il-7ra	il-7ra	ADJ
dpc-2415	93	23	,	,	PUNCT
dpc-2415	93	24	or	or	CCONJ
dpc-2415	93	25	bispecific	bispecific	VERB
dpc-2415	93	26	il-17a	il-17a	PROPN
dpc-2415	93	27	/	/	SYM
dpc-2415	93	28	f	f	PROPN
dpc-2415	93	29	targeting	target	VERB
dpc-2415	93	30	.	.	PUNCT
dpc-2415	94	1	however	however	ADV
dpc-2415	94	2	,	,	PUNCT
dpc-2415	94	3	analysis	analysis	NOUN
dpc-2415	94	4	of	of	ADP
dpc-2415	94	5	the	the	DET
dpc-2415	94	6	population	population	NOUN
dpc-2415	94	7	-	-	PUNCT
dpc-2415	94	8	based	base	VERB
dpc-2415	94	9	electronic	electronic	ADJ
dpc-2415	94	10	medical	medical	ADJ
dpc-2415	94	11	record	record	NOUN
dpc-2415	94	12	database	database	NOUN
dpc-2415	94	13	from	from	ADP
dpc-2415	94	14	the	the	DET
dpc-2415	94	15	uk	uk	PROPN
dpc-2415	94	16	on	on	ADP
dpc-2415	94	17	approximately	approximately	ADV
dpc-2415	94	18	200,000	200,000	NUM
dpc-2415	94	19	patients	patient	NOUN
dpc-2415	94	20	with	with	ADP
dpc-2415	94	21	psoriasis	psoriasis	NOUN
dpc-2415	94	22	indicates	indicate	VERB
dpc-2415	94	23	that	that	SCONJ
dpc-2415	94	24	patients	patient	NOUN
dpc-2415	94	25	with	with	ADP
dpc-2415	94	26	moderate	moderate	ADJ
dpc-2415	94	27	-	-	PUNCT
dpc-2415	94	28	to	to	ADP
dpc-2415	94	29	-	-	PUNCT
dpc-2415	94	30	severe	severe	ADJ
dpc-2415	94	31	disease	disease	NOUN
dpc-2415	94	32	that	that	PRON
dpc-2415	94	33	receive	receive	VERB
dpc-2415	94	34	immunosuppressive	immunosuppressive	ADJ
dpc-2415	94	35	therapies	therapy	NOUN
dpc-2415	94	36	do	do	AUX
dpc-2415	94	37	have	have	VERB
dpc-2415	94	38	an	an	DET
dpc-2415	94	39	increased	increase	VERB
dpc-2415	94	40	risk	risk	NOUN
dpc-2415	94	41	for	for	ADP
dpc-2415	94	42	opportunistic	opportunistic	ADJ
dpc-2415	94	43	infections	infection	NOUN
dpc-2415	94	44	and	and	CCONJ
dpc-2415	94	45	reactivation	reactivation	NOUN
dpc-2415	94	46	of	of	ADP
dpc-2415	94	47	varicella	varicella	NOUN
dpc-2415	94	48	-	-	PUNCT
dpc-2415	94	49	zoster	zoster	NOUN
dpc-2415	94	50	virus	virus	NOUN
dpc-2415	94	51	[	[	X
dpc-2415	94	52	51	51	NUM
dpc-2415	94	53	]	]	PUNCT
dpc-2415	94	54	.	.	PUNCT
dpc-2415	95	1	furthermore	furthermore	ADV
dpc-2415	95	2	,	,	PUNCT
dpc-2415	95	3	analyzing	analyze	VERB
dpc-2415	95	4	data	datum	NOUN
dpc-2415	95	5	from	from	ADP
dpc-2415	95	6	psoriasis	psoriasis	NOUN
dpc-2415	95	7	patients	patient	NOUN
dpc-2415	95	8	treated	treat	VERB
dpc-2415	95	9	with	with	ADP
dpc-2415	95	10	biologic	biologic	NOUN
dpc-2415	95	11	(	(	PUNCT
dpc-2415	95	12	n=2258	n=2258	PROPN
dpc-2415	95	13	)	)	PUNCT
dpc-2415	95	14	or	or	CCONJ
dpc-2415	95	15	non	non	ADJ
dpc-2415	95	16	-	-	ADJ
dpc-2415	95	17	biologic	biologic	ADJ
dpc-2415	95	18	systemic	systemic	ADJ
dpc-2415	95	19	agents	agent	NOUN
dpc-2415	95	20	(	(	PUNCT
dpc-2415	95	21	n=3631	n=3631	NOUN
dpc-2415	95	22	)	)	PUNCT
dpc-2415	95	23	demonstrated	demonstrate	VERB
dpc-2415	95	24	that	that	SCONJ
dpc-2415	95	25	systemic	systemic	ADJ
dpc-2415	95	26	therapies	therapy	NOUN
dpc-2415	95	27	with	with	ADP
dpc-2415	95	28	biologics	biologic	NOUN
dpc-2415	95	29	significantly	significantly	ADV
dpc-2415	95	30	increase	increase	VERB
dpc-2415	95	31	the	the	DET
dpc-2415	95	32	overall	overall	ADJ
dpc-2415	95	33	risk	risk	NOUN
dpc-2415	95	34	for	for	ADP
dpc-2415	95	35	serious	serious	ADJ
dpc-2415	95	36	infection	infection	NOUN
dpc-2415	95	37	[	[	X
dpc-2415	95	38	52	52	NUM
dpc-2415	95	39	]	]	PUNCT
dpc-2415	95	40	.	.	PUNCT
dpc-2415	96	1	the	the	DET
dpc-2415	96	2	extent	extent	NOUN
dpc-2415	96	3	of	of	ADP
dpc-2415	96	4	impairment	impairment	NOUN
dpc-2415	96	5	and	and	CCONJ
dpc-2415	96	6	the	the	DET
dpc-2415	96	7	type	type	NOUN
dpc-2415	96	8	of	of	ADP
dpc-2415	96	9	infection	infection	NOUN
dpc-2415	96	10	are	be	AUX
dpc-2415	96	11	related	relate	VERB
dpc-2415	96	12	to	to	ADP
dpc-2415	96	13	the	the	DET
dpc-2415	96	14	mode	mode	NOUN
dpc-2415	96	15	of	of	ADP
dpc-2415	96	16	action	action	NOUN
dpc-2415	96	17	of	of	ADP
dpc-2415	96	18	individual	individual	ADJ
dpc-2415	96	19	drugs	drug	NOUN
dpc-2415	96	20	or	or	CCONJ
dpc-2415	96	21	drug	drug	NOUN
dpc-2415	96	22	groups	group	NOUN
dpc-2415	96	23	[	[	X
dpc-2415	96	24	1	1	NUM
dpc-2415	96	25	]	]	PUNCT
dpc-2415	96	26	.	.	PUNCT
dpc-2415	97	1	for	for	ADP
dpc-2415	97	2	instance	instance	NOUN
dpc-2415	97	3	,	,	PUNCT
dpc-2415	97	4	tnf	tnf	PROPN
dpc-2415	97	5	-	-	PUNCT
dpc-2415	97	6	α	α	PROPN
dpc-2415	97	7	antagonists	antagonist	NOUN
dpc-2415	97	8	can	can	AUX
dpc-2415	97	9	lead	lead	VERB
dpc-2415	97	10	to	to	ADP
dpc-2415	97	11	the	the	DET
dpc-2415	97	12	reactivation	reactivation	NOUN
dpc-2415	97	13	of	of	ADP
dpc-2415	97	14	latent	latent	NOUN
dpc-2415	97	15	tuberculosis	tuberculosis	NOUN
dpc-2415	97	16	and	and	CCONJ
dpc-2415	97	17	il-17	il-17	NUM
dpc-2415	97	18	neutralization	neutralization	NOUN
dpc-2415	97	19	may	may	AUX
dpc-2415	97	20	result	result	VERB
dpc-2415	97	21	in	in	ADP
dpc-2415	97	22	mucocutaneous	mucocutaneous	ADJ
dpc-2415	97	23	candidiasis	candidiasis	NOUN
dpc-2415	97	24	[	[	X
dpc-2415	97	25	1	1	NUM
dpc-2415	97	26	]	]	PUNCT
dpc-2415	97	27	.	.	PUNCT
dpc-2415	98	1	however	however	ADV
dpc-2415	98	2	,	,	PUNCT
dpc-2415	98	3	it	it	PRON
dpc-2415	98	4	should	should	AUX
dpc-2415	98	5	be	be	AUX
dpc-2415	98	6	noted	note	VERB
dpc-2415	98	7	,	,	PUNCT
dpc-2415	98	8	there	there	PRON
dpc-2415	98	9	is	be	VERB
dpc-2415	98	10	no	no	DET
dpc-2415	98	11	signal	signal	NOUN
dpc-2415	98	12	for	for	ADP
dpc-2415	98	13	increased	increase	VERB
dpc-2415	98	14	risk	risk	NOUN
dpc-2415	98	15	of	of	ADP
dpc-2415	98	16	invasive	invasive	ADJ
dpc-2415	98	17	fungal	fungal	ADJ
dpc-2415	98	18	disease	disease	NOUN
dpc-2415	98	19	due	due	ADP
dpc-2415	98	20	to	to	ADP
dpc-2415	98	21	anti	anti	ADJ
dpc-2415	98	22	-	-	ADJ
dpc-2415	98	23	il-17	il-17	ADV
dpc-2415	98	24	therapy	therapy	NOUN
dpc-2415	98	25	[	[	X
dpc-2415	98	26	53	53	NUM
dpc-2415	98	27	]	]	PUNCT
dpc-2415	98	28	.	.	PUNCT
dpc-2415	99	1	cases	case	NOUN
dpc-2415	99	2	of	of	ADP
dpc-2415	99	3	opportunistic	opportunistic	ADJ
dpc-2415	99	4	infections	infection	NOUN
dpc-2415	99	5	like	like	ADP
dpc-2415	99	6	atypical	atypical	ADJ
dpc-2415	99	7	histoplasmosis	histoplasmosis	NOUN
dpc-2415	99	8	or	or	CCONJ
dpc-2415	99	9	toxoplasmosis	toxoplasmosis	NOUN
dpc-2415	99	10	have	have	AUX
dpc-2415	99	11	been	be	AUX
dpc-2415	99	12	mainly	mainly	ADV
dpc-2415	99	13	reported	report	VERB
dpc-2415	99	14	in	in	ADP
dpc-2415	99	15	connection	connection	NOUN
dpc-2415	99	16	with	with	ADP
dpc-2415	99	17	blocking	block	VERB
dpc-2415	99	18	tnf	tnf	PROPN
dpc-2415	99	19	-	-	PUNCT
dpc-2415	99	20	α	α	PROPN
dpc-2415	99	21	or	or	CCONJ
dpc-2415	99	22	il-12	il-12	PRON
dpc-2415	99	23	/	/	SYM
dpc-2415	99	24	il-23	il-23	NOUN
dpc-2415	99	25	p40	p40	NOUN
dpc-2415	99	26	[	[	X
dpc-2415	99	27	53,54	53,54	NUM
dpc-2415	99	28	]	]	PUNCT
dpc-2415	99	29	.	.	PUNCT
dpc-2415	100	1	accordingly	accordingly	ADV
dpc-2415	100	2	,	,	PUNCT
dpc-2415	100	3	the	the	DET
dpc-2415	100	4	evaluation	evaluation	NOUN
dpc-2415	100	5	of	of	ADP
dpc-2415	100	6	registry	registry	NOUN
dpc-2415	100	7	data	datum	NOUN
dpc-2415	100	8	primarily	primarily	ADV
dpc-2415	100	9	notes	note	VERB
dpc-2415	100	10	the	the	DET
dpc-2415	100	11	association	association	NOUN
dpc-2415	100	12	of	of	ADP
dpc-2415	100	13	the	the	DET
dpc-2415	100	14	use	use	NOUN
dpc-2415	100	15	of	of	ADP
dpc-2415	100	16	infliximab	infliximab	NOUN
dpc-2415	100	17	,	,	PUNCT
dpc-2415	100	18	a	a	DET
dpc-2415	100	19	chimeric	chimeric	ADJ
dpc-2415	100	20	monoclonal	monoclonal	NOUN
dpc-2415	100	21	anti	anti	ADJ
dpc-2415	100	22	-	-	ADJ
dpc-2415	100	23	tnf	tnf	ADJ
dpc-2415	100	24	-	-	PUNCT
dpc-2415	100	25	α	α	NOUN
dpc-2415	100	26	antibody	antibody	NOUN
dpc-2415	100	27	,	,	PUNCT
dpc-2415	100	28	with	with	ADP
dpc-2415	100	29	increased	increase	VERB
dpc-2415	100	30	incidence	incidence	NOUN
dpc-2415	100	31	of	of	ADP
dpc-2415	100	32	pneumonia	pneumonia	NOUN
dpc-2415	100	33	[	[	X
dpc-2415	100	34	44,45	44,45	X
dpc-2415	100	35	]	]	X
dpc-2415	100	36	.	.	PUNCT
dpc-2415	101	1	furthermore	furthermore	ADV
dpc-2415	101	2	,	,	PUNCT
dpc-2415	101	3	while	while	SCONJ
dpc-2415	101	4	neutralizing	neutralize	VERB
dpc-2415	101	5	tnf	tnf	PROPN
dpc-2415	101	6	-	-	PUNCT
dpc-2415	101	7	α	α	PROPN
dpc-2415	101	8	or	or	CCONJ
dpc-2415	101	9	il-17	il-17	NUM
dpc-2415	101	10	has	have	AUX
dpc-2415	101	11	been	be	AUX
dpc-2415	101	12	associated	associate	VERB
dpc-2415	101	13	with	with	ADP
dpc-2415	101	14	such	such	DET
dpc-2415	101	15	a	a	DET
dpc-2415	101	16	risk	risk	NOUN
dpc-2415	101	17	,	,	PUNCT
dpc-2415	101	18	there	there	PRON
dpc-2415	101	19	is	be	VERB
dpc-2415	101	20	no	no	DET
dpc-2415	101	21	evidence	evidence	NOUN
dpc-2415	101	22	that	that	SCONJ
dpc-2415	101	23	blocking	block	VERB
dpc-2415	101	24	il-23	il-23	NOUN
dpc-2415	101	25	increases	increase	VERB
dpc-2415	101	26	the	the	DET
dpc-2415	101	27	risk	risk	NOUN
dpc-2415	101	28	of	of	ADP
dpc-2415	101	29	respiratory	respiratory	ADJ
dpc-2415	101	30	tract	tract	NOUN
dpc-2415	101	31	infections	infection	NOUN
dpc-2415	101	32	[	[	X
dpc-2415	101	33	55	55	NUM
dpc-2415	101	34	]	]	PUNCT
dpc-2415	101	35	.	.	PUNCT
dpc-2415	102	1	despite	despite	SCONJ
dpc-2415	102	2	the	the	DET
dpc-2415	102	3	relevant	relevant	ADJ
dpc-2415	102	4	concomitant	concomitant	ADJ
dpc-2415	102	5	disorders	disorder	NOUN
dpc-2415	102	6	such	such	ADJ
dpc-2415	102	7	as	as	ADP
dpc-2415	102	8	obesity	obesity	NOUN
dpc-2415	102	9	,	,	PUNCT
dpc-2415	102	10	hypertension	hypertension	NOUN
dpc-2415	102	11	,	,	PUNCT
dpc-2415	102	12	and	and	CCONJ
dpc-2415	102	13	diabetes	diabetes	NOUN
dpc-2415	102	14	,	,	PUNCT
dpc-2415	102	15	recent	recent	ADJ
dpc-2415	102	16	data	datum	NOUN
dpc-2415	102	17	accumulated	accumulate	VERB
dpc-2415	102	18	during	during	ADP
dpc-2415	102	19	the	the	DET
dpc-2415	102	20	covid-19	covid-19	PROPN
dpc-2415	102	21	pandemic	pandemic	NOUN
dpc-2415	102	22	indicate	indicate	VERB
dpc-2415	102	23	that	that	SCONJ
dpc-2415	102	24	patients	patient	NOUN
dpc-2415	102	25	with	with	ADP
dpc-2415	102	26	psoriasis	psoriasis	NOUN
dpc-2415	102	27	with	with	ADP
dpc-2415	102	28	or	or	CCONJ
dpc-2415	102	29	without	without	ADP
dpc-2415	102	30	systemic	systemic	ADJ
dpc-2415	102	31	treatment	treatment	NOUN
dpc-2415	102	32	are	be	AUX
dpc-2415	102	33	neither	neither	CCONJ
dpc-2415	102	34	at	at	ADP
dpc-2415	102	35	higher	high	ADJ
dpc-2415	102	36	risk	risk	NOUN
dpc-2415	102	37	for	for	ADP
dpc-2415	102	38	infection	infection	NOUN
dpc-2415	102	39	with	with	ADP
dpc-2415	102	40	sars	sar	NOUN
dpc-2415	102	41	-	-	PUNCT
dpc-2415	102	42	cov-2	cov-2	X
dpc-2415	102	43	nor	nor	CCONJ
dpc-2415	102	44	show	show	VERB
dpc-2415	102	45	more	more	ADV
dpc-2415	102	46	severe	severe	ADJ
dpc-2415	102	47	symptoms	symptom	NOUN
dpc-2415	102	48	 	 	SPACE
dpc-2415	102	49	[	[	X
dpc-2415	102	50	56	56	NUM
dpc-2415	102	51	]	]	PUNCT
dpc-2415	102	52	.	.	PUNCT
dpc-2415	103	1	this	this	PRON
dpc-2415	103	2	might	might	AUX
dpc-2415	103	3	be	be	AUX
dpc-2415	103	4	caused	cause	VERB
dpc-2415	103	5	by	by	ADP
dpc-2415	103	6	the	the	DET
dpc-2415	103	7	fact	fact	NOUN
dpc-2415	103	8	that	that	SCONJ
dpc-2415	103	9	cytokines	cytokine	NOUN
dpc-2415	103	10	,	,	PUNCT
dpc-2415	103	11	review	review	VERB
dpc-2415	103	12	|	|	ADV
dpc-2415	103	13	dermatol	dermatol	ADJ
dpc-2415	103	14	pract	pract	NOUN
dpc-2415	103	15	concept	concept	NOUN
dpc-2415	103	16	.	.	PUNCT
dpc-2415	104	1	2023;13(1):e2023016	2023;13(1):e2023016	NUM
dpc-2415	104	2	5	5	NUM
dpc-2415	104	3	antibiotic	antibiotic	ADJ
dpc-2415	104	4	,	,	PUNCT
dpc-2415	104	5	antiviral	antiviral	NOUN
dpc-2415	104	6	,	,	PUNCT
dpc-2415	104	7	or	or	CCONJ
dpc-2415	104	8	antifungal	antifungal	ADJ
dpc-2415	104	9	therapy	therapy	NOUN
dpc-2415	104	10	.	.	PUNCT
dpc-2415	104	11	  	  	SPACE
dpc-2415	104	12	evaluating	evaluate	VERB
dpc-2415	104	13	the	the	DET
dpc-2415	104	14	risk	risk	NOUN
dpc-2415	104	15	-	-	PUNCT
dpc-2415	104	16	benefit	benefit	NOUN
dpc-2415	104	17	ratio	ratio	NOUN
dpc-2415	104	18	for	for	ADP
dpc-2415	104	19	recurrent	recurrent	ADJ
dpc-2415	104	20	serious	serious	ADJ
dpc-2415	104	21	infections	infection	NOUN
dpc-2415	104	22	,	,	PUNCT
dpc-2415	104	23	therapy	therapy	NOUN
dpc-2415	104	24	can	can	AUX
dpc-2415	104	25	be	be	AUX
dpc-2415	104	26	restarted	restart	VERB
dpc-2415	104	27	once	once	ADV
dpc-2415	104	28	infection	infection	NOUN
dpc-2415	104	29	has	have	AUX
dpc-2415	104	30	been	be	AUX
dpc-2415	104	31	fully	fully	ADV
dpc-2415	104	32	resolved	resolve	VERB
dpc-2415	104	33	,	,	PUNCT
dpc-2415	104	34	empirically	empirically	ADV
dpc-2415	104	35	after	after	ADP
dpc-2415	104	36	2	2	NUM
dpc-2415	104	37	-	-	SYM
dpc-2415	104	38	4	4	NUM
dpc-2415	104	39	weeks	week	NOUN
dpc-2415	104	40	from	from	ADP
dpc-2415	104	41	the	the	DET
dpc-2415	104	42	resolution	resolution	NOUN
dpc-2415	104	43	of	of	ADP
dpc-2415	104	44	the	the	DET
dpc-2415	104	45	infectious	infectious	ADJ
dpc-2415	104	46	event	event	NOUN
dpc-2415	104	47	[	[	X
dpc-2415	104	48	73	73	NUM
dpc-2415	104	49	]	]	PUNCT
dpc-2415	104	50	.	.	PUNCT
dpc-2415	105	1	analogous	analogous	ADJ
dpc-2415	105	2	therapeutic	therapeutic	ADJ
dpc-2415	105	3	management	management	NOUN
dpc-2415	105	4	during	during	ADP
dpc-2415	105	5	the	the	DET
dpc-2415	105	6	sars	sar	NOUN
dpc-2415	105	7	-	-	PUNCT
dpc-2415	105	8	cov-2	cov-2	NOUN
dpc-2415	105	9	pandemic	pandemic	NOUN
dpc-2415	105	10	has	have	AUX
dpc-2415	105	11	been	be	AUX
dpc-2415	105	12	suggested	suggest	VERB
dpc-2415	105	13	[	[	X
dpc-2415	105	14	74,75	74,75	NOUN
dpc-2415	105	15	]	]	PUNCT
dpc-2415	105	16	.	.	PUNCT
dpc-2415	106	1	in	in	ADP
dpc-2415	106	2	the	the	DET
dpc-2415	106	3	event	event	NOUN
dpc-2415	106	4	of	of	ADP
dpc-2415	106	5	sars	sar	NOUN
dpc-2415	106	6	-	-	PUNCT
dpc-2415	106	7	cov-2	cov-2	PART
dpc-2415	106	8	infection	infection	NOUN
dpc-2415	106	9	,	,	PUNCT
dpc-2415	106	10	psoriasis	psoriasis	NOUN
dpc-2415	106	11	treatments	treatment	NOUN
dpc-2415	106	12	should	should	AUX
dpc-2415	106	13	be	be	AUX
dpc-2415	106	14	suspended	suspend	VERB
dpc-2415	106	15	and	and	CCONJ
dpc-2415	106	16	resumed	resume	VERB
dpc-2415	106	17	after	after	ADP
dpc-2415	106	18	complete	complete	ADJ
dpc-2415	106	19	resolution	resolution	NOUN
dpc-2415	106	20	of	of	ADP
dpc-2415	106	21	covid-19	covid-19	PROPN
dpc-2415	106	22	symptoms	symptom	NOUN
dpc-2415	106	23	and	and	CCONJ
dpc-2415	106	24	sars	sar	NOUN
dpc-2415	106	25	-	-	PUNCT
dpc-2415	106	26	cov-2	cov-2	PART
dpc-2415	106	27	negativization	negativization	NOUN
dpc-2415	106	28	.	.	PUNCT
dpc-2415	107	1	on	on	ADP
dpc-2415	107	2	the	the	DET
dpc-2415	107	3	contrary	contrary	NOUN
dpc-2415	107	4	,	,	PUNCT
dpc-2415	107	5	in	in	ADP
dpc-2415	107	6	those	those	DET
dpc-2415	107	7	asymptomatic	asymptomatic	ADJ
dpc-2415	107	8	sars	sar	NOUN
dpc-2415	107	9	-	-	PUNCT
dpc-2415	107	10	cov-2	cov-2	NOUN
dpc-2415	107	11	+	+	NUM
dpc-2415	107	12	patients	patient	NOUN
dpc-2415	107	13	with	with	ADP
dpc-2415	107	14	high	high	ADJ
dpc-2415	107	15	-	-	PUNCT
dpc-2415	107	16	need	need	NOUN
dpc-2415	107	17	-	-	PUNCT
dpc-2415	107	18	to	to	ADP
dpc-2415	107	19	-	-	PUNCT
dpc-2415	107	20	treat	treat	VERB
dpc-2415	107	21	psoriasis	psoriasis	NOUN
dpc-2415	107	22	,	,	PUNCT
dpc-2415	107	23	as	as	ADV
dpc-2415	107	24	well	well	ADV
dpc-2415	107	25	as	as	ADP
dpc-2415	107	26	in	in	ADP
dpc-2415	107	27	psoriasis	psoriasis	NOUN
dpc-2415	107	28	patients	patient	NOUN
dpc-2415	107	29	who	who	PRON
dpc-2415	107	30	have	have	AUX
dpc-2415	107	31	had	have	VERB
dpc-2415	107	32	a	a	DET
dpc-2415	107	33	severe	severe	ADJ
dpc-2415	107	34	hospital	hospital	NOUN
dpc-2415	107	35	course	course	NOUN
dpc-2415	107	36	or	or	CCONJ
dpc-2415	107	37	the	the	DET
dpc-2415	107	38	persistence	persistence	NOUN
dpc-2415	107	39	of	of	ADP
dpc-2415	107	40	1	1	NUM
dpc-2415	107	41	or	or	CCONJ
dpc-2415	107	42	more	more	ADJ
dpc-2415	107	43	symptoms	symptom	NOUN
dpc-2415	107	44	of	of	ADP
dpc-2415	107	45	covid-19	covid-19	PROPN
dpc-2415	107	46	,	,	PUNCT
dpc-2415	107	47	beyond	beyond	ADP
dpc-2415	107	48	the	the	DET
dpc-2415	107	49	acute	acute	ADJ
dpc-2415	107	50	phase	phase	NOUN
dpc-2415	107	51	of	of	ADP
dpc-2415	107	52	the	the	DET
dpc-2415	107	53	illness	illness	NOUN
dpc-2415	107	54	,	,	PUNCT
dpc-2415	107	55	the	the	DET
dpc-2415	107	56	decision	decision	NOUN
dpc-2415	107	57	to	to	PART
dpc-2415	107	58	restart	restart	VERB
dpc-2415	107	59	treatment	treatment	NOUN
dpc-2415	107	60	by	by	ADP
dpc-2415	107	61	the	the	DET
dpc-2415	107	62	fact	fact	NOUN
dpc-2415	107	63	that	that	SCONJ
dpc-2415	107	64	a	a	DET
dpc-2415	107	65	selective	selective	ADJ
dpc-2415	107	66	inhibition	inhibition	NOUN
dpc-2415	107	67	might	might	AUX
dpc-2415	107	68	predispose	predispose	VERB
dpc-2415	107	69	to	to	ADP
dpc-2415	107	70	specific	specific	ADJ
dpc-2415	107	71	infections	infection	NOUN
dpc-2415	107	72	.	.	PUNCT
dpc-2415	108	1	nevertheless	nevertheless	ADV
dpc-2415	108	2	,	,	PUNCT
dpc-2415	108	3	some	some	DET
dpc-2415	108	4	biologic	biologic	NOUN
dpc-2415	108	5	agents	agent	NOUN
dpc-2415	108	6	and	and	CCONJ
dpc-2415	108	7	novel	novel	ADJ
dpc-2415	108	8	small	small	ADJ
dpc-2415	108	9	molecule	molecule	NOUN
dpc-2415	108	10	drugs	drug	NOUN
dpc-2415	108	11	(	(	PUNCT
dpc-2415	108	12	i.e.	i.e.	X
dpc-2415	108	13	,	,	PUNCT
dpc-2415	108	14	apremilast	apremilast	ADJ
dpc-2415	108	15	)	)	PUNCT
dpc-2415	108	16	appeared	appear	VERB
dpc-2415	108	17	to	to	PART
dpc-2415	108	18	be	be	AUX
dpc-2415	108	19	safer	safe	ADJ
dpc-2415	108	20	or	or	CCONJ
dpc-2415	108	21	at	at	ADP
dpc-2415	108	22	least	least	ADJ
dpc-2415	108	23	not	not	PART
dpc-2415	108	24	associated	associate	VERB
dpc-2415	108	25	with	with	ADP
dpc-2415	108	26	significant	significant	ADJ
dpc-2415	108	27	increases	increase	NOUN
dpc-2415	108	28	in	in	ADP
dpc-2415	108	29	the	the	DET
dpc-2415	108	30	risk	risk	NOUN
dpc-2415	108	31	of	of	ADP
dpc-2415	108	32	serious	serious	ADJ
dpc-2415	108	33	infections	infection	NOUN
dpc-2415	108	34	,	,	PUNCT
dpc-2415	108	35	compared	compare	VERB
dpc-2415	108	36	to	to	ADP
dpc-2415	108	37	conventional	conventional	ADJ
dpc-2415	108	38	nonbiologic	nonbiologic	ADJ
dpc-2415	108	39	systemic	systemic	ADJ
dpc-2415	108	40	compounds	compound	NOUN
dpc-2415	108	41	[	[	X
dpc-2415	108	42	72	72	NUM
dpc-2415	108	43	]	]	PUNCT
dpc-2415	108	44	.	.	PUNCT
dpc-2415	109	1	mild	mild	ADJ
dpc-2415	109	2	to	to	ADP
dpc-2415	109	3	moderate	moderate	ADJ
dpc-2415	109	4	infections	infection	NOUN
dpc-2415	109	5	(	(	PUNCT
dpc-2415	109	6	i.e.	i.e.	X
dpc-2415	109	7	,	,	PUNCT
dpc-2415	109	8	upper	upper	ADJ
dpc-2415	109	9	respiratory	respiratory	ADJ
dpc-2415	109	10	tract	tract	NOUN
dpc-2415	109	11	infections	infection	NOUN
dpc-2415	109	12	)	)	PUNCT
dpc-2415	109	13	or	or	CCONJ
dpc-2415	109	14	minor	minor	ADJ
dpc-2415	109	15	surgery	surgery	NOUN
dpc-2415	109	16	(	(	PUNCT
dpc-2415	109	17	i.e.	i.e.	X
dpc-2415	109	18	,	,	PUNCT
dpc-2415	109	19	skin	skin	NOUN
dpc-2415	109	20	surgery	surgery	NOUN
dpc-2415	109	21	,	,	PUNCT
dpc-2415	109	22	dental	dental	ADJ
dpc-2415	109	23	procedures	procedure	NOUN
dpc-2415	109	24	)	)	PUNCT
dpc-2415	109	25	do	do	AUX
dpc-2415	109	26	not	not	PART
dpc-2415	109	27	usually	usually	ADV
dpc-2415	109	28	cause	cause	VERB
dpc-2415	109	29	treatment	treatment	NOUN
dpc-2415	109	30	discontinuation	discontinuation	NOUN
dpc-2415	109	31	where	where	SCONJ
dpc-2415	109	32	it	it	PRON
dpc-2415	109	33	would	would	AUX
dpc-2415	109	34	otherwise	otherwise	ADV
dpc-2415	109	35	be	be	AUX
dpc-2415	109	36	continued	continue	VERB
dpc-2415	109	37	.	.	PUNCT
dpc-2415	110	1	delayed	delay	VERB
dpc-2415	110	2	starting	starting	NOUN
dpc-2415	110	3	or	or	CCONJ
dpc-2415	110	4	interruption	interruption	NOUN
dpc-2415	110	5	of	of	ADP
dpc-2415	110	6	immunomodulatory	immunomodulatory	ADJ
dpc-2415	110	7	therapies	therapy	NOUN
dpc-2415	110	8	is	be	AUX
dpc-2415	110	9	recommended	recommend	VERB
dpc-2415	110	10	in	in	ADP
dpc-2415	110	11	case	case	NOUN
dpc-2415	110	12	of	of	ADP
dpc-2415	110	13	clinically	clinically	ADV
dpc-2415	110	14	meaningful	meaningful	ADJ
dpc-2415	110	15	active	active	ADJ
dpc-2415	110	16	infection	infection	NOUN
dpc-2415	110	17	(	(	PUNCT
dpc-2415	110	18	severe	severe	ADJ
dpc-2415	110	19	signs	sign	NOUN
dpc-2415	110	20	and	and	CCONJ
dpc-2415	110	21	symptoms	symptom	NOUN
dpc-2415	110	22	requiring	require	VERB
dpc-2415	110	23	systemic	systemic	ADJ
dpc-2415	110	24	oral	oral	ADJ
dpc-2415	110	25	or	or	CCONJ
dpc-2415	110	26	intramuscular	intramuscular	ADJ
dpc-2415	110	27	antibiotic	antibiotic	ADJ
dpc-2415	110	28	,	,	PUNCT
dpc-2415	110	29	antiviral	antiviral	NOUN
dpc-2415	110	30	,	,	PUNCT
dpc-2415	110	31	or	or	CCONJ
dpc-2415	110	32	antifungal	antifungal	ADJ
dpc-2415	110	33	therapy	therapy	NOUN
dpc-2415	110	34	)	)	PUNCT
dpc-2415	110	35	or	or	CCONJ
dpc-2415	110	36	serious	serious	ADJ
dpc-2415	110	37	infection	infection	NOUN
dpc-2415	110	38	requiring	require	VERB
dpc-2415	110	39	hospitalization	hospitalization	NOUN
dpc-2415	110	40	or	or	CCONJ
dpc-2415	110	41	intravenous	intravenous	ADJ
dpc-2415	110	42	tnf	tnf	PROPN
dpc-2415	110	43	�	�	PROPN
dpc-2415	110	44	�	�	PROPN
dpc-2415	110	45	il	il	PROPN
dpc-2415	110	46	-2	-2	PROPN
dpc-2415	110	47	3	3	NUM
dpc-2415	110	48	�	�	PROPN
dpc-2415	110	49	�	�	PROPN
dpc-2415	110	50	key	key	ADJ
dpc-2415	110	51	psoriatic	psoriatic	ADJ
dpc-2415	110	52	inflammatory	inflammatory	ADJ
dpc-2415	110	53	mediators	mediator	NOUN
dpc-2415	110	54	�	�	X
dpc-2415	110	55	upper	upper	ADJ
dpc-2415	110	56	and	and	CCONJ
dpc-2415	110	57	lower	low	ADJ
dpc-2415	110	58	respiratory	respiratory	ADJ
dpc-2415	110	59	infections	infection	NOUN
dpc-2415	110	60	�	�	PROPN
dpc-2415	110	61	varicella	varicella	NOUN
dpc-2415	110	62	zoster	zoster	NOUN
dpc-2415	110	63	infections	infection	NOUN
dpc-2415	110	64	�	�	PROPN
dpc-2415	110	65	reactivation	reactivation	NOUN
dpc-2415	110	66	of	of	ADP
dpc-2415	110	67	latent	latent	NOUN
dpc-2415	110	68	tuberculosis	tuberculosis	PRON
dpc-2415	110	69	�	�	NOUN
dpc-2415	110	70	mucocutaneous	mucocutaneous	ADJ
dpc-2415	110	71	candidiasis	candidiasis	NOUN
dpc-2415	110	72	th17	th17	PROPN
dpc-2415	110	73	�	�	PROPN
dpc-2415	110	74	�	�	PROPN
dpc-2415	110	75	neutrophil	neutrophil	NOUN
dpc-2415	110	76	and	and	CCONJ
dpc-2415	110	77	t	t	NOUN
dpc-2415	110	78	-	-	PUNCT
dpc-2415	110	79	cell	cell	NOUN
dpc-2415	110	80	immune	immune	ADJ
dpc-2415	110	81	response	response	NOUN
dpc-2415	110	82	no	no	DET
dpc-2415	110	83	higher	high	ADJ
dpc-2415	110	84	risk	risk	NOUN
dpc-2415	110	85	of	of	ADP
dpc-2415	110	86	covid-19	covid-19	PROPN
dpc-2415	110	87	infection	infection	NOUN
dpc-2415	110	88	�	�	PROPN
dpc-2415	110	89	�	�	PROPN
dpc-2415	110	90	-tnf	-tnf	PROPN
dpc-2415	110	91	�	�	PROPN
dpc-2415	110	92	�	�	PROPN
dpc-2415	110	93	�	�	PROPN
dpc-2415	110	94	�	�	PROPN
dpc-2415	110	95	-il-12/23	-il-12/23	PROPN
dpc-2415	110	96	�	�	PROPN
dpc-2415	110	97	�	�	PROPN
dpc-2415	110	98	-il-23	-il-23	PROPN
dpc-2415	110	99	�	�	PROPN
dpc-2415	110	100	�	�	PROPN
dpc-2415	110	101	-il-17a	-il-17a	PROPN
dpc-2415	110	102	�	�	PROPN
dpc-2415	110	103	�	�	PROPN
dpc-2415	110	104	-il17ra	-il17ra	PART
dpc-2415	110	105	ri	ri	NOUN
dpc-2415	110	106	sk	sk	PROPN
dpc-2415	110	107	s	s	PROPN
dpc-2415	110	108	and	and	CCONJ
dpc-2415	110	109	benefits	benefit	NOUN
dpc-2415	110	110	of	of	ADP
dpc-2415	110	111	cytokine	cytokine	ADJ
dpc-2415	110	112	blocking	block	VERB
dpc-2415	110	113	therapies	therapy	NOUN
dpc-2415	110	114	in	in	ADP
dpc-2415	110	115	psoriasis	psoriasis	NOUN
dpc-2415	110	116	il-17a	il-17a	PROPN
dpc-2415	110	117	,	,	PUNCT
dpc-2415	110	118	il	il	PROPN
dpc-2415	110	119	-17f	-17f	PROPN
dpc-2415	110	120	d	d	PROPN
dpc-2415	110	121	k	k	PROPN
dpc-2415	110	122	k	k	PROPN
dpc-2415	110	123	figure	figure	NOUN
dpc-2415	110	124	1	1	NUM
dpc-2415	110	125	.	.	PUNCT
dpc-2415	111	1	schematization	schematization	NOUN
dpc-2415	111	2	of	of	ADP
dpc-2415	111	3	risks	risk	NOUN
dpc-2415	111	4	and	and	CCONJ
dpc-2415	111	5	benefits	benefit	NOUN
dpc-2415	111	6	of	of	ADP
dpc-2415	111	7	cytokine	cytokine	ADJ
dpc-2415	111	8	blocking	block	VERB
dpc-2415	111	9	therapies	therapy	NOUN
dpc-2415	111	10	in	in	ADP
dpc-2415	111	11	psoriasis	psoriasis	NOUN
dpc-2415	111	12	.	.	PUNCT
dpc-2415	112	1	d	d	PRON
dpc-2415	112	2	dendritic	dendritic	ADJ
dpc-2415	112	3	cell	cell	NOUN
dpc-2415	112	4	,	,	PUNCT
dpc-2415	112	5	il	il	PROPN
dpc-2415	112	6	interleukin	interleukin	PROPN
dpc-2415	112	7	,	,	PUNCT
dpc-2415	112	8	k	k	PROPN
dpc-2415	112	9	keratinocyte	keratinocyte	PROPN
dpc-2415	112	10	,	,	PUNCT
dpc-2415	112	11	th	th	X
dpc-2415	112	12	 	 	SPACE
dpc-2415	112	13	t	t	PROPN
dpc-2415	112	14	helper	helper	NOUN
dpc-2415	112	15	,	,	PUNCT
dpc-2415	112	16	tnf	tnf	PROPN
dpc-2415	112	17	tumor	tumor	NOUN
dpc-2415	112	18	necrosis	necrosis	NOUN
dpc-2415	112	19	factor	factor	NOUN
dpc-2415	112	20	.	.	PUNCT
dpc-2415	113	1	6	6	NUM
dpc-2415	113	2	review	review	NOUN
dpc-2415	113	3	|	|	ADV
dpc-2415	113	4	dermatol	dermatol	ADJ
dpc-2415	113	5	pract	pract	NOUN
dpc-2415	113	6	concept	concept	NOUN
dpc-2415	113	7	.	.	PUNCT
dpc-2415	114	1	2023;13(1):e2023016	2023;13(1):e2023016	NUM
dpc-2415	114	2	2	2	NUM
dpc-2415	114	3	.	.	PUNCT
dpc-2415	114	4	boehncke	boehncke	PROPN
dpc-2415	114	5	wh	wh	PROPN
dpc-2415	114	6	,	,	PUNCT
dpc-2415	114	7	schön	schön	PROPN
dpc-2415	114	8	mp	mp	PROPN
dpc-2415	114	9	.	.	PROPN
dpc-2415	114	10	psoriasis	psoriasis	NOUN
dpc-2415	114	11	.	.	PUNCT
dpc-2415	114	12	 	 	SPACE
dpc-2415	114	13	lancet	lancet	PROPN
dpc-2415	114	14	.	.	PUNCT
dpc-2415	115	1	2015;386(9997):983994	2015;386(9997):983994	NUM
dpc-2415	115	2	.	.	PUNCT
dpc-2415	116	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	116	2	/	/	SYM
dpc-2415	117	1	s0140	s0140	PROPN
dpc-2415	117	2	-	-	PUNCT
dpc-2415	117	3	6736(14)61909	6736(14)61909	NUM
dpc-2415	117	4	-	-	SYM
dpc-2415	117	5	7	7	NUM
dpc-2415	117	6	3	3	NUM
dpc-2415	117	7	.	.	PUNCT
dpc-2415	117	8	nickoloff	nickoloff	NOUN
dpc-2415	117	9	bj	bj	PROPN
dpc-2415	117	10	,	,	PUNCT
dpc-2415	117	11	qin	qin	PROPN
dpc-2415	117	12	jz	jz	PROPN
dpc-2415	117	13	,	,	PUNCT
dpc-2415	117	14	nestle	nestle	PROPN
dpc-2415	117	15	fo	fo	PROPN
dpc-2415	117	16	.	.	PUNCT
dpc-2415	118	1	immunopathogenesis	immunopathogenesis	NOUN
dpc-2415	118	2	of	of	ADP
dpc-2415	118	3	psoriasis	psoriasis	NOUN
dpc-2415	118	4	.	.	PUNCT
dpc-2415	118	5	 	 	SPACE
dpc-2415	119	1	clin	clin	PROPN
dpc-2415	119	2	rev	rev	PROPN
dpc-2415	119	3	allergy	allergy	PROPN
dpc-2415	119	4	immunol	immunol	NOUN
dpc-2415	119	5	.	.	PUNCT
dpc-2415	120	1	2007;33(1	2007;33(1	NUM
dpc-2415	120	2	-	-	SYM
dpc-2415	120	3	2):45	2):45	NUM
dpc-2415	120	4	-	-	PUNCT
dpc-2415	120	5	56	56	NUM
dpc-2415	120	6	.	.	PUNCT
dpc-2415	121	1	doi:10.1007/	doi:10.1007/	NUM
dpc-2415	121	2	s12016	s12016	PROPN
dpc-2415	121	3	-	-	PUNCT
dpc-2415	121	4	007	007	NUM
dpc-2415	121	5	-	-	PUNCT
dpc-2415	121	6	0039	0039	NUM
dpc-2415	121	7	-	-	SYM
dpc-2415	121	8	2	2	NUM
dpc-2415	121	9	4	4	NUM
dpc-2415	121	10	.	.	PUNCT
dpc-2415	122	1	cai	cai	PROPN
dpc-2415	122	2	y	y	PROPN
dpc-2415	122	3	,	,	PUNCT
dpc-2415	122	4	fleming	fleme	VERB
dpc-2415	122	5	c	c	PROPN
dpc-2415	122	6	,	,	PUNCT
dpc-2415	122	7	yan	yan	PROPN
dpc-2415	122	8	j.	j.	PROPN
dpc-2415	122	9	new	new	ADJ
dpc-2415	122	10	insights	insight	NOUN
dpc-2415	122	11	of	of	ADP
dpc-2415	122	12	t	t	NOUN
dpc-2415	122	13	cells	cell	NOUN
dpc-2415	122	14	in	in	ADP
dpc-2415	122	15	the	the	DET
dpc-2415	122	16	pathogenesis	pathogenesis	NOUN
dpc-2415	122	17	of	of	ADP
dpc-2415	122	18	psoriasis	psoriasis	NOUN
dpc-2415	122	19	.	.	PUNCT
dpc-2415	122	20	  	  	SPACE
dpc-2415	123	1	cell	cell	NOUN
dpc-2415	123	2	mol	mol	ADP
dpc-2415	123	3	immunol	immunol	NOUN
dpc-2415	123	4	.	.	PUNCT
dpc-2415	124	1	2012;9(4):302	2012;9(4):302	X
dpc-2415	124	2	-	-	SYM
dpc-2415	124	3	309	309	NUM
dpc-2415	124	4	.	.	PUNCT
dpc-2415	125	1	doi:10.1038	doi:10.1038	NOUN
dpc-2415	125	2	/	/	SYM
dpc-2415	125	3	cmi.2012.15	cmi.2012.15	PROPN
dpc-2415	125	4	5	5	NUM
dpc-2415	125	5	.	.	PUNCT
dpc-2415	125	6	harden	harden	PROPN
dpc-2415	125	7	jl	jl	PROPN
dpc-2415	125	8	,	,	PUNCT
dpc-2415	125	9	krueger	krueger	PROPN
dpc-2415	125	10	jg	jg	PROPN
dpc-2415	125	11	,	,	PUNCT
dpc-2415	125	12	bowcock	bowcock	NOUN
dpc-2415	125	13	am	be	AUX
dpc-2415	125	14	.	.	PUNCT
dpc-2415	126	1	the	the	DET
dpc-2415	126	2	immunogenetics	immunogenetic	NOUN
dpc-2415	126	3	of	of	ADP
dpc-2415	126	4	psoriasis	psoriasis	NOUN
dpc-2415	126	5	:	:	PUNCT
dpc-2415	126	6	a	a	DET
dpc-2415	126	7	comprehensive	comprehensive	ADJ
dpc-2415	126	8	review	review	NOUN
dpc-2415	126	9	.	.	PUNCT
dpc-2415	126	10	 	 	SPACE
dpc-2415	127	1	j	j	PROPN
dpc-2415	127	2	autoimmun	autoimmun	PROPN
dpc-2415	127	3	.	.	PUNCT
dpc-2415	128	1	2015;64:66	2015;64:66	NUM
dpc-2415	128	2	-	-	SYM
dpc-2415	128	3	73	73	NUM
dpc-2415	128	4	.	.	PUNCT
dpc-2415	129	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	129	2	/	/	SYM
dpc-2415	129	3	j.jaut.2015.07.008	j.jaut.2015.07.008	PROPN
dpc-2415	129	4	6	6	NUM
dpc-2415	129	5	.	.	PUNCT
dpc-2415	130	1	elder	elder	PROPN
dpc-2415	130	2	jt	jt	PROPN
dpc-2415	130	3	.	.	PUNCT
dpc-2415	130	4	genome	genome	NOUN
dpc-2415	130	5	-	-	PUNCT
dpc-2415	130	6	wide	wide	ADJ
dpc-2415	130	7	association	association	NOUN
dpc-2415	130	8	scan	scan	PROPN
dpc-2415	130	9	yields	yield	VERB
dpc-2415	130	10	new	new	ADJ
dpc-2415	130	11	insights	insight	NOUN
dpc-2415	130	12	into	into	ADP
dpc-2415	130	13	the	the	DET
dpc-2415	130	14	immunopathogenesis	immunopathogenesis	NOUN
dpc-2415	130	15	of	of	ADP
dpc-2415	130	16	psoriasis	psoriasis	NOUN
dpc-2415	130	17	.	.	PUNCT
dpc-2415	130	18	  	  	SPACE
dpc-2415	131	1	genes	gene	NOUN
dpc-2415	131	2	immun	immun	NOUN
dpc-2415	131	3	.	.	PUNCT
dpc-2415	132	1	2009;10(3):201	2009;10(3):201	NUM
dpc-2415	132	2	-	-	PUNCT
dpc-2415	132	3	209	209	NUM
dpc-2415	132	4	.	.	PUNCT
dpc-2415	133	1	doi:10.1038	doi:10.1038	NOUN
dpc-2415	133	2	/	/	SYM
dpc-2415	133	3	gene.2009.11	gene.2009.11	NOUN
dpc-2415	133	4	7	7	NUM
dpc-2415	133	5	.	.	NOUN
dpc-2415	133	6	capon	capon	NOUN
dpc-2415	133	7	f.	f.	PROPN
dpc-2415	134	1	the	the	DET
dpc-2415	134	2	genetic	genetic	ADJ
dpc-2415	134	3	basis	basis	NOUN
dpc-2415	134	4	of	of	ADP
dpc-2415	134	5	psoriasis	psoriasis	NOUN
dpc-2415	134	6	.	.	PUNCT
dpc-2415	134	7	  	  	SPACE
dpc-2415	135	1	int	int	PROPN
dpc-2415	135	2	j	j	PROPN
dpc-2415	135	3	mol	mol	ADP
dpc-2415	135	4	sci	sci	PROPN
dpc-2415	135	5	.	.	PUNCT
dpc-2415	136	1	2017;18(12):2526	2017;18(12):2526	NUM
dpc-2415	136	2	.	.	PUNCT
dpc-2415	137	1	published	publish	VERB
dpc-2415	137	2	2017	2017	NUM
dpc-2415	137	3	nov	nov	PROPN
dpc-2415	137	4	25	25	NUM
dpc-2415	137	5	.	.	PUNCT
dpc-2415	138	1	doi:10.3390	doi:10.3390	PROPN
dpc-2415	138	2	/	/	SYM
dpc-2415	138	3	ijms	ijm	VERB
dpc-2415	138	4	18122526	18122526	NUM
dpc-2415	138	5	8	8	NUM
dpc-2415	138	6	.	.	PUNCT
dpc-2415	139	1	bianchi	bianchi	PROPN
dpc-2415	139	2	e	e	PROPN
dpc-2415	139	3	,	,	PUNCT
dpc-2415	139	4	rogge	rogge	PROPN
dpc-2415	139	5	l.	l.	PROPN
dpc-2415	139	6	the	the	DET
dpc-2415	139	7	il-23	il-23	NOUN
dpc-2415	139	8	/	/	SYM
dpc-2415	139	9	il-17	il-17	NUM
dpc-2415	139	10	pathway	pathway	NOUN
dpc-2415	139	11	in	in	ADP
dpc-2415	139	12	human	human	ADJ
dpc-2415	139	13	chronic	chronic	ADJ
dpc-2415	139	14	inflammatory	inflammatory	ADJ
dpc-2415	139	15	diseases	disease	NOUN
dpc-2415	139	16	-	-	PUNCT
dpc-2415	139	17	new	new	ADJ
dpc-2415	139	18	insight	insight	NOUN
dpc-2415	139	19	from	from	ADP
dpc-2415	139	20	genetics	genetic	NOUN
dpc-2415	139	21	and	and	CCONJ
dpc-2415	139	22	targeted	target	VERB
dpc-2415	139	23	therapies	therapy	NOUN
dpc-2415	139	24	.	.	PUNCT
dpc-2415	139	25	  	  	SPACE
dpc-2415	139	26	genes	gene	NOUN
dpc-2415	139	27	immun	immun	NOUN
dpc-2415	139	28	.	.	PUNCT
dpc-2415	140	1	2019;20(5):415	2019;20(5):415	NUM
dpc-2415	140	2	-	-	PUNCT
dpc-2415	140	3	425	425	NUM
dpc-2415	140	4	.	.	PUNCT
dpc-2415	141	1	doi:10.1038	doi:10.1038	NOUN
dpc-2415	141	2	/s41435	/s41435	NOUN
dpc-2415	141	3	-	-	PUNCT
dpc-2415	141	4	019	019	NUM
dpc-2415	141	5	-	-	PUNCT
dpc-2415	141	6	0067	0067	NUM
dpc-2415	141	7	-	-	PUNCT
dpc-2415	141	8	y	y	PROPN
dpc-2415	141	9	9	9	NUM
dpc-2415	141	10	.	.	PUNCT
dpc-2415	141	11	ray	ray	NOUN
dpc-2415	141	12	-	-	PUNCT
dpc-2415	141	13	jones	jones	PROPN
dpc-2415	141	14	h	h	PROPN
dpc-2415	141	15	,	,	PUNCT
dpc-2415	141	16	eyre	eyre	PROPN
dpc-2415	141	17	s	s	PROPN
dpc-2415	141	18	,	,	PUNCT
dpc-2415	141	19	barton	barton	PROPN
dpc-2415	141	20	a	a	PROPN
dpc-2415	141	21	,	,	PUNCT
dpc-2415	141	22	warren	warren	PROPN
dpc-2415	141	23	rb	rb	PROPN
dpc-2415	141	24	.	.	PUNCT
dpc-2415	142	1	one	one	NUM
dpc-2415	142	2	snp	snp	VERB
dpc-2415	142	3	at	at	ADP
dpc-2415	142	4	a	a	DET
dpc-2415	142	5	time	time	NOUN
dpc-2415	142	6	:	:	PUNCT
dpc-2415	142	7	moving	move	VERB
dpc-2415	142	8	beyond	beyond	ADP
dpc-2415	142	9	gwas	gwas	NOUN
dpc-2415	142	10	in	in	ADP
dpc-2415	142	11	psoriasis	psoriasis	NOUN
dpc-2415	142	12	.	.	PUNCT
dpc-2415	142	13	  	  	SPACE
dpc-2415	143	1	j	j	PROPN
dpc-2415	143	2	invest	invest	VERB
dpc-2415	143	3	dermatol	dermatol	NOUN
dpc-2415	143	4	.	.	PUNCT
dpc-2415	144	1	2016;136(3):567	2016;136(3):567	NUM
dpc-2415	144	2	-	-	SYM
dpc-2415	144	3	573	573	NUM
dpc-2415	144	4	.	.	PUNCT
dpc-2415	144	5	doi:10.1016	doi:10.1016	PROPN
dpc-2415	144	6	/	/	SYM
dpc-2415	144	7	j.jid.2015.11.025	j.jid.2015.11.025	PROPN
dpc-2415	144	8	10	10	NUM
dpc-2415	144	9	.	.	PUNCT
dpc-2415	145	1	li	li	PROPN
dpc-2415	145	2	b	b	PROPN
dpc-2415	145	3	,	,	PUNCT
dpc-2415	145	4	huang	huang	PROPN
dpc-2415	145	5	l	l	PROPN
dpc-2415	145	6	,	,	PUNCT
dpc-2415	145	7	lv	lv	PROPN
dpc-2415	145	8	p	p	X
dpc-2415	145	9	,	,	PUNCT
dpc-2415	145	10	et	et	PROPN
dpc-2415	145	11	al	al	PROPN
dpc-2415	145	12	.	.	PUNCT
dpc-2415	146	1	the	the	DET
dpc-2415	146	2	role	role	NOUN
dpc-2415	146	3	of	of	ADP
dpc-2415	146	4	th17	th17	PROPN
dpc-2415	146	5	cells	cell	NOUN
dpc-2415	146	6	in	in	ADP
dpc-2415	146	7	psoriasis	psoriasis	NOUN
dpc-2415	146	8	.	.	PUNCT
dpc-2415	146	9	 	 	SPACE
dpc-2415	147	1	immunol	immunol	NOUN
dpc-2415	147	2	res	re	NOUN
dpc-2415	147	3	.	.	PUNCT
dpc-2415	148	1	2020;68(5):296	2020;68(5):296	NUM
dpc-2415	148	2	-	-	SYM
dpc-2415	148	3	309	309	NUM
dpc-2415	148	4	.	.	PUNCT
dpc-2415	149	1	doi:10.1007	doi:10.1007	VERB
dpc-2415	149	2	/	/	SYM
dpc-2415	149	3	s12026	s12026	PRON
dpc-2415	149	4	-	-	PUNCT
dpc-2415	149	5	020	020	NUM
dpc-2415	149	6	-	-	PUNCT
dpc-2415	149	7	09149	09149	NUM
dpc-2415	149	8	-	-	SYM
dpc-2415	149	9	1	1	NUM
dpc-2415	149	10	11	11	NUM
dpc-2415	149	11	.	.	PUNCT
dpc-2415	150	1	martin	martin	PROPN
dpc-2415	150	2	da	da	PROPN
dpc-2415	150	3	,	,	PUNCT
dpc-2415	150	4	towne	towne	PROPN
dpc-2415	150	5	je	je	PROPN
dpc-2415	150	6	,	,	PUNCT
dpc-2415	150	7	kricorian	kricorian	PROPN
dpc-2415	150	8	g	g	PROPN
dpc-2415	150	9	,	,	PUNCT
dpc-2415	150	10	et	et	PROPN
dpc-2415	150	11	al	al	PROPN
dpc-2415	150	12	.	.	PUNCT
dpc-2415	151	1	the	the	DET
dpc-2415	151	2	emerging	emerge	VERB
dpc-2415	151	3	role	role	NOUN
dpc-2415	151	4	of	of	ADP
dpc-2415	151	5	il-17	il-17	NUM
dpc-2415	151	6	in	in	ADP
dpc-2415	151	7	the	the	DET
dpc-2415	151	8	pathogenesis	pathogenesis	NOUN
dpc-2415	151	9	of	of	ADP
dpc-2415	151	10	psoriasis	psoriasis	NOUN
dpc-2415	151	11	:	:	PUNCT
dpc-2415	151	12	preclinical	preclinical	ADJ
dpc-2415	151	13	and	and	CCONJ
dpc-2415	151	14	clinical	clinical	ADJ
dpc-2415	151	15	findings	finding	NOUN
dpc-2415	151	16	.	.	PUNCT
dpc-2415	151	17	  	  	SPACE
dpc-2415	152	1	j	j	PROPN
dpc-2415	152	2	invest	invest	VERB
dpc-2415	152	3	dermatol	dermatol	NOUN
dpc-2415	152	4	.	.	PUNCT
dpc-2415	153	1	2013;133(1):17	2013;133(1):17	VERB
dpc-2415	153	2	-	-	PUNCT
dpc-2415	153	3	26	26	NUM
dpc-2415	153	4	.	.	PUNCT
dpc-2415	154	1	doi:10.1038/	doi:10.1038/	NOUN
dpc-2415	154	2	jid.2012.194	jid.2012.194	PROPN
dpc-2415	154	3	12	12	NUM
dpc-2415	154	4	.	.	PUNCT
dpc-2415	155	1	chiricozzi	chiricozzi	PROPN
dpc-2415	155	2	a	a	PRON
dpc-2415	155	3	,	,	PUNCT
dpc-2415	155	4	guttman	guttman	ADJ
dpc-2415	155	5	-	-	PUNCT
dpc-2415	155	6	yassky	yassky	ADJ
dpc-2415	155	7	e	e	NOUN
dpc-2415	155	8	,	,	PUNCT
dpc-2415	155	9	suárez	suárez	NOUN
dpc-2415	155	10	-	-	PUNCT
dpc-2415	155	11	fariñas	fariñas	NOUN
dpc-2415	155	12	m	m	PROPN
dpc-2415	155	13	,	,	PUNCT
dpc-2415	155	14	et	et	PROPN
dpc-2415	155	15	al	al	PROPN
dpc-2415	155	16	.	.	PROPN
dpc-2415	155	17	integrative	integrative	ADJ
dpc-2415	155	18	responses	response	NOUN
dpc-2415	155	19	to	to	ADP
dpc-2415	155	20	il-17	il-17	NOUN
dpc-2415	155	21	and	and	CCONJ
dpc-2415	155	22	tnf	tnf	PROPN
dpc-2415	155	23	-	-	PUNCT
dpc-2415	155	24	α	α	PROPN
dpc-2415	155	25	in	in	ADP
dpc-2415	155	26	human	human	ADJ
dpc-2415	155	27	keratinocytes	keratinocyte	NOUN
dpc-2415	155	28	account	account	VERB
dpc-2415	155	29	for	for	ADP
dpc-2415	155	30	key	key	ADJ
dpc-2415	155	31	inflammatory	inflammatory	ADJ
dpc-2415	155	32	pathogenic	pathogenic	ADJ
dpc-2415	155	33	circuits	circuit	NOUN
dpc-2415	155	34	in	in	ADP
dpc-2415	155	35	psoriasis	psoriasis	NOUN
dpc-2415	155	36	.	.	PUNCT
dpc-2415	155	37	 	 	SPACE
dpc-2415	156	1	j	j	PROPN
dpc-2415	156	2	invest	invest	VERB
dpc-2415	156	3	dermatol	dermatol	NOUN
dpc-2415	156	4	.	.	PUNCT
dpc-2415	157	1	2011;131(3):677	2011;131(3):677	NUM
dpc-2415	157	2	-	-	SYM
dpc-2415	157	3	687	687	NUM
dpc-2415	157	4	.	.	PUNCT
dpc-2415	158	1	doi:10.1038	doi:10.1038	PROPN
dpc-2415	158	2	/	/	SYM
dpc-2415	158	3	jid	jid	PROPN
dpc-2415	158	4	.2010.340	.2010.340	PUNCT
dpc-2415	158	5	13	13	NUM
dpc-2415	158	6	.	.	PUNCT
dpc-2415	158	7	carrier	carrier	PROPN
dpc-2415	158	8	y	y	PROPN
dpc-2415	158	9	,	,	PUNCT
dpc-2415	158	10	ma	ma	PROPN
dpc-2415	158	11	hl	hl	PROPN
dpc-2415	158	12	,	,	PUNCT
dpc-2415	158	13	ramon	ramon	PROPN
dpc-2415	158	14	he	he	PRON
dpc-2415	158	15	,	,	PUNCT
dpc-2415	158	16	et	et	PROPN
dpc-2415	158	17	al	al	PROPN
dpc-2415	158	18	.	.	PUNCT
dpc-2415	159	1	inter	inter	PROPN
dpc-2415	159	2	-	-	NOUN
dpc-2415	159	3	regulation	regulation	NOUN
dpc-2415	159	4	of	of	ADP
dpc-2415	159	5	th17	th17	PROPN
dpc-2415	159	6	cytokines	cytokine	NOUN
dpc-2415	159	7	and	and	CCONJ
dpc-2415	159	8	the	the	DET
dpc-2415	159	9	il-36	il-36	NOUN
dpc-2415	159	10	cytokines	cytokine	VERB
dpc-2415	159	11	in	in	ADP
dpc-2415	159	12	vitro	vitro	X
dpc-2415	159	13	and	and	CCONJ
dpc-2415	159	14	in	in	ADP
dpc-2415	159	15	vivo	vivo	NOUN
dpc-2415	159	16	:	:	PUNCT
dpc-2415	159	17	implications	implication	NOUN
dpc-2415	159	18	should	should	AUX
dpc-2415	159	19	be	be	AUX
dpc-2415	159	20	taken	take	VERB
dpc-2415	159	21	on	on	ADP
dpc-2415	159	22	a	a	DET
dpc-2415	159	23	case	case	NOUN
dpc-2415	159	24	-	-	PUNCT
dpc-2415	159	25	by	by	ADP
dpc-2415	159	26	-	-	PUNCT
dpc-2415	159	27	case	case	NOUN
dpc-2415	159	28	basis	basis	NOUN
dpc-2415	160	1	[	[	X
dpc-2415	160	2	76,77	76,77	NOUN
dpc-2415	160	3	]	]	X
dpc-2415	160	4	.	.	PUNCT
dpc-2415	161	1	similar	similar	ADJ
dpc-2415	161	2	to	to	ADP
dpc-2415	161	3	active	active	ADJ
dpc-2415	161	4	serious	serious	ADJ
dpc-2415	161	5	infections	infection	NOUN
dpc-2415	161	6	,	,	PUNCT
dpc-2415	161	7	in	in	ADP
dpc-2415	161	8	case	case	NOUN
dpc-2415	161	9	of	of	ADP
dpc-2415	161	10	major	major	ADJ
dpc-2415	161	11	surgery	surgery	NOUN
dpc-2415	161	12	(	(	PUNCT
dpc-2415	161	13	i.e.	i.e.	X
dpc-2415	161	14	,	,	PUNCT
dpc-2415	161	15	under	under	ADP
dpc-2415	161	16	general	general	ADJ
dpc-2415	161	17	anesthesia	anesthesia	PROPN
dpc-2415	161	18	with	with	ADP
dpc-2415	161	19	exposure	exposure	NOUN
dpc-2415	161	20	of	of	ADP
dpc-2415	161	21	large	large	ADJ
dpc-2415	161	22	body	body	NOUN
dpc-2415	161	23	areas	area	NOUN
dpc-2415	161	24	,	,	PUNCT
dpc-2415	161	25	internal	internal	ADJ
dpc-2415	161	26	organ	organ	NOUN
dpc-2415	161	27	surgery	surgery	NOUN
dpc-2415	161	28	)	)	PUNCT
dpc-2415	161	29	,	,	PUNCT
dpc-2415	161	30	guidelines	guideline	NOUN
dpc-2415	161	31	recommend	recommend	VERB
dpc-2415	161	32	treatment	treatment	NOUN
dpc-2415	161	33	interruption	interruption	NOUN
dpc-2415	161	34	,	,	PUNCT
dpc-2415	161	35	evaluating	evaluate	VERB
dpc-2415	161	36	case	case	NOUN
dpc-2415	161	37	-	-	PUNCT
dpc-2415	161	38	by	by	ADP
dpc-2415	161	39	-	-	PUNCT
dpc-2415	161	40	case	case	NOUN
dpc-2415	161	41	patient	patient	NOUN
dpc-2415	161	42	characteristics	characteristic	NOUN
dpc-2415	161	43	,	,	PUNCT
dpc-2415	161	44	the	the	DET
dpc-2415	161	45	risk	risk	NOUN
dpc-2415	161	46	of	of	ADP
dpc-2415	161	47	infection	infection	NOUN
dpc-2415	161	48	,	,	PUNCT
dpc-2415	161	49	the	the	DET
dpc-2415	161	50	risk	risk	NOUN
dpc-2415	161	51	of	of	ADP
dpc-2415	161	52	psoriasis	psoriasis	NOUN
dpc-2415	161	53	worsening	worsen	VERB
dpc-2415	161	54	and	and	CCONJ
dpc-2415	161	55	consultation	consultation	NOUN
dpc-2415	161	56	with	with	ADP
dpc-2415	161	57	the	the	DET
dpc-2415	161	58	surgeon	surgeon	NOUN
dpc-2415	161	59	[	[	X
dpc-2415	161	60	78	78	NUM
dpc-2415	161	61	]	]	PUNCT
dpc-2415	161	62	.	.	PUNCT
dpc-2415	162	1	therapy	therapy	NOUN
dpc-2415	162	2	restart	restart	NOUN
dpc-2415	162	3	can	can	AUX
dpc-2415	162	4	be	be	AUX
dpc-2415	162	5	considered	consider	VERB
dpc-2415	162	6	after	after	ADP
dpc-2415	162	7	full	full	ADJ
dpc-2415	162	8	recovery	recovery	NOUN
dpc-2415	162	9	.	.	PUNCT
dpc-2415	163	1	nevertheless	nevertheless	ADV
dpc-2415	163	2	,	,	PUNCT
dpc-2415	163	3	real	real	ADJ
dpc-2415	163	4	-	-	PUNCT
dpc-2415	163	5	life	life	NOUN
dpc-2415	163	6	data	datum	NOUN
dpc-2415	163	7	on	on	ADP
dpc-2415	163	8	perioperative	perioperative	ADJ
dpc-2415	163	9	management	management	NOUN
dpc-2415	163	10	are	be	AUX
dpc-2415	163	11	limited	limit	VERB
dpc-2415	163	12	and	and	CCONJ
dpc-2415	163	13	do	do	AUX
dpc-2415	163	14	not	not	PART
dpc-2415	163	15	provide	provide	VERB
dpc-2415	163	16	strong	strong	ADJ
dpc-2415	163	17	evidence	evidence	NOUN
dpc-2415	163	18	of	of	ADP
dpc-2415	163	19	perior	perior	ADJ
dpc-2415	163	20	post	post	ADJ
dpc-2415	163	21	-	-	ADJ
dpc-2415	163	22	operative	operative	ADJ
dpc-2415	163	23	complications	complication	NOUN
dpc-2415	163	24	due	due	ADJ
dpc-2415	163	25	to	to	ADP
dpc-2415	163	26	continuous	continuous	ADJ
dpc-2415	163	27	treatment	treatment	NOUN
dpc-2415	163	28	with	with	ADP
dpc-2415	163	29	biologic	biologic	ADJ
dpc-2415	163	30	agents	agent	NOUN
dpc-2415	163	31	or	or	CCONJ
dpc-2415	163	32	apremilast	apremilast	VERB
dpc-2415	164	1	[	[	X
dpc-2415	164	2	78	78	NUM
dpc-2415	164	3	-	-	SYM
dpc-2415	164	4	80	80	NUM
dpc-2415	164	5	]	]	PUNCT
dpc-2415	164	6	.	.	PUNCT
dpc-2415	165	1	infectious	infectious	ADJ
dpc-2415	165	2	diseases	disease	NOUN
dpc-2415	165	3	to	to	PART
dpc-2415	165	4	consider	consider	VERB
dpc-2415	165	5	for	for	ADP
dpc-2415	165	6	selecting	select	VERB
dpc-2415	165	7	biological	biological	ADJ
dpc-2415	165	8	and	and	CCONJ
dpc-2415	165	9	new	new	ADJ
dpc-2415	165	10	small	small	ADJ
dpc-2415	165	11	-	-	PUNCT
dpc-2415	165	12	molecule	molecule	NOUN
dpc-2415	165	13	therapies	therapy	NOUN
dpc-2415	165	14	are	be	AUX
dpc-2415	165	15	listed	list	VERB
dpc-2415	165	16	in	in	ADP
dpc-2415	165	17	table	table	NOUN
dpc-2415	165	18	2	2	NUM
dpc-2415	165	19	.	.	PUNCT
dpc-2415	165	20	conclusion	conclusion	NOUN
dpc-2415	165	21	in	in	ADP
dpc-2415	165	22	an	an	DET
dpc-2415	165	23	era	era	NOUN
dpc-2415	165	24	characterized	characterize	VERB
dpc-2415	165	25	by	by	ADP
dpc-2415	165	26	an	an	DET
dpc-2415	165	27	ever	ever	ADV
dpc-2415	165	28	greater	great	ADJ
dpc-2415	165	29	and	and	CCONJ
dpc-2415	165	30	growing	grow	VERB
dpc-2415	165	31	risk	risk	NOUN
dpc-2415	165	32	of	of	ADP
dpc-2415	165	33	infections	infection	NOUN
dpc-2415	165	34	,	,	PUNCT
dpc-2415	165	35	but	but	CCONJ
dpc-2415	165	36	at	at	ADP
dpc-2415	165	37	the	the	DET
dpc-2415	165	38	same	same	ADJ
dpc-2415	165	39	time	time	NOUN
dpc-2415	165	40	by	by	ADP
dpc-2415	165	41	increasingly	increasingly	ADV
dpc-2415	165	42	specific	specific	ADJ
dpc-2415	165	43	and	and	CCONJ
dpc-2415	165	44	advanced	advanced	ADJ
dpc-2415	165	45	immune	immune	NOUN
dpc-2415	165	46	-	-	PUNCT
dpc-2415	165	47	mediated	mediate	VERB
dpc-2415	165	48	therapies	therapy	NOUN
dpc-2415	165	49	,	,	PUNCT
dpc-2415	165	50	it	it	PRON
dpc-2415	165	51	is	be	AUX
dpc-2415	165	52	necessary	necessary	ADJ
dpc-2415	165	53	to	to	PART
dpc-2415	165	54	always	always	ADV
dpc-2415	165	55	be	be	AUX
dpc-2415	165	56	updated	update	VERB
dpc-2415	165	57	on	on	ADP
dpc-2415	165	58	the	the	DET
dpc-2415	165	59	risk	risk	NOUN
dpc-2415	165	60	of	of	ADP
dpc-2415	165	61	such	such	ADJ
dpc-2415	165	62	infections	infection	NOUN
dpc-2415	165	63	and	and	CCONJ
dpc-2415	165	64	on	on	ADP
dpc-2415	165	65	the	the	DET
dpc-2415	165	66	ability	ability	NOUN
dpc-2415	165	67	to	to	PART
dpc-2415	165	68	manage	manage	VERB
dpc-2415	165	69	them	they	PRON
dpc-2415	165	70	.	.	PUNCT
dpc-2415	166	1	currently	currently	ADV
dpc-2415	166	2	,	,	PUNCT
dpc-2415	166	3	we	we	PRON
dpc-2415	166	4	are	be	AUX
dpc-2415	166	5	witnessing	witness	VERB
dpc-2415	166	6	a	a	DET
dpc-2415	166	7	revolution	revolution	NOUN
dpc-2415	166	8	in	in	ADP
dpc-2415	166	9	the	the	DET
dpc-2415	166	10	treatment	treatment	NOUN
dpc-2415	166	11	of	of	ADP
dpc-2415	166	12	psoriasis	psoriasis	NOUN
dpc-2415	166	13	where	where	SCONJ
dpc-2415	166	14	the	the	DET
dpc-2415	166	15	starting	starting	NOUN
dpc-2415	166	16	point	point	NOUN
dpc-2415	166	17	is	be	AUX
dpc-2415	166	18	the	the	DET
dpc-2415	166	19	translational	translational	ADJ
dpc-2415	166	20	approach	approach	NOUN
dpc-2415	166	21	,	,	PUNCT
dpc-2415	166	22	and	and	CCONJ
dpc-2415	166	23	we	we	PRON
dpc-2415	166	24	firmly	firmly	ADV
dpc-2415	166	25	believe	believe	VERB
dpc-2415	166	26	that	that	SCONJ
dpc-2415	166	27	by	by	ADP
dpc-2415	166	28	following	follow	VERB
dpc-2415	166	29	this	this	DET
dpc-2415	166	30	path	path	NOUN
dpc-2415	166	31	we	we	PRON
dpc-2415	166	32	can	can	AUX
dpc-2415	166	33	reach	reach	VERB
dpc-2415	166	34	a	a	DET
dpc-2415	166	35	wider	wide	ADJ
dpc-2415	166	36	knowledge	knowledge	NOUN
dpc-2415	166	37	that	that	PRON
dpc-2415	166	38	will	will	AUX
dpc-2415	166	39	help	help	VERB
dpc-2415	166	40	us	we	PRON
dpc-2415	166	41	in	in	ADP
dpc-2415	166	42	preventing	prevent	VERB
dpc-2415	166	43	and	and	CCONJ
dpc-2415	166	44	treating	treat	VERB
dpc-2415	166	45	properly	properly	ADV
dpc-2415	166	46	infections	infection	NOUN
dpc-2415	166	47	associated	associate	VERB
dpc-2415	166	48	with	with	ADP
dpc-2415	166	49	psoriasis	psoriasis	NOUN
dpc-2415	166	50	.	.	PUNCT
dpc-2415	167	1	references	reference	NOUN
dpc-2415	167	2	1	1	NUM
dpc-2415	167	3	.	.	PUNCT
dpc-2415	168	1	ghoreschi	ghoreschi	PROPN
dpc-2415	168	2	k	k	NOUN
dpc-2415	168	3	,	,	PUNCT
dpc-2415	168	4	balato	balato	NOUN
dpc-2415	168	5	a	a	PRON
dpc-2415	168	6	,	,	PUNCT
dpc-2415	168	7	enerbäck	enerbäck	ADJ
dpc-2415	168	8	c	c	X
dpc-2415	168	9	,	,	PUNCT
dpc-2415	168	10	sabat	sabat	PROPN
dpc-2415	168	11	r.	r.	PROPN
dpc-2415	168	12	therapeutics	therapeutic	NOUN
dpc-2415	168	13	targeting	target	VERB
dpc-2415	168	14	the	the	DET
dpc-2415	168	15	il-23	il-23	NOUN
dpc-2415	168	16	and	and	CCONJ
dpc-2415	168	17	il-17	il-17	ADV
dpc-2415	168	18	pathway	pathway	NOUN
dpc-2415	168	19	in	in	ADP
dpc-2415	168	20	psoriasis	psoriasis	NOUN
dpc-2415	168	21	.	.	PUNCT
dpc-2415	168	22	  	  	SPACE
dpc-2415	169	1	lancet	lancet	NOUN
dpc-2415	169	2	.	.	PUNCT
dpc-2415	170	1	2021;397(10275):754	2021;397(10275):754	NUM
dpc-2415	170	2	-	-	SYM
dpc-2415	170	3	766	766	NUM
dpc-2415	170	4	.	.	PUNCT
dpc-2415	171	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	171	2	/	/	SYM
dpc-2415	171	3	s0140	s0140	PROPN
dpc-2415	171	4	-	-	PUNCT
dpc-2415	171	5	6736(21)00184	6736(21)00184	NOUN
dpc-2415	171	6	-	-	SYM
dpc-2415	171	7	7	7	NUM
dpc-2415	171	8	table	table	NOUN
dpc-2415	171	9	2	2	NUM
dpc-2415	171	10	.	.	PUNCT
dpc-2415	171	11	infectious	infectious	ADJ
dpc-2415	171	12	diseases	disease	NOUN
dpc-2415	171	13	to	to	PART
dpc-2415	171	14	consider	consider	VERB
dpc-2415	171	15	for	for	ADP
dpc-2415	171	16	selecting	select	VERB
dpc-2415	171	17	biological	biological	ADJ
dpc-2415	171	18	and	and	CCONJ
dpc-2415	171	19	new	new	ADJ
dpc-2415	171	20	small	small	ADJ
dpc-2415	171	21	-	-	PUNCT
dpc-2415	171	22	molecule	molecule	NOUN
dpc-2415	171	23	therapies	therapy	NOUN
dpc-2415	171	24	.	.	PUNCT
dpc-2415	172	1	class	class	NOUN
dpc-2415	172	2	of	of	ADP
dpc-2415	172	3	agents	agent	NOUN
dpc-2415	172	4	drug	drug	NOUN
dpc-2415	172	5	hcv	hcv	PROPN
dpc-2415	172	6	hbv	hbv	NOUN
dpc-2415	172	7	hiv	hiv	PROPN
dpc-2415	172	8	latent	latent	PROPN
dpc-2415	172	9	tb	tb	ADP
dpc-2415	172	10	cmcc	cmcc	NOUN
dpc-2415	172	11	anti	anti	ADJ
dpc-2415	172	12	-	-	ADJ
dpc-2415	172	13	tnf	tnf	ADJ
dpc-2415	172	14	-	-	PUNCT
dpc-2415	172	15	α	α	PROPN
dpc-2415	172	16	etanercept	etanercept	NOUN
dpc-2415	172	17	adalimumab	adalimumab	PROPN
dpc-2415	172	18	infliximab	infliximab	PROPN
dpc-2415	172	19	certolizumab	certolizumab	PROPN
dpc-2415	172	20	golimumab	golimumab	NOUN
dpc-2415	172	21	preferred	prefer	VERB
dpc-2415	172	22	not	not	PART
dpc-2415	172	23	preferred	prefer	VERB
dpc-2415	172	24	preferred	prefer	VERB
dpc-2415	172	25	not	not	PART
dpc-2415	172	26	preferred	prefer	VERB
dpc-2415	172	27	preferred	preferred	ADJ
dpc-2415	172	28	anti	anti	ADJ
dpc-2415	172	29	-	-	ADJ
dpc-2415	172	30	il-12/23	il-12/23	ADJ
dpc-2415	172	31	ustekinumab	ustekinumab	NOUN
dpc-2415	172	32	preferred	prefer	VERB
dpc-2415	172	33	preferred	prefer	VERB
dpc-2415	172	34	preferred	preferred	ADJ
dpc-2415	172	35	preferred	prefer	VERB
dpc-2415	172	36	preferred	preferred	ADJ
dpc-2415	172	37	anti	anti	ADJ
dpc-2415	172	38	-	-	ADJ
dpc-2415	172	39	il-17a	il-17a	PROPN
dpc-2415	172	40	secukinumab	secukinumab	NOUN
dpc-2415	172	41	ixekizumab	ixekizumab	NOUN
dpc-2415	172	42	preferred	prefer	VERB
dpc-2415	172	43	likely	likely	ADV
dpc-2415	172	44	safe	safe	ADJ
dpc-2415	172	45	/	/	SYM
dpc-2415	172	46	not	not	PART
dpc-2415	172	47	enough	enough	ADJ
dpc-2415	172	48	data	datum	NOUN
dpc-2415	172	49	likely	likely	ADV
dpc-2415	172	50	safe	safe	ADJ
dpc-2415	172	51	/	/	SYM
dpc-2415	172	52	not	not	PART
dpc-2415	172	53	enough	enough	ADJ
dpc-2415	172	54	data	datum	NOUN
dpc-2415	172	55	preferred	prefer	VERB
dpc-2415	172	56	not	not	PART
dpc-2415	172	57	preferred	prefer	VERB
dpc-2415	172	58	anti	anti	ADJ
dpc-2415	172	59	-	-	ADJ
dpc-2415	172	60	il-17ra	il-17ra	ADJ
dpc-2415	172	61	brodalumab	brodalumab	NOUN
dpc-2415	172	62	preferred	prefer	VERB
dpc-2415	172	63	likely	likely	ADV
dpc-2415	172	64	safe	safe	ADJ
dpc-2415	172	65	/	/	SYM
dpc-2415	172	66	not	not	PART
dpc-2415	172	67	enough	enough	ADJ
dpc-2415	172	68	data	datum	NOUN
dpc-2415	172	69	likely	likely	ADV
dpc-2415	172	70	safe	safe	ADJ
dpc-2415	172	71	/	/	SYM
dpc-2415	172	72	not	not	PART
dpc-2415	172	73	enough	enough	ADJ
dpc-2415	172	74	data	datum	NOUN
dpc-2415	172	75	preferred	prefer	VERB
dpc-2415	172	76	not	not	PART
dpc-2415	172	77	preferred	prefer	VERB
dpc-2415	172	78	anti	anti	ADJ
dpc-2415	172	79	-	-	ADJ
dpc-2415	172	80	il-23	il-23	ADJ
dpc-2415	172	81	guselkumab	guselkumab	NOUN
dpc-2415	172	82	tildrakizumab	tildrakizumab	PROPN
dpc-2415	172	83	risankizumab	risankizumab	PROPN
dpc-2415	172	84	preferred	prefer	VERB
dpc-2415	172	85	not	not	PART
dpc-2415	172	86	enough	enough	ADJ
dpc-2415	172	87	data	datum	NOUN
dpc-2415	172	88	not	not	PART
dpc-2415	172	89	enough	enough	ADJ
dpc-2415	172	90	data	datum	NOUN
dpc-2415	172	91	preferred	prefer	VERB
dpc-2415	172	92	preferred	preferred	ADJ
dpc-2415	172	93	oral	oral	ADJ
dpc-2415	172	94	novel	novel	ADJ
dpc-2415	172	95	small	small	ADJ
dpc-2415	172	96	molecule	molecule	NOUN
dpc-2415	172	97	apremilast	apremilast	NOUN
dpc-2415	172	98	preferred	prefer	VERB
dpc-2415	172	99	not	not	PART
dpc-2415	172	100	enough	enough	ADJ
dpc-2415	172	101	data	datum	NOUN
dpc-2415	172	102	not	not	PART
dpc-2415	172	103	enough	enough	ADJ
dpc-2415	172	104	data	datum	NOUN
dpc-2415	172	105	preferred	prefer	VERB
dpc-2415	172	106	preferred	preferred	ADJ
dpc-2415	172	107	cmcc	cmcc	NOUN
dpc-2415	172	108	chronic	chronic	ADJ
dpc-2415	172	109	mucocutaneous	mucocutaneous	ADJ
dpc-2415	172	110	candidiasis	candidiasis	NOUN
dpc-2415	172	111	,	,	PUNCT
dpc-2415	172	112	hbv	hbv	NOUN
dpc-2415	172	113	hepatitis	hepatitis	PROPN
dpc-2415	172	114	b	b	PROPN
dpc-2415	172	115	virus	virus	PROPN
dpc-2415	172	116	,	,	PUNCT
dpc-2415	172	117	hcv	hcv	VERB
dpc-2415	172	118	hepatitis	hepatitis	PROPN
dpc-2415	172	119	c	c	PROPN
dpc-2415	172	120	virus	virus	PROPN
dpc-2415	172	121	,	,	PUNCT
dpc-2415	172	122	hiv	hiv	PROPN
dpc-2415	172	123	human	human	ADJ
dpc-2415	172	124	immunodeficiency	immunodeficiency	NOUN
dpc-2415	172	125	virus	virus	NOUN
dpc-2415	172	126	,	,	PUNCT
dpc-2415	172	127	il	il	PROPN
dpc-2415	172	128	interleukin	interleukin	PROPN
dpc-2415	172	129	,	,	PUNCT
dpc-2415	172	130	ra	ra	PROPN
dpc-2415	172	131	receptor	receptor	NOUN
dpc-2415	172	132	a	a	PRON
dpc-2415	172	133	,	,	PUNCT
dpc-2415	172	134	tb	tb	ADP
dpc-2415	172	135	tuberculosis	tuberculosis	NOUN
dpc-2415	172	136	,	,	PUNCT
dpc-2415	172	137	tnf	tnf	PROPN
dpc-2415	172	138	tumor	tumor	NOUN
dpc-2415	172	139	necrosis	necrosis	NOUN
dpc-2415	172	140	factor	factor	NOUN
dpc-2415	172	141	.	.	PUNCT
dpc-2415	173	1	data	datum	NOUN
dpc-2415	173	2	from	from	ADP
dpc-2415	173	3	several	several	ADJ
dpc-2415	173	4	sources	source	NOUN
dpc-2415	173	5	[	[	X
dpc-2415	173	6	99	99	NUM
dpc-2415	173	7	-	-	SYM
dpc-2415	173	8	101	101	NUM
dpc-2415	173	9	]	]	PUNCT
dpc-2415	173	10	.	.	PUNCT
dpc-2415	174	1	review	review	VERB
dpc-2415	174	2	|	|	ADV
dpc-2415	174	3	dermatol	dermatol	ADJ
dpc-2415	174	4	pract	pract	NOUN
dpc-2415	174	5	concept	concept	NOUN
dpc-2415	174	6	.	.	PUNCT
dpc-2415	175	1	2023;13(1):e2023016	2023;13(1):e2023016	NUM
dpc-2415	175	2	7	7	NUM
dpc-2415	175	3	31	31	NUM
dpc-2415	175	4	.	.	PUNCT
dpc-2415	176	1	wolk	wolk	PROPN
dpc-2415	176	2	k	k	PROPN
dpc-2415	176	3	,	,	PUNCT
dpc-2415	176	4	witte	witte	PROPN
dpc-2415	176	5	e	e	PROPN
dpc-2415	176	6	,	,	PUNCT
dpc-2415	176	7	wallace	wallace	PROPN
dpc-2415	176	8	e	e	PROPN
dpc-2415	176	9	,	,	PUNCT
dpc-2415	176	10	et	et	PROPN
dpc-2415	176	11	al	al	PROPN
dpc-2415	176	12	.	.	PROPN
dpc-2415	176	13	il-22	il-22	X
dpc-2415	176	14	regulates	regulate	VERB
dpc-2415	176	15	the	the	DET
dpc-2415	176	16	expression	expression	NOUN
dpc-2415	176	17	of	of	ADP
dpc-2415	176	18	genes	gene	NOUN
dpc-2415	176	19	responsible	responsible	ADJ
dpc-2415	176	20	for	for	ADP
dpc-2415	176	21	antimicrobial	antimicrobial	ADJ
dpc-2415	176	22	defense	defense	NOUN
dpc-2415	176	23	,	,	PUNCT
dpc-2415	176	24	cellular	cellular	ADJ
dpc-2415	176	25	differentiation	differentiation	NOUN
dpc-2415	176	26	,	,	PUNCT
dpc-2415	176	27	and	and	CCONJ
dpc-2415	176	28	mobility	mobility	NOUN
dpc-2415	176	29	in	in	ADP
dpc-2415	176	30	keratinocytes	keratinocyte	NOUN
dpc-2415	176	31	:	:	PUNCT
dpc-2415	176	32	a	a	DET
dpc-2415	176	33	potential	potential	ADJ
dpc-2415	176	34	role	role	NOUN
dpc-2415	176	35	in	in	ADP
dpc-2415	176	36	psoriasis	psoriasis	NOUN
dpc-2415	176	37	.	.	PUNCT
dpc-2415	176	38	 	 	SPACE
dpc-2415	177	1	eur	eur	PROPN
dpc-2415	177	2	j	j	PROPN
dpc-2415	177	3	immunol	immunol	NOUN
dpc-2415	177	4	.	.	PUNCT
dpc-2415	178	1	2006;36(5):1309	2006;36(5):1309	NUM
dpc-2415	178	2	-	-	SYM
dpc-2415	178	3	1323	1323	NUM
dpc-2415	178	4	.	.	PUNCT
dpc-2415	179	1	doi:10.1002/	doi:10.1002/	PROPN
dpc-2415	179	2	eji.200535503	eji.200535503	NUM
dpc-2415	179	3	32	32	NUM
dpc-2415	179	4	.	.	PUNCT
dpc-2415	180	1	mallbris	mallbris	PROPN
dpc-2415	180	2	l	l	PROPN
dpc-2415	180	3	,	,	PUNCT
dpc-2415	180	4	o’brien	o’brien	PROPN
dpc-2415	180	5	kp	kp	PROPN
dpc-2415	180	6	,	,	PUNCT
dpc-2415	180	7	hulthén	hulthén	NOUN
dpc-2415	180	8	a	a	PRON
dpc-2415	180	9	,	,	PUNCT
dpc-2415	180	10	et	et	PROPN
dpc-2415	180	11	al	al	PROPN
dpc-2415	180	12	.	.	PROPN
dpc-2415	181	1	neutrophil	neutrophil	PROPN
dpc-2415	181	2	gelatinase	gelatinase	PROPN
dpc-2415	181	3	associated	associate	VERB
dpc-2415	181	4	lipocalin	lipocalin	PROPN
dpc-2415	181	5	is	be	AUX
dpc-2415	181	6	a	a	DET
dpc-2415	181	7	marker	marker	NOUN
dpc-2415	181	8	for	for	ADP
dpc-2415	181	9	dysregulated	dysregulated	ADJ
dpc-2415	181	10	keratinocyte	keratinocyte	NOUN
dpc-2415	181	11	differentiation	differentiation	NOUN
dpc-2415	181	12	in	in	ADP
dpc-2415	181	13	human	human	ADJ
dpc-2415	181	14	skin	skin	NOUN
dpc-2415	181	15	.	.	PUNCT
dpc-2415	181	16	  	  	SPACE
dpc-2415	181	17	exp	exp	NOUN
dpc-2415	181	18	dermatol	dermatol	NOUN
dpc-2415	181	19	.	.	PUNCT
dpc-2415	182	1	2002;11(6	2002;11(6	NUM
dpc-2415	182	2	):	):	PUNCT
dpc-2415	182	3	584	584	NUM
dpc-2415	182	4	-	-	SYM
dpc-2415	182	5	591	591	NUM
dpc-2415	182	6	.	.	PUNCT
dpc-2415	182	7	doi:10.1034	doi:10.1034	PROPN
dpc-2415	182	8	/	/	SYM
dpc-2415	182	9	j.1600	j.1600	NOUN
dpc-2415	182	10	-	-	PUNCT
dpc-2415	182	11	0625.2002.110611.x	0625.2002.110611.x	NOUN
dpc-2415	182	12	33	33	NUM
dpc-2415	182	13	.	.	PUNCT
dpc-2415	183	1	schröder	schröder	PROPN
dpc-2415	183	2	jm	jm	PROPN
dpc-2415	183	3	.	.	PROPN
dpc-2415	183	4	antimicrobial	antimicrobial	ADJ
dpc-2415	183	5	peptides	peptide	NOUN
dpc-2415	183	6	in	in	ADP
dpc-2415	183	7	healthy	healthy	ADJ
dpc-2415	183	8	skin	skin	NOUN
dpc-2415	183	9	and	and	CCONJ
dpc-2415	183	10	atopic	atopic	NOUN
dpc-2415	183	11	dermatitis	dermatitis	NOUN
dpc-2415	183	12	.	.	PUNCT
dpc-2415	183	13	  	  	SPACE
dpc-2415	183	14	allergol	allergol	PROPN
dpc-2415	183	15	int	int	NOUN
dpc-2415	183	16	.	.	PUNCT
dpc-2415	184	1	2011;60(1):17	2011;60(1):17	NUM
dpc-2415	184	2	-	-	SYM
dpc-2415	184	3	24	24	NUM
dpc-2415	184	4	.	.	PUNCT
dpc-2415	185	1	doi:10.2332	doi:10.2332	PROPN
dpc-2415	185	2	/allergolint.10	/allergolint.10	NOUN
dpc-2415	185	3	-	-	PUNCT
dpc-2415	185	4	rai-0292	rai-0292	NOUN
dpc-2415	185	5	34	34	NUM
dpc-2415	185	6	.	.	PUNCT
dpc-2415	186	1	wang	wang	PROPN
dpc-2415	186	2	g.	g.	PROPN
dpc-2415	186	3	human	human	ADJ
dpc-2415	186	4	antimicrobial	antimicrobial	ADJ
dpc-2415	186	5	peptides	peptide	NOUN
dpc-2415	186	6	and	and	CCONJ
dpc-2415	186	7	proteins	protein	NOUN
dpc-2415	186	8	.	.	PUNCT
dpc-2415	186	9	 	 	SPACE
dpc-2415	187	1	pharmaceuticals	pharmaceutical	NOUN
dpc-2415	187	2	(	(	PUNCT
dpc-2415	187	3	basel	basel	PROPN
dpc-2415	187	4	)	)	PUNCT
dpc-2415	187	5	.	.	PUNCT
dpc-2415	188	1	2014;7(5):545	2014;7(5):545	NUM
dpc-2415	188	2	-	-	SYM
dpc-2415	188	3	594	594	NUM
dpc-2415	188	4	.	.	PUNCT
dpc-2415	189	1	published	publish	VERB
dpc-2415	189	2	2014	2014	NUM
dpc-2415	189	3	may	may	AUX
dpc-2415	189	4	13	13	NUM
dpc-2415	189	5	.	.	PUNCT
dpc-2415	190	1	doi:10.3390	doi:10.3390	PROPN
dpc-2415	190	2	/	/	SYM
dpc-2415	190	3	ph7050545	ph7050545	PROPN
dpc-2415	190	4	35	35	NUM
dpc-2415	190	5	.	.	PUNCT
dpc-2415	191	1	kao	kao	PROPN
dpc-2415	191	2	cy	cy	PROPN
dpc-2415	191	3	,	,	PUNCT
dpc-2415	191	4	chen	chen	PROPN
dpc-2415	191	5	y	y	PROPN
dpc-2415	191	6	,	,	PUNCT
dpc-2415	191	7	thai	thai	PROPN
dpc-2415	191	8	p	p	X
dpc-2415	191	9	,	,	PUNCT
dpc-2415	191	10	et	et	PROPN
dpc-2415	191	11	al	al	PROPN
dpc-2415	191	12	.	.	PROPN
dpc-2415	191	13	il-17	il-17	AUX
dpc-2415	191	14	markedly	markedly	ADV
dpc-2415	191	15	up	up	ADP
dpc-2415	191	16	-	-	PUNCT
dpc-2415	191	17	regulates	regulate	VERB
dpc-2415	191	18	beta	beta	NOUN
dpc-2415	191	19	-	-	PUNCT
dpc-2415	191	20	defensin-2	defensin-2	NUM
dpc-2415	191	21	expression	expression	NOUN
dpc-2415	191	22	in	in	ADP
dpc-2415	191	23	human	human	ADJ
dpc-2415	191	24	airway	airway	NOUN
dpc-2415	191	25	epithelium	epithelium	NOUN
dpc-2415	191	26	via	via	ADP
dpc-2415	191	27	jak	jak	PROPN
dpc-2415	191	28	and	and	CCONJ
dpc-2415	191	29	nf	nf	ADJ
dpc-2415	191	30	-	-	PUNCT
dpc-2415	191	31	kappab	kappab	NOUN
dpc-2415	191	32	signaling	signal	VERB
dpc-2415	191	33	pathways	pathway	NOUN
dpc-2415	191	34	.	.	PUNCT
dpc-2415	191	35	  	  	SPACE
dpc-2415	192	1	j	j	PROPN
dpc-2415	192	2	immunol	immunol	NOUN
dpc-2415	192	3	.	.	PUNCT
dpc-2415	193	1	2004;173(5	2004;173(5	NUM
dpc-2415	193	2	):	):	PUNCT
dpc-2415	193	3	3482	3482	NUM
dpc-2415	193	4	-	-	SYM
dpc-2415	193	5	3491	3491	NUM
dpc-2415	193	6	.	.	PUNCT
dpc-2415	194	1	doi:10.4049	doi:10.4049	PROPN
dpc-2415	194	2	/	/	SYM
dpc-2415	194	3	jimmunol.173.5.3482	jimmunol.173.5.3482	PROPN
dpc-2415	194	4	36	36	NUM
dpc-2415	194	5	.	.	PUNCT
dpc-2415	195	1	liang	liang	PROPN
dpc-2415	195	2	sc	sc	PROPN
dpc-2415	195	3	,	,	PUNCT
dpc-2415	195	4	tan	tan	PROPN
dpc-2415	195	5	xy	xy	PROPN
dpc-2415	195	6	,	,	PUNCT
dpc-2415	195	7	luxenberg	luxenberg	PROPN
dpc-2415	195	8	dp	dp	PROPN
dpc-2415	195	9	,	,	PUNCT
dpc-2415	195	10	et	et	PROPN
dpc-2415	195	11	al	al	PROPN
dpc-2415	195	12	.	.	PUNCT
dpc-2415	196	1	interleukin	interleukin	NOUN
dpc-2415	196	2	(	(	PUNCT
dpc-2415	196	3	il)-22	il)-22	PROPN
dpc-2415	196	4	and	and	CCONJ
dpc-2415	196	5	il-17	il-17	NOUN
dpc-2415	196	6	are	be	AUX
dpc-2415	196	7	coexpressed	coexpresse	VERB
dpc-2415	196	8	by	by	ADP
dpc-2415	196	9	th17	th17	NOUN
dpc-2415	196	10	cells	cell	NOUN
dpc-2415	196	11	and	and	CCONJ
dpc-2415	196	12	cooperatively	cooperatively	ADV
dpc-2415	196	13	enhance	enhance	VERB
dpc-2415	196	14	expression	expression	NOUN
dpc-2415	196	15	of	of	ADP
dpc-2415	196	16	antimicrobial	antimicrobial	ADJ
dpc-2415	196	17	peptides	peptide	NOUN
dpc-2415	196	18	.	.	PUNCT
dpc-2415	196	19	  	  	SPACE
dpc-2415	197	1	j	j	PROPN
dpc-2415	197	2	exp	exp	NOUN
dpc-2415	197	3	med	me	VERB
dpc-2415	197	4	.	.	PUNCT
dpc-2415	198	1	2006;203(10):2271	2006;203(10):2271	X
dpc-2415	198	2	-	-	PUNCT
dpc-2415	198	3	2279	2279	NUM
dpc-2415	198	4	.	.	PUNCT
dpc-2415	199	1	doi:10.1084	doi:10.1084	PROPN
dpc-2415	199	2	/	/	SYM
dpc-2415	199	3	jem.20061308	jem.20061308	ADP
dpc-2415	199	4	37	37	NUM
dpc-2415	199	5	.	.	PUNCT
dpc-2415	200	1	wolk	wolk	PROPN
dpc-2415	200	2	k	k	PROPN
dpc-2415	200	3	,	,	PUNCT
dpc-2415	200	4	warszawska	warszawska	PROPN
dpc-2415	200	5	k	k	PROPN
dpc-2415	200	6	,	,	PUNCT
dpc-2415	200	7	hoeflich	hoeflich	PROPN
dpc-2415	200	8	c	c	NOUN
dpc-2415	200	9	,	,	PUNCT
dpc-2415	200	10	et	et	PROPN
dpc-2415	200	11	al	al	PROPN
dpc-2415	200	12	.	.	PUNCT
dpc-2415	200	13	deficiency	deficiency	NOUN
dpc-2415	200	14	of	of	ADP
dpc-2415	200	15	il-22	il-22	NOUN
dpc-2415	200	16	contributes	contribute	VERB
dpc-2415	200	17	to	to	ADP
dpc-2415	200	18	a	a	DET
dpc-2415	200	19	chronic	chronic	ADJ
dpc-2415	200	20	inflammatory	inflammatory	ADJ
dpc-2415	200	21	disease	disease	NOUN
dpc-2415	200	22	:	:	PUNCT
dpc-2415	200	23	pathogenetic	pathogenetic	ADJ
dpc-2415	200	24	mechanisms	mechanism	NOUN
dpc-2415	200	25	in	in	ADP
dpc-2415	200	26	acne	acne	NOUN
dpc-2415	200	27	inversa	inversa	NOUN
dpc-2415	200	28	.	.	PUNCT
dpc-2415	200	29	  	  	SPACE
dpc-2415	201	1	j	j	PROPN
dpc-2415	201	2	immunol	immunol	NOUN
dpc-2415	201	3	.	.	PUNCT
dpc-2415	202	1	2011;186(2	2011;186(2	ADV
dpc-2415	202	2	):	):	PUNCT
dpc-2415	202	3	1228	1228	NUM
dpc-2415	202	4	-	-	SYM
dpc-2415	202	5	1239	1239	NUM
dpc-2415	202	6	.	.	PUNCT
dpc-2415	203	1	doi:10.4049	doi:10.4049	PROPN
dpc-2415	203	2	/	/	SYM
dpc-2415	203	3	jimmunol.0903907	jimmunol.0903907	PROPN
dpc-2415	203	4	38	38	NUM
dpc-2415	203	5	.	.	PUNCT
dpc-2415	204	1	eyerich	eyerich	PROPN
dpc-2415	204	2	s	s	PROPN
dpc-2415	204	3	,	,	PUNCT
dpc-2415	204	4	wagener	wagener	PROPN
dpc-2415	204	5	j	j	PROPN
dpc-2415	204	6	,	,	PUNCT
dpc-2415	204	7	wenzel	wenzel	PROPN
dpc-2415	204	8	v	v	PROPN
dpc-2415	204	9	,	,	PUNCT
dpc-2415	204	10	et	et	PROPN
dpc-2415	204	11	al	al	PROPN
dpc-2415	204	12	.	.	PROPN
dpc-2415	204	13	il-22	il-22	PROPN
dpc-2415	204	14	and	and	CCONJ
dpc-2415	204	15	tnf	tnf	PROPN
dpc-2415	204	16	-	-	PUNCT
dpc-2415	204	17	α	α	PROPN
dpc-2415	204	18	represent	represent	VERB
dpc-2415	204	19	a	a	DET
dpc-2415	204	20	key	key	ADJ
dpc-2415	204	21	cytokine	cytokine	NOUN
dpc-2415	204	22	combination	combination	NOUN
dpc-2415	204	23	for	for	ADP
dpc-2415	204	24	epidermal	epidermal	ADJ
dpc-2415	204	25	integrity	integrity	NOUN
dpc-2415	204	26	during	during	ADP
dpc-2415	204	27	infection	infection	NOUN
dpc-2415	204	28	with	with	ADP
dpc-2415	204	29	candida	candida	PROPN
dpc-2415	204	30	albicans	albican	NOUN
dpc-2415	204	31	.	.	PUNCT
dpc-2415	204	32	  	  	SPACE
dpc-2415	205	1	eur	eur	PROPN
dpc-2415	205	2	j	j	PROPN
dpc-2415	205	3	immunol	immunol	NOUN
dpc-2415	205	4	.	.	PUNCT
dpc-2415	206	1	2011;41(7	2011;41(7	NUM
dpc-2415	206	2	):	):	PUNCT
dpc-2415	206	3	1894	1894	NUM
dpc-2415	206	4	-	-	SYM
dpc-2415	206	5	1901	1901	NUM
dpc-2415	206	6	.	.	PUNCT
dpc-2415	207	1	doi:10.1002	doi:10.1002	NOUN
dpc-2415	207	2	/	/	SYM
dpc-2415	207	3	eji.201041197	eji.201041197	PROPN
dpc-2415	207	4	39	39	NUM
dpc-2415	207	5	.	.	PUNCT
dpc-2415	208	1	johnston	johnston	PROPN
dpc-2415	208	2	a	a	PROPN
dpc-2415	208	3	,	,	PUNCT
dpc-2415	208	4	xing	xing	PROPN
dpc-2415	208	5	x	x	PROPN
dpc-2415	208	6	,	,	PUNCT
dpc-2415	208	7	guzman	guzman	PROPN
dpc-2415	208	8	am	be	AUX
dpc-2415	208	9	,	,	PUNCT
dpc-2415	208	10	et	et	PROPN
dpc-2415	208	11	al	al	PROPN
dpc-2415	208	12	.	.	PUNCT
dpc-2415	209	1	il-1f5	il-1f5	PROPN
dpc-2415	209	2	,	,	PUNCT
dpc-2415	209	3	-f6	-f6	INTJ
dpc-2415	209	4	,	,	PUNCT
dpc-2415	209	5	-f8	-f8	PROPN
dpc-2415	209	6	,	,	PUNCT
dpc-2415	209	7	and	and	CCONJ
dpc-2415	209	8	-f9	-f9	NOUN
dpc-2415	209	9	:	:	PUNCT
dpc-2415	209	10	a	a	DET
dpc-2415	209	11	novel	novel	NOUN
dpc-2415	209	12	il-1	il-1	ADP
dpc-2415	209	13	family	family	NOUN
dpc-2415	209	14	signaling	signal	VERB
dpc-2415	209	15	system	system	NOUN
dpc-2415	209	16	that	that	PRON
dpc-2415	209	17	is	be	AUX
dpc-2415	209	18	active	active	ADJ
dpc-2415	209	19	in	in	ADP
dpc-2415	209	20	psoriasis	psoriasis	NOUN
dpc-2415	209	21	and	and	CCONJ
dpc-2415	209	22	promotes	promote	VERB
dpc-2415	209	23	keratinocyte	keratinocyte	NOUN
dpc-2415	209	24	antimicrobial	antimicrobial	ADJ
dpc-2415	209	25	peptide	peptide	NOUN
dpc-2415	209	26	expression	expression	NOUN
dpc-2415	209	27	.	.	PUNCT
dpc-2415	209	28	  	  	SPACE
dpc-2415	210	1	j	j	PROPN
dpc-2415	210	2	immunol	immunol	NOUN
dpc-2415	210	3	.	.	PUNCT
dpc-2415	211	1	2011;186(4):2613	2011;186(4):2613	NUM
dpc-2415	211	2	-	-	SYM
dpc-2415	211	3	2622	2622	NUM
dpc-2415	211	4	.	.	PUNCT
dpc-2415	212	1	doi:10.4049	doi:10.4049	NOUN
dpc-2415	212	2	/jimmunol.1003162	/jimmunol.1003162	PUNCT
dpc-2415	213	1	40	40	NUM
dpc-2415	213	2	.	.	PUNCT
dpc-2415	214	1	witte	witte	PROPN
dpc-2415	214	2	k	k	PROPN
dpc-2415	214	3	,	,	PUNCT
dpc-2415	214	4	witte	witte	PROPN
dpc-2415	214	5	e	e	PROPN
dpc-2415	214	6	,	,	PUNCT
dpc-2415	214	7	sabat	sabat	PROPN
dpc-2415	214	8	r	r	NOUN
dpc-2415	214	9	,	,	PUNCT
dpc-2415	214	10	wolk	wolk	NOUN
dpc-2415	214	11	k.	k.	PROPN
dpc-2415	214	12	il-28a	il-28a	PROPN
dpc-2415	214	13	,	,	PUNCT
dpc-2415	214	14	il-28b	il-28b	PROPN
dpc-2415	214	15	,	,	PUNCT
dpc-2415	214	16	and	and	CCONJ
dpc-2415	214	17	il-29	il-29	NUM
dpc-2415	214	18	:	:	PUNCT
dpc-2415	214	19	promising	promise	VERB
dpc-2415	214	20	cytokines	cytokine	NOUN
dpc-2415	214	21	with	with	ADP
dpc-2415	214	22	type	type	NOUN
dpc-2415	214	23	i	i	PRON
dpc-2415	214	24	interferon	interferon	ADJ
dpc-2415	214	25	-	-	PUNCT
dpc-2415	214	26	like	like	ADJ
dpc-2415	214	27	properties	property	NOUN
dpc-2415	214	28	.	.	PUNCT
dpc-2415	214	29	  	  	SPACE
dpc-2415	214	30	cytokine	cytokine	ADJ
dpc-2415	214	31	growth	growth	NOUN
dpc-2415	214	32	factor	factor	NOUN
dpc-2415	214	33	rev	rev	VERB
dpc-2415	214	34	.	.	PUNCT
dpc-2415	215	1	2010;21(4):237	2010;21(4):237	NUM
dpc-2415	215	2	-	-	PUNCT
dpc-2415	215	3	251	251	NUM
dpc-2415	215	4	.	.	PUNCT
dpc-2415	216	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	216	2	/	/	SYM
dpc-2415	216	3	j	j	PROPN
dpc-2415	216	4	.cytogfr	.cytogfr	X
dpc-2415	216	5	.2010.04.002	.2010.04.002	PROPN
dpc-2415	216	6	41	41	NUM
dpc-2415	216	7	.	.	PUNCT
dpc-2415	217	1	sabat	sabat	PROPN
dpc-2415	217	2	r	r	PROPN
dpc-2415	217	3	,	,	PUNCT
dpc-2415	217	4	ouyang	ouyang	PROPN
dpc-2415	217	5	w	w	PROPN
dpc-2415	217	6	,	,	PUNCT
dpc-2415	217	7	wolk	wolk	NOUN
dpc-2415	217	8	k.	k.	PROPN
dpc-2415	217	9	therapeutic	therapeutic	ADJ
dpc-2415	217	10	opportunities	opportunity	NOUN
dpc-2415	217	11	of	of	ADP
dpc-2415	217	12	the	the	DET
dpc-2415	217	13	il-22	il-22	NOUN
dpc-2415	217	14	-	-	PUNCT
dpc-2415	217	15	il-22r1	il-22r1	NOUN
dpc-2415	217	16	system	system	NOUN
dpc-2415	217	17	.	.	PUNCT
dpc-2415	217	18	 	 	SPACE
dpc-2415	218	1	nat	nat	PROPN
dpc-2415	218	2	rev	rev	VERB
dpc-2415	218	3	drug	drug	NOUN
dpc-2415	218	4	discov	discov	NOUN
dpc-2415	218	5	.	.	PUNCT
dpc-2415	219	1	2014;13(1):21	2014;13(1):21	X
dpc-2415	219	2	-	-	SYM
dpc-2415	219	3	38	38	NUM
dpc-2415	219	4	.	.	PUNCT
dpc-2415	219	5	doi:10.1038	doi:10.1038	NOUN
dpc-2415	219	6	/	/	SYM
dpc-2415	219	7	nrd4176	nrd4176	NOUN
dpc-2415	219	8	42	42	NUM
dpc-2415	219	9	.	.	PUNCT
dpc-2415	220	1	kalb	kalb	PROPN
dpc-2415	220	2	re	re	PROPN
dpc-2415	220	3	,	,	PUNCT
dpc-2415	220	4	fiorentino	fiorentino	PROPN
dpc-2415	220	5	df	df	PROPN
dpc-2415	220	6	,	,	PUNCT
dpc-2415	220	7	lebwohl	lebwohl	VERB
dpc-2415	220	8	mg	mg	PROPN
dpc-2415	220	9	,	,	PUNCT
dpc-2415	220	10	et	et	PROPN
dpc-2415	220	11	al	al	PROPN
dpc-2415	220	12	.	.	PROPN
dpc-2415	221	1	risk	risk	NOUN
dpc-2415	221	2	of	of	ADP
dpc-2415	221	3	serious	serious	ADJ
dpc-2415	221	4	infection	infection	NOUN
dpc-2415	221	5	with	with	ADP
dpc-2415	221	6	biologic	biologic	NOUN
dpc-2415	221	7	and	and	CCONJ
dpc-2415	221	8	systemic	systemic	ADJ
dpc-2415	221	9	treatment	treatment	NOUN
dpc-2415	221	10	of	of	ADP
dpc-2415	221	11	psoriasis	psoriasis	NOUN
dpc-2415	221	12	:	:	PUNCT
dpc-2415	221	13	results	result	VERB
dpc-2415	221	14	from	from	ADP
dpc-2415	221	15	the	the	DET
dpc-2415	221	16	psoriasis	psoriasis	NOUN
dpc-2415	221	17	longitudinal	longitudinal	ADJ
dpc-2415	221	18	assessment	assessment	NOUN
dpc-2415	221	19	and	and	CCONJ
dpc-2415	221	20	registry	registry	NOUN
dpc-2415	221	21	(	(	PUNCT
dpc-2415	221	22	psolar	psolar	ADJ
dpc-2415	221	23	)	)	PUNCT
dpc-2415	221	24	.	.	PUNCT
dpc-2415	221	25	  	  	SPACE
dpc-2415	222	1	jama	jama	NOUN
dpc-2415	222	2	dermatol	dermatol	NOUN
dpc-2415	222	3	.	.	PUNCT
dpc-2415	223	1	2015;151(9):961	2015;151(9):961	NUM
dpc-2415	223	2	-	-	SYM
dpc-2415	223	3	969	969	NUM
dpc-2415	223	4	.	.	PUNCT
dpc-2415	224	1	doi:10.1001	doi:10.1001	PROPN
dpc-2415	224	2	/	/	SYM
dpc-2415	224	3	jamadermatol.2015.0718	jamadermatol.2015.0718	PROPN
dpc-2415	224	4	43	43	NUM
dpc-2415	224	5	.	.	PUNCT
dpc-2415	225	1	yiu	yiu	PROPN
dpc-2415	225	2	zzn	zzn	NOUN
dpc-2415	225	3	,	,	PUNCT
dpc-2415	225	4	sorbe	sorbe	PROPN
dpc-2415	225	5	c	c	PROPN
dpc-2415	225	6	,	,	PUNCT
dpc-2415	225	7	lunt	lunt	PROPN
dpc-2415	225	8	m	m	PROPN
dpc-2415	225	9	,	,	PUNCT
dpc-2415	225	10	et	et	PROPN
dpc-2415	225	11	al	al	PROPN
dpc-2415	225	12	.	.	PROPN
dpc-2415	225	13	development	development	PROPN
dpc-2415	225	14	and	and	CCONJ
dpc-2415	225	15	validation	validation	NOUN
dpc-2415	225	16	of	of	ADP
dpc-2415	225	17	a	a	DET
dpc-2415	225	18	multivariable	multivariable	ADJ
dpc-2415	225	19	risk	risk	NOUN
dpc-2415	225	20	prediction	prediction	NOUN
dpc-2415	225	21	model	model	NOUN
dpc-2415	225	22	for	for	ADP
dpc-2415	225	23	serious	serious	ADJ
dpc-2415	225	24	infection	infection	NOUN
dpc-2415	225	25	in	in	ADP
dpc-2415	225	26	patients	patient	NOUN
dpc-2415	225	27	with	with	ADP
dpc-2415	225	28	psoriasis	psoriasis	NOUN
dpc-2415	225	29	receiving	receive	VERB
dpc-2415	225	30	systemic	systemic	ADJ
dpc-2415	225	31	therapy	therapy	NOUN
dpc-2415	225	32	.	.	PUNCT
dpc-2415	225	33	 	 	SPACE
dpc-2415	226	1	br	br	PROPN
dpc-2415	226	2	j	j	PROPN
dpc-2415	226	3	dermatol	dermatol	NOUN
dpc-2415	226	4	.	.	PUNCT
dpc-2415	227	1	2019;180(4):894	2019;180(4):894	NUM
dpc-2415	227	2	-	-	SYM
dpc-2415	227	3	901	901	NUM
dpc-2415	227	4	.	.	PUNCT
dpc-2415	228	1	doi:10.1111	doi:10.1111	NOUN
dpc-2415	228	2	/	/	SYM
dpc-2415	228	3	bjd.17421	bjd.17421	PRON
dpc-2415	228	4	44	44	NUM
dpc-2415	228	5	.	.	PUNCT
dpc-2415	229	1	kao	kao	PROPN
dpc-2415	229	2	lt	lt	PROPN
dpc-2415	229	3	,	,	PUNCT
dpc-2415	229	4	lee	lee	PROPN
dpc-2415	229	5	cz	cz	PROPN
dpc-2415	229	6	,	,	PUNCT
dpc-2415	229	7	liu	liu	PROPN
dpc-2415	229	8	sp	sp	PROPN
dpc-2415	229	9	,	,	PUNCT
dpc-2415	229	10	tsai	tsai	PROPN
dpc-2415	229	11	mc	mc	PROPN
dpc-2415	229	12	,	,	PUNCT
dpc-2415	229	13	lin	lin	PROPN
dpc-2415	229	14	hc	hc	PROPN
dpc-2415	229	15	.	.	PROPN
dpc-2415	229	16	psoriasis	psoriasis	NOUN
dpc-2415	229	17	and	and	CCONJ
dpc-2415	229	18	the	the	DET
dpc-2415	229	19	risk	risk	NOUN
dpc-2415	229	20	of	of	ADP
dpc-2415	229	21	pneumonia	pneumonia	NOUN
dpc-2415	229	22	:	:	PUNCT
dpc-2415	229	23	a	a	DET
dpc-2415	229	24	population	population	NOUN
dpc-2415	229	25	-	-	PUNCT
dpc-2415	229	26	based	base	VERB
dpc-2415	229	27	study	study	NOUN
dpc-2415	229	28	.	.	PUNCT
dpc-2415	229	29	  	  	SPACE
dpc-2415	229	30	plos	plos	PROPN
dpc-2415	229	31	one	one	NUM
dpc-2415	229	32	.	.	PUNCT
dpc-2415	230	1	2014;9(12):e116077	2014;9(12):e116077	X
dpc-2415	230	2	.	.	PUNCT
dpc-2415	231	1	published	publish	VERB
dpc-2415	231	2	2014	2014	NUM
dpc-2415	231	3	dec	dec	PROPN
dpc-2415	231	4	26	26	NUM
dpc-2415	231	5	.	.	PUNCT
dpc-2415	231	6	doi:10.1371	doi:10.1371	PUNCT
dpc-2415	231	7	/	/	PUNCT
dpc-2415	232	1	journal.pone.0116077	journal.pone.0116077	PROPN
dpc-2415	232	2	45	45	NUM
dpc-2415	232	3	.	.	PUNCT
dpc-2415	233	1	svedbom	svedbom	VERB
dpc-2415	233	2	a	a	DET
dpc-2415	233	3	,	,	PUNCT
dpc-2415	233	4	mallbris	mallbris	NOUN
dpc-2415	233	5	l	l	NOUN
dpc-2415	233	6	,	,	PUNCT
dpc-2415	233	7	ståhle	ståhle	ADJ
dpc-2415	233	8	m.	m.	NOUN
dpc-2415	233	9	risk	risk	NOUN
dpc-2415	233	10	of	of	ADP
dpc-2415	233	11	respiratory	respiratory	ADJ
dpc-2415	233	12	infection	infection	NOUN
dpc-2415	233	13	in	in	ADP
dpc-2415	233	14	patients	patient	NOUN
dpc-2415	233	15	with	with	ADP
dpc-2415	233	16	plaque	plaque	NOUN
dpc-2415	233	17	psoriasis	psoriasis	NOUN
dpc-2415	233	18	.	.	PUNCT
dpc-2415	233	19	  	  	SPACE
dpc-2415	234	1	j	j	PROPN
dpc-2415	234	2	am	be	AUX
dpc-2415	234	3	acad	acad	ADJ
dpc-2415	234	4	dermatol	dermatol	NOUN
dpc-2415	234	5	.	.	PUNCT
dpc-2415	235	1	2021;85(4):1013	2021;85(4):1013	NUM
dpc-2415	235	2	-	-	SYM
dpc-2415	235	3	1015	1015	NUM
dpc-2415	235	4	.	.	PUNCT
dpc-2415	236	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	236	2	/	/	SYM
dpc-2415	236	3	j.jaad.2020.12.083	j.jaad.2020.12.083	PROPN
dpc-2415	236	4	46	46	NUM
dpc-2415	236	5	.	.	PUNCT
dpc-2415	237	1	kojanova	kojanova	PROPN
dpc-2415	237	2	m	m	PROPN
dpc-2415	237	3	,	,	PUNCT
dpc-2415	237	4	fialova	fialova	PROPN
dpc-2415	237	5	j	j	PROPN
dpc-2415	237	6	,	,	PUNCT
dpc-2415	237	7	cetkovska	cetkovska	VERB
dpc-2415	237	8	p	p	X
dpc-2415	237	9	,	,	PUNCT
dpc-2415	237	10	et	et	PROPN
dpc-2415	237	11	al	al	PROPN
dpc-2415	237	12	.	.	PROPN
dpc-2415	238	1	characteristics	characteristic	NOUN
dpc-2415	238	2	and	and	CCONJ
dpc-2415	238	3	risk	risk	NOUN
dpc-2415	238	4	profile	profile	NOUN
dpc-2415	238	5	of	of	ADP
dpc-2415	238	6	psoriasis	psoriasis	NOUN
dpc-2415	238	7	patients	patient	NOUN
dpc-2415	238	8	included	include	VERB
dpc-2415	238	9	in	in	ADP
dpc-2415	238	10	the	the	DET
dpc-2415	238	11	czech	czech	PROPN
dpc-2415	238	12	national	national	NOUN
dpc-2415	238	13	in	in	ADP
dpc-2415	238	14	psoriasis	psoriasis	NOUN
dpc-2415	238	15	pathogenesis	pathogenesis	NOUN
dpc-2415	238	16	.	.	PUNCT
dpc-2415	238	17	  	  	SPACE
dpc-2415	239	1	j	j	PROPN
dpc-2415	239	2	invest	invest	VERB
dpc-2415	239	3	dermatol	dermatol	NOUN
dpc-2415	239	4	.	.	PUNCT
dpc-2415	240	1	2011;131(12	2011;131(12	NOUN
dpc-2415	240	2	):	):	PUNCT
dpc-2415	240	3	2428	2428	NUM
dpc-2415	240	4	-	-	SYM
dpc-2415	240	5	2437	2437	NUM
dpc-2415	240	6	.	.	PUNCT
dpc-2415	241	1	doi:10.1038	doi:10.1038	NOUN
dpc-2415	241	2	/	/	SYM
dpc-2415	241	3	jid.2011.234	jid.2011.234	PROPN
dpc-2415	241	4	14	14	NUM
dpc-2415	241	5	.	.	PUNCT
dpc-2415	242	1	wolk	wolk	PROPN
dpc-2415	242	2	k	k	PROPN
dpc-2415	242	3	,	,	PUNCT
dpc-2415	242	4	kunz	kunz	PROPN
dpc-2415	242	5	s	s	PROPN
dpc-2415	242	6	,	,	PUNCT
dpc-2415	242	7	witte	witte	PROPN
dpc-2415	242	8	e	e	PROPN
dpc-2415	242	9	,	,	PUNCT
dpc-2415	242	10	friedrich	friedrich	PROPN
dpc-2415	242	11	m	m	PROPN
dpc-2415	242	12	,	,	PUNCT
dpc-2415	242	13	asadullah	asadullah	PROPN
dpc-2415	242	14	k	k	NOUN
dpc-2415	242	15	,	,	PUNCT
dpc-2415	242	16	sabat	sabat	PROPN
dpc-2415	242	17	r.	r.	PROPN
dpc-2415	242	18	il-22	il-22	PROPN
dpc-2415	242	19	increases	increase	VERB
dpc-2415	242	20	the	the	DET
dpc-2415	242	21	innate	innate	ADJ
dpc-2415	242	22	immunity	immunity	NOUN
dpc-2415	242	23	of	of	ADP
dpc-2415	242	24	tissues	tissue	NOUN
dpc-2415	242	25	.	.	PUNCT
dpc-2415	242	26	  	  	SPACE
dpc-2415	242	27	immunity	immunity	NOUN
dpc-2415	242	28	.	.	PUNCT
dpc-2415	243	1	2004;21(2):241	2004;21(2):241	NUM
dpc-2415	243	2	-	-	PUNCT
dpc-2415	243	3	254	254	NUM
dpc-2415	243	4	.	.	PUNCT
dpc-2415	244	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	244	2	/	/	SYM
dpc-2415	244	3	j.immuni.2004.07.007	j.immuni.2004.07.007	PROPN
dpc-2415	244	4	15	15	NUM
dpc-2415	244	5	.	.	PUNCT
dpc-2415	245	1	witte	witte	PROPN
dpc-2415	245	2	e	e	PROPN
dpc-2415	245	3	,	,	PUNCT
dpc-2415	245	4	kokolakis	kokolakis	PROPN
dpc-2415	245	5	g	g	PROPN
dpc-2415	245	6	,	,	PUNCT
dpc-2415	245	7	witte	witte	PROPN
dpc-2415	245	8	k	k	PROPN
dpc-2415	245	9	,	,	PUNCT
dpc-2415	245	10	et	et	PROPN
dpc-2415	245	11	al	al	PROPN
dpc-2415	245	12	.	.	PROPN
dpc-2415	246	1	il-19	il-19	PROPN
dpc-2415	246	2	is	be	AUX
dpc-2415	246	3	a	a	DET
dpc-2415	246	4	component	component	NOUN
dpc-2415	246	5	of	of	ADP
dpc-2415	246	6	the	the	DET
dpc-2415	246	7	pathogenetic	pathogenetic	ADJ
dpc-2415	246	8	il-23	il-23	NOUN
dpc-2415	246	9	/	/	SYM
dpc-2415	246	10	il-17	il-17	NUM
dpc-2415	246	11	cascade	cascade	NOUN
dpc-2415	246	12	in	in	ADP
dpc-2415	246	13	psoriasis	psoriasis	NOUN
dpc-2415	246	14	.	.	PUNCT
dpc-2415	246	15	 	 	SPACE
dpc-2415	247	1	j	j	PROPN
dpc-2415	247	2	invest	invest	VERB
dpc-2415	247	3	dermatol	dermatol	NOUN
dpc-2415	247	4	.	.	PUNCT
dpc-2415	248	1	2014;134(11):2757	2014;134(11):2757	NOUN
dpc-2415	248	2	-	-	SYM
dpc-2415	248	3	2767	2767	NUM
dpc-2415	248	4	.	.	PUNCT
dpc-2415	249	1	doi:10.1038	doi:10.1038	NOUN
dpc-2415	249	2	/	/	SYM
dpc-2415	249	3	jid.2014.308	jid.2014.308	PROPN
dpc-2415	249	4	16	16	NUM
dpc-2415	249	5	.	.	PUNCT
dpc-2415	250	1	brembilla	brembilla	PROPN
dpc-2415	250	2	nc	nc	PROPN
dpc-2415	250	3	,	,	PUNCT
dpc-2415	250	4	stalder	stalder	PROPN
dpc-2415	250	5	r	r	PROPN
dpc-2415	250	6	,	,	PUNCT
dpc-2415	250	7	senra	senra	NOUN
dpc-2415	250	8	l	l	NOUN
dpc-2415	250	9	,	,	PUNCT
dpc-2415	250	10	boehncke	boehncke	NOUN
dpc-2415	250	11	wh	wh	PROPN
dpc-2415	250	12	.	.	PUNCT
dpc-2415	251	1	il-17a	il-17a	PROPN
dpc-2415	251	2	localizes	localize	VERB
dpc-2415	251	3	in	in	ADP
dpc-2415	251	4	the	the	DET
dpc-2415	251	5	exocytic	exocytic	ADJ
dpc-2415	251	6	compartment	compartment	NOUN
dpc-2415	251	7	of	of	ADP
dpc-2415	251	8	mast	mast	NOUN
dpc-2415	251	9	cells	cell	NOUN
dpc-2415	251	10	in	in	ADP
dpc-2415	251	11	psoriatic	psoriatic	ADJ
dpc-2415	251	12	skin	skin	NOUN
dpc-2415	251	13	.	.	PUNCT
dpc-2415	251	14	 	 	SPACE
dpc-2415	252	1	br	br	PROPN
dpc-2415	252	2	j	j	PROPN
dpc-2415	252	3	dermatol	dermatol	NOUN
dpc-2415	252	4	.	.	PUNCT
dpc-2415	253	1	2017;177(5):1458	2017;177(5):1458	NUM
dpc-2415	253	2	-	-	SYM
dpc-2415	253	3	1460	1460	NUM
dpc-2415	253	4	.	.	PUNCT
dpc-2415	254	1	doi:10.1111	doi:10.1111	ADJ
dpc-2415	254	2	/	/	SYM
dpc-2415	254	3	bjd.15358	bjd.15358	NUM
dpc-2415	254	4	17	17	NUM
dpc-2415	254	5	.	.	PUNCT
dpc-2415	255	1	gaffen	gaffen	PROPN
dpc-2415	255	2	sl	sl	PROPN
dpc-2415	255	3	.	.	PUNCT
dpc-2415	256	1	recent	recent	ADJ
dpc-2415	256	2	advances	advance	NOUN
dpc-2415	256	3	in	in	ADP
dpc-2415	256	4	the	the	DET
dpc-2415	256	5	il-17	il-17	NUM
dpc-2415	256	6	cytokine	cytokine	ADJ
dpc-2415	256	7	family	family	NOUN
dpc-2415	256	8	.	.	PUNCT
dpc-2415	256	9	 	 	SPACE
dpc-2415	257	1	curr	curr	PROPN
dpc-2415	257	2	opin	opin	NOUN
dpc-2415	257	3	immunol	immunol	NOUN
dpc-2415	257	4	.	.	PUNCT
dpc-2415	258	1	2011;23(5):613	2011;23(5):613	NUM
dpc-2415	258	2	-	-	SYM
dpc-2415	258	3	619	619	NUM
dpc-2415	258	4	.	.	PUNCT
dpc-2415	258	5	doi:10.1016	doi:10.1016	PROPN
dpc-2415	258	6	/	/	SYM
dpc-2415	258	7	j.coi.2011	j.coi.2011	PROPN
dpc-2415	258	8	.	.	PUNCT
dpc-2415	259	1	07.006	07.006	NUM
dpc-2415	259	2	18	18	NUM
dpc-2415	259	3	.	.	PUNCT
dpc-2415	260	1	gaffen	gaffen	PROPN
dpc-2415	260	2	sl	sl	PROPN
dpc-2415	260	3	,	,	PUNCT
dpc-2415	260	4	jain	jain	PROPN
dpc-2415	260	5	r	r	PROPN
dpc-2415	260	6	,	,	PUNCT
dpc-2415	260	7	garg	garg	PROPN
dpc-2415	260	8	av	av	PROPN
dpc-2415	260	9	,	,	PUNCT
dpc-2415	260	10	cua	cua	VERB
dpc-2415	260	11	dj	dj	NOUN
dpc-2415	260	12	.	.	PUNCT
dpc-2415	261	1	the	the	DET
dpc-2415	261	2	il-23	il-23	NOUN
dpc-2415	261	3	-	-	PUNCT
dpc-2415	261	4	il-17	il-17	NOUN
dpc-2415	261	5	immune	immune	ADJ
dpc-2415	261	6	axis	axis	NOUN
dpc-2415	261	7	:	:	PUNCT
dpc-2415	261	8	from	from	ADP
dpc-2415	261	9	mechanisms	mechanism	NOUN
dpc-2415	261	10	to	to	ADP
dpc-2415	261	11	therapeutic	therapeutic	ADJ
dpc-2415	261	12	testing	testing	NOUN
dpc-2415	261	13	.	.	PUNCT
dpc-2415	261	14	 	 	SPACE
dpc-2415	262	1	nat	nat	PROPN
dpc-2415	262	2	rev	rev	VERB
dpc-2415	262	3	immunol	immunol	NOUN
dpc-2415	262	4	.	.	PUNCT
dpc-2415	263	1	2014;14(9):585	2014;14(9):585	NUM
dpc-2415	263	2	-	-	SYM
dpc-2415	263	3	600	600	NUM
dpc-2415	263	4	.	.	PUNCT
dpc-2415	263	5	doi:10.1038	doi:10.1038	NOUN
dpc-2415	263	6	/	/	SYM
dpc-2415	263	7	nri3707	nri3707	NOUN
dpc-2415	263	8	19	19	NUM
dpc-2415	263	9	.	.	PUNCT
dpc-2415	264	1	keijsers	keijser	NOUN
dpc-2415	264	2	rrmc	rrmc	PROPN
dpc-2415	264	3	,	,	PUNCT
dpc-2415	264	4	hendriks	hendriks	PROPN
dpc-2415	264	5	agm	agm	PROPN
dpc-2415	264	6	,	,	PUNCT
dpc-2415	264	7	van	van	PROPN
dpc-2415	264	8	erp	erp	PROPN
dpc-2415	264	9	pej	pej	PROPN
dpc-2415	264	10	,	,	PUNCT
dpc-2415	264	11	et	et	PROPN
dpc-2415	264	12	al	al	PROPN
dpc-2415	264	13	.	.	PROPN
dpc-2415	265	1	in	in	ADP
dpc-2415	265	2	vivo	vivo	ADJ
dpc-2415	265	3	induction	induction	NOUN
dpc-2415	265	4	of	of	ADP
dpc-2415	265	5	cutaneous	cutaneous	ADJ
dpc-2415	265	6	inflammation	inflammation	NOUN
dpc-2415	265	7	results	result	NOUN
dpc-2415	265	8	in	in	ADP
dpc-2415	265	9	the	the	DET
dpc-2415	265	10	accumulation	accumulation	NOUN
dpc-2415	265	11	of	of	ADP
dpc-2415	265	12	extracellular	extracellular	ADJ
dpc-2415	265	13	trap	trap	NOUN
dpc-2415	265	14	-	-	PUNCT
dpc-2415	265	15	forming	form	VERB
dpc-2415	265	16	neutrophils	neutrophil	NOUN
dpc-2415	265	17	expressing	express	VERB
dpc-2415	265	18	rorγt	rorγt	NOUN
dpc-2415	265	19	and	and	CCONJ
dpc-2415	265	20	il-17	il-17	X
dpc-2415	265	21	.	.	PUNCT
dpc-2415	265	22	 	 	SPACE
dpc-2415	265	23	j	j	PROPN
dpc-2415	265	24	invest	invest	VERB
dpc-2415	265	25	dermatol	dermatol	NOUN
dpc-2415	265	26	.	.	PUNCT
dpc-2415	266	1	2014;134(5):1276	2014;134(5):1276	NUM
dpc-2415	266	2	-	-	SYM
dpc-2415	266	3	1284	1284	NUM
dpc-2415	266	4	.	.	PUNCT
dpc-2415	267	1	doi:10.1038	doi:10.1038	NOUN
dpc-2415	267	2	/jid.2013.526	/jid.2013.526	PROPN
dpc-2415	268	1	20	20	NUM
dpc-2415	268	2	.	.	PUNCT
dpc-2415	268	3	brembilla	brembilla	PROPN
dpc-2415	268	4	nc	nc	PROPN
dpc-2415	268	5	,	,	PUNCT
dpc-2415	268	6	senra	senra	NOUN
dpc-2415	268	7	l	l	NOUN
dpc-2415	268	8	,	,	PUNCT
dpc-2415	268	9	boehncke	boehncke	NOUN
dpc-2415	268	10	wh	wh	PROPN
dpc-2415	268	11	.	.	PUNCT
dpc-2415	269	1	the	the	DET
dpc-2415	269	2	il-17	il-17	NUM
dpc-2415	269	3	family	family	NOUN
dpc-2415	269	4	of	of	ADP
dpc-2415	269	5	cytokines	cytokine	NOUN
dpc-2415	269	6	in	in	ADP
dpc-2415	269	7	psoriasis	psoriasis	NOUN
dpc-2415	269	8	:	:	PUNCT
dpc-2415	269	9	il-17a	il-17a	PROPN
dpc-2415	269	10	and	and	CCONJ
dpc-2415	269	11	beyond	beyond	ADP
dpc-2415	269	12	.	.	PUNCT
dpc-2415	269	13	 	 	SPACE
dpc-2415	269	14	front	front	ADJ
dpc-2415	269	15	immunol	immunol	NOUN
dpc-2415	269	16	.	.	PUNCT
dpc-2415	270	1	2018;9:1682	2018;9:1682	X
dpc-2415	270	2	.	.	PUNCT
dpc-2415	271	1	published	publish	VERB
dpc-2415	271	2	2018	2018	NUM
dpc-2415	271	3	aug	aug	PROPN
dpc-2415	271	4	2	2	NUM
dpc-2415	271	5	.	.	PUNCT
dpc-2415	271	6	doi:10.3389	doi:10.3389	PROPN
dpc-2415	271	7	/	/	SYM
dpc-2415	271	8	fimmu	fimmu	NOUN
dpc-2415	271	9	.2018.01682	.2018.01682	PROPN
dpc-2415	271	10	21	21	NUM
dpc-2415	271	11	.	.	PUNCT
dpc-2415	272	1	senra	senra	NOUN
dpc-2415	272	2	l	l	PROPN
dpc-2415	272	3	,	,	PUNCT
dpc-2415	272	4	mylonas	mylonas	PROPN
dpc-2415	272	5	a	a	PRON
dpc-2415	272	6	,	,	PUNCT
dpc-2415	272	7	kavanagh	kavanagh	PROPN
dpc-2415	272	8	rd	rd	PROPN
dpc-2415	272	9	,	,	PUNCT
dpc-2415	272	10	et	et	PROPN
dpc-2415	272	11	al	al	PROPN
dpc-2415	272	12	.	.	PUNCT
dpc-2415	273	1	il-17e	il-17e	NOUN
dpc-2415	273	2	(	(	PUNCT
dpc-2415	273	3	il-25	il-25	NOUN
dpc-2415	273	4	)	)	PUNCT
dpc-2415	273	5	enhances	enhance	VERB
dpc-2415	273	6	innate	innate	ADJ
dpc-2415	273	7	immune	immune	ADJ
dpc-2415	273	8	responses	response	NOUN
dpc-2415	273	9	during	during	ADP
dpc-2415	273	10	skin	skin	NOUN
dpc-2415	273	11	inflammation	inflammation	NOUN
dpc-2415	273	12	.	.	PUNCT
dpc-2415	273	13	 	 	SPACE
dpc-2415	274	1	j	j	PROPN
dpc-2415	274	2	invest	invest	VERB
dpc-2415	274	3	dermatol	dermatol	NOUN
dpc-2415	274	4	.	.	PUNCT
dpc-2415	275	1	2019;139(8):1732	2019;139(8):1732	NUM
dpc-2415	275	2	-	-	NUM
dpc-2415	275	3	1742.e17	1742.e17	NUM
dpc-2415	275	4	.	.	PUNCT
dpc-2415	276	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	276	2	/	/	SYM
dpc-2415	276	3	j	j	PROPN
dpc-2415	276	4	.jid.2019.01.021	.jid.2019.01.021	PROPN
dpc-2415	277	1	22	22	NUM
dpc-2415	277	2	.	.	PUNCT
dpc-2415	278	1	johnston	johnston	PROPN
dpc-2415	278	2	a	a	PROPN
dpc-2415	278	3	,	,	PUNCT
dpc-2415	278	4	fritz	fritz	PROPN
dpc-2415	278	5	y	y	PROPN
dpc-2415	278	6	,	,	PUNCT
dpc-2415	278	7	dawes	dawes	X
dpc-2415	278	8	sm	sm	PROPN
dpc-2415	278	9	,	,	PUNCT
dpc-2415	278	10	et	et	PROPN
dpc-2415	278	11	al	al	PROPN
dpc-2415	278	12	.	.	PROPN
dpc-2415	278	13	keratinocyte	keratinocyte	PROPN
dpc-2415	278	14	overexpression	overexpression	NOUN
dpc-2415	278	15	of	of	ADP
dpc-2415	278	16	il-17c	il-17c	NOUN
dpc-2415	278	17	promotes	promote	VERB
dpc-2415	278	18	psoriasiform	psoriasiform	NOUN
dpc-2415	278	19	skin	skin	NOUN
dpc-2415	278	20	inflammation	inflammation	NOUN
dpc-2415	278	21	.	.	PUNCT
dpc-2415	278	22	 	 	SPACE
dpc-2415	279	1	j	j	PROPN
dpc-2415	279	2	immunol	immunol	NOUN
dpc-2415	279	3	.	.	PUNCT
dpc-2415	280	1	2013;190(5):2252	2013;190(5):2252	NUM
dpc-2415	280	2	-	-	SYM
dpc-2415	280	3	2262	2262	NUM
dpc-2415	280	4	.	.	PUNCT
dpc-2415	281	1	doi:10.4049	doi:10.4049	PROPN
dpc-2415	281	2	/	/	SYM
dpc-2415	281	3	jimmunol.1201505	jimmunol.1201505	PROPN
dpc-2415	281	4	23	23	NUM
dpc-2415	281	5	.	.	PUNCT
dpc-2415	282	1	montero	montero	PROPN
dpc-2415	282	2	-	-	PUNCT
dpc-2415	282	3	vilchez	vilchez	PROPN
dpc-2415	282	4	t	t	PROPN
dpc-2415	282	5	,	,	PUNCT
dpc-2415	282	6	segura	segura	ADJ
dpc-2415	282	7	-	-	PUNCT
dpc-2415	282	8	fernández	fernández	PROPN
dpc-2415	282	9	-	-	PUNCT
dpc-2415	282	10	nogueras	nogueras	ADJ
dpc-2415	282	11	mv	mv	PROPN
dpc-2415	282	12	,	,	PUNCT
dpc-2415	282	13	pérezrodríguez	pérezrodríguez	PROPN
dpc-2415	282	14	i	i	PROPN
dpc-2415	282	15	,	,	PUNCT
dpc-2415	282	16	et	et	PROPN
dpc-2415	282	17	al	al	PROPN
dpc-2415	282	18	.	.	PROPN
dpc-2415	282	19	skin	skin	NOUN
dpc-2415	282	20	barrier	barrier	NOUN
dpc-2415	282	21	function	function	NOUN
dpc-2415	282	22	in	in	ADP
dpc-2415	282	23	psoriasis	psoriasis	NOUN
dpc-2415	282	24	and	and	CCONJ
dpc-2415	282	25	atopic	atopic	NOUN
dpc-2415	282	26	dermatitis	dermatitis	NOUN
dpc-2415	282	27	:	:	PUNCT
dpc-2415	282	28	transepidermal	transepidermal	ADJ
dpc-2415	282	29	water	water	NOUN
dpc-2415	282	30	loss	loss	NOUN
dpc-2415	282	31	and	and	CCONJ
dpc-2415	282	32	temperature	temperature	NOUN
dpc-2415	282	33	as	as	ADP
dpc-2415	282	34	useful	useful	ADJ
dpc-2415	282	35	tools	tool	NOUN
dpc-2415	282	36	to	to	PART
dpc-2415	282	37	assess	assess	VERB
dpc-2415	282	38	disease	disease	NOUN
dpc-2415	282	39	severity	severity	NOUN
dpc-2415	282	40	.	.	PUNCT
dpc-2415	282	41	 	 	SPACE
dpc-2415	283	1	j	j	PROPN
dpc-2415	283	2	clin	clin	PROPN
dpc-2415	283	3	med	me	VERB
dpc-2415	283	4	.	.	PUNCT
dpc-2415	284	1	2021;10(2	2021;10(2	NUM
dpc-2415	284	2	):	):	PUNCT
dpc-2415	284	3	359	359	NUM
dpc-2415	284	4	.	.	PUNCT
dpc-2415	285	1	published	publish	VERB
dpc-2415	285	2	2021	2021	NUM
dpc-2415	285	3	jan	jan	PROPN
dpc-2415	285	4	19	19	NUM
dpc-2415	285	5	.	.	PUNCT
dpc-2415	285	6	doi:10.3390	doi:10.3390	PROPN
dpc-2415	285	7	/	/	SYM
dpc-2415	285	8	jcm10020359	jcm10020359	ADJ
dpc-2415	285	9	24	24	NUM
dpc-2415	285	10	.	.	PUNCT
dpc-2415	285	11	stawczyk	stawczyk	NOUN
dpc-2415	285	12	-	-	PUNCT
dpc-2415	285	13	macieja	macieja	PROPN
dpc-2415	285	14	m	m	PROPN
dpc-2415	285	15	,	,	PUNCT
dpc-2415	285	16	szczerkowska	szczerkowska	NOUN
dpc-2415	285	17	-	-	PUNCT
dpc-2415	285	18	dobosz	dobosz	NOUN
dpc-2415	285	19	a	a	NOUN
dpc-2415	285	20	,	,	PUNCT
dpc-2415	285	21	rębała	rębała	ADJ
dpc-2415	285	22	k	k	PROPN
dpc-2415	285	23	,	,	PUNCT
dpc-2415	285	24	purzycka	purzycka	PROPN
dpc-2415	285	25	-	-	PUNCT
dpc-2415	285	26	bohdan	bohdan	PROPN
dpc-2415	285	27	d.	d.	PROPN
dpc-2415	285	28	genetic	genetic	PROPN
dpc-2415	285	29	background	background	NOUN
dpc-2415	285	30	of	of	ADP
dpc-2415	285	31	skin	skin	NOUN
dpc-2415	285	32	barrier	barrier	NOUN
dpc-2415	285	33	dysfunction	dysfunction	NOUN
dpc-2415	285	34	in	in	ADP
dpc-2415	285	35	the	the	DET
dpc-2415	285	36	pathogenesis	pathogenesis	NOUN
dpc-2415	285	37	of	of	ADP
dpc-2415	285	38	psoriasis	psoriasis	NOUN
dpc-2415	285	39	vulgaris	vulgaris	NOUN
dpc-2415	285	40	.	.	PUNCT
dpc-2415	285	41	 	 	SPACE
dpc-2415	286	1	postepy	postepy	ADJ
dpc-2415	286	2	dermatol	dermatol	NOUN
dpc-2415	286	3	alergol	alergol	NOUN
dpc-2415	286	4	.	.	PUNCT
dpc-2415	287	1	2015;32(2):123	2015;32(2):123	NOUN
dpc-2415	287	2	-	-	SYM
dpc-2415	287	3	126	126	NUM
dpc-2415	287	4	.	.	PUNCT
dpc-2415	287	5	doi:10.5114	doi:10.5114	PROPN
dpc-2415	287	6	/	/	SYM
dpc-2415	287	7	pdia.2014.44003	pdia.2014.44003	NOUN
dpc-2415	287	8	25	25	NUM
dpc-2415	287	9	.	.	PUNCT
dpc-2415	288	1	henseler	henseler	PROPN
dpc-2415	288	2	t	t	PROPN
dpc-2415	288	3	,	,	PUNCT
dpc-2415	288	4	christophers	christophers	PROPN
dpc-2415	288	5	e.	e.	PROPN
dpc-2415	288	6	disease	disease	PROPN
dpc-2415	288	7	concomitance	concomitance	NOUN
dpc-2415	288	8	in	in	ADP
dpc-2415	288	9	psoriasis	psoriasis	NOUN
dpc-2415	288	10	.	.	PUNCT
dpc-2415	288	11	 	 	SPACE
dpc-2415	289	1	j	j	PROPN
dpc-2415	289	2	am	be	AUX
dpc-2415	289	3	acad	acad	ADJ
dpc-2415	289	4	dermatol	dermatol	NOUN
dpc-2415	289	5	.	.	PUNCT
dpc-2415	290	1	1995;32(6):982	1995;32(6):982	NUM
dpc-2415	290	2	-	-	PUNCT
dpc-2415	290	3	986	986	NUM
dpc-2415	290	4	.	.	PUNCT
dpc-2415	290	5	doi:10.1016/0190	doi:10.1016/0190	VERB
dpc-2415	290	6	-9622(95	-9622(95	SYM
dpc-2415	290	7	)	)	PUNCT
dpc-2415	290	8	91336	91336	NUM
dpc-2415	290	9	-	-	SYM
dpc-2415	290	10	x	x	SYM
dpc-2415	290	11	26	26	NUM
dpc-2415	290	12	.	.	PUNCT
dpc-2415	291	1	christophers	christopher	NOUN
dpc-2415	291	2	e	e	PROPN
dpc-2415	291	3	,	,	PUNCT
dpc-2415	291	4	henseler	henseler	ADJ
dpc-2415	291	5	t.	t.	NOUN
dpc-2415	291	6	contrasting	contrast	VERB
dpc-2415	291	7	disease	disease	NOUN
dpc-2415	291	8	patterns	pattern	NOUN
dpc-2415	291	9	in	in	ADP
dpc-2415	291	10	psoriasis	psoriasis	NOUN
dpc-2415	291	11	and	and	CCONJ
dpc-2415	291	12	atopic	atopic	NOUN
dpc-2415	291	13	dermatitis	dermatitis	NOUN
dpc-2415	291	14	.	.	PUNCT
dpc-2415	291	15	 	 	SPACE
dpc-2415	291	16	arch	arch	ADJ
dpc-2415	291	17	dermatol	dermatol	NOUN
dpc-2415	291	18	res	re	NOUN
dpc-2415	291	19	.	.	PROPN
dpc-2415	291	20	1987;279	1987;279	NUM
dpc-2415	291	21	suppl	suppl	PROPN
dpc-2415	291	22	:	:	PUNCT
dpc-2415	291	23	s48	s48	NOUN
dpc-2415	291	24	-	-	PUNCT
dpc-2415	291	25	s51	s51	PROPN
dpc-2415	291	26	.	.	PUNCT
dpc-2415	292	1	doi:10.1007	doi:10.1007	PROPN
dpc-2415	292	2	/	/	SYM
dpc-2415	292	3	bf00585919	bf00585919	PROPN
dpc-2415	292	4	27	27	NUM
dpc-2415	292	5	.	.	PUNCT
dpc-2415	293	1	schröder	schröder	PROPN
dpc-2415	293	2	jm	jm	PROPN
dpc-2415	293	3	,	,	PUNCT
dpc-2415	293	4	harder	hard	ADJ
dpc-2415	293	5	j.	j.	PROPN
dpc-2415	293	6	human	human	PROPN
dpc-2415	293	7	beta	beta	NOUN
dpc-2415	293	8	-	-	PUNCT
dpc-2415	293	9	defensin-2	defensin-2	NOUN
dpc-2415	293	10	.	.	PUNCT
dpc-2415	293	11	 	 	SPACE
dpc-2415	294	1	int	int	PROPN
dpc-2415	294	2	j	j	PROPN
dpc-2415	294	3	biochem	biochem	PROPN
dpc-2415	294	4	cell	cell	NOUN
dpc-2415	294	5	biol	biol	PROPN
dpc-2415	294	6	.	.	PUNCT
dpc-2415	295	1	1999;31(6):645	1999;31(6):645	NUM
dpc-2415	295	2	-	-	PUNCT
dpc-2415	295	3	651	651	NUM
dpc-2415	295	4	.	.	PUNCT
dpc-2415	296	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	296	2	/	/	SYM
dpc-2415	296	3	s1357	s1357	PROPN
dpc-2415	296	4	-	-	PUNCT
dpc-2415	296	5	2725(99)00013	2725(99)00013	NUM
dpc-2415	296	6	-	-	SYM
dpc-2415	296	7	8	8	NUM
dpc-2415	296	8	28	28	NUM
dpc-2415	296	9	.	.	PUNCT
dpc-2415	297	1	ong	ong	PROPN
dpc-2415	297	2	py	py	PROPN
dpc-2415	297	3	,	,	PUNCT
dpc-2415	297	4	ohtake	ohtake	PROPN
dpc-2415	297	5	t	t	PROPN
dpc-2415	297	6	,	,	PUNCT
dpc-2415	297	7	brandt	brandt	PROPN
dpc-2415	297	8	c	c	PROPN
dpc-2415	297	9	,	,	PUNCT
dpc-2415	297	10	et	et	PROPN
dpc-2415	297	11	al	al	PROPN
dpc-2415	297	12	.	.	PROPN
dpc-2415	297	13	endogenous	endogenous	ADJ
dpc-2415	297	14	antimicrobial	antimicrobial	ADJ
dpc-2415	297	15	peptides	peptide	NOUN
dpc-2415	297	16	and	and	CCONJ
dpc-2415	297	17	skin	skin	NOUN
dpc-2415	297	18	infections	infection	NOUN
dpc-2415	297	19	in	in	ADP
dpc-2415	297	20	atopic	atopic	NOUN
dpc-2415	297	21	dermatitis	dermatitis	NOUN
dpc-2415	297	22	.	.	PUNCT
dpc-2415	297	23	 	 	SPACE
dpc-2415	298	1	n	n	PROPN
dpc-2415	298	2	engl	engl	PROPN
dpc-2415	298	3	j	j	PROPN
dpc-2415	298	4	med	med	PROPN
dpc-2415	298	5	.	.	PUNCT
dpc-2415	299	1	2002;347(15):1151	2002;347(15):1151	NUM
dpc-2415	299	2	-	-	SYM
dpc-2415	299	3	1160	1160	NUM
dpc-2415	299	4	.	.	PUNCT
dpc-2415	300	1	doi:10.1056	doi:10.1056	PROPN
dpc-2415	300	2	/	/	SYM
dpc-2415	300	3	nejmoa021481	nejmoa021481	PROPN
dpc-2415	300	4	29	29	NUM
dpc-2415	300	5	.	.	PUNCT
dpc-2415	301	1	wolk	wolk	PROPN
dpc-2415	301	2	k	k	PROPN
dpc-2415	301	3	,	,	PUNCT
dpc-2415	301	4	witte	witte	PROPN
dpc-2415	301	5	k	k	PROPN
dpc-2415	301	6	,	,	PUNCT
dpc-2415	301	7	witte	witte	PROPN
dpc-2415	301	8	e	e	PROPN
dpc-2415	301	9	,	,	PUNCT
dpc-2415	301	10	et	et	PROPN
dpc-2415	301	11	al	al	PROPN
dpc-2415	301	12	.	.	PROPN
dpc-2415	301	13	il-29	il-29	PART
dpc-2415	301	14	is	be	AUX
dpc-2415	301	15	produced	produce	VERB
dpc-2415	301	16	by	by	ADP
dpc-2415	301	17	t(h)17	t(h)17	PROPN
dpc-2415	301	18	cells	cell	NOUN
dpc-2415	301	19	and	and	CCONJ
dpc-2415	301	20	mediates	mediate	VERB
dpc-2415	301	21	the	the	DET
dpc-2415	301	22	cutaneous	cutaneous	ADJ
dpc-2415	301	23	antiviral	antiviral	ADJ
dpc-2415	301	24	competence	competence	NOUN
dpc-2415	301	25	in	in	ADP
dpc-2415	301	26	psoriasis	psoriasis	NOUN
dpc-2415	301	27	.	.	PUNCT
dpc-2415	301	28	  	  	SPACE
dpc-2415	302	1	sci	sci	PROPN
dpc-2415	302	2	transl	transl	PROPN
dpc-2415	302	3	med	med	PROPN
dpc-2415	302	4	.	.	PUNCT
dpc-2415	303	1	2013;5(204):204ra129	2013;5(204):204ra129	NUM
dpc-2415	303	2	.	.	PUNCT
dpc-2415	304	1	doi:10.1126/	doi:10.1126/	NOUN
dpc-2415	304	2	scitranslmed.3006245	scitranslmed.3006245	PROPN
dpc-2415	304	3	30	30	NUM
dpc-2415	304	4	.	.	PUNCT
dpc-2415	305	1	gläser	gläser	NOUN
dpc-2415	305	2	r	r	NOUN
dpc-2415	305	3	,	,	PUNCT
dpc-2415	305	4	harder	hard	ADJ
dpc-2415	305	5	j	j	PROPN
dpc-2415	305	6	,	,	PUNCT
dpc-2415	305	7	lange	lange	PROPN
dpc-2415	305	8	h	h	NOUN
dpc-2415	305	9	,	,	PUNCT
dpc-2415	305	10	bartels	bartels	PROPN
dpc-2415	305	11	j	j	PROPN
dpc-2415	305	12	,	,	PUNCT
dpc-2415	305	13	christophers	christophers	PROPN
dpc-2415	305	14	e	e	PROPN
dpc-2415	305	15	,	,	PUNCT
dpc-2415	305	16	schröder	schröder	PROPN
dpc-2415	305	17	jm	jm	PROPN
dpc-2415	305	18	.	.	PROPN
dpc-2415	305	19	antimicrobial	antimicrobial	ADJ
dpc-2415	305	20	psoriasin	psoriasin	NOUN
dpc-2415	305	21	(	(	PUNCT
dpc-2415	305	22	s100a7	s100a7	ADJ
dpc-2415	305	23	)	)	PUNCT
dpc-2415	305	24	protects	protect	VERB
dpc-2415	305	25	human	human	ADJ
dpc-2415	305	26	skin	skin	NOUN
dpc-2415	305	27	from	from	ADP
dpc-2415	305	28	escherichia	escherichia	NOUN
dpc-2415	305	29	coli	coli	NOUN
dpc-2415	305	30	infection	infection	NOUN
dpc-2415	305	31	.	.	PUNCT
dpc-2415	305	32	 	 	SPACE
dpc-2415	306	1	nat	nat	PROPN
dpc-2415	306	2	immunol	immunol	NOUN
dpc-2415	306	3	.	.	PUNCT
dpc-2415	307	1	2005;6(1):57	2005;6(1):57	NUM
dpc-2415	307	2	-	-	SYM
dpc-2415	307	3	64	64	NUM
dpc-2415	307	4	.	.	PUNCT
dpc-2415	308	1	doi:10.1038	doi:10.1038	NOUN
dpc-2415	308	2	/	/	SYM
dpc-2415	308	3	ni1142	ni1142	PROPN
dpc-2415	308	4	8	8	NUM
dpc-2415	308	5	review	review	NOUN
dpc-2415	308	6	|	|	ADV
dpc-2415	308	7	dermatol	dermatol	ADJ
dpc-2415	308	8	pract	pract	NOUN
dpc-2415	308	9	concept	concept	NOUN
dpc-2415	308	10	.	.	PUNCT
dpc-2415	309	1	2023;13(1):e2023016	2023;13(1):e2023016	NUM
dpc-2415	309	2	biologics	biologic	NOUN
dpc-2415	309	3	:	:	PUNCT
dpc-2415	309	4	a	a	DET
dpc-2415	309	5	cohort	cohort	NOUN
dpc-2415	309	6	study	study	NOUN
dpc-2415	309	7	from	from	ADP
dpc-2415	309	8	northeast	northeast	PROPN
dpc-2415	309	9	italy	italy	PROPN
dpc-2415	309	10	.	.	PUNCT
dpc-2415	309	11	 	 	SPACE
dpc-2415	309	12	am	be	AUX
dpc-2415	309	13	j	j	PROPN
dpc-2415	309	14	clin	clin	PROPN
dpc-2415	309	15	dermatol	dermatol	NOUN
dpc-2415	309	16	.	.	PUNCT
dpc-2415	310	1	2020;21(5):749	2020;21(5):749	PROPN
dpc-2415	310	2	-	-	PUNCT
dpc-2415	310	3	751	751	NUM
dpc-2415	310	4	.	.	PUNCT
dpc-2415	311	1	doi:10.1007	doi:10.1007	VERB
dpc-2415	311	2	/	/	SYM
dpc-2415	311	3	s40257	s40257	NOUN
dpc-2415	311	4	-	-	PUNCT
dpc-2415	311	5	020	020	NUM
dpc-2415	311	6	-	-	PUNCT
dpc-2415	311	7	00552	00552	NUM
dpc-2415	311	8	-	-	PUNCT
dpc-2415	311	9	w	w	NOUN
dpc-2415	311	10	62	62	NUM
dpc-2415	311	11	.	.	PUNCT
dpc-2415	312	1	talamonti	talamonti	PROPN
dpc-2415	312	2	m	m	PROPN
dpc-2415	312	3	,	,	PUNCT
dpc-2415	312	4	galluzzo	galluzzo	PROPN
dpc-2415	312	5	m	m	PROPN
dpc-2415	312	6	,	,	PUNCT
dpc-2415	312	7	chiricozzi	chiricozzi	VERB
dpc-2415	312	8	a	a	NOUN
dpc-2415	312	9	,	,	PUNCT
dpc-2415	313	1	et	et	PROPN
dpc-2415	313	2	al	al	PROPN
dpc-2415	313	3	.	.	PROPN
dpc-2415	313	4	characteristic	characteristic	ADJ
dpc-2415	313	5	of	of	ADP
dpc-2415	313	6	chronic	chronic	ADJ
dpc-2415	313	7	plaque	plaque	NOUN
dpc-2415	313	8	psoriasis	psoriasis	NOUN
dpc-2415	313	9	patients	patient	NOUN
dpc-2415	313	10	treated	treat	VERB
dpc-2415	313	11	with	with	ADP
dpc-2415	313	12	biologics	biologic	NOUN
dpc-2415	313	13	in	in	ADP
dpc-2415	313	14	italy	italy	PROPN
dpc-2415	313	15	during	during	ADP
dpc-2415	313	16	the	the	DET
dpc-2415	313	17	covid-19	covid-19	PROPN
dpc-2415	313	18	pandemic	pandemic	NOUN
dpc-2415	313	19	:	:	PUNCT
dpc-2415	313	20	risk	risk	VERB
dpc-2415	313	21	analysis	analysis	NOUN
dpc-2415	313	22	from	from	ADP
dpc-2415	313	23	the	the	DET
dpc-2415	313	24	pso	pso	NOUN
dpc-2415	313	25	-	-	PUNCT
dpc-2415	313	26	bio	bio	NOUN
dpc-2415	313	27	-	-	ADJ
dpc-2415	313	28	covid	covid	ADJ
dpc-2415	313	29	observational	observational	ADJ
dpc-2415	313	30	study	study	NOUN
dpc-2415	313	31	.	.	PUNCT
dpc-2415	313	32	 	 	SPACE
dpc-2415	314	1	expert	expert	NOUN
dpc-2415	314	2	opin	opin	NOUN
dpc-2415	314	3	biol	biol	NOUN
dpc-2415	314	4	ther	ther	ADV
dpc-2415	314	5	.	.	PUNCT
dpc-2415	315	1	2021;21(2):271	2021;21(2):271	NOUN
dpc-2415	315	2	-	-	SYM
dpc-2415	315	3	277	277	NUM
dpc-2415	315	4	.	.	PUNCT
dpc-2415	316	1	doi:10.1080/14712598.2021.1853698	doi:10.1080/14712598.2021.1853698	PROPN
dpc-2415	316	2	63	63	NUM
dpc-2415	316	3	.	.	PUNCT
dpc-2415	317	1	smith	smith	PROPN
dpc-2415	317	2	ch	ch	PROPN
dpc-2415	317	3	,	,	PUNCT
dpc-2415	317	4	yiu	yiu	PROPN
dpc-2415	317	5	zzn	zzn	NOUN
dpc-2415	317	6	,	,	PUNCT
dpc-2415	317	7	bale	bale	NOUN
dpc-2415	317	8	t	t	PROPN
dpc-2415	317	9	,	,	PUNCT
dpc-2415	317	10	et	et	PROPN
dpc-2415	317	11	al	al	PROPN
dpc-2415	317	12	.	.	PROPN
dpc-2415	318	1	british	british	PROPN
dpc-2415	318	2	association	association	PROPN
dpc-2415	318	3	of	of	ADP
dpc-2415	318	4	dermatologists	dermatologists	PROPN
dpc-2415	318	5	guidelines	guideline	NOUN
dpc-2415	318	6	for	for	ADP
dpc-2415	318	7	biologic	biologic	NOUN
dpc-2415	318	8	therapy	therapy	NOUN
dpc-2415	318	9	for	for	ADP
dpc-2415	318	10	psoriasis	psoriasis	NOUN
dpc-2415	318	11	2020	2020	NUM
dpc-2415	318	12	:	:	PUNCT
dpc-2415	318	13	a	a	DET
dpc-2415	318	14	rapid	rapid	ADJ
dpc-2415	318	15	update	update	NOUN
dpc-2415	318	16	.	.	PUNCT
dpc-2415	318	17	  	  	SPACE
dpc-2415	319	1	br	br	PROPN
dpc-2415	319	2	j	j	PROPN
dpc-2415	319	3	dermatol	dermatol	NOUN
dpc-2415	319	4	.	.	PUNCT
dpc-2415	320	1	2020;183(4):628	2020;183(4):628	NUM
dpc-2415	320	2	-	-	PUNCT
dpc-2415	320	3	637	637	NUM
dpc-2415	320	4	.	.	PUNCT
dpc-2415	321	1	doi:10.1111	doi:10.1111	ADJ
dpc-2415	321	2	/	/	SYM
dpc-2415	321	3	bjd.19039	bjd.19039	PROPN
dpc-2415	321	4	64	64	NUM
dpc-2415	321	5	.	.	PUNCT
dpc-2415	322	1	sterling	sterling	NOUN
dpc-2415	322	2	tr	tr	VERB
dpc-2415	322	3	,	,	PUNCT
dpc-2415	322	4	njie	njie	ADV
dpc-2415	322	5	g	g	NOUN
dpc-2415	322	6	,	,	PUNCT
dpc-2415	322	7	zenner	zenner	PROPN
dpc-2415	322	8	d	d	PROPN
dpc-2415	322	9	,	,	PUNCT
dpc-2415	322	10	et	et	PROPN
dpc-2415	322	11	al	al	PROPN
dpc-2415	322	12	.	.	PUNCT
dpc-2415	323	1	guidelines	guideline	NOUN
dpc-2415	323	2	for	for	ADP
dpc-2415	323	3	the	the	DET
dpc-2415	323	4	treatment	treatment	NOUN
dpc-2415	323	5	of	of	ADP
dpc-2415	323	6	latent	latent	NOUN
dpc-2415	323	7	tuberculosis	tuberculosis	NOUN
dpc-2415	323	8	infection	infection	NOUN
dpc-2415	323	9	:	:	PUNCT
dpc-2415	323	10	recommendations	recommendation	NOUN
dpc-2415	323	11	from	from	ADP
dpc-2415	323	12	the	the	DET
dpc-2415	323	13	national	national	ADJ
dpc-2415	323	14	tuberculosis	tuberculosis	PROPN
dpc-2415	323	15	controllers	controller	NOUN
dpc-2415	323	16	association	association	PROPN
dpc-2415	323	17	and	and	CCONJ
dpc-2415	323	18	cdc	cdc	PROPN
dpc-2415	323	19	,	,	PUNCT
dpc-2415	323	20	2020	2020	NUM
dpc-2415	323	21	.	.	PUNCT
dpc-2415	323	22	 	 	SPACE
dpc-2415	323	23	mmwr	mmwr	ADJ
dpc-2415	323	24	recomm	recomm	NOUN
dpc-2415	323	25	rep	rep	PROPN
dpc-2415	323	26	.	.	PROPN
dpc-2415	323	27	2020;69(1):1	2020;69(1):1	NUM
dpc-2415	323	28	-	-	SYM
dpc-2415	323	29	11	11	NUM
dpc-2415	323	30	.	.	PUNCT
dpc-2415	324	1	published	publish	VERB
dpc-2415	324	2	2020	2020	NUM
dpc-2415	324	3	feb	feb	PROPN
dpc-2415	324	4	14	14	NUM
dpc-2415	324	5	.	.	PUNCT
dpc-2415	325	1	doi:10.15585	doi:10.15585	NOUN
dpc-2415	325	2	/	/	SYM
dpc-2415	325	3	mmwr.rr6901a1	mmwr.rr6901a1	NOUN
dpc-2415	325	4	65	65	NUM
dpc-2415	325	5	.	.	PUNCT
dpc-2415	326	1	nogueira	nogueira	PROPN
dpc-2415	326	2	m	m	PROPN
dpc-2415	326	3	,	,	PUNCT
dpc-2415	326	4	warren	warren	PROPN
dpc-2415	326	5	rb	rb	PROPN
dpc-2415	326	6	,	,	PUNCT
dpc-2415	326	7	torres	torre	VERB
dpc-2415	326	8	t.	t.	ADJ
dpc-2415	326	9	risk	risk	NOUN
dpc-2415	326	10	of	of	ADP
dpc-2415	326	11	tuberculosis	tuberculosis	NOUN
dpc-2415	326	12	reactivation	reactivation	NOUN
dpc-2415	326	13	with	with	ADP
dpc-2415	326	14	interleukin	interleukin	NOUN
dpc-2415	326	15	(	(	PUNCT
dpc-2415	326	16	il)-17	il)-17	PROPN
dpc-2415	326	17	and	and	CCONJ
dpc-2415	326	18	il-23	il-23	VERB
dpc-2415	326	19	inhibitors	inhibitor	NOUN
dpc-2415	326	20	in	in	ADP
dpc-2415	326	21	psoriasis	psoriasis	NOUN
dpc-2415	326	22	time	time	NOUN
dpc-2415	326	23	for	for	ADP
dpc-2415	326	24	a	a	DET
dpc-2415	326	25	paradigm	paradigm	NOUN
dpc-2415	326	26	change	change	NOUN
dpc-2415	326	27	.	.	PUNCT
dpc-2415	326	28	  	  	SPACE
dpc-2415	327	1	j	j	PROPN
dpc-2415	327	2	eur	eur	PROPN
dpc-2415	327	3	acad	acad	PROPN
dpc-2415	327	4	dermatol	dermatol	NOUN
dpc-2415	327	5	venereol	venereol	NOUN
dpc-2415	327	6	.	.	PUNCT
dpc-2415	328	1	2021;35(4):824	2021;35(4):824	NUM
dpc-2415	328	2	-	-	PUNCT
dpc-2415	328	3	834	834	NUM
dpc-2415	328	4	.	.	PUNCT
dpc-2415	329	1	doi:10.1111	doi:10.1111	PROPN
dpc-2415	329	2	/	/	SYM
dpc-2415	329	3	jdv.16866	jdv.16866	PROPN
dpc-2415	329	4	66	66	NUM
dpc-2415	329	5	.	.	PUNCT
dpc-2415	330	1	papp	papp	PROPN
dpc-2415	330	2	ka	ka	PROPN
dpc-2415	330	3	,	,	PUNCT
dpc-2415	330	4	haraoui	haraoui	PROPN
dpc-2415	330	5	b	b	PROPN
dpc-2415	330	6	,	,	PUNCT
dpc-2415	330	7	kumar	kumar	PROPN
dpc-2415	330	8	d	d	PROPN
dpc-2415	330	9	,	,	PUNCT
dpc-2415	330	10	et	et	PROPN
dpc-2415	330	11	al	al	PROPN
dpc-2415	330	12	.	.	PUNCT
dpc-2415	330	13	vaccination	vaccination	NOUN
dpc-2415	330	14	guidelines	guideline	NOUN
dpc-2415	330	15	for	for	ADP
dpc-2415	330	16	patients	patient	NOUN
dpc-2415	330	17	with	with	ADP
dpc-2415	330	18	immune	immune	NOUN
dpc-2415	330	19	-	-	PUNCT
dpc-2415	330	20	mediated	mediate	VERB
dpc-2415	330	21	disorders	disorder	NOUN
dpc-2415	330	22	on	on	ADP
dpc-2415	330	23	immunosuppressive	immunosuppressive	ADJ
dpc-2415	330	24	therapies	therapy	NOUN
dpc-2415	330	25	.	.	PUNCT
dpc-2415	330	26	  	  	SPACE
dpc-2415	331	1	j	j	PROPN
dpc-2415	331	2	cutan	cutan	PROPN
dpc-2415	331	3	med	med	ADJ
dpc-2415	331	4	surg	surg	NOUN
dpc-2415	331	5	.	.	PUNCT
dpc-2415	332	1	2019;23(1):50	2019;23(1):50	X
dpc-2415	332	2	-	-	SYM
dpc-2415	332	3	74	74	NUM
dpc-2415	332	4	.	.	PUNCT
dpc-2415	332	5	doi:10.1177/1203475418811335	doi:10.1177/1203475418811335	NOUN
dpc-2415	333	1	67	67	NUM
dpc-2415	333	2	.	.	PUNCT
dpc-2415	334	1	wine	wine	NOUN
dpc-2415	334	2	-	-	PUNCT
dpc-2415	334	3	lee	lee	PROPN
dpc-2415	334	4	l	l	PROPN
dpc-2415	334	5	,	,	PUNCT
dpc-2415	334	6	keller	keller	PROPN
dpc-2415	334	7	sc	sc	PROPN
dpc-2415	334	8	,	,	PUNCT
dpc-2415	334	9	wilck	wilck	PROPN
dpc-2415	334	10	mb	mb	PROPN
dpc-2415	334	11	,	,	PUNCT
dpc-2415	334	12	gluckman	gluckman	NOUN
dpc-2415	334	13	sj	sj	PROPN
dpc-2415	334	14	,	,	PUNCT
dpc-2415	334	15	van	van	PROPN
dpc-2415	334	16	voorhees	voorhees	PROPN
dpc-2415	334	17	as	as	ADP
dpc-2415	334	18	.	.	PROPN
dpc-2415	335	1	from	from	ADP
dpc-2415	335	2	the	the	DET
dpc-2415	335	3	medical	medical	ADJ
dpc-2415	335	4	board	board	NOUN
dpc-2415	335	5	of	of	ADP
dpc-2415	335	6	the	the	DET
dpc-2415	335	7	national	national	ADJ
dpc-2415	335	8	psoriasis	psoriasis	NOUN
dpc-2415	335	9	foundation	foundation	NOUN
dpc-2415	335	10	:	:	PUNCT
dpc-2415	335	11	vaccination	vaccination	NOUN
dpc-2415	335	12	in	in	ADP
dpc-2415	335	13	adult	adult	NOUN
dpc-2415	335	14	patients	patient	NOUN
dpc-2415	335	15	on	on	ADP
dpc-2415	335	16	systemic	systemic	ADJ
dpc-2415	335	17	therapy	therapy	NOUN
dpc-2415	335	18	for	for	ADP
dpc-2415	335	19	psoriasis	psoriasis	NOUN
dpc-2415	335	20	.	.	PUNCT
dpc-2415	335	21	 	 	SPACE
dpc-2415	336	1	j	j	PROPN
dpc-2415	336	2	am	be	AUX
dpc-2415	336	3	acad	acad	ADJ
dpc-2415	336	4	dermatol	dermatol	NOUN
dpc-2415	336	5	.	.	PUNCT
dpc-2415	337	1	2013;69(6):1003	2013;69(6):1003	PROPN
dpc-2415	337	2	-	-	SYM
dpc-2415	337	3	1013	1013	NUM
dpc-2415	337	4	.	.	PUNCT
dpc-2415	338	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	338	2	/	/	SYM
dpc-2415	338	3	j	j	PROPN
dpc-2415	338	4	.jaad.2013.06.046	.jaad.2013.06.046	NUM
dpc-2415	338	5	68	68	NUM
dpc-2415	338	6	.	.	PUNCT
dpc-2415	339	1	balagon	balagon	PROPN
dpc-2415	339	2	mv	mv	PROPN
dpc-2415	339	3	,	,	PUNCT
dpc-2415	339	4	walsh	walsh	PROPN
dpc-2415	339	5	ds	ds	PROPN
dpc-2415	339	6	,	,	PUNCT
dpc-2415	339	7	tan	tan	PROPN
dpc-2415	339	8	pl	pl	PROPN
dpc-2415	339	9	,	,	PUNCT
dpc-2415	339	10	et	et	PROPN
dpc-2415	339	11	al	al	PROPN
dpc-2415	339	12	.	.	PUNCT
dpc-2415	339	13	improvement	improvement	NOUN
dpc-2415	339	14	in	in	ADP
dpc-2415	339	15	psoriasis	psoriasis	NOUN
dpc-2415	339	16	after	after	ADP
dpc-2415	339	17	intradermal	intradermal	ADJ
dpc-2415	339	18	administration	administration	NOUN
dpc-2415	339	19	of	of	ADP
dpc-2415	339	20	heat	heat	NOUN
dpc-2415	339	21	-	-	PUNCT
dpc-2415	339	22	killed	kill	VERB
dpc-2415	339	23	mycobacterium	mycobacterium	NOUN
dpc-2415	339	24	vaccae	vaccae	NOUN
dpc-2415	339	25	.	.	PUNCT
dpc-2415	339	26	  	  	SPACE
dpc-2415	340	1	int	int	PROPN
dpc-2415	340	2	j	j	PROPN
dpc-2415	340	3	dermatol	dermatol	NOUN
dpc-2415	340	4	.	.	PUNCT
dpc-2415	341	1	2000;39(1):51	2000;39(1):51	NUM
dpc-2415	341	2	-	-	SYM
dpc-2415	341	3	58	58	NUM
dpc-2415	341	4	.	.	PUNCT
dpc-2415	342	1	doi:10.1046	doi:10.1046	ADJ
dpc-2415	342	2	/	/	SYM
dpc-2415	342	3	j.1365	j.1365	NOUN
dpc-2415	342	4	-	-	PUNCT
dpc-2415	342	5	4362.2000.00862.x	4362.2000.00862.x	NUM
dpc-2415	342	6	69	69	NUM
dpc-2415	342	7	.	.	PUNCT
dpc-2415	343	1	o’daly	o’daly	PROPN
dpc-2415	344	1	ja	ja	PROPN
dpc-2415	344	2	,	,	PUNCT
dpc-2415	344	3	gleason	gleason	PROPN
dpc-2415	344	4	j	j	PROPN
dpc-2415	344	5	,	,	PUNCT
dpc-2415	344	6	lezama	lezama	PROPN
dpc-2415	344	7	r	r	NOUN
dpc-2415	344	8	,	,	PUNCT
dpc-2415	344	9	rodriguez	rodriguez	PROPN
dpc-2415	344	10	pj	pj	PROPN
dpc-2415	344	11	,	,	PUNCT
dpc-2415	344	12	silva	silva	PROPN
dpc-2415	344	13	e	e	PROPN
dpc-2415	344	14	,	,	PUNCT
dpc-2415	344	15	indriago	indriago	PROPN
dpc-2415	344	16	nr	nr	PROPN
dpc-2415	344	17	.	.	PUNCT
dpc-2415	345	1	antigens	antigen	NOUN
dpc-2415	345	2	from	from	ADP
dpc-2415	345	3	leishmania	leishmania	NOUN
dpc-2415	345	4	amastigotes	amastigote	NOUN
dpc-2415	345	5	inducing	induce	VERB
dpc-2415	345	6	clinical	clinical	ADJ
dpc-2415	345	7	remission	remission	NOUN
dpc-2415	345	8	of	of	ADP
dpc-2415	345	9	psoriatic	psoriatic	ADJ
dpc-2415	345	10	arthritis	arthritis	NOUN
dpc-2415	345	11	.	.	PUNCT
dpc-2415	346	1	arch	arch	ADJ
dpc-2415	346	2	dermatol	dermatol	NOUN
dpc-2415	346	3	res	re	NOUN
dpc-2415	346	4	.	.	PUNCT
dpc-2415	347	1	2011;303(6):399	2011;303(6):399	NUM
dpc-2415	347	2	 	 	SPACE
dpc-2415	347	3	pubmed	pubmed	PROPN
dpc-2415	347	4	 	 	SPACE
dpc-2415	347	5	-415	-415	PROPN
dpc-2415	347	6	.	.	PUNCT
dpc-2415	348	1	doi	doi	NOUN
dpc-2415	348	2	:	:	PUNCT
dpc-2415	348	3	10.1007	10.1007	NUM
dpc-2415	348	4	/	/	SYM
dpc-2415	348	5	s00403	s00403	NOUN
dpc-2415	348	6	-	-	PUNCT
dpc-2415	348	7	011	011	NUM
dpc-2415	348	8	-	-	PUNCT
dpc-2415	348	9	1133	1133	NUM
dpc-2415	348	10	-	-	SYM
dpc-2415	348	11	0	0	NUM
dpc-2415	348	12	.	.	PUNCT
dpc-2415	349	1	70	70	NUM
dpc-2415	349	2	.	.	PUNCT
dpc-2415	350	1	el	el	PROPN
dpc-2415	350	2	-	-	PUNCT
dpc-2415	350	3	darouti	darouti	PROPN
dpc-2415	350	4	ma	ma	PROPN
dpc-2415	350	5	,	,	PUNCT
dpc-2415	350	6	hegazy	hegazy	PROPN
dpc-2415	350	7	ra	ra	PROPN
dpc-2415	350	8	,	,	PUNCT
dpc-2415	350	9	abdel	abdel	PROPN
dpc-2415	350	10	hay	hay	PROPN
dpc-2415	350	11	rm	rm	PROPN
dpc-2415	350	12	,	,	PUNCT
dpc-2415	350	13	rashed	rashe	VERB
dpc-2415	350	14	la	la	PROPN
dpc-2415	350	15	.	.	PUNCT
dpc-2415	351	1	study	study	PROPN
dpc-2415	351	2	of	of	ADP
dpc-2415	351	3	t	t	PROPN
dpc-2415	351	4	helper	helper	NOUN
dpc-2415	351	5	(	(	PUNCT
dpc-2415	351	6	17	17	NUM
dpc-2415	351	7	)	)	PUNCT
dpc-2415	351	8	and	and	CCONJ
dpc-2415	351	9	t	t	X
dpc-2415	351	10	regulatory	regulatory	ADJ
dpc-2415	351	11	cells	cell	NOUN
dpc-2415	351	12	in	in	ADP
dpc-2415	351	13	psoriatic	psoriatic	ADJ
dpc-2415	351	14	patients	patient	NOUN
dpc-2415	351	15	receiving	receive	VERB
dpc-2415	351	16	live	live	ADV
dpc-2415	351	17	attenuated	attenuate	VERB
dpc-2415	351	18	varicella	varicella	NOUN
dpc-2415	351	19	vaccine	vaccine	NOUN
dpc-2415	351	20	therapy	therapy	NOUN
dpc-2415	351	21	in	in	ADP
dpc-2415	351	22	a	a	DET
dpc-2415	351	23	randomized	randomized	ADJ
dpc-2415	351	24	controlled	control	VERB
dpc-2415	351	25	trial	trial	NOUN
dpc-2415	351	26	.	.	PUNCT
dpc-2415	351	27	 	 	SPACE
dpc-2415	352	1	eur	eur	PROPN
dpc-2415	352	2	j	j	PROPN
dpc-2415	352	3	dermatol	dermatol	NOUN
dpc-2415	352	4	.	.	PUNCT
dpc-2415	353	1	2014;24(4):464	2014;24(4):464	NUM
dpc-2415	353	2	-	-	SYM
dpc-2415	353	3	469	469	NUM
dpc-2415	353	4	.	.	PUNCT
dpc-2415	353	5	doi:10.1684	doi:10.1684	PROPN
dpc-2415	353	6	/	/	SYM
dpc-2415	353	7	ejd.2014.2377	ejd.2014.2377	PROPN
dpc-2415	353	8	71	71	NUM
dpc-2415	353	9	.	.	PUNCT
dpc-2415	354	1	diotallevi	diotallevi	PROPN
dpc-2415	354	2	f	f	PROPN
dpc-2415	354	3	,	,	PUNCT
dpc-2415	354	4	campanati	campanati	PROPN
dpc-2415	354	5	a	a	PRON
dpc-2415	354	6	,	,	PUNCT
dpc-2415	354	7	radi	radi	NOUN
dpc-2415	354	8	g	g	NOUN
dpc-2415	354	9	,	,	PUNCT
dpc-2415	354	10	et	et	PROPN
dpc-2415	354	11	al	al	PROPN
dpc-2415	354	12	.	.	PROPN
dpc-2415	354	13	vaccination	vaccination	NOUN
dpc-2415	354	14	against	against	ADP
dpc-2415	354	15	sars	sar	NOUN
dpc-2415	354	16	-	-	PUNCT
dpc-2415	354	17	cov-2	cov-2	NOUN
dpc-2415	354	18	and	and	CCONJ
dpc-2415	354	19	psoriasis	psoriasis	NOUN
dpc-2415	354	20	:	:	PUNCT
dpc-2415	354	21	the	the	DET
dpc-2415	354	22	three	three	NUM
dpc-2415	354	23	things	thing	NOUN
dpc-2415	354	24	every	every	DET
dpc-2415	354	25	dermatologist	dermatologist	NOUN
dpc-2415	354	26	should	should	AUX
dpc-2415	354	27	know	know	VERB
dpc-2415	354	28	.	.	PUNCT
dpc-2415	354	29	  	  	SPACE
dpc-2415	355	1	j	j	PROPN
dpc-2415	355	2	eur	eur	PROPN
dpc-2415	355	3	acad	acad	PROPN
dpc-2415	355	4	dermatol	dermatol	NOUN
dpc-2415	355	5	venereol	venereol	NOUN
dpc-2415	355	6	.	.	PUNCT
dpc-2415	356	1	2021	2021	NUM
dpc-2415	356	2	;	;	PUNCT
dpc-2415	356	3	35(7):e428	35(7):e428	PROPN
dpc-2415	356	4	-	-	PUNCT
dpc-2415	356	5	e430	e430	PROPN
dpc-2415	356	6	.	.	PUNCT
dpc-2415	357	1	doi:10.1111	doi:10.1111	PROPN
dpc-2415	357	2	/	/	SYM
dpc-2415	357	3	jdv.17256	jdv.17256	PROPN
dpc-2415	357	4	72	72	NUM
dpc-2415	357	5	.	.	PUNCT
dpc-2415	358	1	dávila	dávila	NOUN
dpc-2415	358	2	-	-	PUNCT
dpc-2415	358	3	seijo	seijo	NOUN
dpc-2415	358	4	p	p	NOUN
dpc-2415	358	5	,	,	PUNCT
dpc-2415	358	6	dauden	dauden	ADJ
dpc-2415	358	7	e	e	NOUN
dpc-2415	358	8	,	,	PUNCT
dpc-2415	358	9	descalzo	descalzo	VERB
dpc-2415	358	10	ma	ma	PROPN
dpc-2415	358	11	,	,	PUNCT
dpc-2415	358	12	et	et	PROPN
dpc-2415	358	13	al	al	PROPN
dpc-2415	358	14	.	.	PROPN
dpc-2415	358	15	infections	infection	NOUN
dpc-2415	358	16	in	in	ADP
dpc-2415	358	17	moderate	moderate	ADJ
dpc-2415	358	18	to	to	SCONJ
dpc-2415	358	19	severe	severe	ADJ
dpc-2415	358	20	psoriasis	psoriasis	NOUN
dpc-2415	358	21	patients	patient	NOUN
dpc-2415	358	22	treated	treat	VERB
dpc-2415	358	23	with	with	ADP
dpc-2415	358	24	biological	biological	ADJ
dpc-2415	358	25	drugs	drug	NOUN
dpc-2415	358	26	compared	compare	VERB
dpc-2415	358	27	to	to	ADP
dpc-2415	358	28	classic	classic	ADJ
dpc-2415	358	29	systemic	systemic	ADJ
dpc-2415	358	30	drugs	drug	NOUN
dpc-2415	358	31	:	:	PUNCT
dpc-2415	358	32	findings	finding	NOUN
dpc-2415	358	33	from	from	ADP
dpc-2415	358	34	the	the	DET
dpc-2415	358	35	biobadaderm	biobadaderm	NOUN
dpc-2415	358	36	registry	registry	NOUN
dpc-2415	358	37	.	.	PUNCT
dpc-2415	358	38	  	  	SPACE
dpc-2415	359	1	j	j	PROPN
dpc-2415	359	2	invest	invest	VERB
dpc-2415	359	3	dermatol	dermatol	NOUN
dpc-2415	359	4	.	.	PUNCT
dpc-2415	360	1	2017;137(2):313	2017;137(2):313	NUM
dpc-2415	360	2	-	-	SYM
dpc-2415	360	3	321	321	NUM
dpc-2415	360	4	.	.	PUNCT
dpc-2415	361	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	361	2	/	/	SYM
dpc-2415	361	3	j.jid.2016.08.034	j.jid.2016.08.034	PROPN
dpc-2415	361	4	73	73	NUM
dpc-2415	361	5	.	.	PUNCT
dpc-2415	362	1	rademaker	rademaker	PROPN
dpc-2415	362	2	m	m	PROPN
dpc-2415	362	3	,	,	PUNCT
dpc-2415	362	4	agnew	agnew	PROPN
dpc-2415	362	5	k	k	PROPN
dpc-2415	362	6	,	,	PUNCT
dpc-2415	362	7	anagnostou	anagnostou	PROPN
dpc-2415	362	8	n	n	CCONJ
dpc-2415	362	9	,	,	PUNCT
dpc-2415	362	10	et	et	PROPN
dpc-2415	362	11	al	al	PROPN
dpc-2415	362	12	.	.	PUNCT
dpc-2415	362	13	psoriasis	psoriasis	NOUN
dpc-2415	362	14	and	and	CCONJ
dpc-2415	362	15	infection	infection	NOUN
dpc-2415	362	16	.	.	PUNCT
dpc-2415	363	1	a	a	DET
dpc-2415	363	2	clinical	clinical	ADJ
dpc-2415	363	3	practice	practice	NOUN
dpc-2415	363	4	narrative	narrative	NOUN
dpc-2415	363	5	.	.	PUNCT
dpc-2415	363	6	 	 	SPACE
dpc-2415	364	1	australas	australa	VERB
dpc-2415	364	2	j	j	PROPN
dpc-2415	364	3	dermatol	dermatol	NOUN
dpc-2415	364	4	.	.	PUNCT
dpc-2415	365	1	2019;60(2):91	2019;60(2):91	NUM
dpc-2415	365	2	-	-	SYM
dpc-2415	365	3	98	98	NUM
dpc-2415	365	4	.	.	PUNCT
dpc-2415	366	1	doi:10.1111	doi:10.1111	NOUN
dpc-2415	366	2	/	/	SYM
dpc-2415	366	3	ajd.12895	ajd.12895	X
dpc-2415	366	4	74	74	NUM
dpc-2415	366	5	.	.	PUNCT
dpc-2415	367	1	talamonti	talamonti	PROPN
dpc-2415	367	2	m	m	PROPN
dpc-2415	367	3	,	,	PUNCT
dpc-2415	367	4	galluzzo	galluzzo	PROPN
dpc-2415	367	5	m	m	PROPN
dpc-2415	367	6	,	,	PUNCT
dpc-2415	367	7	chiricozzi	chiricozzi	VERB
dpc-2415	367	8	a	a	NOUN
dpc-2415	367	9	,	,	PUNCT
dpc-2415	367	10	et	et	PROPN
dpc-2415	367	11	al	al	PROPN
dpc-2415	367	12	.	.	PUNCT
dpc-2415	367	13	management	management	NOUN
dpc-2415	367	14	of	of	ADP
dpc-2415	367	15	biological	biological	ADJ
dpc-2415	367	16	therapies	therapy	NOUN
dpc-2415	367	17	for	for	ADP
dpc-2415	367	18	chronic	chronic	ADJ
dpc-2415	367	19	plaque	plaque	NOUN
dpc-2415	367	20	psoriasis	psoriasis	NOUN
dpc-2415	367	21	during	during	ADP
dpc-2415	367	22	covid-19	covid-19	PROPN
dpc-2415	367	23	emergency	emergency	NOUN
dpc-2415	367	24	in	in	ADP
dpc-2415	367	25	italy	italy	PROPN
dpc-2415	367	26	.	.	PUNCT
dpc-2415	367	27	 	 	SPACE
dpc-2415	368	1	j	j	PROPN
dpc-2415	368	2	eur	eur	PROPN
dpc-2415	368	3	acad	acad	PROPN
dpc-2415	368	4	dermatol	dermatol	NOUN
dpc-2415	368	5	venereol	venereol	NOUN
dpc-2415	368	6	.	.	PUNCT
dpc-2415	369	1	2020;34(12):e770	2020;34(12):e770	X
dpc-2415	369	2	-	-	PUNCT
dpc-2415	369	3	e772	e772	PROPN
dpc-2415	369	4	.	.	PUNCT
dpc-2415	370	1	doi:10.1111	doi:10.1111	PROPN
dpc-2415	370	2	/	/	SYM
dpc-2415	370	3	jdv.16841	jdv.16841	PROPN
dpc-2415	370	4	75	75	NUM
dpc-2415	370	5	.	.	PUNCT
dpc-2415	371	1	gelfand	gelfand	PROPN
dpc-2415	371	2	jm	jm	PROPN
dpc-2415	371	3	,	,	PUNCT
dpc-2415	371	4	armstrong	armstrong	PROPN
dpc-2415	371	5	aw	aw	INTJ
dpc-2415	371	6	,	,	PUNCT
dpc-2415	371	7	bell	bell	PROPN
dpc-2415	371	8	s	s	PROPN
dpc-2415	371	9	,	,	PUNCT
dpc-2415	371	10	et	et	PROPN
dpc-2415	371	11	al	al	PROPN
dpc-2415	371	12	.	.	PUNCT
dpc-2415	371	13	national	national	PROPN
dpc-2415	371	14	psoriasis	psoriasis	NOUN
dpc-2415	371	15	foundation	foundation	NOUN
dpc-2415	371	16	covid-19	covid-19	PROPN
dpc-2415	371	17	task	task	PROPN
dpc-2415	371	18	force	force	NOUN
dpc-2415	371	19	guidance	guidance	NOUN
dpc-2415	371	20	for	for	ADP
dpc-2415	371	21	management	management	NOUN
dpc-2415	371	22	of	of	ADP
dpc-2415	371	23	psoriatic	psoriatic	ADJ
dpc-2415	371	24	disease	disease	NOUN
dpc-2415	371	25	during	during	ADP
dpc-2415	371	26	the	the	DET
dpc-2415	371	27	pandemic	pandemic	ADJ
dpc-2415	371	28	:	:	PUNCT
dpc-2415	371	29	version	version	NOUN
dpc-2415	371	30	2	2	NUM
dpc-2415	371	31	-	-	PUNCT
dpc-2415	371	32	advances	advance	NOUN
dpc-2415	371	33	registry	registry	NOUN
dpc-2415	371	34	biorep	biorep	NOUN
dpc-2415	371	35	and	and	CCONJ
dpc-2415	371	36	a	a	DET
dpc-2415	371	37	comparison	comparison	NOUN
dpc-2415	371	38	with	with	ADP
dpc-2415	371	39	other	other	ADJ
dpc-2415	371	40	registries	registry	NOUN
dpc-2415	371	41	.	.	PUNCT
dpc-2415	371	42	  	  	SPACE
dpc-2415	372	1	int	int	PROPN
dpc-2415	372	2	j	j	PROPN
dpc-2415	372	3	dermatol	dermatol	NOUN
dpc-2415	372	4	.	.	PUNCT
dpc-2415	373	1	2017;56(4):428	2017;56(4):428	NOUN
dpc-2415	373	2	-	-	PUNCT
dpc-2415	373	3	434	434	NUM
dpc-2415	373	4	.	.	PUNCT
dpc-2415	374	1	doi:10.1111	doi:10.1111	NOUN
dpc-2415	374	2	/	/	SYM
dpc-2415	374	3	ijd.13543	ijd.13543	DET
dpc-2415	374	4	47	47	NUM
dpc-2415	374	5	.	.	PUNCT
dpc-2415	375	1	nast	nast	PROPN
dpc-2415	375	2	a	a	PRON
dpc-2415	375	3	,	,	PUNCT
dpc-2415	375	4	gisondi	gisondi	NOUN
dpc-2415	375	5	p	p	NOUN
dpc-2415	375	6	,	,	PUNCT
dpc-2415	375	7	ormerod	ormerod	VERB
dpc-2415	375	8	ad	ad	NOUN
dpc-2415	375	9	,	,	PUNCT
dpc-2415	375	10	et	et	PROPN
dpc-2415	375	11	al	al	PROPN
dpc-2415	375	12	.	.	PROPN
dpc-2415	375	13	european	european	PROPN
dpc-2415	375	14	s3	s3	PROPN
dpc-2415	375	15	-	-	PUNCT
dpc-2415	375	16	guidelines	guideline	NOUN
dpc-2415	375	17	on	on	ADP
dpc-2415	375	18	the	the	DET
dpc-2415	375	19	systemic	systemic	ADJ
dpc-2415	375	20	treatment	treatment	NOUN
dpc-2415	375	21	of	of	ADP
dpc-2415	375	22	psoriasis	psoriasis	NOUN
dpc-2415	375	23	vulgaris	vulgaris	NOUN
dpc-2415	375	24	--	--	PUNCT
dpc-2415	375	25	update	update	NOUN
dpc-2415	375	26	2015	2015	NUM
dpc-2415	375	27	-	-	PUNCT
dpc-2415	375	28	-short	-short	NOUN
dpc-2415	375	29	version	version	NOUN
dpc-2415	375	30	--	--	PUNCT
dpc-2415	375	31	edf	edf	PROPN
dpc-2415	375	32	in	in	ADP
dpc-2415	375	33	cooperation	cooperation	NOUN
dpc-2415	375	34	with	with	ADP
dpc-2415	375	35	eadv	eadv	PROPN
dpc-2415	375	36	and	and	CCONJ
dpc-2415	375	37	ipc	ipc	PROPN
dpc-2415	375	38	.	.	PROPN
dpc-2415	375	39	 	 	SPACE
dpc-2415	376	1	j	j	PROPN
dpc-2415	376	2	eur	eur	PROPN
dpc-2415	376	3	acad	acad	PROPN
dpc-2415	376	4	dermatol	dermatol	NOUN
dpc-2415	376	5	venereol	venereol	NOUN
dpc-2415	376	6	.	.	PUNCT
dpc-2415	377	1	2015;29(12):2277	2015;29(12):2277	NUM
dpc-2415	377	2	-	-	PUNCT
dpc-2415	377	3	2294	2294	NUM
dpc-2415	377	4	.	.	PUNCT
dpc-2415	378	1	doi:10.1111	doi:10.1111	NOUN
dpc-2415	378	2	/	/	SYM
dpc-2415	378	3	jdv.13354	jdv.13354	X
dpc-2415	378	4	48	48	NUM
dpc-2415	378	5	.	.	PUNCT
dpc-2415	379	1	balak	balak	PROPN
dpc-2415	379	2	dmw	dmw	PROPN
dpc-2415	379	3	,	,	PUNCT
dpc-2415	379	4	gerdes	gerdes	PROPN
dpc-2415	379	5	s	s	PROPN
dpc-2415	379	6	,	,	PUNCT
dpc-2415	379	7	parodi	parodi	PROPN
dpc-2415	379	8	a	a	NOUN
dpc-2415	379	9	,	,	PUNCT
dpc-2415	379	10	salgado	salgado	PROPN
dpc-2415	379	11	-	-	PROPN
dpc-2415	379	12	boquete	boquete	PROPN
dpc-2415	379	13	l.	l.	PROPN
dpc-2415	379	14	long	long	ADJ
dpc-2415	379	15	-	-	PUNCT
dpc-2415	379	16	term	term	NOUN
dpc-2415	379	17	safety	safety	NOUN
dpc-2415	379	18	of	of	ADP
dpc-2415	379	19	oral	oral	ADJ
dpc-2415	379	20	systemic	systemic	ADJ
dpc-2415	379	21	therapies	therapy	NOUN
dpc-2415	379	22	for	for	ADP
dpc-2415	379	23	psoriasis	psoriasis	NOUN
dpc-2415	379	24	:	:	PUNCT
dpc-2415	379	25	a	a	DET
dpc-2415	379	26	comprehensive	comprehensive	ADJ
dpc-2415	379	27	review	review	NOUN
dpc-2415	379	28	of	of	ADP
dpc-2415	379	29	the	the	DET
dpc-2415	379	30	literature	literature	NOUN
dpc-2415	379	31	.	.	PUNCT
dpc-2415	379	32	  	  	SPACE
dpc-2415	380	1	dermatol	dermatol	NOUN
dpc-2415	380	2	ther	ther	ADV
dpc-2415	380	3	(	(	PUNCT
dpc-2415	380	4	heidelb	heidelb	NOUN
dpc-2415	380	5	)	)	PUNCT
dpc-2415	380	6	.	.	PUNCT
dpc-2415	381	1	2020;10(4):589	2020;10(4):589	NUM
dpc-2415	381	2	-	-	PUNCT
dpc-2415	381	3	613	613	PROPN
dpc-2415	381	4	.	.	PUNCT
dpc-2415	381	5	doi:10.1007	doi:10.1007	PROPN
dpc-2415	381	6	/	/	SYM
dpc-2415	381	7	s13555	s13555	PROPN
dpc-2415	381	8	-	-	PUNCT
dpc-2415	381	9	020	020	NUM
dpc-2415	381	10	-	-	PUNCT
dpc-2415	381	11	00409	00409	NUM
dpc-2415	381	12	-	-	SYM
dpc-2415	381	13	4	4	NUM
dpc-2415	381	14	49	49	NUM
dpc-2415	381	15	.	.	PUNCT
dpc-2415	382	1	mrowietz	mrowietz	PROPN
dpc-2415	382	2	u	u	PROPN
dpc-2415	382	3	,	,	PUNCT
dpc-2415	382	4	sorbe	sorbe	PROPN
dpc-2415	382	5	c	c	PROPN
dpc-2415	382	6	,	,	PUNCT
dpc-2415	382	7	reich	reich	PROPN
dpc-2415	382	8	k	k	PROPN
dpc-2415	382	9	,	,	PUNCT
dpc-2415	382	10	et	et	PROPN
dpc-2415	382	11	al	al	PROPN
dpc-2415	382	12	.	.	PROPN
dpc-2415	382	13	fumaric	fumaric	ADJ
dpc-2415	382	14	acid	acid	PROPN
dpc-2415	382	15	esters	ester	NOUN
dpc-2415	382	16	for	for	ADP
dpc-2415	382	17	the	the	DET
dpc-2415	382	18	treatment	treatment	NOUN
dpc-2415	382	19	of	of	ADP
dpc-2415	382	20	psoriasis	psoriasis	NOUN
dpc-2415	382	21	in	in	ADP
dpc-2415	382	22	germany	germany	PROPN
dpc-2415	382	23	:	:	PUNCT
dpc-2415	382	24	characterising	characterise	VERB
dpc-2415	382	25	patients	patient	NOUN
dpc-2415	382	26	in	in	ADP
dpc-2415	382	27	routine	routine	ADJ
dpc-2415	382	28	care	care	NOUN
dpc-2415	382	29	.	.	PUNCT
dpc-2415	382	30	 	 	SPACE
dpc-2415	383	1	eur	eur	PROPN
dpc-2415	383	2	j	j	PROPN
dpc-2415	383	3	dermatol	dermatol	NOUN
dpc-2415	383	4	.	.	PUNCT
dpc-2415	384	1	2020;30(1):41	2020;30(1):41	NUM
dpc-2415	384	2	-	-	SYM
dpc-2415	384	3	48	48	NUM
dpc-2415	384	4	.	.	PUNCT
dpc-2415	385	1	doi:10.1684	doi:10.1684	NOUN
dpc-2415	385	2	/ejd.2020.3709	/ejd.2020.3709	PROPN
dpc-2415	386	1	50	50	NUM
dpc-2415	386	2	.	.	PUNCT
dpc-2415	386	3	balato	balato	PROPN
dpc-2415	386	4	a	a	PRON
dpc-2415	386	5	,	,	PUNCT
dpc-2415	386	6	scala	scala	PROPN
dpc-2415	386	7	e	e	NOUN
dpc-2415	386	8	,	,	PUNCT
dpc-2415	386	9	balato	balato	PROPN
dpc-2415	386	10	n	n	CCONJ
dpc-2415	386	11	,	,	PUNCT
dpc-2415	386	12	et	et	PROPN
dpc-2415	386	13	al	al	PROPN
dpc-2415	386	14	.	.	PUNCT
dpc-2415	387	1	biologics	biologic	NOUN
dpc-2415	387	2	that	that	PRON
dpc-2415	387	3	inhibit	inhibit	VERB
dpc-2415	387	4	the	the	DET
dpc-2415	387	5	th17	th17	PROPN
dpc-2415	387	6	pathway	pathway	NOUN
dpc-2415	387	7	and	and	CCONJ
dpc-2415	387	8	related	related	ADJ
dpc-2415	387	9	cytokines	cytokine	NOUN
dpc-2415	387	10	to	to	PART
dpc-2415	387	11	treat	treat	VERB
dpc-2415	387	12	inflammatory	inflammatory	ADJ
dpc-2415	387	13	disorders	disorder	NOUN
dpc-2415	387	14	.	.	PUNCT
dpc-2415	387	15	 	 	SPACE
dpc-2415	388	1	expert	expert	NOUN
dpc-2415	388	2	opin	opin	NOUN
dpc-2415	388	3	biol	biol	NOUN
dpc-2415	388	4	ther	ther	ADV
dpc-2415	388	5	.	.	PUNCT
dpc-2415	389	1	2017;17(11):1363	2017;17(11):1363	X
dpc-2415	389	2	-	-	SYM
dpc-2415	389	3	1374	1374	NUM
dpc-2415	389	4	.	.	PUNCT
dpc-2415	390	1	doi:10.10	doi:10.10	PROPN
dpc-2415	390	2	80/14712598.2017.1363884	80/14712598.2017.1363884	NUM
dpc-2415	390	3	51	51	NUM
dpc-2415	390	4	.	.	PUNCT
dpc-2415	391	1	takeshita	takeshita	PROPN
dpc-2415	391	2	j	j	PROPN
dpc-2415	391	3	,	,	PUNCT
dpc-2415	391	4	shin	shin	PROPN
dpc-2415	391	5	db	db	PROPN
dpc-2415	391	6	,	,	PUNCT
dpc-2415	391	7	ogdie	ogdie	VERB
dpc-2415	391	8	a	a	PRON
dpc-2415	391	9	,	,	PUNCT
dpc-2415	391	10	gelfand	gelfand	PROPN
dpc-2415	391	11	jm	jm	PROPN
dpc-2415	391	12	.	.	PROPN
dpc-2415	391	13	risk	risk	NOUN
dpc-2415	391	14	of	of	ADP
dpc-2415	391	15	serious	serious	ADJ
dpc-2415	391	16	infection	infection	NOUN
dpc-2415	391	17	,	,	PUNCT
dpc-2415	391	18	opportunistic	opportunistic	ADJ
dpc-2415	391	19	infection	infection	NOUN
dpc-2415	391	20	,	,	PUNCT
dpc-2415	391	21	and	and	CCONJ
dpc-2415	391	22	herpes	herpe	NOUN
dpc-2415	391	23	zoster	zoster	NOUN
dpc-2415	391	24	among	among	ADP
dpc-2415	391	25	patients	patient	NOUN
dpc-2415	391	26	with	with	ADP
dpc-2415	391	27	psoriasis	psoriasis	NOUN
dpc-2415	391	28	in	in	ADP
dpc-2415	391	29	the	the	DET
dpc-2415	391	30	united	united	PROPN
dpc-2415	391	31	 	 	SPACE
dpc-2415	391	32	kingdom	kingdom	NOUN
dpc-2415	391	33	.	.	PUNCT
dpc-2415	391	34	 	 	SPACE
dpc-2415	392	1	j	j	PROPN
dpc-2415	392	2	invest	invest	VERB
dpc-2415	392	3	dermatol	dermatol	NOUN
dpc-2415	392	4	.	.	PUNCT
dpc-2415	393	1	2018;138(8):1726	2018;138(8):1726	NUM
dpc-2415	393	2	-	-	SYM
dpc-2415	393	3	1735	1735	NUM
dpc-2415	393	4	.	.	PUNCT
dpc-2415	393	5	doi:10.1016	doi:10.1016	PROPN
dpc-2415	393	6	/	/	SYM
dpc-2415	393	7	j.jid.2018.01.039	j.jid.2018.01.039	PROPN
dpc-2415	393	8	52	52	NUM
dpc-2415	393	9	.	.	PUNCT
dpc-2415	393	10	dobry	dobry	PROPN
dpc-2415	394	1	as	as	ADP
dpc-2415	394	2	,	,	PUNCT
dpc-2415	394	3	quesenberry	quesenberry	NOUN
dpc-2415	394	4	cp	cp	NOUN
dpc-2415	394	5	,	,	PUNCT
dpc-2415	394	6	ray	ray	PROPN
dpc-2415	394	7	gt	gt	PROPN
dpc-2415	394	8	,	,	PUNCT
dpc-2415	394	9	geier	geier	PROPN
dpc-2415	394	10	jl	jl	PROPN
dpc-2415	394	11	,	,	PUNCT
dpc-2415	394	12	asgari	asgari	PROPN
dpc-2415	394	13	mm	mm	PROPN
dpc-2415	394	14	.	.	PUNCT
dpc-2415	394	15	serious	serious	ADJ
dpc-2415	394	16	infections	infection	NOUN
dpc-2415	394	17	among	among	ADP
dpc-2415	394	18	a	a	DET
dpc-2415	394	19	large	large	ADJ
dpc-2415	394	20	cohort	cohort	NOUN
dpc-2415	394	21	of	of	ADP
dpc-2415	394	22	subjects	subject	NOUN
dpc-2415	394	23	with	with	ADP
dpc-2415	394	24	systemically	systemically	ADV
dpc-2415	394	25	treated	treat	VERB
dpc-2415	394	26	psoriasis	psoriasis	NOUN
dpc-2415	394	27	.	.	PUNCT
dpc-2415	394	28	  	  	SPACE
dpc-2415	395	1	j	j	PROPN
dpc-2415	395	2	am	be	AUX
dpc-2415	395	3	acad	acad	ADJ
dpc-2415	395	4	dermatol	dermatol	NOUN
dpc-2415	395	5	.	.	PUNCT
dpc-2415	396	1	2017;77(5):838	2017;77(5):838	NUM
dpc-2415	396	2	-	-	SYM
dpc-2415	396	3	844	844	NUM
dpc-2415	396	4	.	.	PUNCT
dpc-2415	397	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	397	2	/	/	SYM
dpc-2415	397	3	j.jaad.2017.07.047	j.jaad.2017.07.047	CCONJ
dpc-2415	397	4	53	53	NUM
dpc-2415	397	5	.	.	PUNCT
dpc-2415	398	1	lee	lee	PROPN
dpc-2415	398	2	mp	mp	PROPN
dpc-2415	398	3	,	,	PUNCT
dpc-2415	398	4	wu	wu	PROPN
dpc-2415	398	5	kk	kk	PROPN
dpc-2415	398	6	,	,	PUNCT
dpc-2415	398	7	lee	lee	PROPN
dpc-2415	398	8	eb	eb	PROPN
dpc-2415	398	9	,	,	PUNCT
dpc-2415	398	10	wu	wu	PROPN
dpc-2415	398	11	jj	jj	PROPN
dpc-2415	398	12	.	.	PROPN
dpc-2415	398	13	risk	risk	NOUN
dpc-2415	398	14	for	for	ADP
dpc-2415	398	15	deep	deep	ADJ
dpc-2415	398	16	fungal	fungal	ADJ
dpc-2415	398	17	infections	infection	NOUN
dpc-2415	398	18	during	during	ADP
dpc-2415	398	19	il-17	il-17	ADV
dpc-2415	398	20	and	and	CCONJ
dpc-2415	398	21	il-23	il-23	NOUN
dpc-2415	398	22	inhibitor	inhibitor	NOUN
dpc-2415	398	23	therapy	therapy	NOUN
dpc-2415	398	24	for	for	ADP
dpc-2415	398	25	psoriasis	psoriasis	NOUN
dpc-2415	398	26	.	.	PUNCT
dpc-2415	398	27	  	  	SPACE
dpc-2415	398	28	cutis	cutis	NOUN
dpc-2415	398	29	.	.	PUNCT
dpc-2415	399	1	2020;106(4):199	2020;106(4):199	NUM
dpc-2415	399	2	-	-	SYM
dpc-2415	399	3	205	205	NUM
dpc-2415	399	4	.	.	PUNCT
dpc-2415	400	1	doi:10.12788	doi:10.12788	PROPN
dpc-2415	400	2	/	/	SYM
dpc-2415	400	3	cutis.0088	cutis.0088	PROPN
dpc-2415	400	4	54	54	NUM
dpc-2415	400	5	.	.	PUNCT
dpc-2415	401	1	wood	wood	PROPN
dpc-2415	401	2	kl	kl	PROPN
dpc-2415	401	3	,	,	PUNCT
dpc-2415	401	4	hage	hage	PROPN
dpc-2415	401	5	ca	ca	PROPN
dpc-2415	401	6	,	,	PUNCT
dpc-2415	401	7	knox	knox	PROPN
dpc-2415	401	8	ks	ks	PROPN
dpc-2415	401	9	,	,	PUNCT
dpc-2415	401	10	et	et	PROPN
dpc-2415	401	11	al	al	PROPN
dpc-2415	401	12	.	.	PROPN
dpc-2415	401	13	histoplasmosis	histoplasmosis	NOUN
dpc-2415	401	14	after	after	ADP
dpc-2415	401	15	treatment	treatment	NOUN
dpc-2415	401	16	with	with	ADP
dpc-2415	401	17	anti	anti	ADJ
dpc-2415	401	18	-	-	ADJ
dpc-2415	401	19	tumor	tumor	ADJ
dpc-2415	401	20	necrosis	necrosis	NOUN
dpc-2415	401	21	factor	factor	NOUN
dpc-2415	401	22	-	-	PUNCT
dpc-2415	401	23	alpha	alpha	NOUN
dpc-2415	401	24	therapy	therapy	NOUN
dpc-2415	401	25	.	.	PUNCT
dpc-2415	401	26	  	  	SPACE
dpc-2415	401	27	am	be	AUX
dpc-2415	401	28	j	j	PROPN
dpc-2415	401	29	respir	respir	NOUN
dpc-2415	401	30	crit	crit	PROPN
dpc-2415	401	31	care	care	NOUN
dpc-2415	401	32	med	me	VERB
dpc-2415	401	33	.	.	PUNCT
dpc-2415	402	1	2003;167(9):1279	2003;167(9):1279	NUM
dpc-2415	402	2	-	-	SYM
dpc-2415	402	3	1282	1282	NUM
dpc-2415	402	4	.	.	PUNCT
dpc-2415	403	1	doi:10.1164	doi:10.1164	NOUN
dpc-2415	403	2	/rccm.200206	/rccm.200206	PUNCT
dpc-2415	403	3	-	-	PUNCT
dpc-2415	403	4	563oc	563oc	NOUN
dpc-2415	403	5	55	55	NUM
dpc-2415	403	6	.	.	PUNCT
dpc-2415	404	1	syed	syed	PROPN
dpc-2415	404	2	mn	mn	PROPN
dpc-2415	404	3	,	,	PUNCT
dpc-2415	404	4	shin	shin	PROPN
dpc-2415	404	5	db	db	PROPN
dpc-2415	404	6	,	,	PUNCT
dpc-2415	404	7	wan	wan	PROPN
dpc-2415	404	8	mt	mt	PROPN
dpc-2415	404	9	,	,	PUNCT
dpc-2415	404	10	winthrop	winthrop	PROPN
dpc-2415	404	11	kl	kl	PROPN
dpc-2415	404	12	,	,	PUNCT
dpc-2415	404	13	gelfand	gelfand	PROPN
dpc-2415	404	14	jm	jm	PROPN
dpc-2415	404	15	.	.	PUNCT
dpc-2415	405	1	the	the	DET
dpc-2415	405	2	risk	risk	NOUN
dpc-2415	405	3	of	of	ADP
dpc-2415	405	4	respiratory	respiratory	ADJ
dpc-2415	405	5	tract	tract	NOUN
dpc-2415	405	6	infections	infection	NOUN
dpc-2415	405	7	in	in	ADP
dpc-2415	405	8	patients	patient	NOUN
dpc-2415	405	9	with	with	ADP
dpc-2415	405	10	psoriasis	psoriasis	NOUN
dpc-2415	405	11	treated	treat	VERB
dpc-2415	405	12	with	with	ADP
dpc-2415	405	13	interleukin	interleukin	NOUN
dpc-2415	405	14	23	23	NUM
dpc-2415	405	15	pathway	pathway	NOUN
dpc-2415	405	16	-	-	PUNCT
dpc-2415	405	17	inhibiting	inhibit	VERB
dpc-2415	405	18	biologics	biologic	NOUN
dpc-2415	405	19	:	:	PUNCT
dpc-2415	405	20	a	a	DET
dpc-2415	405	21	metaestimate	metaestimate	NOUN
dpc-2415	405	22	of	of	ADP
dpc-2415	405	23	pivotal	pivotal	ADJ
dpc-2415	405	24	trials	trial	NOUN
dpc-2415	405	25	relevant	relevant	ADJ
dpc-2415	405	26	to	to	PART
dpc-2415	405	27	decision	decision	VERB
dpc-2415	405	28	making	making	NOUN
dpc-2415	405	29	during	during	ADP
dpc-2415	405	30	the	the	DET
dpc-2415	405	31	covid-19	covid-19	PROPN
dpc-2415	405	32	pandemic	pandemic	NOUN
dpc-2415	405	33	.	.	PUNCT
dpc-2415	405	34	  	  	SPACE
dpc-2415	406	1	j	j	PROPN
dpc-2415	406	2	am	be	AUX
dpc-2415	406	3	acad	acad	ADJ
dpc-2415	406	4	dermatol	dermatol	NOUN
dpc-2415	406	5	.	.	PUNCT
dpc-2415	407	1	2020;83(5	2020;83(5	NUM
dpc-2415	407	2	):	):	PUNCT
dpc-2415	407	3	1523	1523	NUM
dpc-2415	407	4	-	-	SYM
dpc-2415	407	5	1526	1526	NUM
dpc-2415	407	6	.	.	PUNCT
dpc-2415	408	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	408	2	/	/	SYM
dpc-2415	408	3	j.jaad.2020.06.1014	j.jaad.2020.06.1014	PROPN
dpc-2415	408	4	56	56	NUM
dpc-2415	408	5	.	.	PUNCT
dpc-2415	409	1	carugno	carugno	VERB
dpc-2415	409	2	a	a	PRON
dpc-2415	409	3	,	,	PUNCT
dpc-2415	409	4	gambini	gambini	PROPN
dpc-2415	409	5	dm	dm	PROPN
dpc-2415	409	6	,	,	PUNCT
dpc-2415	409	7	raponi	raponi	NOUN
dpc-2415	409	8	f	f	PROPN
dpc-2415	409	9	,	,	PUNCT
dpc-2415	409	10	et	et	PROPN
dpc-2415	409	11	al	al	PROPN
dpc-2415	409	12	.	.	PUNCT
dpc-2415	410	1	covid-19	covid-19	PROPN
dpc-2415	410	2	and	and	CCONJ
dpc-2415	410	3	biologics	biologic	NOUN
dpc-2415	410	4	for	for	ADP
dpc-2415	410	5	psoriasis	psoriasis	NOUN
dpc-2415	410	6	:	:	PUNCT
dpc-2415	410	7	a	a	DET
dpc-2415	410	8	high	high	ADJ
dpc-2415	410	9	-	-	PUNCT
dpc-2415	410	10	epidemic	epidemic	NOUN
dpc-2415	410	11	area	area	NOUN
dpc-2415	410	12	experience	experience	NOUN
dpc-2415	410	13	-	-	PUNCT
dpc-2415	410	14	bergamo	bergamo	NOUN
dpc-2415	410	15	,	,	PUNCT
dpc-2415	410	16	lombardy	lombardy	PROPN
dpc-2415	410	17	,	,	PUNCT
dpc-2415	410	18	italy	italy	PROPN
dpc-2415	410	19	.	.	PUNCT
dpc-2415	410	20	  	  	SPACE
dpc-2415	411	1	j	j	PROPN
dpc-2415	411	2	am	be	AUX
dpc-2415	411	3	acad	acad	ADJ
dpc-2415	411	4	dermatol	dermatol	NOUN
dpc-2415	411	5	.	.	PUNCT
dpc-2415	412	1	2020;83(1):292	2020;83(1):292	NUM
dpc-2415	412	2	-	-	PUNCT
dpc-2415	412	3	294	294	NUM
dpc-2415	412	4	.	.	PUNCT
dpc-2415	412	5	doi:10.1016	doi:10.1016	PROPN
dpc-2415	412	6	/	/	SYM
dpc-2415	412	7	j.jaad.2020.04.165	j.jaad.2020.04.165	PROPN
dpc-2415	412	8	57	57	NUM
dpc-2415	412	9	.	.	PUNCT
dpc-2415	413	1	witte	witte	NOUN
dpc-2415	413	2	-	-	PUNCT
dpc-2415	413	3	händel	händel	PROPN
dpc-2415	413	4	e	e	NOUN
dpc-2415	413	5	,	,	PUNCT
dpc-2415	413	6	wolk	wolk	NOUN
dpc-2415	413	7	k	k	PROPN
dpc-2415	413	8	,	,	PUNCT
dpc-2415	413	9	tsaousi	tsaousi	PROPN
dpc-2415	413	10	a	a	PRON
dpc-2415	413	11	,	,	PUNCT
dpc-2415	413	12	et	et	PROPN
dpc-2415	413	13	al	al	PROPN
dpc-2415	413	14	.	.	PUNCT
dpc-2415	414	1	the	the	DET
dpc-2415	414	2	il-1	il-1	ADJ
dpc-2415	414	3	pathway	pathway	NOUN
dpc-2415	414	4	is	be	AUX
dpc-2415	414	5	hyperactive	hyperactive	ADJ
dpc-2415	414	6	in	in	ADP
dpc-2415	414	7	hidradenitis	hidradenitis	PROPN
dpc-2415	414	8	suppurativa	suppurativa	NOUN
dpc-2415	414	9	and	and	CCONJ
dpc-2415	414	10	contributes	contribute	VERB
dpc-2415	414	11	to	to	ADP
dpc-2415	414	12	skin	skin	NOUN
dpc-2415	414	13	infiltration	infiltration	NOUN
dpc-2415	414	14	and	and	CCONJ
dpc-2415	414	15	destruction	destruction	NOUN
dpc-2415	414	16	.	.	PUNCT
dpc-2415	414	17	  	  	SPACE
dpc-2415	415	1	j	j	PROPN
dpc-2415	415	2	invest	invest	VERB
dpc-2415	415	3	dermatol	dermatol	NOUN
dpc-2415	415	4	.	.	PUNCT
dpc-2415	416	1	2019	2019	NUM
dpc-2415	416	2	;	;	PUNCT
dpc-2415	416	3	139(6):1294	139(6):1294	NUM
dpc-2415	416	4	-	-	PROPN
dpc-2415	416	5	1305	1305	NUM
dpc-2415	416	6	.	.	PUNCT
dpc-2415	417	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	417	2	/	/	SYM
dpc-2415	417	3	j.jid.2018.11.018	j.jid.2018.11.018	PROPN
dpc-2415	417	4	58	58	NUM
dpc-2415	417	5	.	.	PUNCT
dpc-2415	418	1	sabat	sabat	PROPN
dpc-2415	418	2	r	r	NOUN
dpc-2415	418	3	,	,	PUNCT
dpc-2415	418	4	wolk	wolk	NOUN
dpc-2415	418	5	k	k	PROPN
dpc-2415	418	6	,	,	PUNCT
dpc-2415	418	7	loyal	loyal	ADJ
dpc-2415	418	8	l	l	NOUN
dpc-2415	418	9	,	,	PUNCT
dpc-2415	418	10	döcke	döcke	PROPN
dpc-2415	418	11	wd	wd	PROPN
dpc-2415	418	12	,	,	PUNCT
dpc-2415	418	13	ghoreschi	ghoreschi	ADJ
dpc-2415	418	14	k.	k.	PROPN
dpc-2415	418	15	t	t	PROPN
dpc-2415	418	16	cell	cell	NOUN
dpc-2415	418	17	pathology	pathology	NOUN
dpc-2415	418	18	in	in	ADP
dpc-2415	418	19	skin	skin	NOUN
dpc-2415	418	20	inflammation	inflammation	NOUN
dpc-2415	418	21	.	.	PUNCT
dpc-2415	418	22	 	 	SPACE
dpc-2415	419	1	semin	semin	PROPN
dpc-2415	419	2	immunopathol	immunopathol	PROPN
dpc-2415	419	3	.	.	PUNCT
dpc-2415	420	1	2019;41(3	2019;41(3	NUM
dpc-2415	420	2	):	):	PUNCT
dpc-2415	420	3	359	359	NUM
dpc-2415	420	4	-	-	SYM
dpc-2415	420	5	377	377	NUM
dpc-2415	420	6	.	.	PUNCT
dpc-2415	420	7	doi:10.1007	doi:10.1007	VERB
dpc-2415	420	8	/	/	SYM
dpc-2415	420	9	s00281	s00281	NOUN
dpc-2415	420	10	-	-	PUNCT
dpc-2415	420	11	019	019	NUM
dpc-2415	420	12	-	-	PUNCT
dpc-2415	420	13	00742	00742	NUM
dpc-2415	420	14	-	-	SYM
dpc-2415	420	15	7	7	NUM
dpc-2415	420	16	59	59	NUM
dpc-2415	420	17	.	.	PUNCT
dpc-2415	421	1	solimani	solimani	PROPN
dpc-2415	421	2	f	f	PROPN
dpc-2415	421	3	,	,	PUNCT
dpc-2415	421	4	meier	meier	PROPN
dpc-2415	421	5	k	k	PROPN
dpc-2415	421	6	,	,	PUNCT
dpc-2415	421	7	ghoreschi	ghoreschi	PROPN
dpc-2415	421	8	k.	k.	PROPN
dpc-2415	421	9	janus	janus	PROPN
dpc-2415	421	10	kinase	kinase	PROPN
dpc-2415	421	11	signaling	signal	VERB
dpc-2415	421	12	as	as	ADP
dpc-2415	421	13	risk	risk	NOUN
dpc-2415	421	14	factor	factor	NOUN
dpc-2415	421	15	and	and	CCONJ
dpc-2415	421	16	therapeutic	therapeutic	ADJ
dpc-2415	421	17	target	target	NOUN
dpc-2415	421	18	for	for	ADP
dpc-2415	421	19	severe	severe	ADJ
dpc-2415	421	20	sars	sar	NOUN
dpc-2415	421	21	-	-	PUNCT
dpc-2415	421	22	cov-2	cov-2	NOUN
dpc-2415	421	23	infection	infection	NOUN
dpc-2415	421	24	.	.	PUNCT
dpc-2415	421	25	  	  	SPACE
dpc-2415	422	1	eur	eur	PROPN
dpc-2415	422	2	j	j	PROPN
dpc-2415	422	3	immunol	immunol	NOUN
dpc-2415	422	4	.	.	PUNCT
dpc-2415	423	1	2021;51(5):1071	2021;51(5):1071	NUM
dpc-2415	423	2	-	-	SYM
dpc-2415	423	3	1075	1075	NUM
dpc-2415	423	4	.	.	PUNCT
dpc-2415	424	1	doi:10.1002	doi:10.1002	NOUN
dpc-2415	424	2	/eji.202149173	/eji.202149173	PROPN
dpc-2415	424	3	60	60	NUM
dpc-2415	424	4	.	.	PUNCT
dpc-2415	425	1	gisondi	gisondi	PROPN
dpc-2415	425	2	p	p	NOUN
dpc-2415	425	3	,	,	PUNCT
dpc-2415	425	4	talamonti	talamonti	PROPN
dpc-2415	425	5	m	m	PROPN
dpc-2415	425	6	,	,	PUNCT
dpc-2415	425	7	chiricozzi	chiricozzi	VERB
dpc-2415	425	8	a	a	NOUN
dpc-2415	425	9	,	,	PUNCT
dpc-2415	425	10	et	et	PROPN
dpc-2415	425	11	al	al	PROPN
dpc-2415	425	12	.	.	PUNCT
dpc-2415	426	1	treat	treat	PROPN
dpc-2415	426	2	-	-	PUNCT
dpc-2415	426	3	to	to	ADP
dpc-2415	426	4	-	-	PUNCT
dpc-2415	426	5	target	target	NOUN
dpc-2415	426	6	approach	approach	NOUN
dpc-2415	426	7	for	for	ADP
dpc-2415	426	8	the	the	DET
dpc-2415	426	9	management	management	NOUN
dpc-2415	426	10	of	of	ADP
dpc-2415	426	11	patients	patient	NOUN
dpc-2415	426	12	with	with	ADP
dpc-2415	426	13	moderate	moderate	ADJ
dpc-2415	426	14	-	-	PUNCT
dpc-2415	426	15	to	to	ADP
dpc-2415	426	16	-	-	PUNCT
dpc-2415	426	17	severe	severe	ADJ
dpc-2415	426	18	plaque	plaque	NOUN
dpc-2415	426	19	psoriasis	psoriasis	NOUN
dpc-2415	426	20	:	:	PUNCT
dpc-2415	426	21	consensus	consensus	NOUN
dpc-2415	426	22	recommendations	recommendation	NOUN
dpc-2415	426	23	.	.	PUNCT
dpc-2415	426	24	  	  	SPACE
dpc-2415	427	1	dermatol	dermatol	NOUN
dpc-2415	427	2	ther	ther	ADV
dpc-2415	427	3	(	(	PUNCT
dpc-2415	427	4	heidelb	heidelb	NOUN
dpc-2415	427	5	)	)	PUNCT
dpc-2415	427	6	.	.	PUNCT
dpc-2415	428	1	2021;11(1):235	2021;11(1):235	NUM
dpc-2415	428	2	-	-	SYM
dpc-2415	428	3	252	252	NUM
dpc-2415	428	4	.	.	PUNCT
dpc-2415	428	5	doi:10.1007	doi:10.1007	VERB
dpc-2415	428	6	/	/	SYM
dpc-2415	428	7	s13555	s13555	PROPN
dpc-2415	428	8	-	-	PUNCT
dpc-2415	428	9	020	020	NUM
dpc-2415	428	10	-00475	-00475	NOUN
dpc-2415	428	11	-	-	SYM
dpc-2415	428	12	8	8	NUM
dpc-2415	428	13	61	61	NUM
dpc-2415	428	14	.	.	PUNCT
dpc-2415	429	1	piaserico	piaserico	PROPN
dpc-2415	429	2	s	s	PART
dpc-2415	429	3	,	,	PUNCT
dpc-2415	429	4	gisondi	gisondi	NOUN
dpc-2415	429	5	p	p	NOUN
dpc-2415	429	6	,	,	PUNCT
dpc-2415	429	7	cazzaniga	cazzaniga	ADV
dpc-2415	429	8	s	s	PROPN
dpc-2415	429	9	,	,	PUNCT
dpc-2415	429	10	naldi	naldi	PROPN
dpc-2415	429	11	l.	l.	PROPN
dpc-2415	429	12	lack	lack	NOUN
dpc-2415	429	13	of	of	ADP
dpc-2415	429	14	evidence	evidence	NOUN
dpc-2415	429	15	for	for	ADP
dpc-2415	429	16	an	an	DET
dpc-2415	429	17	increased	increase	VERB
dpc-2415	429	18	risk	risk	NOUN
dpc-2415	429	19	of	of	ADP
dpc-2415	429	20	severe	severe	ADJ
dpc-2415	429	21	covid-19	covid-19	PROPN
dpc-2415	429	22	in	in	ADP
dpc-2415	429	23	psoriasis	psoriasis	NOUN
dpc-2415	429	24	patients	patient	NOUN
dpc-2415	429	25	on	on	ADP
dpc-2415	429	26	review	review	NOUN
dpc-2415	429	27	|	|	ADV
dpc-2415	429	28	dermatol	dermatol	ADJ
dpc-2415	429	29	pract	pract	NOUN
dpc-2415	429	30	concept	concept	NOUN
dpc-2415	429	31	.	.	PUNCT
dpc-2415	430	1	2023;13(1):e2023016	2023;13(1):e2023016	NUM
dpc-2415	430	2	9	9	NUM
dpc-2415	430	3	89	89	NUM
dpc-2415	430	4	.	.	PUNCT
dpc-2415	431	1	ha	ha	INTJ
dpc-2415	432	1	hl	hl	PROPN
dpc-2415	432	2	,	,	PUNCT
dpc-2415	432	3	wang	wang	PROPN
dpc-2415	432	4	h	h	PROPN
dpc-2415	432	5	,	,	PUNCT
dpc-2415	432	6	claudio	claudio	PROPN
dpc-2415	432	7	e	e	NOUN
dpc-2415	432	8	,	,	PUNCT
dpc-2415	432	9	tang	tang	PROPN
dpc-2415	432	10	w	w	PROPN
dpc-2415	432	11	,	,	PUNCT
dpc-2415	432	12	siebenlist	siebenlist	NOUN
dpc-2415	432	13	u.	u.	PROPN
dpc-2415	432	14	il-20	il-20	PROPN
dpc-2415	432	15	-	-	PUNCT
dpc-2415	432	16	receptor	receptor	NOUN
dpc-2415	432	17	signaling	signal	VERB
dpc-2415	432	18	delimits	delimit	VERB
dpc-2415	432	19	il-17	il-17	ADP
dpc-2415	432	20	production	production	NOUN
dpc-2415	432	21	in	in	ADP
dpc-2415	432	22	psoriatic	psoriatic	ADJ
dpc-2415	432	23	inflammation	inflammation	NOUN
dpc-2415	432	24	.	.	PUNCT
dpc-2415	432	25	 	 	SPACE
dpc-2415	433	1	j	j	PROPN
dpc-2415	433	2	invest	invest	VERB
dpc-2415	433	3	dermatol	dermatol	NOUN
dpc-2415	433	4	.	.	PUNCT
dpc-2415	434	1	2020;140(1):143	2020;140(1):143	NUM
dpc-2415	434	2	-	-	PUNCT
dpc-2415	434	3	151.e3	151.e3	NUM
dpc-2415	434	4	.	.	PUNCT
dpc-2415	435	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	435	2	/	/	SYM
dpc-2415	435	3	j	j	PROPN
dpc-2415	435	4	.jid.2019.06.127	.jid.2019.06.127	NOUN
dpc-2415	436	1	90	90	NUM
dpc-2415	436	2	.	.	PUNCT
dpc-2415	437	1	brandt	brandt	PROPN
dpc-2415	437	2	k	k	PROPN
dpc-2415	437	3	,	,	PUNCT
dpc-2415	437	4	singh	singh	PROPN
dpc-2415	437	5	pb	pb	ADP
dpc-2415	437	6	,	,	PUNCT
dpc-2415	437	7	bulfone	bulfone	NOUN
dpc-2415	437	8	-	-	PUNCT
dpc-2415	437	9	paus	paus	NOUN
dpc-2415	437	10	s	s	PROPN
dpc-2415	437	11	,	,	PUNCT
dpc-2415	437	12	rückert	rückert	PROPN
dpc-2415	437	13	r.	r.	PROPN
dpc-2415	437	14	interleukin-21	interleukin-21	PROPN
dpc-2415	437	15	:	:	PUNCT
dpc-2415	437	16	a	a	DET
dpc-2415	437	17	new	new	ADJ
dpc-2415	437	18	modulator	modulator	NOUN
dpc-2415	437	19	of	of	ADP
dpc-2415	437	20	immunity	immunity	NOUN
dpc-2415	437	21	,	,	PUNCT
dpc-2415	437	22	infection	infection	NOUN
dpc-2415	437	23	,	,	PUNCT
dpc-2415	437	24	and	and	CCONJ
dpc-2415	437	25	cancer	cancer	NOUN
dpc-2415	437	26	.	.	PUNCT
dpc-2415	437	27	 	 	SPACE
dpc-2415	437	28	cytokine	cytokine	ADJ
dpc-2415	437	29	growth	growth	NOUN
dpc-2415	437	30	factor	factor	NOUN
dpc-2415	437	31	rev	rev	VERB
dpc-2415	437	32	.	.	PROPN
dpc-2415	438	1	2007;18(3	2007;18(3	NUM
dpc-2415	438	2	-	-	PUNCT
dpc-2415	438	3	4):223	4):223	PROPN
dpc-2415	438	4	-	-	PUNCT
dpc-2415	438	5	232	232	NUM
dpc-2415	438	6	.	.	PUNCT
dpc-2415	439	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	439	2	/	/	SYM
dpc-2415	439	3	j	j	PROPN
dpc-2415	439	4	.cytogfr.2007.04.003	.cytogfr.2007.04.003	NOUN
dpc-2415	440	1	91	91	NUM
dpc-2415	440	2	.	.	PUNCT
dpc-2415	441	1	elsaesser	elsaesser	PROPN
dpc-2415	441	2	h	h	NOUN
dpc-2415	441	3	,	,	PUNCT
dpc-2415	441	4	sauer	sauer	PROPN
dpc-2415	441	5	k	k	PROPN
dpc-2415	441	6	,	,	PUNCT
dpc-2415	441	7	brooks	brooks	PROPN
dpc-2415	441	8	dg	dg	PROPN
dpc-2415	441	9	.	.	PUNCT
dpc-2415	442	1	il-21	il-21	PRON
dpc-2415	442	2	is	be	AUX
dpc-2415	442	3	required	require	VERB
dpc-2415	442	4	to	to	PART
dpc-2415	442	5	control	control	VERB
dpc-2415	442	6	chronic	chronic	ADJ
dpc-2415	442	7	viral	viral	ADJ
dpc-2415	442	8	infection	infection	NOUN
dpc-2415	442	9	[	[	X
dpc-2415	442	10	published	publish	VERB
dpc-2415	442	11	correction	correction	NOUN
dpc-2415	442	12	appears	appear	VERB
dpc-2415	442	13	in	in	ADP
dpc-2415	442	14	science	science	NOUN
dpc-2415	442	15	.	.	PUNCT
dpc-2415	443	1	2009	2009	NUM
dpc-2415	443	2	aug	aug	PROPN
dpc-2415	443	3	21;325(5943):946	21;325(5943):946	NUM
dpc-2415	443	4	]	]	PUNCT
dpc-2415	443	5	.	.	PUNCT
dpc-2415	443	6	 	 	SPACE
dpc-2415	443	7	science	science	NOUN
dpc-2415	443	8	.	.	PUNCT
dpc-2415	444	1	2009;324(5934	2009;324(5934	NUM
dpc-2415	444	2	):	):	PUNCT
dpc-2415	444	3	1569	1569	NUM
dpc-2415	444	4	-	-	SYM
dpc-2415	444	5	1572	1572	NUM
dpc-2415	444	6	.	.	PUNCT
dpc-2415	445	1	doi:10.1126	doi:10.1126	PROPN
dpc-2415	445	2	/	/	SYM
dpc-2415	445	3	science.1174182	science.1174182	PROPN
dpc-2415	445	4	92	92	NUM
dpc-2415	445	5	.	.	PUNCT
dpc-2415	446	1	chan	chan	PROPN
dpc-2415	446	2	tc	tc	PROPN
dpc-2415	446	3	,	,	PUNCT
dpc-2415	446	4	hawkes	hawkes	PROPN
dpc-2415	446	5	je	je	PROPN
dpc-2415	446	6	,	,	PUNCT
dpc-2415	446	7	krueger	krueger	PROPN
dpc-2415	446	8	jg	jg	PROPN
dpc-2415	446	9	.	.	PUNCT
dpc-2415	447	1	interleukin	interleukin	NOUN
dpc-2415	447	2	23	23	NUM
dpc-2415	447	3	in	in	ADP
dpc-2415	447	4	the	the	DET
dpc-2415	447	5	skin	skin	NOUN
dpc-2415	447	6	:	:	PUNCT
dpc-2415	447	7	role	role	NOUN
dpc-2415	447	8	in	in	ADP
dpc-2415	447	9	psoriasis	psoriasis	NOUN
dpc-2415	447	10	pathogenesis	pathogenesis	NOUN
dpc-2415	447	11	and	and	CCONJ
dpc-2415	447	12	selective	selective	ADJ
dpc-2415	447	13	interleukin	interleukin	NOUN
dpc-2415	447	14	23	23	NUM
dpc-2415	447	15	blockade	blockade	NOUN
dpc-2415	447	16	as	as	ADP
dpc-2415	447	17	treatment	treatment	NOUN
dpc-2415	447	18	.	.	PUNCT
dpc-2415	447	19	  	  	SPACE
dpc-2415	448	1	ther	ther	VERB
dpc-2415	448	2	adv	adv	PROPN
dpc-2415	448	3	chronic	chronic	ADJ
dpc-2415	448	4	dis	dis	PROPN
dpc-2415	448	5	.	.	PUNCT
dpc-2415	449	1	2018;9(5	2018;9(5	NUM
dpc-2415	449	2	):	):	PUNCT
dpc-2415	449	3	111	111	NUM
dpc-2415	449	4	-	-	SYM
dpc-2415	449	5	119	119	NUM
dpc-2415	449	6	.	.	PUNCT
dpc-2415	450	1	doi:10.1177/2040622318759282	doi:10.1177/2040622318759282	PROPN
dpc-2415	450	2	93	93	NUM
dpc-2415	450	3	.	.	PUNCT
dpc-2415	451	1	sun	sun	NOUN
dpc-2415	451	2	r	r	PROPN
dpc-2415	451	3	,	,	PUNCT
dpc-2415	451	4	abraham	abraham	PROPN
dpc-2415	451	5	c.	c.	PROPN
dpc-2415	451	6	il23	il23	PROPN
dpc-2415	451	7	promotes	promote	VERB
dpc-2415	451	8	antimicrobial	antimicrobial	ADJ
dpc-2415	451	9	pathways	pathway	NOUN
dpc-2415	451	10	in	in	ADP
dpc-2415	451	11	human	human	ADJ
dpc-2415	451	12	macrophages	macrophage	NOUN
dpc-2415	451	13	,	,	PUNCT
dpc-2415	451	14	which	which	PRON
dpc-2415	451	15	are	be	AUX
dpc-2415	451	16	reduced	reduce	VERB
dpc-2415	451	17	with	with	ADP
dpc-2415	451	18	the	the	DET
dpc-2415	451	19	ibd	ibd	NOUN
dpc-2415	451	20	-	-	PUNCT
dpc-2415	451	21	protective	protective	ADJ
dpc-2415	451	22	il23r	il23r	NOUN
dpc-2415	451	23	r381q	r381q	PROPN
dpc-2415	451	24	variant	variant	NOUN
dpc-2415	451	25	.	.	PUNCT
dpc-2415	451	26	  	  	SPACE
dpc-2415	451	27	cell	cell	NOUN
dpc-2415	451	28	mol	mol	ADP
dpc-2415	451	29	gastroenterol	gastroenterol	NOUN
dpc-2415	451	30	hepatol	hepatol	ADJ
dpc-2415	451	31	.	.	PUNCT
dpc-2415	452	1	2020;10(4):673	2020;10(4):673	X
dpc-2415	452	2	-	-	PUNCT
dpc-2415	452	3	697	697	NUM
dpc-2415	452	4	.	.	PUNCT
dpc-2415	452	5	doi:10.1016	doi:10.1016	PROPN
dpc-2415	452	6	/	/	SYM
dpc-2415	452	7	j	j	PROPN
dpc-2415	452	8	.jcmgh.2020.05.007	.jcmgh.2020.05.007	PROPN
dpc-2415	452	9	94	94	NUM
dpc-2415	452	10	.	.	PUNCT
dpc-2415	453	1	stephen	stephen	PROPN
dpc-2415	453	2	-	-	PUNCT
dpc-2415	453	3	victor	victor	PROPN
dpc-2415	453	4	e	e	PROPN
dpc-2415	453	5	,	,	PUNCT
dpc-2415	453	6	fickenscher	fickenscher	NOUN
dpc-2415	453	7	h	h	NOUN
dpc-2415	453	8	,	,	PUNCT
dpc-2415	453	9	bayry	bayry	PROPN
dpc-2415	453	10	j.	j.	PROPN
dpc-2415	453	11	il-26	il-26	PROPN
dpc-2415	453	12	:	:	PUNCT
dpc-2415	453	13	an	an	DET
dpc-2415	453	14	emerging	emerge	VERB
dpc-2415	453	15	proinflammatory	proinflammatory	ADJ
dpc-2415	453	16	member	member	NOUN
dpc-2415	453	17	of	of	ADP
dpc-2415	453	18	the	the	DET
dpc-2415	453	19	il-10	il-10	DET
dpc-2415	453	20	cytokine	cytokine	ADJ
dpc-2415	453	21	family	family	NOUN
dpc-2415	453	22	with	with	ADP
dpc-2415	453	23	multifaceted	multifaceted	ADJ
dpc-2415	453	24	actions	action	NOUN
dpc-2415	453	25	in	in	ADP
dpc-2415	453	26	antiviral	antiviral	ADJ
dpc-2415	453	27	,	,	PUNCT
dpc-2415	453	28	antimicrobial	antimicrobial	ADJ
dpc-2415	453	29	,	,	PUNCT
dpc-2415	453	30	and	and	CCONJ
dpc-2415	453	31	autoimmune	autoimmune	ADJ
dpc-2415	453	32	responses	response	NOUN
dpc-2415	453	33	.	.	PUNCT
dpc-2415	453	34	  	  	SPACE
dpc-2415	454	1	plos	plos	PROPN
dpc-2415	454	2	pathog	pathog	PROPN
dpc-2415	454	3	.	.	PUNCT
dpc-2415	455	1	2016;12(6):e1005624	2016;12(6):e1005624	X
dpc-2415	455	2	.	.	PUNCT
dpc-2415	455	3	published	publish	VERB
dpc-2415	455	4	2016	2016	NUM
dpc-2415	455	5	jun	jun	PROPN
dpc-2415	455	6	23	23	NUM
dpc-2415	455	7	.	.	PUNCT
dpc-2415	456	1	doi:10.1371	doi:10.1371	PROPN
dpc-2415	456	2	/	/	SYM
dpc-2415	457	1	journal.ppat.1005624	journal.ppat.1005624	PROPN
dpc-2415	457	2	95	95	NUM
dpc-2415	457	3	.	.	PUNCT
dpc-2415	458	1	scala	scala	PROPN
dpc-2415	458	2	e	e	PROPN
dpc-2415	458	3	,	,	PUNCT
dpc-2415	458	4	di	di	X
dpc-2415	458	5	caprio	caprio	PROPN
dpc-2415	458	6	r	r	PROPN
dpc-2415	458	7	,	,	PUNCT
dpc-2415	458	8	cacciapuoti	cacciapuoti	NOUN
dpc-2415	458	9	s	s	PROPN
dpc-2415	458	10	,	,	PUNCT
dpc-2415	458	11	et	et	PROPN
dpc-2415	458	12	al	al	PROPN
dpc-2415	458	13	.	.	PUNCT
dpc-2415	459	1	a	a	DET
dpc-2415	459	2	new	new	ADJ
dpc-2415	459	3	t	t	PROPN
dpc-2415	459	4	helper	helper	NOUN
dpc-2415	459	5	17	17	NUM
dpc-2415	459	6	cytokine	cytokine	NOUN
dpc-2415	459	7	in	in	ADP
dpc-2415	459	8	hidradenitis	hidradenitis	PROPN
dpc-2415	459	9	suppurativa	suppurativa	NOUN
dpc-2415	459	10	:	:	PUNCT
dpc-2415	459	11	antimicrobial	antimicrobial	ADJ
dpc-2415	459	12	and	and	CCONJ
dpc-2415	459	13	proinflammatory	proinflammatory	ADJ
dpc-2415	459	14	role	role	NOUN
dpc-2415	459	15	of	of	ADP
dpc-2415	459	16	interleukin-26	interleukin-26	PROPN
dpc-2415	459	17	.	.	PUNCT
dpc-2415	459	18	  	  	SPACE
dpc-2415	460	1	br	br	PROPN
dpc-2415	460	2	j	j	PROPN
dpc-2415	460	3	dermatol	dermatol	NOUN
dpc-2415	460	4	.	.	PUNCT
dpc-2415	461	1	2019	2019	NUM
dpc-2415	461	2	;	;	PUNCT
dpc-2415	461	3	181(5):1038	181(5):1038	NUM
dpc-2415	461	4	-	-	PUNCT
dpc-2415	461	5	1045	1045	NUM
dpc-2415	461	6	.	.	PUNCT
dpc-2415	462	1	doi:10.1111	doi:10.1111	ADJ
dpc-2415	462	2	/	/	SYM
dpc-2415	462	3	bjd.17854	bjd.17854	SYM
dpc-2415	462	4	96	96	NUM
dpc-2415	462	5	.	.	PUNCT
dpc-2415	463	1	murrieta	murrieta	PROPN
dpc-2415	463	2	-	-	PUNCT
dpc-2415	463	3	coxca	coxca	PROPN
dpc-2415	463	4	jm	jm	PROPN
dpc-2415	463	5	,	,	PUNCT
dpc-2415	463	6	rodríguez	rodríguez	NOUN
dpc-2415	463	7	-	-	PUNCT
dpc-2415	463	8	martínez	martínez	PROPN
dpc-2415	463	9	s	s	NOUN
dpc-2415	463	10	,	,	PUNCT
dpc-2415	463	11	cancino	cancino	NOUN
dpc-2415	463	12	-	-	PUNCT
dpc-2415	463	13	diaz	diaz	PROPN
dpc-2415	463	14	me	i	PRON
dpc-2415	463	15	,	,	PUNCT
dpc-2415	463	16	markert	markert	VERB
dpc-2415	463	17	ur	ur	INTJ
dpc-2415	463	18	,	,	PUNCT
dpc-2415	463	19	favaro	favaro	PROPN
dpc-2415	463	20	rr	rr	PROPN
dpc-2415	463	21	,	,	PUNCT
dpc-2415	463	22	morales	morales	PROPN
dpc-2415	463	23	-	-	PUNCT
dpc-2415	463	24	prieto	prieto	NOUN
dpc-2415	463	25	dm	dm	PROPN
dpc-2415	463	26	.	.	PUNCT
dpc-2415	463	27	il-36	il-36	PART
dpc-2415	464	1	cytokines	cytokine	VERB
dpc-2415	464	2	:	:	PUNCT
dpc-2415	464	3	regulators	regulator	NOUN
dpc-2415	464	4	of	of	ADP
dpc-2415	464	5	inflammatory	inflammatory	ADJ
dpc-2415	464	6	responses	response	NOUN
dpc-2415	464	7	and	and	CCONJ
dpc-2415	464	8	their	their	PRON
dpc-2415	464	9	emerging	emerge	VERB
dpc-2415	464	10	role	role	NOUN
dpc-2415	464	11	in	in	ADP
dpc-2415	464	12	immunology	immunology	NOUN
dpc-2415	464	13	of	of	ADP
dpc-2415	464	14	reproduction	reproduction	NOUN
dpc-2415	464	15	.	.	PUNCT
dpc-2415	464	16	 	 	SPACE
dpc-2415	465	1	int	int	PROPN
dpc-2415	465	2	j	j	PROPN
dpc-2415	465	3	mol	mol	ADP
dpc-2415	465	4	sci	sci	PROPN
dpc-2415	465	5	.	.	PUNCT
dpc-2415	466	1	2019;20(7):1649	2019;20(7):1649	NUM
dpc-2415	466	2	.	.	PUNCT
dpc-2415	467	1	published	publish	VERB
dpc-2415	467	2	2019	2019	NUM
dpc-2415	467	3	apr	apr	NOUN
dpc-2415	467	4	3	3	NUM
dpc-2415	467	5	.	.	PUNCT
dpc-2415	467	6	doi:10.3390	doi:10.3390	NOUN
dpc-2415	467	7	/	/	SYM
dpc-2415	467	8	ijms20071649	ijms20071649	PROPN
dpc-2415	467	9	97	97	NUM
dpc-2415	467	10	.	.	PUNCT
dpc-2415	468	1	wang	wang	PROPN
dpc-2415	468	2	p	p	PROPN
dpc-2415	468	3	,	,	PUNCT
dpc-2415	468	4	gamero	gamero	NOUN
dpc-2415	468	5	am	am	NOUN
dpc-2415	468	6	,	,	PUNCT
dpc-2415	468	7	jensen	jensen	PROPN
dpc-2415	468	8	le	le	PROPN
dpc-2415	468	9	.	.	PROPN
dpc-2415	468	10	il-36	il-36	PUNCT
dpc-2415	468	11	promotes	promote	VERB
dpc-2415	468	12	anti	anti	ADJ
dpc-2415	468	13	-	-	ADJ
dpc-2415	468	14	viral	viral	ADJ
dpc-2415	468	15	immunity	immunity	NOUN
dpc-2415	468	16	by	by	ADP
dpc-2415	468	17	boosting	boost	VERB
dpc-2415	468	18	sensitivity	sensitivity	NOUN
dpc-2415	468	19	to	to	ADP
dpc-2415	468	20	ifn	ifn	NOUN
dpc-2415	468	21	-	-	PUNCT
dpc-2415	468	22	α	α	NOUN
dpc-2415	468	23	/	/	SYM
dpc-2415	468	24	β	β	X
dpc-2415	468	25	in	in	ADP
dpc-2415	468	26	irf1	irf1	PROPN
dpc-2415	468	27	dependent	dependent	ADJ
dpc-2415	468	28	and	and	CCONJ
dpc-2415	468	29	independent	independent	ADJ
dpc-2415	468	30	manners	manner	NOUN
dpc-2415	468	31	.	.	PUNCT
dpc-2415	468	32	  	  	SPACE
dpc-2415	469	1	nat	nat	PROPN
dpc-2415	469	2	commun	commun	PROPN
dpc-2415	469	3	.	.	PUNCT
dpc-2415	470	1	2019;10(1):4700	2019;10(1):4700	NUM
dpc-2415	470	2	.	.	PUNCT
dpc-2415	471	1	published	publish	VERB
dpc-2415	471	2	2019	2019	NUM
dpc-2415	471	3	oct	oct	NOUN
dpc-2415	471	4	16	16	NUM
dpc-2415	471	5	.	.	PUNCT
dpc-2415	472	1	doi:10.1038	doi:10.1038	NOUN
dpc-2415	472	2	/	/	SYM
dpc-2415	472	3	s41467	s41467	NOUN
dpc-2415	472	4	-	-	PUNCT
dpc-2415	472	5	019	019	NUM
dpc-2415	472	6	-	-	PUNCT
dpc-2415	472	7	12318	12318	NUM
dpc-2415	472	8	-	-	PUNCT
dpc-2415	472	9	y	y	NOUN
dpc-2415	472	10	98	98	NUM
dpc-2415	472	11	.	.	PUNCT
dpc-2415	473	1	ogawa	ogawa	PROPN
dpc-2415	473	2	e	e	PROPN
dpc-2415	473	3	,	,	PUNCT
dpc-2415	473	4	sato	sato	PROPN
dpc-2415	473	5	y	y	PROPN
dpc-2415	473	6	,	,	PUNCT
dpc-2415	473	7	minagawa	minagawa	PROPN
dpc-2415	473	8	a	a	PRON
dpc-2415	473	9	,	,	PUNCT
dpc-2415	473	10	okuyama	okuyama	PROPN
dpc-2415	473	11	r.	r.	PROPN
dpc-2415	473	12	pathogenesis	pathogenesis	NOUN
dpc-2415	473	13	of	of	ADP
dpc-2415	473	14	psoriasis	psoriasis	NOUN
dpc-2415	473	15	and	and	CCONJ
dpc-2415	473	16	development	development	NOUN
dpc-2415	473	17	of	of	ADP
dpc-2415	473	18	treatment	treatment	NOUN
dpc-2415	473	19	.	.	PUNCT
dpc-2415	473	20	  	  	SPACE
dpc-2415	474	1	j	j	PROPN
dpc-2415	474	2	dermatol	dermatol	NOUN
dpc-2415	474	3	.	.	PUNCT
dpc-2415	475	1	2018;45(3):264	2018;45(3):264	NUM
dpc-2415	475	2	-	-	PUNCT
dpc-2415	475	3	272	272	NUM
dpc-2415	475	4	.	.	PUNCT
dpc-2415	475	5	doi:10.1111/1346	doi:10.1111/1346	VERB
dpc-2415	475	6	-	-	PUNCT
dpc-2415	475	7	8138.14139	8138.14139	NUM
dpc-2415	475	8	99	99	NUM
dpc-2415	475	9	.	.	PUNCT
dpc-2415	476	1	lambert	lambert	PROPN
dpc-2415	476	2	jlw	jlw	PROPN
dpc-2415	476	3	,	,	PUNCT
dpc-2415	476	4	segaert	segaert	NOUN
dpc-2415	476	5	s	s	PROPN
dpc-2415	476	6	,	,	PUNCT
dpc-2415	476	7	ghislain	ghislain	NOUN
dpc-2415	476	8	pd	pd	PROPN
dpc-2415	476	9	,	,	PUNCT
dpc-2415	476	10	et	et	PROPN
dpc-2415	476	11	al	al	PROPN
dpc-2415	476	12	.	.	PROPN
dpc-2415	476	13	practical	practical	ADJ
dpc-2415	476	14	recommendations	recommendation	NOUN
dpc-2415	476	15	for	for	ADP
dpc-2415	476	16	systemic	systemic	ADJ
dpc-2415	476	17	treatment	treatment	NOUN
dpc-2415	476	18	in	in	ADP
dpc-2415	476	19	psoriasis	psoriasis	NOUN
dpc-2415	476	20	in	in	ADP
dpc-2415	476	21	case	case	NOUN
dpc-2415	476	22	of	of	ADP
dpc-2415	476	23	coexisting	coexist	VERB
dpc-2415	476	24	inflammatory	inflammatory	ADJ
dpc-2415	476	25	,	,	PUNCT
dpc-2415	476	26	neurologic	neurologic	ADJ
dpc-2415	476	27	,	,	PUNCT
dpc-2415	476	28	infectious	infectious	ADJ
dpc-2415	476	29	or	or	CCONJ
dpc-2415	476	30	malignant	malignant	ADJ
dpc-2415	476	31	disorders	disorder	NOUN
dpc-2415	476	32	(	(	PUNCT
dpc-2415	476	33	beta	beta	NOUN
dpc-2415	476	34	-	-	PUNCT
dpc-2415	476	35	pso	pso	NOUN
dpc-2415	476	36	:	:	PUNCT
dpc-2415	476	37	belgian	belgian	ADJ
dpc-2415	476	38	evidence	evidence	NOUN
dpc-2415	476	39	-	-	PUNCT
dpc-2415	476	40	based	base	VERB
dpc-2415	476	41	treatment	treatment	NOUN
dpc-2415	476	42	advice	advice	NOUN
dpc-2415	476	43	in	in	ADP
dpc-2415	476	44	psoriasis	psoriasis	NOUN
dpc-2415	476	45	;	;	PUNCT
dpc-2415	476	46	part	part	NOUN
dpc-2415	476	47	2	2	NUM
dpc-2415	476	48	)	)	PUNCT
dpc-2415	476	49	.	.	PUNCT
dpc-2415	476	50	 	 	SPACE
dpc-2415	477	1	j	j	PROPN
dpc-2415	477	2	eur	eur	PROPN
dpc-2415	477	3	acad	acad	PROPN
dpc-2415	477	4	dermatol	dermatol	NOUN
dpc-2415	477	5	venereol	venereol	NOUN
dpc-2415	477	6	.	.	PUNCT
dpc-2415	478	1	2020;34(9	2020;34(9	NUM
dpc-2415	478	2	):	):	PUNCT
dpc-2415	478	3	1914	1914	NUM
dpc-2415	478	4	-	-	SYM
dpc-2415	478	5	1923	1923	NUM
dpc-2415	478	6	.	.	PUNCT
dpc-2415	479	1	doi:10.1111	doi:10.1111	ADJ
dpc-2415	479	2	/	/	SYM
dpc-2415	479	3	jdv.16683	jdv.16683	PROPN
dpc-2415	479	4	100	100	NUM
dpc-2415	479	5	.	.	PUNCT
dpc-2415	480	1	kaushik	kaushik	PROPN
dpc-2415	480	2	sb	sb	PROPN
dpc-2415	480	3	,	,	PUNCT
dpc-2415	480	4	lebwohl	lebwohl	VERB
dpc-2415	480	5	mg	mg	PROPN
dpc-2415	480	6	.	.	PUNCT
dpc-2415	481	1	psoriasis	psoriasis	NOUN
dpc-2415	481	2	:	:	PUNCT
dpc-2415	481	3	which	which	DET
dpc-2415	481	4	therapy	therapy	NOUN
dpc-2415	481	5	for	for	ADP
dpc-2415	481	6	which	which	PRON
dpc-2415	481	7	patient	patient	NOUN
dpc-2415	481	8	:	:	PUNCT
dpc-2415	481	9	psoriasis	psoriasis	NOUN
dpc-2415	481	10	comorbidities	comorbiditie	NOUN
dpc-2415	481	11	and	and	CCONJ
dpc-2415	481	12	preferred	preferred	ADJ
dpc-2415	481	13	systemic	systemic	ADJ
dpc-2415	481	14	agents	agent	NOUN
dpc-2415	481	15	.	.	PUNCT
dpc-2415	481	16	 	 	SPACE
dpc-2415	482	1	j	j	PROPN
dpc-2415	482	2	am	be	AUX
dpc-2415	482	3	acad	acad	ADJ
dpc-2415	482	4	dermatol	dermatol	NOUN
dpc-2415	482	5	.	.	PUNCT
dpc-2415	483	1	2019;80(1):27	2019;80(1):27	NUM
dpc-2415	483	2	-	-	SYM
dpc-2415	483	3	40	40	NUM
dpc-2415	483	4	.	.	PUNCT
dpc-2415	484	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	484	2	/	/	SYM
dpc-2415	484	3	j.	j.	PROPN
dpc-2415	484	4	jaad.2018.06.057	jaad.2018.06.057	VERB
dpc-2415	484	5	101	101	NUM
dpc-2415	484	6	.	.	PUNCT
dpc-2415	485	1	blauvelt	blauvelt	AUX
dpc-2415	485	2	a	a	PRON
dpc-2415	485	3	,	,	PUNCT
dpc-2415	485	4	lebwohl	lebwohl	ADJ
dpc-2415	485	5	mg	mg	PROPN
dpc-2415	485	6	,	,	PUNCT
dpc-2415	485	7	bissonnette	bissonnette	PROPN
dpc-2415	485	8	r.	r.	PROPN
dpc-2415	485	9	il-23	il-23	NOUN
dpc-2415	485	10	/	/	SYM
dpc-2415	485	11	il-17a	il-17a	PROPN
dpc-2415	485	12	dysfunction	dysfunction	NOUN
dpc-2415	485	13	phenotypes	phenotype	NOUN
dpc-2415	485	14	inform	inform	VERB
dpc-2415	485	15	possible	possible	ADJ
dpc-2415	485	16	clinical	clinical	ADJ
dpc-2415	485	17	effects	effect	NOUN
dpc-2415	485	18	from	from	ADP
dpc-2415	485	19	anti	anti	ADJ
dpc-2415	485	20	-	-	ADJ
dpc-2415	485	21	il-17a	il-17a	ADJ
dpc-2415	485	22	therapies	therapy	NOUN
dpc-2415	485	23	.	.	PUNCT
dpc-2415	485	24	  	  	SPACE
dpc-2415	486	1	j	j	PROPN
dpc-2415	486	2	invest	invest	VERB
dpc-2415	486	3	dermatol	dermatol	NOUN
dpc-2415	486	4	.	.	PUNCT
dpc-2415	487	1	2015;135(8	2015;135(8	NUM
dpc-2415	487	2	):	):	PUNCT
dpc-2415	487	3	1946	1946	NUM
dpc-2415	487	4	-	-	SYM
dpc-2415	487	5	1953	1953	NUM
dpc-2415	487	6	.	.	PUNCT
dpc-2415	488	1	doi:10.1038	doi:10.1038	NOUN
dpc-2415	488	2	/	/	SYM
dpc-2415	488	3	jid.2015.144	jid.2015.144	PROPN
dpc-2415	488	4	in	in	ADP
dpc-2415	488	5	psoriatic	psoriatic	ADJ
dpc-2415	488	6	disease	disease	NOUN
dpc-2415	488	7	management	management	NOUN
dpc-2415	488	8	,	,	PUNCT
dpc-2415	488	9	covid-19	covid-19	PROPN
dpc-2415	488	10	vaccines	vaccine	NOUN
dpc-2415	488	11	,	,	PUNCT
dpc-2415	488	12	and	and	CCONJ
dpc-2415	488	13	covid-19	covid-19	PROPN
dpc-2415	488	14	treatments	treatment	NOUN
dpc-2415	488	15	.	.	PUNCT
dpc-2415	488	16	  	  	SPACE
dpc-2415	489	1	j	j	PROPN
dpc-2415	489	2	am	be	AUX
dpc-2415	489	3	acad	acad	ADJ
dpc-2415	489	4	dermatol	dermatol	NOUN
dpc-2415	489	5	.	.	PUNCT
dpc-2415	490	1	2021;84(5	2021;84(5	NUM
dpc-2415	490	2	):	):	PUNCT
dpc-2415	490	3	1254	1254	NUM
dpc-2415	490	4	-	-	SYM
dpc-2415	490	5	1268	1268	NUM
dpc-2415	490	6	.	.	PUNCT
dpc-2415	491	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	491	2	/	/	SYM
dpc-2415	491	3	j.jaad.2020.12.058	j.jaad.2020.12.058	PROPN
dpc-2415	491	4	76	76	NUM
dpc-2415	491	5	.	.	PUNCT
dpc-2415	492	1	gisondi	gisondi	NOUN
dpc-2415	492	2	p	p	NOUN
dpc-2415	492	3	,	,	PUNCT
dpc-2415	492	4	piaserico	piaserico	NOUN
dpc-2415	492	5	s	s	PART
dpc-2415	492	6	,	,	PUNCT
dpc-2415	492	7	bordin	bordin	VERB
dpc-2415	492	8	c	c	NOUN
dpc-2415	492	9	,	,	PUNCT
dpc-2415	492	10	alaibac	alaibac	PROPN
dpc-2415	492	11	m	m	PROPN
dpc-2415	492	12	,	,	PUNCT
dpc-2415	492	13	girolomoni	girolomoni	VERB
dpc-2415	492	14	g	g	NOUN
dpc-2415	492	15	,	,	PUNCT
dpc-2415	492	16	naldi	naldi	PROPN
dpc-2415	492	17	l.	l.	PROPN
dpc-2415	492	18	cutaneous	cutaneous	ADJ
dpc-2415	492	19	manifestations	manifestation	NOUN
dpc-2415	492	20	of	of	ADP
dpc-2415	492	21	sars	sar	NOUN
dpc-2415	492	22	-	-	PUNCT
dpc-2415	492	23	cov-2	cov-2	PART
dpc-2415	492	24	infection	infection	NOUN
dpc-2415	492	25	:	:	PUNCT
dpc-2415	492	26	a	a	DET
dpc-2415	492	27	clinical	clinical	ADJ
dpc-2415	492	28	update	update	NOUN
dpc-2415	492	29	.	.	PUNCT
dpc-2415	492	30	 	 	SPACE
dpc-2415	493	1	j	j	PROPN
dpc-2415	493	2	eur	eur	PROPN
dpc-2415	493	3	acad	acad	PROPN
dpc-2415	493	4	dermatol	dermatol	NOUN
dpc-2415	493	5	venereol	venereol	NOUN
dpc-2415	493	6	.	.	PUNCT
dpc-2415	494	1	2020;34(11):2499	2020;34(11):2499	NUM
dpc-2415	494	2	-	-	SYM
dpc-2415	494	3	2504	2504	NUM
dpc-2415	494	4	.	.	PUNCT
dpc-2415	495	1	doi:10.1111	doi:10.1111	NOUN
dpc-2415	495	2	/	/	SYM
dpc-2415	495	3	jdv.16774	jdv.16774	PROPN
dpc-2415	495	4	77	77	NUM
dpc-2415	495	5	.	.	PUNCT
dpc-2415	496	1	gadarowski	gadarowski	PROPN
dpc-2415	496	2	mb	mb	PROPN
dpc-2415	496	3	,	,	PUNCT
dpc-2415	496	4	balogh	balogh	PROPN
dpc-2415	496	5	ea	ea	PROPN
dpc-2415	496	6	,	,	PUNCT
dpc-2415	496	7	bashyam	bashyam	PROPN
dpc-2415	496	8	am	be	AUX
dpc-2415	496	9	,	,	PUNCT
dpc-2415	496	10	feldman	feldman	PROPN
dpc-2415	496	11	sr	sr	PROPN
dpc-2415	496	12	.	.	PUNCT
dpc-2415	497	1	examining	examine	VERB
dpc-2415	497	2	recommendations	recommendation	NOUN
dpc-2415	497	3	for	for	ADP
dpc-2415	497	4	the	the	DET
dpc-2415	497	5	use	use	NOUN
dpc-2415	497	6	of	of	ADP
dpc-2415	497	7	biologics	biologic	NOUN
dpc-2415	497	8	and	and	CCONJ
dpc-2415	497	9	other	other	ADJ
dpc-2415	497	10	systemic	systemic	ADJ
dpc-2415	497	11	therapies	therapy	NOUN
dpc-2415	497	12	during	during	ADP
dpc-2415	497	13	covid-19	covid-19	PROPN
dpc-2415	497	14	:	:	PUNCT
dpc-2415	497	15	a	a	DET
dpc-2415	497	16	review	review	NOUN
dpc-2415	497	17	and	and	CCONJ
dpc-2415	497	18	comparison	comparison	NOUN
dpc-2415	497	19	of	of	ADP
dpc-2415	497	20	available	available	ADJ
dpc-2415	497	21	dermatology	dermatology	NOUN
dpc-2415	497	22	guidelines	guideline	NOUN
dpc-2415	497	23	and	and	CCONJ
dpc-2415	497	24	patient	patient	ADJ
dpc-2415	497	25	registries	registry	NOUN
dpc-2415	497	26	[	[	X
dpc-2415	497	27	published	publish	VERB
dpc-2415	497	28	online	online	ADV
dpc-2415	497	29	ahead	ahead	ADV
dpc-2415	497	30	of	of	ADP
dpc-2415	497	31	print	print	NOUN
dpc-2415	497	32	,	,	PUNCT
dpc-2415	497	33	2020	2020	NUM
dpc-2415	497	34	oct	oct	NOUN
dpc-2415	497	35	30	30	NUM
dpc-2415	497	36	]	]	PUNCT
dpc-2415	497	37	.	.	PUNCT
dpc-2415	497	38	 	 	SPACE
dpc-2415	498	1	j	j	PROPN
dpc-2415	498	2	dermatolog	dermatolog	PROPN
dpc-2415	498	3	treat	treat	NOUN
dpc-2415	498	4	.	.	PUNCT
dpc-2415	499	1	2020;1	2020;1	NUM
dpc-2415	499	2	-	-	SYM
dpc-2415	499	3	5	5	NUM
dpc-2415	499	4	.	.	PUNCT
dpc-2415	500	1	doi:10.1080/09546634.2020.1808154	doi:10.1080/09546634.2020.1808154	NOUN
dpc-2415	500	2	78	78	NUM
dpc-2415	500	3	.	.	PUNCT
dpc-2415	501	1	nast	nast	PROPN
dpc-2415	501	2	a	a	PRON
dpc-2415	501	3	,	,	PUNCT
dpc-2415	501	4	smith	smith	PROPN
dpc-2415	501	5	c	c	PROPN
dpc-2415	501	6	,	,	PUNCT
dpc-2415	501	7	spuls	spuls	PROPN
dpc-2415	501	8	pi	pi	PROPN
dpc-2415	501	9	,	,	PUNCT
dpc-2415	501	10	et	et	PROPN
dpc-2415	501	11	al	al	PROPN
dpc-2415	501	12	.	.	PROPN
dpc-2415	502	1	euroguiderm	euroguiderm	PROPN
dpc-2415	502	2	guideline	guideline	NOUN
dpc-2415	502	3	on	on	ADP
dpc-2415	502	4	the	the	DET
dpc-2415	502	5	systemic	systemic	ADJ
dpc-2415	502	6	treatment	treatment	NOUN
dpc-2415	502	7	of	of	ADP
dpc-2415	502	8	psoriasis	psoriasis	NOUN
dpc-2415	502	9	vulgaris	vulgaris	NOUN
dpc-2415	502	10	part	part	NOUN
dpc-2415	502	11	1	1	NUM
dpc-2415	502	12	:	:	PUNCT
dpc-2415	502	13	treatment	treatment	NOUN
dpc-2415	502	14	and	and	CCONJ
dpc-2415	502	15	monitoring	monitoring	NOUN
dpc-2415	502	16	recommendations	recommendation	NOUN
dpc-2415	502	17	.	.	PUNCT
dpc-2415	502	18	  	  	SPACE
dpc-2415	503	1	j	j	PROPN
dpc-2415	503	2	eur	eur	PROPN
dpc-2415	503	3	acad	acad	PROPN
dpc-2415	503	4	dermatol	dermatol	NOUN
dpc-2415	503	5	venereol	venereol	NOUN
dpc-2415	503	6	.	.	PUNCT
dpc-2415	504	1	2020;34(11):2461	2020;34(11):2461	X
dpc-2415	504	2	-	-	PROPN
dpc-2415	504	3	2498	2498	NUM
dpc-2415	504	4	.	.	PUNCT
dpc-2415	505	1	doi:10.1111	doi:10.1111	ADJ
dpc-2415	505	2	/	/	SYM
dpc-2415	505	3	jdv.16915	jdv.16915	PROPN
dpc-2415	505	4	79	79	NUM
dpc-2415	505	5	.	.	PUNCT
dpc-2415	506	1	den	den	NOUN
dpc-2415	506	2	broeder	broeder	NOUN
dpc-2415	506	3	aa	aa	NOUN
dpc-2415	506	4	,	,	PUNCT
dpc-2415	506	5	creemers	creemers	PROPN
dpc-2415	506	6	mc	mc	PROPN
dpc-2415	506	7	,	,	PUNCT
dpc-2415	506	8	fransen	fransen	PROPN
dpc-2415	506	9	j	j	PROPN
dpc-2415	506	10	,	,	PUNCT
dpc-2415	506	11	et	et	PROPN
dpc-2415	506	12	al	al	PROPN
dpc-2415	506	13	.	.	PUNCT
dpc-2415	507	1	risk	risk	NOUN
dpc-2415	507	2	factors	factor	NOUN
dpc-2415	507	3	for	for	ADP
dpc-2415	507	4	surgical	surgical	ADJ
dpc-2415	507	5	site	site	NOUN
dpc-2415	507	6	infections	infection	NOUN
dpc-2415	507	7	and	and	CCONJ
dpc-2415	507	8	other	other	ADJ
dpc-2415	507	9	complications	complication	NOUN
dpc-2415	507	10	in	in	ADP
dpc-2415	507	11	elective	elective	ADJ
dpc-2415	507	12	surgery	surgery	NOUN
dpc-2415	507	13	in	in	ADP
dpc-2415	507	14	patients	patient	NOUN
dpc-2415	507	15	with	with	ADP
dpc-2415	507	16	rheumatoid	rheumatoid	NOUN
dpc-2415	507	17	arthritis	arthritis	NOUN
dpc-2415	507	18	with	with	ADP
dpc-2415	507	19	special	special	ADJ
dpc-2415	507	20	attention	attention	NOUN
dpc-2415	507	21	for	for	ADP
dpc-2415	507	22	anti	anti	ADJ
dpc-2415	507	23	-	-	ADJ
dpc-2415	507	24	tumor	tumor	ADJ
dpc-2415	507	25	necrosis	necrosis	NOUN
dpc-2415	507	26	factor	factor	NOUN
dpc-2415	507	27	:	:	PUNCT
dpc-2415	507	28	a	a	DET
dpc-2415	507	29	large	large	ADJ
dpc-2415	507	30	retrospective	retrospective	ADJ
dpc-2415	507	31	study	study	NOUN
dpc-2415	507	32	.	.	PUNCT
dpc-2415	507	33	 	 	SPACE
dpc-2415	508	1	j	j	NOUN
dpc-2415	508	2	  	  	SPACE
dpc-2415	508	3	rheumatol	rheumatol	NOUN
dpc-2415	508	4	.	.	PUNCT
dpc-2415	509	1	2007;34(4):689	2007;34(4):689	NUM
dpc-2415	509	2	-	-	PUNCT
dpc-2415	509	3	695	695	NUM
dpc-2415	509	4	.	.	PUNCT
dpc-2415	509	5	80	80	NUM
dpc-2415	509	6	.	.	PUNCT
dpc-2415	510	1	pappas	pappas	PROPN
dpc-2415	510	2	da	da	PROPN
dpc-2415	510	3	,	,	PUNCT
dpc-2415	510	4	giles	giles	PROPN
dpc-2415	510	5	jt	jt	PROPN
dpc-2415	510	6	.	.	PUNCT
dpc-2415	511	1	do	do	AUX
dpc-2415	511	2	antitumor	antitumor	PROPN
dpc-2415	511	3	necrosis	necrosis	NOUN
dpc-2415	511	4	factor	factor	NOUN
dpc-2415	511	5	agents	agent	NOUN
dpc-2415	511	6	increase	increase	VERB
dpc-2415	511	7	the	the	DET
dpc-2415	511	8	risk	risk	NOUN
dpc-2415	511	9	of	of	ADP
dpc-2415	511	10	postoperative	postoperative	ADJ
dpc-2415	511	11	orthopedic	orthopedic	ADJ
dpc-2415	511	12	infections	infection	NOUN
dpc-2415	511	13	?	?	PUNCT
dpc-2415	511	14	.	.	PUNCT
dpc-2415	511	15	  	  	SPACE
dpc-2415	512	1	curr	curr	PROPN
dpc-2415	512	2	opin	opin	NOUN
dpc-2415	512	3	rheumatol	rheumatol	NOUN
dpc-2415	512	4	.	.	PUNCT
dpc-2415	513	1	2008;20(4):450	2008;20(4):450	NUM
dpc-2415	513	2	-	-	NOUN
dpc-2415	513	3	456	456	NUM
dpc-2415	513	4	.	.	PUNCT
dpc-2415	514	1	doi:10.1097	doi:10.1097	PROPN
dpc-2415	514	2	/	/	SYM
dpc-2415	514	3	bor.0b013e32	bor.0b013e32	NOUN
dpc-2415	514	4	82fcc345	82fcc345	PROPN
dpc-2415	514	5	81	81	NUM
dpc-2415	514	6	.	.	PUNCT
dpc-2415	515	1	aragane	aragane	PROPN
dpc-2415	515	2	y	y	PROPN
dpc-2415	515	3	,	,	PUNCT
dpc-2415	515	4	riemann	riemann	PROPN
dpc-2415	515	5	h	h	PROPN
dpc-2415	515	6	,	,	PUNCT
dpc-2415	515	7	bhardwaj	bhardwaj	PROPN
dpc-2415	515	8	rs	rs	PROPN
dpc-2415	515	9	,	,	PUNCT
dpc-2415	515	10	et	et	PROPN
dpc-2415	515	11	al	al	PROPN
dpc-2415	515	12	.	.	PROPN
dpc-2415	516	1	il-12	il-12	NOUN
dpc-2415	516	2	is	be	AUX
dpc-2415	516	3	expressed	express	VERB
dpc-2415	516	4	and	and	CCONJ
dpc-2415	516	5	released	release	VERB
dpc-2415	516	6	by	by	ADP
dpc-2415	516	7	human	human	ADJ
dpc-2415	516	8	keratinocytes	keratinocyte	NOUN
dpc-2415	516	9	and	and	CCONJ
dpc-2415	516	10	epidermoid	epidermoid	VERB
dpc-2415	516	11	carcinoma	carcinoma	NOUN
dpc-2415	516	12	cell	cell	NOUN
dpc-2415	516	13	lines	line	NOUN
dpc-2415	516	14	.	.	PUNCT
dpc-2415	516	15	 	 	SPACE
dpc-2415	517	1	j	j	PROPN
dpc-2415	517	2	immunol	immunol	NOUN
dpc-2415	517	3	.	.	PUNCT
dpc-2415	518	1	1994;153(12):5366	1994;153(12):5366	PROPN
dpc-2415	518	2	-	-	SYM
dpc-2415	518	3	5372	5372	NUM
dpc-2415	518	4	.	.	PUNCT
dpc-2415	519	1	82	82	NUM
dpc-2415	519	2	.	.	PUNCT
dpc-2415	519	3	hamza	hamza	PROPN
dpc-2415	519	4	t	t	PROPN
dpc-2415	519	5	,	,	PUNCT
dpc-2415	519	6	barnett	barnett	PROPN
dpc-2415	519	7	jb	jb	PROPN
dpc-2415	519	8	,	,	PUNCT
dpc-2415	519	9	li	li	PROPN
dpc-2415	519	10	b.	b.	PROPN
dpc-2415	519	11	interleukin	interleukin	PROPN
dpc-2415	519	12	12	12	NUM
dpc-2415	519	13	a	a	DET
dpc-2415	519	14	key	key	ADJ
dpc-2415	519	15	immunoregulatory	immunoregulatory	ADJ
dpc-2415	519	16	cytokine	cytokine	NOUN
dpc-2415	519	17	in	in	ADP
dpc-2415	519	18	infection	infection	NOUN
dpc-2415	519	19	applications	application	NOUN
dpc-2415	519	20	.	.	PUNCT
dpc-2415	519	21	  	  	SPACE
dpc-2415	520	1	int	int	PROPN
dpc-2415	520	2	j	j	PROPN
dpc-2415	520	3	mol	mol	ADP
dpc-2415	520	4	sci	sci	PROPN
dpc-2415	520	5	.	.	PUNCT
dpc-2415	521	1	2010;11(3):789	2010;11(3):789	PROPN
dpc-2415	521	2	-	-	SYM
dpc-2415	521	3	806	806	NUM
dpc-2415	521	4	.	.	PUNCT
dpc-2415	522	1	published	publish	VERB
dpc-2415	522	2	2010	2010	NUM
dpc-2415	522	3	feb	feb	NOUN
dpc-2415	522	4	26	26	NUM
dpc-2415	522	5	.	.	PUNCT
dpc-2415	523	1	doi:10.3390	doi:10.3390	NOUN
dpc-2415	523	2	/ijms11030789	/ijms11030789	PROPN
dpc-2415	524	1	83	83	NUM
dpc-2415	524	2	.	.	PUNCT
dpc-2415	525	1	kanda	kanda	PROPN
dpc-2415	525	2	n	n	PROPN
dpc-2415	525	3	,	,	PUNCT
dpc-2415	525	4	watanabe	watanabe	PROPN
dpc-2415	525	5	s.	s.	PROPN
dpc-2415	525	6	il-12	il-12	NOUN
dpc-2415	525	7	,	,	PUNCT
dpc-2415	525	8	il-23	il-23	NOUN
dpc-2415	525	9	,	,	PUNCT
dpc-2415	525	10	and	and	CCONJ
dpc-2415	525	11	il-27	il-27	AUX
dpc-2415	525	12	enhance	enhance	VERB
dpc-2415	525	13	human	human	ADJ
dpc-2415	525	14	beta	beta	NOUN
dpc-2415	525	15	-	-	PUNCT
dpc-2415	525	16	defensin-2	defensin-2	NOUN
dpc-2415	525	17	production	production	NOUN
dpc-2415	525	18	in	in	ADP
dpc-2415	525	19	human	human	ADJ
dpc-2415	525	20	keratinocytes	keratinocyte	NOUN
dpc-2415	525	21	.	.	PUNCT
dpc-2415	525	22	 	 	SPACE
dpc-2415	526	1	eur	eur	PROPN
dpc-2415	526	2	j	j	PROPN
dpc-2415	526	3	immunol	immunol	NOUN
dpc-2415	526	4	.	.	PUNCT
dpc-2415	527	1	2008;38(5):1287	2008;38(5):1287	NUM
dpc-2415	527	2	-	-	SYM
dpc-2415	527	3	1296	1296	NUM
dpc-2415	527	4	.	.	PUNCT
dpc-2415	528	1	doi:10.1002	doi:10.1002	NOUN
dpc-2415	528	2	/	/	SYM
dpc-2415	528	3	eji.2007	eji.2007	PROPN
dpc-2415	528	4	38051	38051	NUM
dpc-2415	528	5	84	84	NUM
dpc-2415	528	6	.	.	PUNCT
dpc-2415	529	1	furue	furue	PROPN
dpc-2415	529	2	m	m	PROPN
dpc-2415	529	3	,	,	PUNCT
dpc-2415	529	4	furue	furue	PROPN
dpc-2415	529	5	k	k	PROPN
dpc-2415	529	6	,	,	PUNCT
dpc-2415	529	7	tsuji	tsuji	PROPN
dpc-2415	529	8	g	g	PROPN
dpc-2415	529	9	,	,	PUNCT
dpc-2415	529	10	nakahara	nakahara	ADJ
dpc-2415	529	11	t.	t.	PROPN
dpc-2415	529	12	interleukin-17a	interleukin-17a	PROPN
dpc-2415	529	13	and	and	CCONJ
dpc-2415	529	14	keratinocytes	keratinocyte	NOUN
dpc-2415	529	15	in	in	ADP
dpc-2415	529	16	psoriasis	psoriasis	NOUN
dpc-2415	529	17	.	.	PUNCT
dpc-2415	529	18	  	  	SPACE
dpc-2415	530	1	int	int	PROPN
dpc-2415	530	2	j	j	PROPN
dpc-2415	530	3	mol	mol	ADP
dpc-2415	530	4	sci	sci	PROPN
dpc-2415	530	5	.	.	PUNCT
dpc-2415	531	1	2020;21(4):1275	2020;21(4):1275	NUM
dpc-2415	531	2	.	.	PUNCT
dpc-2415	532	1	published	publish	VERB
dpc-2415	532	2	2020	2020	NUM
dpc-2415	532	3	feb	feb	PROPN
dpc-2415	532	4	13	13	NUM
dpc-2415	532	5	.	.	PUNCT
dpc-2415	533	1	doi:10.3390	doi:10.3390	PROPN
dpc-2415	533	2	/	/	SYM
dpc-2415	533	3	ijms21041275	ijms21041275	PROPN
dpc-2415	533	4	85	85	NUM
dpc-2415	533	5	.	.	PUNCT
dpc-2415	534	1	pappu	pappu	PROPN
dpc-2415	534	2	r	r	PROPN
dpc-2415	534	3	,	,	PUNCT
dpc-2415	534	4	ramirez	ramirez	NOUN
dpc-2415	534	5	-	-	PUNCT
dpc-2415	534	6	carrozzi	carrozzi	PROPN
dpc-2415	534	7	v	v	NOUN
dpc-2415	534	8	,	,	PUNCT
dpc-2415	534	9	sambandam	sambandam	NOUN
dpc-2415	534	10	a.	a.	NOUN
dpc-2415	534	11	the	the	DET
dpc-2415	534	12	interleukin-17	interleukin-17	PROPN
dpc-2415	534	13	cytokine	cytokine	ADJ
dpc-2415	534	14	family	family	NOUN
dpc-2415	534	15	:	:	PUNCT
dpc-2415	534	16	critical	critical	ADJ
dpc-2415	534	17	players	player	NOUN
dpc-2415	534	18	in	in	ADP
dpc-2415	534	19	host	host	NOUN
dpc-2415	534	20	defence	defence	NOUN
dpc-2415	534	21	and	and	CCONJ
dpc-2415	534	22	inflammatory	inflammatory	ADJ
dpc-2415	534	23	diseases	disease	NOUN
dpc-2415	534	24	.	.	PUNCT
dpc-2415	534	25	  	  	SPACE
dpc-2415	534	26	immunology	immunology	NOUN
dpc-2415	534	27	.	.	PUNCT
dpc-2415	535	1	2011;134(1):8	2011;134(1):8	PROPN
dpc-2415	535	2	-	-	SYM
dpc-2415	535	3	16	16	NUM
dpc-2415	535	4	.	.	PUNCT
dpc-2415	536	1	doi:10.1111	doi:10.1111	ADJ
dpc-2415	536	2	/	/	SYM
dpc-2415	536	3	j.1365	j.1365	NOUN
dpc-2415	536	4	-	-	PUNCT
dpc-2415	536	5	2567.2011.03465.x	2567.2011.03465.x	NUM
dpc-2415	536	6	86	86	NUM
dpc-2415	536	7	.	.	PUNCT
dpc-2415	537	1	kusagaya	kusagaya	PROPN
dpc-2415	537	2	h	h	PROPN
dpc-2415	537	3	,	,	PUNCT
dpc-2415	537	4	fujisawa	fujisawa	PROPN
dpc-2415	537	5	t	t	PROPN
dpc-2415	537	6	,	,	PUNCT
dpc-2415	537	7	yamanaka	yamanaka	PROPN
dpc-2415	537	8	k	k	PROPN
dpc-2415	537	9	,	,	PUNCT
dpc-2415	537	10	et	et	PROPN
dpc-2415	537	11	al	al	PROPN
dpc-2415	537	12	.	.	PUNCT
dpc-2415	537	13	toll	toll	NOUN
dpc-2415	537	14	-	-	PUNCT
dpc-2415	537	15	like	like	ADJ
dpc-2415	537	16	receptor	receptor	NOUN
dpc-2415	537	17	-	-	PUNCT
dpc-2415	537	18	mediated	mediate	VERB
dpc-2415	537	19	airway	airway	NOUN
dpc-2415	537	20	il-17c	il-17c	NOUN
dpc-2415	537	21	enhances	enhance	VERB
dpc-2415	537	22	epithelial	epithelial	ADJ
dpc-2415	537	23	host	host	NOUN
dpc-2415	537	24	defense	defense	NOUN
dpc-2415	537	25	in	in	ADP
dpc-2415	537	26	an	an	DET
dpc-2415	537	27	autocrine	autocrine	NOUN
dpc-2415	537	28	/	/	SYM
dpc-2415	537	29	paracrine	paracrine	NOUN
dpc-2415	537	30	manner	manner	NOUN
dpc-2415	537	31	.	.	PUNCT
dpc-2415	537	32	 	 	SPACE
dpc-2415	538	1	am	be	AUX
dpc-2415	538	2	j	j	PROPN
dpc-2415	538	3	respir	respir	NOUN
dpc-2415	538	4	cell	cell	NOUN
dpc-2415	538	5	mol	mol	ADP
dpc-2415	538	6	biol	biol	PROPN
dpc-2415	538	7	.	.	PUNCT
dpc-2415	539	1	2014;50(1):30	2014;50(1):30	NUM
dpc-2415	539	2	-	-	SYM
dpc-2415	539	3	39	39	NUM
dpc-2415	539	4	.	.	PUNCT
dpc-2415	540	1	doi:10.1165	doi:10.1165	NOUN
dpc-2415	540	2	/	/	SYM
dpc-2415	540	3	rcmb.2013	rcmb.2013	NOUN
dpc-2415	540	4	-	-	PUNCT
dpc-2415	540	5	0130oc	0130oc	ADJ
dpc-2415	540	6	87	87	NUM
dpc-2415	540	7	.	.	PUNCT
dpc-2415	541	1	ramirez	ramirez	NOUN
dpc-2415	541	2	-	-	PUNCT
dpc-2415	541	3	carrozzi	carrozzi	PROPN
dpc-2415	541	4	v	v	NOUN
dpc-2415	541	5	,	,	PUNCT
dpc-2415	541	6	sambandam	sambandam	NOUN
dpc-2415	541	7	a	a	PRON
dpc-2415	541	8	,	,	PUNCT
dpc-2415	541	9	luis	luis	PROPN
dpc-2415	541	10	e	e	PROPN
dpc-2415	541	11	,	,	PUNCT
dpc-2415	541	12	et	et	PROPN
dpc-2415	541	13	al	al	PROPN
dpc-2415	541	14	.	.	PROPN
dpc-2415	541	15	il-17c	il-17c	PROPN
dpc-2415	541	16	regulates	regulate	VERB
dpc-2415	541	17	the	the	DET
dpc-2415	541	18	innate	innate	ADJ
dpc-2415	541	19	immune	immune	ADJ
dpc-2415	541	20	function	function	NOUN
dpc-2415	541	21	of	of	ADP
dpc-2415	541	22	epithelial	epithelial	ADJ
dpc-2415	541	23	cells	cell	NOUN
dpc-2415	541	24	in	in	ADP
dpc-2415	541	25	an	an	DET
dpc-2415	541	26	autocrine	autocrine	NOUN
dpc-2415	541	27	manner	manner	NOUN
dpc-2415	541	28	.	.	PUNCT
dpc-2415	541	29	 	 	SPACE
dpc-2415	542	1	nat	nat	PROPN
dpc-2415	542	2	immunol	immunol	NOUN
dpc-2415	542	3	.	.	PUNCT
dpc-2415	543	1	2011;12(12):1159	2011;12(12):1159	NUM
dpc-2415	543	2	-	-	SYM
dpc-2415	543	3	1166	1166	NUM
dpc-2415	543	4	.	.	PUNCT
dpc-2415	544	1	published	publish	VERB
dpc-2415	544	2	2011	2011	NUM
dpc-2415	544	3	oct	oct	NOUN
dpc-2415	544	4	12	12	NUM
dpc-2415	544	5	.	.	PUNCT
dpc-2415	545	1	doi:10.1038	doi:10.1038	PROPN
dpc-2415	545	2	/	/	SYM
dpc-2415	545	3	ni.2156	ni.2156	PROPN
dpc-2415	545	4	88	88	NUM
dpc-2415	545	5	.	.	PUNCT
dpc-2415	546	1	xu	xu	PROPN
dpc-2415	546	2	m	m	PROPN
dpc-2415	546	3	,	,	PUNCT
dpc-2415	546	4	lu	lu	PROPN
dpc-2415	546	5	h	h	PROPN
dpc-2415	546	6	,	,	PUNCT
dpc-2415	546	7	lee	lee	PROPN
dpc-2415	546	8	yh	yh	PROPN
dpc-2415	546	9	,	,	PUNCT
dpc-2415	546	10	et	et	PROPN
dpc-2415	546	11	al	al	PROPN
dpc-2415	546	12	.	.	PUNCT
dpc-2415	547	1	an	an	DET
dpc-2415	547	2	interleukin-25	interleukin-25	PROPN
dpc-2415	547	3	-	-	PUNCT
dpc-2415	547	4	mediated	mediate	VERB
dpc-2415	547	5	autoregulatory	autoregulatory	ADJ
dpc-2415	547	6	circuit	circuit	NOUN
dpc-2415	547	7	in	in	ADP
dpc-2415	547	8	keratinocytes	keratinocyte	NOUN
dpc-2415	547	9	plays	play	VERB
dpc-2415	547	10	a	a	DET
dpc-2415	547	11	pivotal	pivotal	ADJ
dpc-2415	547	12	role	role	NOUN
dpc-2415	547	13	in	in	ADP
dpc-2415	547	14	psoriatic	psoriatic	ADJ
dpc-2415	547	15	skin	skin	NOUN
dpc-2415	547	16	inflammation	inflammation	NOUN
dpc-2415	547	17	.	.	PUNCT
dpc-2415	547	18	 	 	SPACE
dpc-2415	548	1	immunity	immunity	NOUN
dpc-2415	548	2	.	.	PUNCT
dpc-2415	549	1	2018;48(4):787	2018;48(4):787	NUM
dpc-2415	549	2	-	-	PUNCT
dpc-2415	549	3	798.e4	798.e4	NUM
dpc-2415	549	4	.	.	PUNCT
dpc-2415	550	1	doi:10.1016	doi:10.1016	PROPN
dpc-2415	550	2	/	/	SYM
dpc-2415	550	3	j.immuni.2018.03.019	j.immuni.2018.03.019	PROPN